Annexure-1 Patents Granted for Drugs (Products and ... · 4028/delnp/2009 27‐04‐2016 “process...
Transcript of Annexure-1 Patents Granted for Drugs (Products and ... · 4028/delnp/2009 27‐04‐2016 “process...
Application_number Patent_date_Of_G
rant
TITLE_OF_INVENTION PATENT_NUMBER
1432/MUMNP/2010 01‐04‐2016 A METHOD OF ADAPTING THE PROCEDURE FOR EPICUTANEOUS
DESENSITIZATION
272455
1844/KOLNP/2008 01‐04‐2016 [4‐(6‐HALO‐7‐SUBSTITUTED ‐2,4‐DIOXO‐1,4‐DIHYDRO‐2H‐
QUINAZOLIN‐3‐YL)‐PHENYL]‐5‐CHLORO‐THIOPHEN‐2‐YL‐
SULFONYLUREAS AND FORMS AND METHODS RELATED THERETO
272457
2284/CHE/2007 05‐04‐2016 STILBENE BASED COMPOUNDS AS HDAC INHIBITORS 272490
306/DELNP/2009 05‐04‐2016 "A COMPOSITION FOR ENHANCING EXECUTIVE COGNITIVE
FUNCTION IN A HEALTHY HUMAN SUBJECT"
272500
3512/KOLNP/2008 05‐04‐2016 BIFUNCTIONAL HISTONE DEACETYLASE INHIBITORS 272514
3451/DELNP/2006 07‐04‐2016 "VINFLUNINE PHARMACEUTICAL COMPOSITION AND PROCESS FOR
PREPARING THE SAME."
273980
2481/MUM/2008 10‐04‐2016 PREPARATION OF PHENYLACETIC ACID DERIVATIVE 276185
2019/MUM/2008 12‐04‐2016 STABLE ORAL ATORVASTATIN FORMULATION AND PROCESS OF ITS
PREPARATION
272594
4334/DELNP/2008 12‐04‐2016 “A LENTIVIRAL VECTOR‐BASED VACCINE” 272595
118/DELNP/2009 12‐04‐2016 “STABLE LAQUINIMOD PREPARATIONS” 272596
4129/KOLNP/2009 12‐04‐2016 RECONSTITUTED SURFACTANTS HAVING IMPROVED PROPERTIES 272602
2218/CHE/2007 13/04/2016 CARBON NANOSPHERE‐N‐(4‐CHLORO‐3‐TRIFLUOROMETHYL‐
PHENYL)‐2‐ETHOXY‐6‐PENTADECYLBENZAMIDE COMPOSITION AND
A PROCESS THEREOF
272637
1876/KOLNP/2010 13‐04‐2016 COMPOSITIONS AND METHODS FOR TREATING DISEASES OF THE
NAIL
272623
3140/CHENP/2006 13‐04‐2016 PHARMACEUTICAL COMPOSITIONS COMPRISING IBOPAMINE
MALEATE AND PROCESS FOR PREPARING THE SAME
272638
1106/MUM/2010 18‐04‐2016 CINAMIC COMPOUNDS AND DERIVATIVES THEREFROM FOR THE
INHIBITION OF HISTONE DEACETYLASE
272653
3893/KOLNP/2007 18‐04‐2016 A METHOD FOR PRODUCING AN EXTRACT OF GINKGO BILOBA
HAVING A REDUCED CONTENT OF 4'‐O‐METHYL PYRIDOXINE AND
BIFLAVONES
272655
2754/DELNP/2009 18‐04‐2016 "A METHOD OF MAKING STANNSOPORFIN AND STANNSOPORFIN
SO PRODUCED"
272659
679/DELNP/2009 19‐04‐2016 "PHARMACEUTICAL COMPOSITIONS 457" 272674
266/MUM/2011 19‐04‐2016 LIPOPOLYMERIC NANOCAPSULES FOR DELIVERING HYDROPHOBIC
DRUGS
272675
131/MUM/2006 19‐04‐2016 NOVEL 11β‐HYDROXYANDROSTA‐4‐ENE‐3‐ONES 272676
52/MUMNP/2011 20‐04‐2016 “A NATURAL ALLICIN TABLET AND PREPARATION METHOD
THEREOF”
272692
478/DELNP/2011 22/04/2016 "THE USE OF WNT5‐A PEPTIDE DERIVATES FOR THE TREATMENT OF
MELANOMA AND GASTRIC CANCER"
272745
1352/MUM/2006 25‐04‐2016 ANTIMICROBIAL DERIVATIVES OF ANACARDIC ACID AND PROCESS
FOR PREPARING THE SAME
272748
358/MUMNP/2009 25‐04‐2016 “MODIFIED ERYTHROPOIETIN” 272749
2190/MUM/2011 26‐04‐2016 "A NANOCOCHLEATE ‐NANOSPHERE COMPLEX" 272767
212/MUM/2010 26‐04‐2016 COMPLEXED ANTIBODY‐SUBSTRATE NANO‐PARTICULATES FOR
BINDING OF CHROMATIN FRAGMENTS
272769
523/MUM/2007 26‐04‐2016 A METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION
COMPRISING FLUCONAZOLE
272779
146/MUM/2012 26‐04‐2016 TRANSNASAL MICROEMULSION OF AN ANTISPASTIC AGENT 272781
518/KOLNP/2009 27‐04‐2016 METHODS OF SYNTHESIS AND/OR PURIFICATION OF
DIAMINOPHENOTHIAZINIUM COMPOUNDS
272791
1664/KOLNP/2007 27‐04‐2016 AN OPHTHALMIC OIL‐IN‐WATER EMULSION 272797
1113/MUM/2008 27‐04‐2016 COMBINED MEASLES‐HUMAN PAPILLOMA VACCINE FOR
THERAPEUTIC AND PROPHYLACTIC USE
272803
ANNEXURE‐1‐ Patents Granted for Drugs/Medicines (Products and Processes) related to fields of Chemicals and
Biotechnology during last 3 years and current year .
Page 1 of 85
4028/DELNP/2009 27‐04‐2016 “PROCESS FOR MANUFACTURING OPHTHALMIC OIL‐IN‐WATER
EMULSIONS”
272807
2078/MUM/2007 28/04/2016 STABLE PHARMACEUTICAL COMPOSITIONS OF CALCITRIOL AND
MINERAL SUPPLEMENTS
272821
2728/KOLNP/2007 28‐04‐2016 A PROCESS FOR THE PRODUCTION OF A TABLET 272820
212/DELNP/2011 03‐05‐2016 "MULTIPHASE PERSONAL CARE COMPOSITION WITH ENHANCED
DEPOSITION"
272918
8751/DELNP/2007 04‐05‐2016 "A HOMOGENEOUS PHARMACEUTICAL COMPOSITION FOR
TREATING INFLAMMATORY DISORDER"
272946
3849/CHENP/2008 06‐05‐2016 A READY TO DRINK LIQUID FOR ALZHEIMER PATIENTS 272979
1992/DEL/2008 06‐05‐2016 "1,2,4,5‐TETRAHYDRO‐3H‐BENZAZEPINE COMPOUNDS, A PROCESS
FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM"
272987
2271/KOLNP/2009 09‐05‐2016 HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF
DIABETES AND METABOLIC DISORDERS
272993
2707/DELNP/2007 11‐05‐2016 "COMBINATIONS OF NICOTINIC ACETYLCHOLINE ALPHA 7
RECEPTOR AGONISTS"
273041
1919/CHENP/2008 12‐05‐2016 PHYSICALLY AND CHEMICALLY STABLE, WATER‐SOLUBLE,
AMPHIPHILIC POLYMER‐PDGF COMPLEX AND A METHOD THEREOF
273059
4187/KOLNP/2008 16‐05‐2016 ANTIFUNGAL AGENTS 273093
7490/DELNP/2006 18‐05‐2016 "PHARMACEUTICAL COMPOSITIONS FOR DRUG DELIVERY" 273120
1702/MUM/2009 19‐05‐2016 WATER‐BASED ANTI‐LICE PHARMACEUTICAL COMPOSITIONS AND
THE PROCESS FOR PREPARING THE SAME
273136
1945/MUMNP/2007 23‐05‐2016 A COMPOSITION FREE FROM PRESERVING AGENT AND PARTICLES 273167
2067/KOLNP/2008 24‐05‐2016 AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS 273186
741/MUMNP/2008 25‐05‐2016 A COMPOSITION THAT COMPRISES DISACCHARIDE 273212
573/DELNP/2009 26/05/2016 "N‐TERMINAL DERIVATISATION OF PROTEINS WITH
POLYSACCHARIDES"
273231
2318/DELNP/2009 27‐05‐2016 "AN IpaD POLYPEPTIDE AND KIT THEREOF" 273263
4515/DELNP/2009 30/05/2016 POLYPEPTIDE FILMS AND METHODS 273297
7300/DELNP/2007 31‐05‐2016 "VACCINE" 273328
369/CHE/2010 31‐05‐2016 A THIN FILM DRUG DELIVERY SYSTEM AND A PROCESS FOR MAKING
THE SAME
273337
2501/DELNP/2010 31‐05‐2016 "HYDROXYAPATITE‐TARGETING MULTIARM POLYMERS AND
CONJUGATES MADE THEREFROM"
273340
1170/MUMNP/2010 03‐06‐2016 PERSONAL CARE COMPOSITION 273405
1707/KOLNP/2008 07‐06‐2016 METHOD FOR PREPARING A FAXTOR IX FORMULATION 273436
4563/DELNP/2009 08‐06‐2016 "A linear cyclodextrin containing polymer conjugate " 273456
2025/MUMNP/2010 09‐06‐2016 PROCESS FOR THE PREPARATION OF DONEPEZIL HYDROCHLORIDE 273476
477/MUMNP/2009 09‐06‐2016 COMPOSITION FOR PROMOTING ACTIVITY OF ANTI‐CANCER
THERAPIES
273477
2051/MUMNP/2008 12‐06‐2016 SKIN LIGHTENING AGENTS, COMPOSITIONS AND METHODS 277929
37/MUMNP/2010 14‐06‐2016 PIPERIDINE/PIPERAZINE DERIVATIVES 273531
5131/DELNP/2009 15‐06‐2016 "PHARMACEUTICAL COMPOSITION FOR TREATING INFLUENZA
VIRUS INFECTION"
273554
1994/CHE/2006 15‐06‐2016 AN IMPROVED PROCESS FOR PREPARING ROSUVASTATIN CALCIUM 273564
2266/DEL/2009 16‐06‐2016 "USE OF IVABRADINE AS DIAGNOSTIC AGENT IN THE METHOD OF
CORONARY ANGIOGRAPHY BY MULTISLICE COMPUTED
TOMOGRAPHY"
273579
7760/DELNP/2009 17‐06‐2016 "Valproate, dicloroacetate and alkyl phosphate esters of honokiol
and their use in the treating cancers"
273597
690/MUM/2008 20‐06‐2016 FORMULTION CONTAINING ANTIARRHYTHMIC DRUG 273623
1780/KOLNP/2009 21‐06‐2016 DICLOFENAC GEL 273641
692/MUM/2008 21‐06‐2016 ENTERIC COATED COMPOSITION OF PANTOPRAZOLE 273642
Page 2 of 85
2714/MUMNP/2008 21‐06‐2016 A BIOADHESIVE CONTROLLED RELEASE MONOLITHIC TABLET FOR
THE TREATMENT OF FEMALE GENITAL DISORDERS
273646
68/DELNP/2008 22‐06‐2016 PROCESS FOR SYNTHESIZING A CETP INHIBITOR. 273675
1008/CHE/2005 24‐06‐2016 NEW IMPROVED GEL FORMULATION 273717
3327/CHENP/2008 24‐06‐2016 RECOMBINANT MONOVALENT ANTIBODIES AND METHODS FOR
PRODUCTION THEREOF
273720
1327/MUM/2005 27‐06‐2016 IMPROVED COMPOSITIONS FOR CANCER THERAPY 273763
3052/DELNP/2008 28‐06‐2016 "INTERLEUKIN‐13 ANTIBODY COMPOSITION" 273776
10732/DELNP/2008 29‐06‐2016 FIBER‐REINFORCED COMPOSITES AND METHOD FOR THE
MANUFACTURE THEREOF
273818
8968/DELNP/2007 29‐06‐2016 "LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL" 273815
1074/KOL/2008 30‐06‐2016 A METHOD FOR PREPARING A PHARMACEUTICAL COMPOSITION
FOR TREATMENT OF PSORIASIS
273880
4529/DELNP/2007 30‐06‐2016 "A METHOD FOR STABILIZING DONEPEZIL OR A PHARMACEUTICAL
SALT THEREOF"
273889
4148/CHENP/2008 01‐07‐2016 COMPOSITION, PROCESS FOR PREPARATION AND METHOD OF USE 273958
1810/DELNP/2008 04‐07‐2016 "An aqueous, stable, sterile argatroban composition" 273991
3739/CHENP/2009 10‐07‐2016 “AN HBV VACCINE AND A PROCESS OF PREPARING THE SAME” 276267
911/CHENP/2008 11‐07‐2016 PHOSPHONATED RIFAMYCINS 274081
4652/DELNP/2007 11‐07‐2016 'COMPOSITIONS COMPRISING ORNITHINE AND PHENYLACETATE OR
PHENYLBUTYRATE FOR TREATING HEPATIC ENCEPHALOPATHY'
274090
481/MUM/2010 11‐07‐2016 "AN IMPROVED PROCESS FOR THE PREPARATION OF HMG‐COA
REDUCTASE INHIBITORS VIA CHIRAL DIOL SULFONES
INTERMEDIATES"
274096
265/KOLNP/2010 12‐07‐2016 PROCESS FOR THE PREPARATION OF CONTROLLED‐RELEASE SOLID
FORMULATIONS CONTAINING OXCARBAZEPINE, AND
FORMULATIONS OBTAINABLE BY SAID PROCESS
274107
429/MUMNP/2010 12‐07‐2016 POLYPEPTIDE, MATRIX AND METHOD OF INDUCING EX VIVO TISSUE
FORMATION
274118
718/MUMNP/2010 12‐07‐2016 COMPLEX COMPRISING SOLUBLE FRAGMENT OF INFLUENZA VIRUS
PB2 PROTEIN CAPABLE OF BINDING RNA‐CAP
274124
3420/DELNP/2008 13‐07‐2016 METHOD OF INHIBITING THE PROLIFERATION AND MIGRATION OF
HELICOBACTER PYLORI
274146
1196/DEL/2010 14‐07‐2016 SALBUTAMOL PATCH AND A PROCESS OF PREPARATION THEREOF 274160
7665/DELNP/2009 14‐07‐2016 "BENEFIT AGENT CONTAINING DELIVERY PARTICLE" 274161
6760/DELNP/2007 14‐07‐2016 "PHARMACEUTICAL FORMS WITH IMPROVED PHARMACOKINETIC
PROPERTIES"
274179
4366/CHENP/2008 14‐07‐2016 PHARMACEUTICAL COMPOSITION AND A SOFT GELATIN CAPSULE
FORMULATION COMPRISING A BI‐CYCLIC COMPOUND
274184
1902/DELNP/2008 15‐07‐2016 "POLYSACCHARIDE VACCINE FOR STAPHYLOCOCCAL INFECTIONS" 274200
1295/KOLNP/2009 15‐07‐2016 METHODS OF SYNTHESIZING PHARMACEUTICAL SALTS OF A
FACTOR XA INHIBITOR
274223
1951/DELNP/2009 15‐07‐2016 "VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT" 274225
5462/DELNP/2007 15‐07‐2016 "ANTITUMOR AGENT" 274234
1610/MUMNP/2009 19‐07‐2016 A PROCESS OF PREPARING CRYSTALLINE POLYMORPHIC FORMS OF
COUMPOUND I
274275
140/MUM/2009 21‐07‐2016 CONTROLLED RELEASE CHRONOTHERAPEUTIC PHARMACEUTICAL
COMPOSITION
274321
255/CHE/2006 22‐07‐2016 AN IMPROVED PROCESS FOR THE PREPARATION OF DONEPEZIL
HYDROCHLORIDE
274375
1367/CHENP/2008 22‐07‐2016 COMPOSITIONS FOR STIMULATING NEUROGENESIS AND
INHIBITING NEURONAL DEGENERATION
274385
64/MUM/2010 22‐07‐2016 PROCESSES FOR THE PREPARATION OF ENTACAPONE POLYMORPHS 274386
6040/DELNP/2007 23‐07‐2016 "A GLYCERIN‐FREE DEXIBUPROPEN COMPOSITION AND A METHOD
THEREOF"
274402
Page 3 of 85
36/MUMNP/2010 25‐07‐2016 PIPERIDINE/PIPERAZINE DERIVATIVES 274409
1937/MUMNP/2008 25‐07‐2016 CRUSH‐RESISTANT OXYCODONE TABLETS INTENDED FOR
PREVENTING ACCIDENTAL, MISUSE AND UNLAWFUL DIVERSION
274418
2612/DEL/2013 25‐07‐2016 "A PROCESS FOR PREPARATION OF NON‐LIQUID CHEWABLE
PARTICULATE MOUTH COOLANT"
274429
2500/DEL/2013 25‐07‐2016 "A PROCESS FOR PREPARATION OF SLOW RELEASE CHEWABLE
BREATH FRESHENER COMPOSITION"
274438
2032/CHE/2007 26‐07‐2016 SKIN CARE / LIGHTENING AGENT BASED ON PROTOCATECHUIC ACID
DERIVATIVES AND COMPOSITIONS THEREOF
274460
1221/MUMNP/2009 27‐07‐2016 ANTIBACTERIAL QUINOLINE DERIVATIVES 274511
1068/MUMNP/2009 29‐07‐2016 ACYLAMINOPYRAZOLES AS FGFR INHIBITORS 274580
6016/DELNP/2009 29‐07‐2016 "A CONJUGATE OF INSULIN AND VITAMIN B12 FOR ORAL DELIVERY" 274582
2360/DELNP/2008 29‐07‐2016 "COMPOSITION BASED ON MINERAL CONCENTRATES DERIVED FOR
PRECIOUS STONES"
274602
635/DELNP/2008 29‐07‐2016 "SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS FOR
HIGHLY WATER SOLUBLE DRUGS"
274605
545/DEL/2009 30‐07‐2016 "ATTRACTANT COMPOSITION FOR BED BUGS 274635
1247/KOLNP/2009 02‐08‐2016 PROBIOTIC ORAL DOSAGE FORMS 274654
2193/KOLNP/2009 02‐08‐2016 A PROCESS FOR PREPARATION OF A SUSTAINED‐RELEASE
COMPOSITION OF A MICROCAPSULE
274669
322/KOLNP/2011 02‐08‐2016 PURINE DERIVATIVES FOR USE IN THE TREATMENT OF ALLERGIC,
INFLAMMATORY AND INFECTIOUS DISEASES
274674
6015/CHENP/2009 05‐08‐2016 PROCESS FOR MAKING GALANTAMINE 274735
2558/MUMNP/2010 05‐08‐2016 A POLYMERIC CONJUGATE , 274737
4853/DELNP/2009 08‐08‐2016 "VEGETARIAN MICROCAPSULES" 274755
1753/MUMNP/2010 08‐08‐2016 CATIONIC COPOLYMERS FORMULATED WITH PIGMENTED
COSMETIC COMPOSITIONS EXHIBITING RADIANCE WITH SOFT
FOCUS
274758
2457/CHENP/2009 08‐08‐2016 CANINE LYME DISEASE VACCINE 274768
3297/CHENP/2006 09‐08‐2016 A SUBSTITUTED MORPHOLINE COMPOUND 274781
510/CHENP/2009 09‐08‐2016 POLYMERIZABLE DENTAL MATERIAL 274786
1756/MUM/2009 10‐08‐2016 AN AQUEOUS COMPOSITION SUITABLE FOR INTRANASAL DRUG
DELIVERY
274812
5149/DELNP/2010 11‐08‐2016 "METHOD FOR THE PRODUCTION OF PELLETS FOR AN ACTIVE
SUBSTANCE
AND PHARMACEUTICAL FORMULATION"
274840
2443/MUMNP/2011 11‐08‐2016 PARTICULATE MATERIAL FOR CONTROLLED RELEASE OF ACTIVE
INGREDIENTS
274843
2360/CHE/2006 11‐08‐2016 XENO‐FREE AND FEEDER FREE CULTURE CONDITIONS FOR HUMAN
EMBRYONIC STEM CELLS AND METHODS THEREOF
274858
1266/CHENP/2010 11‐08‐2016 HIGH AFFINITY HUMAN ANTIBODIES TO HUMAN NERVE GROWTH
FACTOR
274868
937/DELNP/2009 11‐08‐2016 "TRIAZINE DERIVATIVES AS SODIUM CHANNEL BLOCKERS AND
ANTIFOLATES"
274872
3588/DELNP/2011 11‐08‐2016 "NOVEL METHOD FOR PREPARING GRANULATES OF ACTIVE
PRINCIPLES, AND GRANULATES OBTAINED THEREOF"
274880
656/DEL/2009 11‐08‐2016 "MULTIPLE ACTION SUSTAINED RELEASE HYBRID CONJUGATE" 274883
2713/MUM/2009 16/08/2016 TOPICAL MEDICINAL FORMULATION 274950
2049/MUMNP/2010 16‐08‐2016 HIGH INTERNAL PHASE WATER‐IN‐OIL EMULSION COMPOSITION 274961
923/CHE/2006 16‐08‐2016 "3‐(HETEROCYCLYL)‐N‐(ARYLSULFONYL)INDOLE DERIVATIVES AS
FUNCTIONAL 5‐HT6 LIGANDS"
274974
942/MUM/2008 17‐08‐2016 A PROCESS OF PREPARING FREE FLOWING POLYACRYLIC ACID
GRANULES
274978
7313/CHENP/2010 17‐08‐2016 RECOMBINANT CHIMERIC ANTIGENS FOR DIAGNOSIS OF SCRUB
TYPHUS
274995
Page 4 of 85
3272/CHENP/2008 18‐08‐2016 A NUCLEAR RECEPTOR BINDING AGENT 3‐FLUORO‐N‐(4‐
FLUOROPHENYL)‐4‐HYDROXY‐N‐(4‐HYDROXYPHENYL)BENZAMIDE
275013
4630/DELNP/2009 22‐08‐2016 "LIPOSOMAL PHARMACEUTICAL PREPARATION AND METHOD FOR
MANUFACTURING THE SAME"
275058
3305/CHE/2008 22‐08‐2016 CONTROLLED RELEASE FORMULATIONS OF ANTI‐TUBERCULAR
DRUGS USING DIFFERENT BIODEGRADABLE NATURAL POLYMERS
275061
423/KOLNP/2006 22‐08‐2016 RAPIDLY DISINTEGRATING TASTE‐MASKED TABLET 275079
2499/DEL/2013 22‐08‐2016 "A PROCESS FOR PREPARATION OF A DENTAL HEALTH
COMPOSITION"
275091
3311/DELNP/2007 24/08/2016 "TRANSDERMAL DELIVERY SYSTEMS FOR EXTENDED RELEASE OF
SUFENTANIL"
275134
799/KOLNP/2010 26‐08‐2016 PHARMACEUTICAL COMPOSITIONS CONTAINING DOPAMINE
RECEPTOR LIGANDS AND METHODS OF TREATMENT USING
DOPAMINE RECEPTOR LIGANDS
275181
7988/DELNP/2006 26‐08‐2016 "PHOSPHOLIPID GEL COMPOSITIONS FOR DRUG DELIVERY AND
METHODS OF TREATING CONDITIONS USING SAME"
275182
3156/DELNP/2008 26‐08‐2016 TRIAZOLE DERIVATIVES AS INHIBITORS OF 11‐BETA‐
HYDROXYSTEROID DEHYDROGENASE‐1
275190
3916/CHENP/2007 26‐08‐2016 CHEMICALLY DEFINED VACCINE STABILIZER 275195
7133/DELNP/2008 26‐08‐2016 "MICROSPHERES COMPRISING NANOCAPSULES CONTAINING A
LIPOPHILIC DRUG"
275196
1875/KOLNP/2010 29‐08‐2016 NANOEMULSIONS 275218
6172/DELNP/2008 29‐08‐2016 "MATERIAL" 275230
3451/KOLNP/2010 30‐08‐2016 PYRROLIDINE DERIVATIVES 275254
5249/DELNP/2009 30‐08‐2016 WOUND DRESSING WITH A BACTERIAL ADSORBING COMPOSITION
AND MOISTURE HOLDING SYSTEM
275256
2598/DEL/2008 30‐08‐2016 QUINAZOLINONE LINKED PYRROLO[2,1‐C][1,4]BENZODIAZEPINE
HYBRIDS AS POTENTIAL ANTICANCER AGENTS AND PROCESS FOR
THE PREPARATION THEREOF
275269
41/MUMNP/2011 30‐08‐2016 LIQUID CLEANSING COMPOSITIONS COMPRISING MICROFIBROUS
CELLULOSE SUSPENDING POLYMERS
275270
2701/DEL/2011 31/08/2016 HERBAL LEECH REPELLANT SPRAY FORMULATION AND A PROCESS
FOR PREPARATION THEREOF
275383
2239/DELNP/2008 31‐08‐2016 "COMPOSITION COMPRISING AT LEAST ONE NAPHTHOIC ACID
DERIVATIVE AND AT LEAST ONE COMPOUND OF POLYURETHANE
POLYMER TYPE OR DERIVATIVES THEREOF, PREPARATION
PROCESSES THEREFOR AND USES THEREOF"
275336
2589/KOLNP/2009 31‐08‐2016 MAPK/ERK KINASE INHIBITORS 275359
4133/DELNP/2008 31‐08‐2016 "FUNCTIONAL INFLUENZA VIRUS LIKE PARTICLES (VLPS)" 275385
7579/DELNP/2008 05‐09‐2016 "Mono‐substituted furanyl‐ or thiopheneyl‐n‐oxysulfonamides
compound of formula(Vx)”
275455
6840/DELNP/2008 06‐09‐2016 "ANTI‐INFECTIVE SOLUTION COMPRISING A COMPOUND OF
PYRIDO (3,2,1‐IJ)‐BENZOXADIAZINE TYPE"
275471
2632/DELNP/2012 07‐09‐2016 "HEPARANASE ACTIVITY INHIBITOR" 275486
4048/CHENP/2008 08‐09‐2016 PHARMACEUTICAL COMPOSITIONS COMPRISING MIXTURES OF
POLYMERS AND ACTIVE INGREDIENTS SPARINGLY SOLUBLE IN
WATER
274779
2763/MUM/2010 08‐09‐2016 "NOVEL CIPROFLOXACIN OTIC SOLUTIONS" 274795
2427/CHENP/2008 09‐09‐2016 FLUORESCENT NANOPARTICLES 275540
1479/MUM/2009 12‐09‐2016 A PROCESS FOR SYNTHESIS OF DIARYLPYRIMIDINE NON‐
NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR
275560
2508/KOLNP/2006 12‐09‐2016 COMBINED MEDICAMENT COMPRISING A VECTOR OF AN ISOLATED
POLYNUCLEOTIDE, ENCODING AN ENZYME THAT CONVERTS A
PRODRUG INTO AN ACTIVE CYTOTOXIC COMPOUND
275575
3914/DELNP/2011 13‐09‐2016 "PERFUME SYSTEMS" 275594
6986/DELNP/2006 14‐09‐2016 "A COATED TABLET COMPRISING A TABLET CORE" 275601
1855/MUMNP/2008 15‐09‐2016 DUAL PHASE ABRASIVE TOOTHPASTE COMPOSITION 275618
Page 5 of 85
690/KOL/2008 15‐09‐2016 A BASIS PARTICLE AND A METHOD FOR MANUFACTURING THE
SAME.
275630
696/DEL/2008 15‐09‐2016 A METHOD FOR THE PREPARATION OF FENTANYL 275640
6594/CHENP/2008 19‐09‐2016 PHARMACEUTICAL COMPOSITIONS FOR SUSTAINED RELEASE OF
PHENYEPHRINE
275692
5300/CHENP/2008 20‐09‐2016 PHARMACEUTICAL FORMULATIONS COMPRISING CRYSTALLINE
HYDROCHLORIDE MONOHYDRATE SALT OF SALT OF (5S,8S)‐ 8‐[{
(1R)‐1‐‐(3,5 ‐ BIS‐ (TRIFLUOROMETHY)PHENYL]‐ETHOXY}‐METHYL]‐8‐
PHENYL‐1 7‐DIAZA‐SPIRO[4 5]DECAN‐2‐ONE
275738
381/MUM/2009 21‐09‐2016 PHARMACEUTICAL FORMULATIONS OF TELMISARTAN AND
PROCESS FOR PREPARING THE SAME
275761
485/DELNP/2011 22/09/2016 "USE OF OPIOID ANTAGONISTS FOR TREATING URINARY
RETENTION"
275826
1343/DELNP/2011 22‐09‐2016 "FILM PREPARATION CONTAINING LOPERAMIDE HYDROCHLORIDE" 275787
1118/DEL/2007 22‐09‐2016 "PHARMACEUTICAL COMPOSITIONS OF NEVIRAPINE AND
STAVUDINE AND PROCESS OF PREPARATION THEREOF"
275805
3789/DELNP/2008 23‐09‐2016 “EXTERNAL PREPARATION FOR SKIN CONTAINING A
PHOSPHORYLATED SACCHARIDE"
275847
4915/DELNP/2010 24‐09‐2016 "OPHTHALMIC COMPOSITIONS WITH AN AMPHOTERIC
SURFACTANT AND HYALURONIC ACID"
275883
5338/DELNP/2011 25‐09‐2016 “PHARMACEUTICAL COMPOSITION CONTAINING AN ANIONIC
DRUG, AND A PRODUCTION METHOD THEREFOF”
275891
3567/CHENP/2008 26‐09‐2016 THERMOREVERSIBLE OIL‐IN‐WATER EMULSION 275900
1313/DELNP/2006 27‐09‐2016 "NOVEL GLP‐1 DERIVATIVES" 275964
9973/DELNP/2007 27‐09‐2016 "A PHARMACEUTICAL COMPOSITION FOR TOPICAL
ADMINISTRATION"
275970
1936/MUM/2006 28‐09‐2016 NOVEL LYOPHILIZED AND STABILIZED FORMULATIONS OF PEG‐
INTERFERON ALPHA CONJUGATES
275974
154/MUM/2010 28‐09‐2016 A METHOD OF SCREENING /IDENTIFYING AEGLE MARMELOS
DERIVED AEGELINE ACETYLCHOLINESTERASE
275977
1529/MUMNP/2009 28‐09‐2016 A COMPOSITION FOR TREATING XEROSTOMIA 275981
5338/CHENP/2007 28‐09‐2016 RESPONSIVE MRI CONTRAST AGENTS 276002
353/DELNP/2008 29‐09‐2016 "SUSTAINED RELEASE OF ANTIINFECTIVES" 276035
9943/DELNP/2008 29‐09‐2016 "PROCESS FOR THE SYNTHESIS OF (+) AND (‐)‐1‐(3,4‐
DICHLOROPHENYL)‐3‐AZABICYCLO[3.1.0]HEXANE"
276078
4061/DELNP/2007 29‐09‐2016 "AQUEOUS OPHTHALMIC SUSPENSION OF CRYSTALLINE
REBAMIPIDE"
276080
7095/DELNP/2007 30‐09‐2016 "TOOTH WHITENER" 276116
754/DELNP/2008 30‐09‐2016 "PEPTIDE APTAMERS THAT BIND TO THE REP PROTEINS OF SSDNA
VIRUSES"
276133
2312/KOLNP/2007 05‐10‐2016 NANOPARTICLE COMPOSITION AND METHODS FOR SYNTHESIS
THEREOF
273005
559/MUMNP/2006 05‐10‐2016 MEDICAMENT ON THE BASIS OF HONEY, PREPARATION AND USE
THEREOF
276226
2496/MUMNP/2008 06‐10‐2016 A PHARMACEUTICAL BLOOD GAS NO CARRIER COMPOSITION 276234
167/MUM/2011 06‐10‐2016 A PROCESS FOR THE PREPARATION OF AMORPHOUS FORM OF
VILAZODONE HYDROCHLORIDE
276243
909/MUM/2008 07‐10‐2016 SMART DRUG DELIVERY SYSTEM 276264
3048/MUM/2009 07‐10‐2016 STABILIZED DONEPEZIL FORMULATIONS 276272
262/DELNP/2009 08‐10‐2016 ORAL LIQUID PHARMACEUTICAL COMPOSITION 274817
2639/DEL/2007 10‐10‐2016 AN IMPROVED PROCESS FOR PREPARATION OF TRANS‐3, 4‐
DIARYLCHROMAN
276287
2587/MUMNP/2008 13‐10‐2016 STABLE PHARMACEUTICAL COMPOSITION CONTAINING DOCETAXEL
AND A METHOD OF MANUFACTURING THE SAME
276298
1597/MUMNP/2010 13‐10‐2016 PLATINUM COMPLEX COMPOUND AND UTILIZATION OF THE SAME 276300
1451/DELNP/2008 14‐10‐2016 "PYRROLOPYRIDINE DERIVATIVES AND USE OF SAME AS PPAR
RECEPTOR MODULATORS"
276310
3593/CHENP/2010 14‐10‐2016 NOVEL IMIDAZOLE‐SUBSTITUTED ARYLAMIDE COMPOUNDS 276322
Page 6 of 85
1652/MUM/2009 14‐10‐2016 A NOVEL HERBAL HYDRO‐GEL COMPOSITION FOR SKIN WOUNDS 276328
805/MUMNP/2011 17‐10‐2016 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND
TREATMENT OF DIABETES OR OBESITY COMPRISING A COMPOUND
THAT INHIBITS ACTIVITY OF DIPEPTIDYL PEPTIDASE‐IV, AND OTHER
ANTIDIABETIC OR ANTIOBESITY AGENTS AS ACTIVE INGREDIENTS
276357
2343/KOLNP/2010 18‐10‐2016 DRUG DELIVERY SYSTEM FOR ADMINISTRATION OF A WATER
SOLUBLE, CATIONIC AND AMPHIPHILIC PHARMACEUTICALLY
ACTIVE SUBSTANCE
276371
1130/MUM/2010 18‐10‐2016 NOVEL HYPOGLYCEMIC COMPOUNDS 276375
2472/KOLNP/2010 18‐10‐2016 COMPRESSED CHEWING GUM TABLET 276386
1188/KOL/2009 19‐10‐2016 AMINO ACID MOISTURISER 276395
968/KOL/2007 19‐10‐2016 PHARMACEUTICAL COMPOSITIONS OF RIFAXIMIN 276412
1590/MUMNP/2010 20‐10‐2016 “PHARMACEUTICAL COMPOSITION WITH GELLING PROPERTIES
CONTAINING A TYROSINE DERIVATIVE”
276429
993/CHENP/2009 21‐10‐2016 COSMETIC OR DERMATOLOGICAL PREPARATIONS COMPRISING N‐
ACETYLCYSTEINE
276465
1599/MUMNP/2010 21‐10‐2016 A PHARMACEUTICAL COMPOSITION 276478
1415/KOLNP/2009 24‐10‐2016 3‐HYDROXY‐1,5‐DIHYDRO‐PYRROL‐2‐ONE DERIVATIVES AS
INHIBITORS OF GLUTAMINYL CYCLASE FOR THE TREATMENT OF
ULCER, CANCER AND OTHER DISEASES
276495
3139/DELNP/2010 24‐10‐2016 "ORAL CARE PRODUCT AND METHODS OF USE AND MANUFACTURE
THEREOF"
276502
3101/DELNP/2004 25‐10‐2016 "ORODISPERSABLE PHARMACEUTICAL FORMULATION" 276555
497/CHENP/2009 26‐10‐2016 A COSMETIC METHOD FOR SUNSCREENING HUMAN AND ANIMAL
HAIR AND SKIN
276583
2527/KOLNP/2009 26‐10‐2016 MEDICALLY ACTIVE PLASTER 276603
2325/DELNP/2010 26‐10‐2016 "COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A
POLYMER BEARING JUNCTION GROUPS, AND COSMETIC
TREATMENT METHOD"
276618
6631/DELNP/2010 26‐10‐2016 "HAIR CONDITIONING COMPOSITION" 276624
1190/KOL/2005 26‐10‐2016 A BIOCOMPATIBLE, NON‐BIODEGRADABLE, NON‐TOXIC POLYMER
USEFUL FOR PHARMACEUTICAL PREPARATIONS
276626
123/MUM/2012 27‐10‐2016 A METHOD FOR PREPARING NANOSTRUCTURED CALCIUM SILICATE
AS DRUG DELIVERY AGENT.
276632
4322/KOLNP/2009 28‐10‐2016 DI‐SUBSTITUTED AMIDES FOR ENHANCING GLUTAMATERGIC
SYNAPTIC RESPONSES
276686
58/DEL/2007 28‐10‐2016 AN INDUSTRIAL PROCESS FOR THE PREPARATION OF PURE
ROPINIROLE
276691
6352/DELNP/2009 28‐10‐2016 A Pharmaceutical Formulation Comprising δ‐aminolevulinic Acid
And An Iron Compound
276697
2042/DELNP/2008 31/10/2016 "ANTIFUNGAL COMPOSITION" 276783
3310/DELNP/2010 31‐10‐2016 "OLIGOMER‐TRICYCLIC CONJUGATES" 276777
1449/MUMNP/2010 02‐11‐2016 HYDROPHOBIC MODIFIED PRES‐DERIVED PEPTIDES OF HEPATITIS B
VIRUS (HBV) AND THEIR USE AS HBV AND HDV ENTRY INHIBITORS
276854
2579/DELNP/2011 02‐11‐2016 "CLEANSING FORMULATIONS COMPRISING NON‐CELLULOSIC
POLYSACCHARIDES WITH MIXED CATIONIC SUBSTITUENTS"
276869
5854/DELNP/2009 03‐11‐2016 " A STABLE DIGESTIVE ENZYME COMPOSITIONS HAVING COATED
PARTICLES AND ITS USE THEREOF"
276890
5492/CHENP/2009 04‐11‐2016 "EPILATORY COMPOSITIONS" 276905
812/MUMNP/2011 07‐11‐2016 METHOD FOR PREPARING EXTRACT FRACTION REINFORCED WITH
GINSENOSIDES RG1 OR RB1 FROM GINSENG
276936
907/CHE/2007 07‐11‐2016 A PROCESS FOR THE PREPARATION OF 6‐(5‐CHLOROPYRID‐2‐YL)‐5‐
(4‐METHYLPIPERAZIN‐1‐YL)‐CARBONYLOXY‐7‐0X0‐5,6‐
DIHYDROPYRROLO‐[3,4‐B]‐PYRAZINE AND IT’S ENETIOMERICALLY
ENRICHED ISOMER
276937
5704/CHENP/2008 07‐11‐2016 PEPTIDE COMPLEMENTARY TO ACETYLCHOLINE RECEPTOR AND
COMPOSITIONS COMPRISING THEREOF
276941
Page 7 of 85
5372/DELNP/2008 07‐11‐2016 SUBLIMABLE SUSTAINED RELEASE DELIVERY SYSTEM AND METHOD
OF MAKING SAME
276950
6054/CHENP/2009 07‐11‐2016 “A COMPOSITION AND PROCESS THEREOF” 276959
244/DEL/2003 08‐11‐2016 A CONTRACEPTIVE COMPOSITION 274841
7998/DELNP/2009 08‐11‐2016 "PHARMACEUTICAL SOLID PREPARATION COMPRISING
BENZAZEPINES AND PRODUCTION METHOD THEREOF"
276983
954/CHENP/2010 08‐11‐2016 METHOD FOR DETERMINING EROSIVE POTENTIAL IN SALIVA OF AN
ORAL COMPOSITION AND THE COMPOSITION
277001
8539/DELNP/2010 08‐11‐2016 CONTROLLED RELEASE CORTICOSTEROID COMPOSITIONS AND
METHODS FOR THE TREATMENT OF OTIC DISORDERS
277022
3244/DELNP/2010 08‐11‐2016 "USE OF OLIGOSACCHARIDES CONTAINING N‐ACETYLLACTOSAMINE
FOR MATURATION OF IMMUNE RESPONSES IN NEONATES"
277031
6/CHE/2004 09‐11‐2016 3‐(PYRROLIDIN‐3‐YL)INDOLES AS 5‐HT6 RECEPTORS MODULATORS 277044
2356/CHENP/2008 09‐11‐2016 PREPARATION FOR IONTOPHORESIS 277052
2034/KOLNP/2005 10‐11‐2016 A PHARMACEUTICAL COMPOSITION COMPRISING FACIALLY
AMPHIPHILIC OLIGOMERS
277095
689/KOL/2008 11‐11‐2016 ORALLY‐DISINTEGRATING TABLET AND MANUFACTURING METHOD
THEREOF
277135
532/CHENP/2009 11‐11‐2016 A CONCENTRATED ANTIBIOTIC FORMULATION AND A SOLUTION 277141
5515/DELNP/2009 11‐11‐2016 "STABILIZATION OF VITAMIN B12" 277148
2180/DELNP/2010 11‐11‐2016 "MIXED METAL COMPOUNDS FOR TREATMENT OF HYPERPHOS
PHATAEMIA"
277152
1433/MUMNP/2010 11‐11‐2016 IMMUNOTHERAPEUTIC METHOD FOR INCREASING GROUNDNUT
TOLERANCE IN A SUBJECT
277159
2877/KOLNP/2009 16‐11‐2016 COMPOUNDS FOR THE PREVENTION OF CARDIOVASCULAR
DISEASES
277244
1032/MUMNP/2012 17‐11‐2016 LIPID LAYER FORMING COMPOSITION FOR ADMINISTRATION ONTO
A SURFACE OF A LIVING ORGANISM.
277299
2012/MUM/2007 17‐11‐2016 TOPICAL FORMULATION CONTAINING HALOBETASOL 277300
5399/CHENP/2008 17‐11‐2016 PHARMACEUTICAL COMPOSITION FOR EXTERNAL USE 277303
1016/MUMNP/2010 17‐11‐2016 “NEW THERAPEUTIC APPROACHES FOR TREATING CMT AND
RELATED DISORDERS”
277318
1175/CHENP/2006 18‐11‐2016 An Injectable Pharmaceutical Product 277357
242/DEL/2005 18‐11‐2016 "A PROCESS FOR THE INDUSTRIAL SYNTHESIS OF THE AGOMELATIN
COMPOUND”
277368
21/CHENP/2009 18‐11‐2016 METHOD FOR PRODUCING LIPASE, TRANSFORMED YARROWIA
LIPOLYTICA CELL CAPABLE OF PRODUCING SAID LIPASE AND THEIR
USES
277386
3393/CHENP/2010 22‐11‐2016 COMPOSITIONS FOR ENHANCING THE IMMUNOGENICITY OF A
VACCINE
277451
2636/MUM/2011 22‐11‐2016 AN IMPROVED PROCESS FOR PREPARING FESOTERODINE AND ITS
SALT
277456
672/MUM/2011 22‐11‐2016 "CONJOINED LIPID BASED MULTI COMPARTMENT NANOVESICLES
FOR DRUG DELIVERY".
277461
2061/MUM/2007 22‐11‐2016 NOVEL OPHTHALMIC COMPOSITIONS 277467
7035/DELNP/2010 23‐11‐2016 "ORAL COMPOSITIONS COMPRISING SHELLAC WAX AND BLEACHED
SHELLAC FOR USE IN STOMATOLOGY AND DENTAL CARE"
277496
8257/DELNP/2009 23‐11‐2016 "FORMULATION CONTAINING HYDROCARBONS" 277527
1152/KOL/2007 24‐11‐2016 PROCESS FOR THE PREPARATION OFCOMPOSITION CONSISTING OF
AMORPHOUS FORM OF
CARVEDILOL DIHYDROGENPHOSPHATE
277561
1999/DEL/2010 24‐11‐2016 A NOVEL FORMULATION TO TRANSDERMALLY DELIVER
ANTIHYPERTENSIVE AGENT WITH PERMEABILITY ENHANCER
277571
125/MUM/2012 24‐11‐2016 "A TRIAZOLE LINKED PICOLYLIMINE CONJUGATE OF CALIX[6]ARENE" 277575
1869/CHE/2006 25‐11‐2016 A PROCESS FOR THE PREPARATION OF CANDESARTAN 277607
Page 8 of 85
2872/MUM/2011 28‐11‐2016 A COMPOUND FOR SKIN AND A METHOD OF MAKING THE SAME 277635
7692/DELNP/2009 28‐11‐2016 “MATRIX‐TYPE TRANSDERMAL DRUG DELIVERY SYSTEM AND
PREPARATION METHOD THEREOF”
277659
4410/DELNP/2009 28‐11‐2016 "A METHOD FOR MAKING AN IMMUNOGENIC CONJUGATE" 277665
3064/KOLNP/2009 28‐11‐2016 PYRAZOLO PYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS 277693
3197/KOLNP/2007 29/11/2016 SUBLINGUAL COATED TABLET 277767
272/MUM/2007 29‐11‐2016 A HERBAL COMPOSITION FOR THE PREVENTION AND TREATMENT
OF ENDOPARASITES OR TAPEWORMINFESTATION IN ANIMALS,
277700
10441/DELNP/2008 29‐11‐2016 "COMPOSITIONS OF GLYCOPYRRONIUM SALT FOR INHALATION" 277715
6594/DELNP/2008 29‐11‐2016 “A METHOD FOR IMPROVING THE PHARMACEUTIC PROPERTIES OF
MICROPARTICLES COMPRISING DIKETOPIPERAZINE AND AN ACTIVE
AGENT”
277719
413/MUM/2012 30/11/2016 "A GREENER PROCESS FOR THE PREPARATION OF SULFONAMIDE
CHALCONE DERIVATIVES
277772
6355/CHENP/2008 30/11/2016 SPRAYABLE GEL‐TYPE SKIN/MUCOSA‐ADHESIVE PREPARATION AND
ADMINISTRATION SYSTEM USING THE PREPARATION
277801
1379/MUMNP/2012 30‐11‐2016 CIRCULATION OF COMPONENTS DURING MICROFLUIDIZATION
AND/OR HOMOGENIZATION EMULSIONS
277780
7066/DELNP/2007 30‐11‐2016 HUMANIZED L243 ANTIBODIES 277789
1736/CHENP/2009 01‐12‐2016 PERSONAL CARE COMPOSITIONS HAVING DERIVATIZED
QUATERNIZED CELLULOSE ETHERS
277838
8563/DELNP/2010 01‐12‐2016 “STABILIZED TRANSDERMAL DRUG DELIVERY SYSTEM” 277846
2578/MUM/2008 02‐12‐2016 PHARMACEUTICAL FORMULATION 277866
3599/DELNP/2011 02‐12‐2016 "Granulate of gamma‐ hydroxybutyric acid and process of
preparation thereof"
277875
1899/MUMNP/2010 02‐12‐2016 “1,5‐DIPHENYL‐PYRROLIDIN‐2‐ONE COMPOUNDS AS CB‐1
LIGANDS”
277883
6776/DELNP/2009 02‐12‐2016 TRIAZOLE DERIVATIVES WHICH ARE SMO ANTAGONISTS 277884
2014/MUM/2007 05‐12‐2016 AN IMPROVED PROCESS FOR PREPARATION OF PHOSPHATE
BINDING POLYMER
277891
1666/MUMNP/2008 06‐12‐2016 MEDICATED PATCH 277922
1890/CHE/2007 07‐12‐2016 PROCESS FOR THE PREPARATION OF CARBAPENEM ANTIBIOTIC 277942
2411/MUM/2008 07‐12‐2016 ELECTROCHEMICAL COMPOSITION AND ASSOCIATED TECHNOLOGY 277969
1523/MUM/2007 07‐12‐2016 A PROCESS OF LYOPHILIZATION OF A FORMULATION COMPRISING
HIB‐PRT‐TT CONJUGATE
277981
350/MUM/2009 07‐12‐2016 CANCER CELL BINDING RECOMBINANT LECTIN WITH ANTITUMOR
ACTIVITY AND METHOD OF PREPARATION
277986
5452/DELNP/2010 07‐12‐2016 LIQUID FORMULATION OF FSH 277994
4516/KOLNP/2009 08‐12‐2016 METHODS FOR PRODUCING ARIPIPRAZOLE SUSPENSION AND
FREEZE‐DRIED FORMULATION
274907
1431/MUMNP/2010 08‐12‐2016 METHOD AND COMPOSITIONS FOR CUTANEOUS IMMUNISATION 278014
730/KOLNP/2010 09‐12‐2016 PROCESS FOR THE PREPARATION OF COMPOUNDS USEFUL AS
INHIBITORS OF SGLT
275564
9174/DELNP/2007 09‐12‐2016 "PHARMACEUTICAL COMPOSITIONS COMPRISING OF ARSENOUS
ACID, ITS SODIUM SALT AND ITS DERIVATIVES INTENDED FOR THE
TREATMENT OF UROGENITAL CANCER AND ITS METASTASIS"
278046
4144/KOLNP/2009 09‐12‐2016 PROCESS FOR OBTAINING STEROIDAL PHOSPHATE COMPOUNDS 278053
3737/DELNP/2009 09‐12‐2016 "Injection solution for treating arthritic disorders" 278054
2587/MUMNP/2010 09‐12‐2016 EXTERNAL PREPARATION FOR SKIN 278058
875/CHENP/2009 09‐12‐2016 PHARMACEUTICAL COMPOSITION WITH CONTROLLED ACTIVE
INGREDIENT DELIVERY FOR ACTIVE INGREDIENTS WITH GOOD
SOLUBILITY IN WATER
278062
Page 9 of 85
8211/DELNP/2007 09‐12‐2016 "A DIABODY MOLECULE COMPRISING A FIRST POLYPEPTIDE CHAIN
AND A SECOND POLYPEPTIDE CHAIN"
278072
7696/DELNP/2008 14‐12‐2016 "POLYPEPTIDE USEFUL IN VACCINE PREPARATION FOR LUNG
CANCER"
278095
2005/KOLNP/2010 14‐12‐2016 A METHOD FOR FORMULATING 6‐(5‐FLUORO‐ 2‐(3,4,5‐
TRIMETHOXYPHENYLAMINO)PYRIMIDIN‐4‐YLAMINO)‐2,2‐
DIMETHYL‐3‐OXO‐2H‐PYRIDO[3,2‐ B][L,4]OXAZIN‐4(3H)‐YL)METHYL
PHOSPHATE DISODIUM SALT INTO A FORMULATION FOR TABLET
COMPRESSION
278101
2694/MUMNP/2010 14‐12‐2016 SUNSCREEN COMPOSITE PARTICLES IN COSMETIC COMPOSITIONS 278105
2777/DELNP/2009 14‐12‐2016 "A METHOD FOR MAKING A SLOW RELEASE ESTRADIOL
FORMULATION"
278115
608/DEL/2008 14‐12‐2016 C2‐FLUORO SUBSTITUTED PIPERAZINE LINKED PYRROLO[2,1‐
C)[1,4]BENZODIAZEPINE DIMERS AND A PROCESS FOR THE
PREPARATION THEREOF
278139
1377/CHE/2009 15‐12‐2016 ORAL LIQUID COMPOSITIONS OF RESVERATROL OR ITS
PHARMACEUTICALLY ACCEPTABLE SALT
278152
6933/DELNP/2007 16‐12‐2016 "ENDOPARASITICIDAL COMPOSITIONS" 278191
1245/CHE/2006 16‐12‐2016 IMPROVED PROCESS FOR THE PREPARATION OF CEFORANIDE IN
PURE FORM
278213
59/CHENP/2009 16‐12‐2016 BROAD SPECTRUM AND SKIN FRIENDLY DISINFECTING
COMPOSITION
278216
340/KOLNP/2010 19‐12‐2016 A SKIN DRESSING WITH NITRITE SALT 278238
4230/DELNP/2008 19‐12‐2016 "TRANSDERMAL THERAPEUTIC SYSTEM" 278261
4342/KOLNP/2007 19‐12‐2016 ORAL DELIVERY DEVICES FOR COLONIC RELEASE OF ADSORBENTS 278272
4527/CHENP/2010 20/12/2016 HIGH CONCENTRATION ANTIBODY‐CONTAINING LIQUID
FORMULATION
278326
6556/DELNP/2008 20‐12‐2016 "COMPOSITIONS AND METHODS FOR THE TREATMENT AND
PREVENTION OF DISEASE"
278276
6640/CHENP/2008 20‐12‐2016 OXOPYRIDINE COMPOUDS AS P38 MAP KINASE INHIBITORS 278314
3650/CHENP/2007 20‐12‐2016 A COMBINATION OF A CYTOTOXIC COMPOUND AND PYRAZOLE
COMPOUNDS
278316
5058/DELNP/2009 21‐12‐2016 "INHIBITORS OF AKT ACTIVITY" 278395
3413/DELNP/2011 21‐12‐2016 "ORAL CARE COMPOSITIONS COMPRISING SPHERICAL FUSED
SILICA"
278351
9296/DELNP/2007 22‐12‐2016 "A COMPOUND OF FORMULA IV" 278409
2437/KOLNP/2011 23/12/2016 PREPARATION METHOD OF POLYMERIC MICELLES COMPOSITION
CONTAINING A POORLY WATER‐SOLUBLE DRUG
278479
6094/DELNP/2005 23‐12‐2016 "RESOLUTION OF ALPHA‐(PHENOXY) PHENYLACETIC ACID
DERIVATIVES"
278459
6085/DELNP/2010 23‐12‐2016 "OXADIAZOANTHRACENE COMPOUNDS FOR THE TREATMENT OF
DIABETES"
278473
7373/DELNP/2010 26‐12‐2016 "TETRAZOLE COMPOUNDS FOR REDUCING URIC ACID" 278529
3716/DELNP/2008 26‐12‐2016 "An EGFRvIII peptide and temzolomide" 278538
8255/DELNP/2009 26‐12‐2016 HYDROCARBON MIXTURES AND USE THEREOF 278571
8909/DELNP/2010 26‐12‐2016 “COMBINATION OF PILOCARPIN AND METHIMAZOL FOR TREATING
CHARCOT‐MARIETOOTH DISEASE AND RELATED DISORDERS”
278573
1317/DEL/2008 26‐12‐2016 IMPROVED PROCESS FOR PRODUCING S‐OMEPRAZOLE
MAGNESIUM IN AMORPHOUS FORM
278588
2904/DELNP/2004 27‐12‐2016 Process for the Preparation of a Composition comprising IL‐18
Inhibitor
278617
7799/DELNP/2009 27‐12‐2016 "VACCINE PEPTIDE COMBINATIONS AGAINST CAT ALLERGY" 278624
1367/CHE/2011 27‐12‐2016 IMMUNOGENIC COMPOSITION FOR LYMPHATIC FILARIAL VACCINE 278637
4364/DELNP/2009 28/12/2016 “AN INSULINOTROPIC COMPLEX USING AN IMMUNOGLOBULIN
FRAGMENT”
278654
Page 10 of 85
6678/DELNP/2007 28‐12‐2016 "PHARMACEUTICALLY ACTIVE PHOSPHATE BINDERS, THEIR
MANUFACTURE, COMPOSITIONS CONTAINING THEM AND THEIR
USE"
278666
2605/KOLNP/2008 28‐12‐2016 FGF‐RECEPTOR AGONIST DIMERIC COMPOUNDS 278672
4714/DELNP/2007 28‐12‐2016 "A LIQUID PHARMACEUTICAL FORMULATION" 278673
8331/DELNP/2007 28‐12‐2016 "PRODUCTION OF GLUCOSAMINE FROM PLANT SPECIES" 278680
8304/DELNP/2008 28‐12‐2016 "A COMPOSITION COMPRISING AN AQUEOUS LUBRICANT BASE" 278692
7700/DELNP/2007 28‐12‐2016 "ANTI ‐ INFLAMMATORY FORMULATION" 278700
1246/CHE/2006 29‐12‐2016 IMPROVED PROCESS FOR THE PREPARATION OF CEFEPIME
INTERMEDIATE
278712
7813/DELNP/2007 29‐12‐2016 NOVEL VACCINE FORMULATIONS 278719
2938/KOLNP/2011 29‐12‐2016 A PROCESS FOR THE PREPARATION OF A POLYMER CONJUGATE OF
AN INDOLOCARBAZOLE COMPOUND
278723
5312/DELNP/2010 29‐12‐2016 RESUSCITATION FLUID 278740
3174/DELNP/2010 29‐12‐2016 "COMPOSITIONS AND DEVICES" 278745
678/DEL/2007 30‐12‐2016 A VACCINE COMPOSITION COMPRISING POLYMERIC
NANOPARTICLES AND MICROPARTICLES FOR INDUCING TH1 AND
TH2 RESPONSE
278769
3646/DELNP/2010 30‐12‐2016 "A POWERFUL VACCINE COMPOSITION COMPRISING A
LIPOPEPTIDE AND POLY I:C AS AN ADJUVANT"
278784
6146/DELNP/2006 31‐12‐2016 "INDAZOLES, BENZOTHIAZOLES ,BENZOISOTHIAZOLES,
BENZISOXAZOLES, AND PREPARATION AND USES THEREOF"
278844
1945/MUMNP/2011 04‐01‐2017 "METHOD FOR PREPARING ACYCLOVIR 2/3 HYDRATE" 278935
947/DEL/2007 05‐01‐2017 "PROCESS FOR STABILISING THIPHENE DERIVATIVES" 278947
783/DELNP/2009 05‐01‐2017 "A METHOD FOR MAKING SOLID DISPERSIONS OF MIDOSTAURIN" 278972
261/KOLNP/2010 05‐01‐2017 NEW ANTIMICROBIAL COMPOUNDS, THEIR SYNTHESIS AND THEIR
USE FOR TREATMENT OF MAMMALIAN INFECTIONS
278976
2721/MUMNP/2010 06‐01‐2017 TOPICAL GEL COMPOSITION FOR THE TREATMENT OF ACTINIC
KERATOSIS
278979
1406/MUM/2009 06‐01‐2017 COSMETIC OR PHARMACEUTICAL PREPARATION FOR THE SKIN 278986
1529/CHE/2008 06‐01‐2017 IMPROVED PROCESS FOR THE PREPARATION OF HIGH PURITY
SUNITINIB AND ITS PHARMACEUTICALLY ACCEPTABLE SALT
278989
3730/CHENP/2011 06‐01‐2017 A METHOD OF PREPARING AN ISOLATED MULTIPOTENT
GLOMERULAR MESENCHYMAL STEM CELLS
278992
4716/DELNP/2009 06‐01‐2017 "AGGLOMERATED HYDROXYETHYLCELLULOSE COMPOSITION" 278993
3752/KOLNP/2009 06‐01‐2017 NOVEL COMPOUNDS FOR TREATING MENTAL DISORDERS, AND
PREPARATION AND USES THEREOF
279002
4638/DELNP/2010 06‐01‐2017 “METHOD OF PRODUCING JAPANESE ENCEPHALITIS VACCINE
STABLY STORABLE OVER LONG TIME AND USE OF THE VACCINE”
279004
2490/DELNP/2004 09‐01‐2017 "COUPLING LOW MOLECULAR SUBSTANCES TO A MODIFIED
POLYSACCHARIDE"
279011
6442/DELNP/2010 09‐01‐2017 "PROCESSES OF MAKING ORAL COMPOSITIONS CONTAINING GEL
NETWORKS"
279013
10382/DELNP/2008 09‐01‐2017 “LOW DOSE SUBLINGUAL TABLETS OF OPIOID ANALGESICS AND
PREPARATION PROCESS”
279019
4840/DELNP/2009 09‐01‐2017 "SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS" 279024
7881/DELNP/2006 09‐01‐2017 "PRE‐FORMULATIONS FOR IN‐SITU GENERATION OF CONTROLLED
RELESE LIPID FORMULATIONS"
279042
2698/MUMNP/2010 10‐01‐2017 COSMETIC SUNSCREEN COMPOSITE PARTICULES 279071
1514/MUM/2006 10‐01‐2017 PELLETS OF HERBAL EXTRACTS AND PROCESS FOR PREPARING THE
SAME
279073
38/KOLNP/2007 11‐01‐2017 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS 279102
2571/KOLNP/2008 12‐01‐2017 AN IMMUNOGENIC COMPOSITION FOR INFANTS COMPRISING A
MULTIVALENT STREPTOCOCCUS PNEUMONIAE VACCINE
279133
5845/DELNP/2006 12‐01‐2017 TOOTH‐WHITENING COMPOSITIONS COMPRISING SILICONE
POLYMER AND METHODS THEREFOR"
279150
Page 11 of 85
1757/DELNP/2009 12‐01‐2017 "METHODS FOR DELIVERING VOLATILE ANESTHETICS FOR
REGIONAL ANESTHESIA AND/OR PAIN RELIEF"
279149
4593/DELNP/2009 12‐01‐2017 "METHOD FOR TREATING OR PREVENTING SYSTEMIC
INFLAMMATION"
279161
4182/KOLNP/2010 13/01/2017 FUSED BICYCLIC PYRIMIDINE COMPOUNDS AS AURORA KINASE
INHIBITORS
279196
5114/DELNP/2008 13‐01‐2017 "FORMULATION" 279178
1861/MUM/2010 16‐01‐2017 TELMISARTAN AND HYDROCHLOROTHIAZIDE COMPOSITION 279229
1680/CHE/2005 17‐01‐2017 AN IMPROVED PROCESS FOR THE PREPARATION OF SODIUM SALT
OF CEPHALOSPORIN ANTIBIOTIC
279294
2612/CHE/2010 17‐01‐2017 PROCESS FOR THE PREPARATION OF 5‐BENZYLOXY‐2‐ (4‐
BENZYLOXYPHENYL) ‐3‐ METHYL‐1H‐INDOLE
279266
2204/MUM/2011 17‐01‐2017 "PREPARATION OF SUBSTITUTED 1H‐IMIDAZO[4,5‐C] QUINOLINE" 279270
273/MUM/2007 18‐01‐2017 A HERBAL THERAPEUTIC PRODUCT FOR THE PREVENTION AND
TREATMENT OF RETENTION OFPLACENTA IN CATTLE AND
BUFFALOES
279313
2864/CHE/2007 18‐01‐2017 IMPROVED PROCESS FOR THE PREPARATION OF (2E)‐2‐CYANO‐3‐
(3,4‐DIHYDROXY‐5‐NITROPHENYL)‐N,N‐DIETHYL‐2‐PROPENAMIDE
POLYMORPHIC FORM A
279316
4711/DELNP/2009 18‐01‐2017 "PHARMACEUTICAL COMPOSITION" 279322
526/CHE/2008 18‐01‐2017 AN IMPROVED PROCESS FOR THE PREPARATION OF APREPITANT 279324
5094/DELNP/2008 18‐01‐2017 "NUCLEOTIDE AND OLIGONUCLEOTIDE PRODRUGS" 279329
5458/DELNP/2006 18‐01‐2017 "STEROID‐CONTAINING SUSTAINED RELEASE INTRAOCULAR
IMPLANTS AND RELATED METHODS"
279332
719/DEL/2009 19‐01‐2017 NOVEL SYNERGISTIC COMBINATION OF FERULA ASAFOETIDA WITH
DEHYDRATED DIALDOL PRODUCT AS POTENT ANTIFUNGAL AGENT
279380
8360/DELNP/2008 19‐01‐2017 "CONTROLLED RELEASE DELIVERY DEVICE COMPRISING AN
ORGANOSOL COAT"
279389
1025/DEL/2006 19‐01‐2017 "A compound of 4‐(1‐Adamantyl)‐2‐substitutedquinolone
derivatives as new structural class of anti‐tuberculosis agents"
279395
2366/MUMNP/2011 19‐01‐2017 ADJUVANT COMPOSITIONS COMPRISING A NON‐IONIC
ISOTONICITY AGENT
279396
681/KOL/2008 19‐01‐2017 COSMETIC HAIR COMPOSITIONS COMPRISING FUNCTIONALIZED
METAL OXIDE LAYERED PIGMENTS
279401
386/DELNP/2010 20‐01‐2017 "PHARMACEUTICAL COMPOSITIONS" 279429
18/DEL/2006 23‐01‐2017 "NANOPARTICULATE FORMULATION FOR ORAL DELIVERY OF
COENZYME Q10"
279439
2847/DELNP/2010 23‐01‐2017 "ORAL CARE REGIMEN" 279451
2575/KOLNP/2010 23‐01‐2017 A METHOD FOR PREPARING PARTICLES OF CYCLOSPORINE A 279458
8115/DELNP/2010 23‐01‐2017 "ADMINISTRABLE COMPOSITIONS" 279459
906/CHE/2005 24‐01‐2017 "COMPOSITIONS OF ANTI VIRAL COMPOUND" 279483
1865/MUMNP/2012 24‐01‐2017 “METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITION 279488
9388/DELNP/2008 24‐01‐2017 "AN IN VITRO METHOD OF STIMULATING T CELLS" 279489
4642/DELNP/2009 24‐01‐2017 POLYMERIC CARRIERS OF THERAPEUTIC AGENTS AND
RECOGNITION MOIETIES FOR ANTIBODY‐BASED TARGETING OF
DISEASE SITES
279497
1050/CHE/2006 24‐01‐2017 AN IMPROVED PROCESS FOR THE PREPARATION OF ARIPIPRAZOLE 279496
4548/DELNP/2007 24‐01‐2017 "ORAL TREATMENT COMPOSITIONS CONTAINING AN ANTI‐
ADHESION AGENT, ANTIBACTERIAL AGENT AND INCOMPATIBLE
COMPOUND"
279523
313/DEL/2006 25‐01‐2017 A PHARAMACEUTICAL FORMULATION CONTAINING QUERCETIN
FOT THE TREATMENT OF DIABETIC NEPHROPATHY
279549
7819/DELNP/2009 25‐01‐2017 "A COMPOUND OF FORMULA (I)" 279540
1854/CHENP/2008 25‐01‐2017 (R)‐6‐METHYLOXAALKYL EXEMESTANE COMPOUNDS AND RELATED
METHOD OF USE
279563
Page 12 of 85
3329/MUM/2010 27‐01‐2017 LIPIDIC NANOPARTICLES BASED COMPOSITION AND METHOD OF
FORMULATION AND USE THEREOF
279598
6204/DELNP/2009 27‐01‐2017 "TRICYCLIC NITROGEN CONTAINING COMPOUNDS AS
ANTIBACTERIAL AGENTS"
279599
3076/CHENP/2008 27‐01‐2017 Pharmaceutical Composition comprising hemicalcium salt of (E)‐7‐
[4‐(4‐fluorophenyl)‐6‐isopropyl‐2‐
[methyl(methylsulfonyl)amino]pyrimidin‐5‐yl]‐(3R,5S)‐3,5‐
dihydroxyhept‐6‐enoic acid
279608
5003/DELNP/2008 27‐01‐2017 "SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE
AND TWO OR MORE POLYLACTIDE‐CO‐GLYCOLIDE POLYMERS"
279610
2216/CHE/2007 27‐01‐2017 ORAL MEDICAMENT CONTAINING ANTHELMINTICS 279642
973/CHE/2010 27‐01‐2017 A LOW PH SKIN CARE COSMETIC COMPOSITION 279643
8937/DELNP/2008 27‐01‐2017 STABILIZED COMPOSITIONS CONTAINING ALKALINE LABILE DRUGS 279672
4256/KOLNP/2008 28‐01‐2017 THIONINIUM COMPOUNDS. 279680
1329/DELNP/2004 28‐01‐2017 "DRUG DELIVERY SYSTEM FOR CONSCIOUS SEDATION" 279679
4227/DELNP/2012 28‐01‐2017 "POLYMERIC BIGUANIDE PRESERVATION OF PRECIPITATED
CALCIUM CARBONATE"
279681
7478/DELNP/2009 30‐01‐2017 SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF
MICROPARTICLES
279699
4933/DELNP/2008 30‐01‐2017 "A METHOD FOR THE PREPARATION OF A GRANULATED CALCIUM‐
CONTAINING COMPOUND"
279721
8324/DELNP/2010 30‐01‐2017 NOVEL ADJUVANT COMPOSITIONS 279724
2449/MUMNP/2012 30‐01‐2017 POLYSACCHARIDE CONJUGATION WITH DETOXIFIED E. COLI HEAT
LABILE ENTEROTOXIN (LT) USED AS VACCINE
279735
4569/DELNP/2006 30‐01‐2017 "A METHOD OF PRODUCING A DELIVERY SYSTEM SAID DELIVERY
SYSTEM AND A COMPOSITION THEREOF"
279737
832/DELNP/2010 30‐01‐2017 A Method For Preparing A CONJUGATE VACCINE 279748
1186/MUMNP/2010 30‐01‐2017 SKIN EXTERNAL PREPARATIONS 279759
2460/DEL/2005 30‐01‐2017 "NOVEL 1‐[(4‐DIPHENYLMETYL)‐PIPERAZIN‐1‐YL]‐3‐
ARYLOXYPROPAN‐2‐OL
279758
475/DELNP/2009 30‐01‐2017 A METHOD FOR THE PRODUCTION OF HYDROLYZED ALLERGEN 279764
10555/DELNP/2008 30‐01‐2017 "PROLYL HYDROXYLASE INHIBITORS" 279762
1368/MUMNP/2011 31‐01‐2017 MODIFIED GIARDIA PROTOZOAN PARASITE AND VACCINE
COMPRISING THE SAME
279795
7894/DELNP/2007 31‐01‐2017 COSMETIC COMPOSITIONS CONTAINING ESTERS BASED ON 2‐
PROPYLHEPTANOL
279831
1468/DEL/2012 31‐01‐2017 "A PROCESS FOR PREVENTING AN CURING DIABETES BY ULTRA
VIOLET RADIATION"
279880
329/CHENP/2009 02‐02‐2017 PHARMACEUTICALLY ACCEPTABLE SOLUBILIZING COMPOSITION
AND PHARMACEUTICAL DOSAGE FORM CONTAINING SAME
279913
1252/CHE/2007 06‐02‐2017 ENTERIC COATED GRANULE AND METHOD FOR PREPARING THE
SAME
279955
327/CHENP/2009 06‐02‐2017 SKIN EXTERNAL PREPARATION 279959
2606/DELNP/2009 06‐02‐2017 "GALENICAL FORM FOR THE ADMINISTRATION OF ACTIVE
INGREDIENTS BY TRANSMUCOUS MEANS"
279984
7833/DELNP/2010 06‐02‐2017 "ORAL COMPOSITIONS AND USES THEREOF" 280001
2002/MUM/2011 07‐02‐2017 "PHARMACEUTICAL COMBINATION" 280009
5471/DELNP/2010 08‐02‐2017 "VOLATILE ANESTHETIC COMPOSITIONS COMPRISING EXTRACTIVE
SOLVENTS FOR REGIONAL ANESTHESIA AND/OR PAIN RELIEF"
286008
5787/DELNP/2012 08‐02‐2017 A PHARMACEUTICAL COMPOSITION COMPRISING 3 BETA HYDROXY
5 ALPHA PREGNAN 20 ONE WITH IMPROVED STORAGE AND
SOLUBILITY PROPERTIES
280053
2064/DELNP/2010 10‐02‐2017 "PERSONAL CARE COMPOSITIONS COMPRISING UNDECYL
SULFATES"
280115
3676/DELNP/2010 10‐02‐2017 "IMPROVED TAXANE DELIVERY SYSTEM" 280122
263/CHENP/2009 10‐02‐2017 FCYRIIB‐SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF 280132
Page 13 of 85
1510/MUM/2008 10‐02‐2017 FOSAPREPITANT AND PROCESSES FOR THE PREPARATION THEREOF 280136
2498/DELNP/2011 13‐02‐2017 2‐ACYLAMINOPROPOANOL‐TYPE GLUCOSYLCERAMIDE SYNTHASE
INHIBITORS
280166
8570/DELNP/2009 13‐02‐2017 "HYDROLYSABLE POLYMERIC FMOC‐LINKERS" 280172
946/MUMNP/2010 13‐02‐2017 RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING
ANTIGENS FOR COLON AND PANCREATIC CANCERS
280184
1856/MUMNP/2009 13‐02‐2017 ASPARTATE OF 1‐CYCLOPROPYL‐6‐FLUORO‐7‐(8‐METHOXYIMINO‐
2,6‐DIAZA‐ SPIRO[3.4]OCT‐6‐YL)‐4‐OXO‐1,4‐DIHYDRO‐
[1,8]NAPHTHYRIDINE‐3‐CARBOXYLIC ACID, METHOD FOR
PREPARING THE SAME, AND ANTIMICROBIAL PHARMACEUTICAL
COMPOSITION COMPRISING THE SAME
280193
3953/DELNP/2011 14‐02‐2017 "METHOD FOR PREPARING PERSONAL CARE COMPOSITION
COMPRISING SURFACTANT AND HIGH MELTING POINT FATTY
COMPOUND"
280241
2305/DELNP/2008 15/02/2017 "QUINOLINES AND THEIR THERAPEUTIC USE" 280286
3490/CHENP/2010 15/02/2017 AQUEOUS SHEAR‐THINNING PERSONAL CARE COMPOSITION 280272
3695/CHENP/2008 15‐02‐2017 BIOLOGICALLY ACTIVE COMPOSITION COMPRISING
ETHYLCELLULOSE
280251
2743/DELNP/2009 15‐02‐2017 "HAEMAGGLUTININ H5 PROTEIN OF INFLUENZA VIRUS " 280257
2770/MUM/2010 15‐02‐2017 DISINFECTANT AND METHOD FOR ITS PREPARATION AND USE 280259
1265/KOL/2009 16‐02‐2017 AN AQUEOUS TRANSPARENT SOLUTION FOR USE IN PERSONAL
CARE FORMULATIONS
280310
861/CHENP/2008 16‐02‐2017 N‐(ARYLAMINO)‐SULFONAMIDE INHIBITORS OF MEK 280313
4007/KOLNP/2009 16‐02‐2017 A PROCESS FOR PREPARING 2‐(5‐(4‐(2‐
MORPHOLINOETHOXY)PHENYL)PYRIDIN‐2‐YL)‐N‐
BENZYLACETAMIDE
280315
8184/DELNP/2009 17‐02‐2017 "PEPTIDE SLOW‐RELEASE FORMULATIONS" 280334
2492/CHE/2009 17‐02‐2017 "PROCESS FOR THE PREPARATION OF LAMIVUDINE" 280339
2477/KOLNP/2008 17‐02‐2017 ETHANOL‐PRECIPITATED PHASEOLUS VULGARIS EXTRACTS, THEIR
USE AND FORMULATIONS
280375
2643/DEL/2009 20‐02‐2017 "Recombinant Domain III envelope protein useful for detecting
Japanese Encephalitis Virus"
280386
3414/DELNP/2011 20‐02‐2017 "ORAL CARE COMPOSITIONS WITH IMPROVED AESTHETICS AND
FUSED SILICA"
280390
5540/DELNP/2009 20‐02‐2017 "A COMPOUND" 280402
990/CHENP/2010 20‐02‐2017 NEW COMPOSITIONS BASED ON POLYSACCHARIDES GRAFTED BY
POLYAMINE OR POLYSULPHURISED COMPOUNDS
280405
10770/DELNP/2008 20‐02‐2017 "HIGH FLUORIDE ION ORAL CARE COMPOSITION AND METHOD FOR
MAINTAINING ANTICARIES ACTIVITY"
280440
5047/DELNP/2010 21/02/2017 STABLE ELSAMITRUCIN SALT FORMULATIONS 280504
3690/CHENP/2008 21/02/2017 POLYMER FORMULATIONS OF CETP INHIBITORS 280475
1068/CHENP/2009 21‐02‐2017 ANTI‐MICROBIAL PHOTODYNAMIC THERAPY 280444
164/KOLNP/2011 21‐02‐2017 QUINOXALINEDIONE DERIVATIVES 280467
3266/DELNP/2011 21‐02‐2017 "ORAL CARE COMPOSITIONS" 280513
5738/DELNP/2010 22/02/2017 "TREATING NEURODEGENERATIVE DISEASES WITH PROGRANULIN
(PGRN)"
280570
267/CHENP/2009 22‐02‐2017 A LIQUID PHARMACEUTICAL FORMULATION AND A PROCESSFOR
THE PREPARATION THEREOF
280534
733/MUMNP/2010 22‐02‐2017 HAIR CARE COMPOSITION. 280545
8151/DELNP/2011 22‐02‐2017 "ORAL COMPOSITIONS CONTAINING POLYGUANIDINIUM
COMPOUNDS AND METHODS OF MANUFACTURE AND USE
THEREOF"
280569
7848/DELNP/2007 22‐02‐2017 "SUBSTITUTED OXAZOLE DERIVATIVES AND THEIR USE AS TYROSINE
KINASE INHIBITORS"
280571
5239/DELNP/2005 23/02/2017 "PHOSPHONATE COMPOUND" 280586
Page 14 of 85
5522/DELNP/2008 23‐02‐2017 "SUBSTITUTED 4‐AMINO‐PYRROLOTRIAZINE DERIVATIVES USEFUL
FOR TREATING HYPER‐PROLIFERATIVE DISORDERS AND DISEASES
ASSOCIATED WITH ANGIOGENESIS"
280620
5068/DELNP/2008 23‐02‐2017 HYDROPHOBIC CORE CARRIER COMPOSITIONS FOR DELIVERY OF
THERAPEUTIC AGENTS, METHODS OF MAKING AND USING THE
SAME
280639
2190/DEL/2004 27‐02‐2017 "NITRO‐GROUP BASED TOPICAL FORMULATION FOR TREATMENT
OF ACUTE PPRIPHERAL MICROVASCULAR DISEASES"
280668
3441/DELNP/2006 27‐02‐2017 "POLYCYCLIC COMPOUNDS SUITABLE FOR USE IN TREATMENT OF
RESPIRATORY SUNCYTIAL VIRUS
280675
1665/MUM/2009 27‐02‐2017 A PROCESS FOR PREPARATION OF A LOTION FOR TREATMENT OF
CORN
280682
2301/DEL/2006 27‐02‐2017 A PHARMACEUTICAL AEROSOL FORMULATION AND A METHOD FOR
PREPARATION THEREOF
280711
1654/DELNP/2007 27‐02‐2017 "ANTIDIABETIC ORAL INSULIN‐BIGU ANIDE COMBINATION." 280713
5186/DELNP/2011 27‐02‐2017 PHARMACEUTICAL COMPOSITION COMPRISING ALEGLITAZAR 280728
2076/MUMNP/2010 28‐02‐2017 “TRANSDERMALLY ABSORBABLE PREPARATION” 280762
665/DELNP/2010 28‐02‐2017 "RADIOPHARMACEUTICAL COMPOSITION" 280769
1166/DELNP/2010 28‐02‐2017 "NON‐AQUEOUS COMPOSITIONS" 280794
2158/DEL/2009 28‐02‐2017 PH SENSITIVE CONTROLLED RELEASE MICROCAPSULES AND A
PROCESS OF PREPARATION OF THE SAME
280828
884/DEL/2007 28‐02‐2017 "PROBES AND PRIMERS FOR IDENTIFICATION OF MYCOBACTERIAL
PROTEIN USEFUL AS POTENTIAL DRUG TARGETS"
280840
7906/DELNP/2008 28‐02‐2017 BIORESORBABLE CONTROLLED‐RELEASE COMPOSITION 280862
7492/DELNP/2010 01‐03‐2017 "PHARMACEUTICAL COMPOSITIONS COMPRISING BRIVARACETAM" 280886
2003/MUM/2007 01‐03‐2017 PROCESS FOR PREPARATION OF (S) (N‐[[3‐[3‐FLUORO‐4‐(4‐
MORPHOLINYL)PHENYL]‐2‐OXO‐5‐ OXAZOLIDINYL]
METHYL]ACETAMIDE
280889
117/MUMNP/2011 01‐03‐2017 PROCESS FOR PREPARING MICROPARTICLES 280892
8803/DELNP/2011 02‐03‐2017 "A SOLID DOSE COMPOSITION" 280923
1415/DEL/2010 02‐03‐2017 "HERBAL OIL COMPOSITION IN CONTROLLING BLOOD SUGAR
WITHOUT RISK OF HYPOGLYCEMEA"
280929
564/DELNP/2011 02‐03‐2017 “TRIAZOLO [4, 5‐D] PYRAMIDINE DERIVATIVES AND THEIR USE AS
PURINE RECEPTOR ANTAGONISTS”
280942
410/DELNP/2010 03‐03‐2017 VIROSOMES COMPRISING HEMAGGLUTININ DERIVED FROM AN
INFLUENZA VIRUS PRODUCED IN A CELL LINE, COMPOSITIONS,
METHODS OF MANUFACTURING, USE THEREOF
280973
2677/MUM/2011 03‐03‐2017 "MULTIPARTICULATE CONTROLLED POROSITY OSMOTIC SYSTEM" 280989
4890/DELNP/2008 03‐03‐2017 "SALT OF POTASSIUM ATP CHANNEL OPENER " 280967
401/MUM/2008 03‐03‐2017 PROCESS FOR THE PREPARATION OF 4‐AMINO‐N‐[1‐(1‐CYCLOHEX‐3‐
ENYLMETHYL)‐4‐PIPERIDYL]‐2‐ETHOXY‐5‐NITRO‐BENZAMIDE AND
SALTS THEREOF
280974
7750/DELNP/2008 03‐03‐2017 "8‐AZABICYCLO[3.2.1] OCTANE COMPOUNDS AS MU OPIOID
RECEPTOR ANTAGONISTS"
280975
2222/DELNP/2010 06‐03‐2017 “CRYSTALLINE FORMS OF TRYPTOPHAN HYDROXYLASE INHIBITOR
AND PHARMCEUTICALLY ACCEPTABLE SALTS THEREOF ”
281019
3208/KOLNP/2007 06‐03‐2017 APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF
COMPLEMENT‐RELATED DISORDERS
281057
45/DEL/2009 06‐03‐2017 SYNTHESIS OF HEXADECYL CIS‐9 TETRADECENOATE AND
HEXADECYL CIS‐10‐TETRADECENOATE AND THEIR EVALUATION FOR
ANTI ARTHRITIS PROPERTIES IN RATS
281062
203/CHENP/2010 07‐03‐2017 FUSED HETEROARYL PYRIDYL AND PHENYL
BENZENESULFONAMIDES AS CCR2 MODULATORS FOR THE
TREATMENT OF INFLAMMATION
284869
8359/DELNP/2008 07‐03‐2017 "DRUG DELIVERY COMPOSITION" 281085
Page 15 of 85
4982/DELNP/2010 07‐03‐2017 CONDENSED AMINODIHYDROTHIAZINE DERIVATIVE 281114
5143/DELNP/2010 07‐03‐2017 "PHARMACEUTICAL COMPOSITIONS CONTAINING AT LEAST ONE
PROTEINACEOUS ACTIVE INGREDIENT PROTECTED AGAINST
DIGESTIVE ENZYMES"
281118
3622/DELNP/2010 08‐03‐2017 "A SHAMPOO COMPOSITION AND METHOD OF PREPARATION
THEREOF"
281133
1051/DELNP/2007 08‐03‐2017 "CERAMIDE DERIVATIVES AS MODULATORS OF IMMUNITY AND
AUTOIMMUNITY"
281138
1257/CHE/2007 08‐03‐2017 AN IMPROVED PROCESS FOR THE PREPARATION OF GALANTAMINE
HYDROBROMIDE
281143
571/DELNP/2009 08‐03‐2017 "A COMPOSITION COMPRISING A POPULATION OF
POLYSACCHARIDE DERIVATIVES"
281171
9159/DELNP/2008 09‐03‐2017 “STEREOSELECTIVE REDUCTION OF A MORPHINONE” 281211
3580/CHENP/2010 09‐03‐2017 A COMPOSITION COMPRISING OF VITAMIN E DERIVATIVE AND
ANNEXIN V
281224
201647026752 09‐03‐2017 BICYCLIC HETEROCYCLYL DERIVATIVES AS IRAK4 INHIBITORS 281230
5487/DELNP/2011 09‐03‐2017 PAIN TREATMENT 281233
2694/MUM/2009 10‐03‐2017 TOPICAL MEDICINAL FORMULATION FOR FUNGAL INFECTION OF
NAILS
288008
1214/MUMNP/2011 10‐03‐2017 “METHOD FOR PREPARING MICROSPHERES AND MICROSPHERES
PRODUCED THEREBY”
281237
4157/CHENP/2009 10‐03‐2017 INDAZOLE DERIVATIVES AS KINASE INHIBITORS AND PROCESS FOR
PREPARING THE SAME
281246
1651/CHE/2007 10‐03‐2017 A PROCESS FOR PREPARATION OF A NOVEL COMPOUND
DIHYDROXY GYMNEMIC TRIACETATE FROM GYMNEMA SYLVESTRE
R.BR.LEAVES WITH ANTIDIABETIC ACTIVITY
281259
2001/MUMNP/2010 10‐03‐2017 “PHARMACEUTICAL COMPOSITION 271” 281260
2697/CHENP/2010 14/03/2017 COVALENTLY BOUND GLYCOLIPIDS 281294
1802/DEL/2008 14‐03‐2017 "MIXTURES WHICH CAN BE ISOLATED FROM EUGENIA JAMBOLANA
LAMARCK SEEDS, THEIR PREPARATION AND THEIR USE AS
MEDICAMENTS"
281291
4481/CHENP/2008 14‐03‐2017 AN IMIDAZOQUINOLINE AND A PHARMACEUTICAL COMPOSITION
COMPRISING IMIDAZOQUINOLINE DERIVATIVE
281301
9145/DELNP/2010 15‐03‐2017 FULVIC ACID AND ANTIBIOTIC COMBINATION 281318
5294/KOLNP/2008 15‐03‐2017 REDUCED COENZYME Q10‐CONTAINING COMPOSITION AND
METHOD FOR PRODUCING THE SAME
281348
2879/DELNP/2012 15‐03‐2017 "CARRAGEENAN‐CONTAINING AQUEOUS ANTIMICROBIAL
COMPOSITIONS"
281352
1176/CHE/2008 15‐03‐2017 AN IMPROVED PROCESS FOR THE PREPARATION OF CEFOZOPRAN 281355
1150/DELNP/2004 15‐03‐2017 "PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING
OXY GROUP BEARING AROMATIC ALDEHYDES"
281356
2487/DELNP/2008 16‐03‐2017 "COMPOSITION WITH SUSTAINED RELEASE OF THE ACTIVE
INGREDIENT, PROCESS FOR THE PREPATATION THEROF AND USE
THEREOF"
281384
437/MUM/2010 17/03/2017 "STABILIZED FLUCONAZOLE POLYMORPH III FORMULATION" 281430
4303/KOLNP/2010 17‐03‐2017 BENZOFURANE, BENZOTHIOPHENE, BENZOTHIAZOL DERIVATIVES
AS FXR MODULATORS
281414
1507/KOLNP/2010 17‐03‐2017 ANTIMALARIAL COMPOUNDS WITH FLEXIBLE SIDE‐CHAINS 281417
1466/DELNP/2008 17‐03‐2017 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INNER
EAR DISORDERS
281434
1902/MUM/2008 20‐03‐2017 AN IMPROVED PROCESS FOR REPARING TELMISARTAN AND
INTERMEDIATES THEREOF
281469
1202/CHE/2006 20‐03‐2017 A SYNERGISTIC ANTI‐TUMOR COMPOSITION 281500
1375/DELNP/2011 20‐03‐2017 “PHARMACEUTICAL COMPOSITIONS AND METHODS FOR
STABILIZING THE SAME”
281502
114/DEL/2006 20‐03‐2017 STABLE PHARMACEUTICAL COMPOSITION OF AN ACID LABILE
COMPOUND AND PROCESS FOR PREPARING THEREOF
281512
Page 16 of 85
1866/KOLNP/2010 21‐03‐2017 4‐PYRAZOLYL‐N‐ARYLPYRIMIDIN‐2‐AMINES AND 4‐PYRAZOLYL‐N‐
HETEROARYLPYRIMIDIN‐2‐AMINES AS JANUS KINASE INHIBITORS
281540
3337/CHENP/2006 22‐03‐2017 A CONJUGATE COMPRISING AN ENTRY INHIBITOR COVALENTLY
ATTACHED TO A WATER SOLUBLE POLYMER
281609
6279/CHENP/2008 22‐03‐2017 PYRIDONE SULFONAMIDES AND PYRIDONE SULFAMIDES AS MEK
INHIBITORS
281617
5058/KOLNP/2010 22‐03‐2017 SERIES OF SKIN‐WHITENING (LIGHTENING) COMPOUNDS 281625
9605/DELNP/2007 22‐03‐2017 AEROSOLIZED FLUOROQUINOLONES AND USES THEREOF 281647
5326/DELNP/2010 22‐03‐2017 "BITHERAPY AND TRITHERAPY USED FOR TREATING AN HIV‐
POSITIVE PATIENT"
281664
1575/DELNP/2004 22‐03‐2017 "PERORAL ACTIVE AGENT SUSPENSION" 281669
1608/DELNP/2010 22‐03‐2017 "PHARMACEUTICAL COMPOSITIONS" 281676
5857/DELNP/2009 22‐03‐2017 "PHARMACEUTICAL COMPOSITION" 281679
264/KOLNP/2010 23/03/2017 QUATERNARY OPIOID CARBOXAMIDES 281686
4097/DELNP/2010 24‐03‐2017 "ANTI‐VEGF ANTIBODY COMPOSITIONS AND METHODS" 281735
1281/CHE/2007 24‐03‐2017 IMPROVED PROCESS FOR THE PREPARATION OF RABEPRAZOLE 281737
1135/DELNP/2011 24‐03‐2017 “PHARMACEUTICAL COMPOSITION FOR TREATING HYPERTENSION
AND METABILIC SYNDROME AND USE THEREOF”
281788
1337/DEL/2007 24‐03‐2017 "COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A
POLYCONDENSATE, METHOD OF COSMETIC TREATMENT USING
SAID COMPOSITION, SAID POLYCONDENSATE AND METHOD AND
PREPARATION"
281790
2904/CHENP/2008 27/03/2017 PHARMACEUTICAL COMBINATION,PROCESS AND KIT THEREOF 281831
1486/CHE/2009 27‐03‐2017 PROCESS FOR PREPARING METADOXINE 281820
7586/DELNP/2009 27‐03‐2017 "A METHOD OF PREPARING A HYDRAZIDE" 281842
6839/DELNP/2007 27‐03‐2017 COMPOSITION OF INHIBITION OF CATHEPSIN K 281853
3682/KOLNP/2008 28/03/2017 METHODS FOR PREPARING COMPLEX MULTIVALENT
IMMUNOGENIC CONJUGATES
281882
584/KOLNP/2010 28/03/2017 SOLID PREPARATION COMPRISING ALOGLIPTIN AND METFORMIN
HYDROCHLORIDE
281903
2450/DEL/2008 28/03/2017 A HOMEOPATHIC PREPARATION FOR RELEASE OF STUCK PLACENTA
DURING DELIVERY OF BABIES IN ANIMALS
281902
695/KOLNP/2011 28‐03‐2017 PERSONAL CARE PRODUCTS 281866
7641/CHENP/2010 28‐03‐2017 HYBRID PROTEIN COMPRISING SHIGA TOXIN PROTEINS, CHOLERA
TOXIN PROTEINS OR ESCHERICHIA COLI HEAT‐LABILE TOXIN
PROTEINS
281867
5693/CHENP/2008 28‐03‐2017 ANTIBACTERIAL AGENTS 281872
790/DELNP/2010 28‐03‐2017 "NOVEL CONJUGATED PROTEINS AND PEPTIDES" 281873
54/DELNP/2010 28‐03‐2017 "ENCHANCEMENT OF THE EFFICACY OF THERAPEUTIC PROTEINS" 281893
2513/CHENP/2009 28‐03‐2017 “AN INTRA‐MAMMARY TEAT SEALANT FORMULATION” 281895
5265/DELNP/2009 28‐03‐2017 A pharmaceutical composition for the treatment or prevention of
Endometriosis
281899
1534/CHE/2010 28‐03‐2017 A NOVEL SYNERGISTIC PHARMACEUTICAL COMPOSITION FOR
TOPICAL APPLICATIONS
281900
8923/DELNP/2008 28‐03‐2017 "SOLID ORAL COMPOSITIONS BASED ON S‐ADENOSYL METHIONINE
AND/OR NADH AND PROCESS FOR OBTAINING THEM"
281920
2123/MUMNP/2011 29/03/2017 COMPOSITION COMPRISING CLIMBAZOLE FUNGICIDE AND ZINC
GLUCONATE
281943
768/DEL/2010 29‐03‐2017 α‐YOHIMBINE AND ITS DERIVATIVES AS ANTIPSYCHOTIC AGENTS
AND PROCESS OF THEIR PREPARATIONS
281936
9908/DELNP/2008 29‐03‐2017 "RECOMBINANT OR TRANSGENIC FACTOR VII COMPOSITION, EACH
FACTOR VII MOLECULE HAVING TWO N‐GLYCOSYLATION SITES
WITH DEFINED GLYCAN UNITS"
281970
805/KOLNP/2010 29‐03‐2017 INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY 281974
2984/MUM/2009 29‐03‐2017 A NOVEL PHARMACEUTICAL FLOATING DOSAGE FORM 281980
Page 17 of 85
650/CHE/2008 29‐03‐2017 A MONOCLONAL ANTIBODY AND A METHOD THEREOF 281985
1552/MUM/2010 29‐03‐2017 CALCIUM CITRATE MALATE SUSPENSION 281997
300/DELNP/2007 29‐03‐2017 "A SOLUTION OF LEVODOPA" 282012
3543/KOLNP/2009 29‐03‐2017 PHENYL AMINO PYRIMIDINE COMPOUNDS AND USES THEREOF 282013
2613/KOLNP/2011 30/03/2017 COATING MATERIAL FOR SOLID MEDICINE AND SOLID MEDICINE
FORMED WITH SAME
282120
2453/DEL/2008 30/03/2017 A HOMEOPATHIC COMPOSITION FOR PREVENTION OF
MISCARRIAGE IN ANIMALS
282049
1471/MUM/2007 30‐03‐2017 PROCESS OF LYOPHILIZATION OF FORMULATION CONTAINING
MANNITOL
282033
7528/CHENP/2009 30‐03‐2017 VESICLE USEFUL FOR EXTERNAL PREPARATION FOR SKIN, AND
EXTERNAL PREPARATION FOR SKIN COMPRISING THE VESICLE
282040
1930/MUM/2009 30‐03‐2017 NOVEL COMPLEX FOR TREATMENT AND/OR PROPHYLAXIS OF
PARASITIC INFECTIONS
282069
4279/DELNP/2006 30‐03‐2017 "A LIPOPHILE COMPLEXES" 282118
2190/DELNP/2009 31/03/2017 “GRANULATE CONTAINING A PHARMACEUTICALLY ACTIVE
SUBSTANCE AND METHOD FOR ITS MANUFACTURE”
282283
8783/CHENP/2011 31‐03‐2017 A PHARMACEUTICAL COMPOSITION COMPRISING CENTHAQUIN 282155
602/DEL/2008 31‐03‐2017 NOVEL PHENANATHRYLPHENOL LINKED PYRROLO [2,1,‐C][1,4]
BENZODIAZEPINE HYBRIDS AS POTENTIAL ANTITUMOUR AGENTS
AND PROCESS FOR THE PREPARATION THEREOF
282164
622/KOLNP/2006 31‐03‐2017 AN OIL IN WATER FOAMABLE EMULSION 282189
4632/CHENP/2009 31‐03‐2017 DERMAL FILM‐FORMING LIQUID FORMULATIONS FOR DRUG
RELEASE TO SKIN
282235
5203/DELNP/2011 31‐03‐2017 "HYLAURONIC ACID CONTAINING COMPOSITIONS FOR TREATMENT
OF WOUNDS, SCARS, POST‐SURGICAL ADHESION FORMATION"
282264
4851/DELNP/2007 31‐03‐2017 "ORAL CARE COMPOSITIONS CONTAINING FLAVONOIDS AND
FLAVANS"
282271
1848/MUM/2011 04‐04‐2017 "ANTI‐THROMBOTIC COMPOUNDS" 282322
7603/CHENP/2010 04‐04‐2017 PHARMACEUTICAL COMPOSITION COMPRISING RECOMBINANT
HUMAN GROWTH HORMONE PEGYLATED PRODRUG CONJUGATE
282323
1017/CHE/2010 05‐04‐2017 PHARMACEUTICAL COMPOSITION COMPRISING TAMARIND SEED
POLYOSE FOR MODIFIED RELEASE OF DRUG
282337
2996/MUM/2010 05‐04‐2017 "PHARMACEUTICAL COMPOSITION OF SERRATIOPEPTIDASE" 282344
5465/DELNP/2008 06‐04‐2017 "A PROCESS FOR MAKING A POLYCABOXYLIC ACID COMPOSITION " 282384
3338/DELNP/2009 06‐04‐2017 "PROCESS FOR PREPARING A WATER‐IN‐OIL EMULSION
COMPRISING AN IMMUNOSTIMULATORY COMPLEX"
282374
2281/MUM/2010 06‐04‐2017 PROCESS FOR THE PREPARATION OF 2‐ARYL THIAZOLE DERIVATIVE 282377
1916/CHENP/2009 07‐04‐2017 FORMULATIONS COMPRISING CYCLIC COMPOUNDS 282398
7469/DELNP/2009 07‐04‐2017 "IMPROVED DEPOT FORMULAITONS" 282406
235/DEL/2005 12‐04‐2017 A PROCESS FOR PREPARATION OF A TOPICAL FORMULATION FOR
PREVENTION AND MANAGEMENT OF PERIPHERAL VASCULAR
DISEASES
282466
2656/MUM/2011 12‐04‐2017 "A PROCESS FOR THE PREPARATION OF POLYHERBAL
FORMULATION EFFECTIVE TO TREAT KIDNEY STONES"
282473
3256/MUM/2010 12‐04‐2017 "BIOTRANSFORMATION OF BIOLOGICALLY ACTIVE COMPOUNDS
FROM MEDICINAL PLANTS"
282486
4329/DELNP/2008 12‐04‐2017 "CAMPTOTHECIN DERIVATIVES AS CHEMORADIOSENSITIZING
AGENTS"
282487
2347/MUMNP/2010 13‐04‐2017 “PHENYL AND BENZODIOXINYL SUBSTITUTED INDAZOLES
DERIVATIVES”
282502
1720/CHE/2008 13‐04‐2017 CONTROLLED RELEASE DRUG FORMULATION OF POORLY SOLUBLE
DRUG WITH CONSTANT DRUG RELEASE RATE
282506
1772/MUM/2011 17‐04‐2017 AN APPARATUS AND PROCESS TO DETERMINE THE DURATION OF
BIOADHESION IN VITRO
282543
Page 18 of 85
2940/CHENP/2009 18/04/2017 A DRUG SOLUTION CONTAINING PACK WITH A REDUCED
DISSOLVED OXYGEN CONTENT
282569
3954/DELNP/2011 19‐04‐2017 "PERSONAL CARE COMPOSITION IN THE FORM OF AN ARTICLE
HAVING A HYDROPHOBIC SURFACE‐RESIDENT COATING"
282606
1471/MUMNP/2009 19‐04‐2017 “FLUORESCENT EMULSIONS FOR OPTICAL IMAGING” 282607
2550/KOLNP/2010 20‐04‐2017 CHEMICAL MOLECULES THAT INHIBIT THE SLICING MECHANISM
FOR TREATING DISEASES RESULTING FROM SPLICING ANOMALIES
282628
9345/DELNP/2010 20‐04‐2017 "SYNERGISTIC PRESERVATIVE BLENDS" 282631
5788/DELNP/2011 20‐04‐2017 "PROCESSES FOR COATING A CARRIER WITH MICROPARTICLES" 282639
1967/KOLNP/2005 20‐04‐2017 3‐ALKYLIDENEHYDRAZINO SUBSTITUTED HETEROARYL
COMPOUNDS AS THROMBOPOIETIN RECEPTOR ACTIVATORS
282646
4249/CHENP/2008 21‐04‐2017 FLUORIDE COMPOSITION AND METHODS FOR DENTAL
MINERALIZATION
282664
4173/DELNP/2008 21‐04‐2017 "SEGMENTED PHARMACEUTICAL DOSAGE FORMS" 282668
2547/CHE/2007 24‐04‐2017 AN IMPROVED PROCESS FOR THE PURIFICATION OF CEFTIOFUR
HYDROCHLORIDE
282686
451/CHENP/2011 24‐04‐2017 STABILIZATION OF BODY‐CARE AND HOUSEHOLD PRODUCTS 282688
7217/DELNP/2009 24‐04‐2017 "DRUG COMBINATION OF BETA 2 AGONIST AND A PROGESTIN FOR
THE TREATMENT OF MUSCLE LOSS"
282691
2930/CHE/2007 24‐04‐2017 PROCESS FOR PRODUCING 2‐[1‐METHYL‐5‐(4‐METHYLBENZOYL)‐
PYRROL‐2‐YL ACETIC ACID OR SALT THEREOF
282712
6161/DELNP/2009 24‐04‐2017 "A BALLISTIC RESISTANT FIBROUS COMPOSITE" 282714
4597/KOLNP/2010 25‐04‐2017 THIENOPYRIDONE DERIVATIVES AS AMP‐ACTIVATED PROTEIN
KINASE(AMPK) ACTIVATORS
282754
1753/KOLNP/2010 25‐04‐2017 A METHOD OF FORMING A SOLID PHARMACEUTICAL DOSAGE
FORM WITH VISIBLE MICRO‐AND NANO STRUCTURED SURFACES
282759
10316/DELNP/2008 26‐04‐2017 "DHA ESTERS AND USE THEREOF IN TREATMENT AND PREVENTION
OF CARDIOVASCULAR DISEASE"
282802
4325/CHENP/2007 26‐04‐2017 A COMPOSITION FOR IMMUNIZATION AGAINST MYCOBACTERIUM
INFECTIONS
282828
1838/MUMNP/2010 26‐04‐2017 PYRIMIDINE‐2‐AMINE COMPOUNDS AND THEIR USE AS INHIBITORS
OF JAK KINASES
282831
3371/DELNP/2010 27‐04‐2017 CORTICOSTEROID COMPOSITIONS 282871
74/DEL/2007 27‐04‐2017 "A NOVEL ANTIMICROBIAL POLYHERBAL COMPOSITION" 282906
3076/DELNP/2010 28/04/2017 “NOVEL HISTONE DEACETYLASE INHIBITORS" 282938
3269/DELNP/2009 28‐04‐2017 LAYERED PHARMACEUTICAL FORMULATIONS COMPRISING AN
INTERMEDIATE RAPIDLY DISSOLVING LAYER
282966
886/MUMNP/2012 28‐04‐2017 A PROCESS FOR PREPARING MICROCAPSULES HAVING A CORE
ENCAPSULATED WITHIN A METALOXIDE SHELL,
282972
1847/MUMNP/2010 28‐04‐2017 NOVEL METHOD FOR THE PRODUCTION OF SULPHONYLPYRROLES
AS HDAC INHIBITORS
282991
1596/KOLNP/2010 28‐04‐2017 STABILIZED PEDIATRIC SUSPENSION OF CARISBAMATE 282992
2553/MUM/2010 02‐05‐2017 PHARMACEUTICAL COMPOSITIONS OF CURCUMIN 283059
2446/MUM/2007 03‐05‐2017 A ONCE A DAY, STABLE PHARMACEUTICAL COMPOSITION FOR
ORAL ADMINISTRATION
283075
10790/DELNP/2008 03‐05‐2017 "Aqueous liquid formulation for inhalation comprising a sulfoalkyl
ether beta‐cyclodextrin and corticosteroid"
283080
1074/KOLNP/2010 03‐05‐2017 AN IMPLANTABLE MEDICAL DEVICE 283083
3839/DELNP/2011 04‐05‐2017 "Pharmaceutical Compositions for treating and/or preventing Inner
Ear Conditions"
283101
2732/DELNP/2010 05‐05‐2017 "DIALYSIS SOLUTIONS CONTAINING PYROPHOSPHATES" 283152
9406/DELNP/2008 05‐05‐2017 "PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES" 283133
2038/MUM/2008 05‐05‐2017 A COMPOSITION FOR MAKING JALJEERA AND A PROCESS THEREOF 283145
3180/DELNP/2010 05‐05‐2017 "PREVENTION AND TREATMENT OF SECONDARY INFECTIONS
FOLLOWING VIRAL INFECTION"
283154
287/MUM/2009 06‐05‐2017 PHARMACEUTICAL COMPOSITION FOR ATHEROSCLEROSIS 283909
Page 19 of 85
10056/DELNP/2008 08‐05‐2017 "AN ANTI‐NR10/IL‐31RA ANTIBODY AND USE THEREOF" 283171
1768/MUMNP/2011 08‐05‐2017 DISPERSION OF PHYTOSTEROLS 283174
8326/DELNP/2009 08‐05‐2017 "STERILE, INJECTABLE AQUEOUS FORMULATION" 283175
608/DEL/2011 08‐05‐2017 SKIN TREATING COMPOSITION AND APPLICATIONS THEREOF 283187
3683/KOLNP/2010 09‐05‐2017 QUINOXALINONE DERIVATIVES AS INSULIN SECRETION
STIMULATORS
283208
191/MUMNP/2010 09‐05‐2017 “PHENYLACETIC ACID COMPOUND” 283225
2286/MUM/2012 11‐05‐2017 "PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF LEG
CRAMPS."
283236
1651/DELNP/2009 11‐05‐2017 "SOLID CITRATE AND TARTRATE SALTS OF DPP‐IV INHIBITORS" 283269
6565/DELNP/2009 11‐05‐2017 IMMUNOGENIC COMPOSITIONS COMPRISING MYCOBACTERIUM
TUBERCULOSIS POLYPEPTIDES AND FUSIONS THEREOF
283276
3600/CHENP/2009 15/05/2017 LIPASE VARIANTS FOR PHARMACEUTICAL USE 283306
2726/KOLNP/2011 16‐05‐2017 COATED SOLID PREPARATION 283336
1743/KOLNP/2008 17‐05‐2017 ANTINEOPLASTIC COMBINATIONS WITH MTOR INHIBITOR,
HERCEPTIN, AND/OR HKI‐272
283351
2557/CHENP/2009 17‐05‐2017 TES7 AND ANTIBODIES THAT BIND THERETO 283355
7960/DELNP/2006 17‐05‐2017 "PHTHALAZINE DERIVATIVES AS PARP INHIBITORS" 283357
3018/MUM/2009 17‐05‐2017 A PROCESS FOR PREPARATION OF MULTIPARTICULATE MODIFIED
RELEASE PHARMACEUTICAL COMPOSITIONS
283367
794/CHE/2009 18‐05‐2017 PROCESS FOR THE PREPARATION OF DESMOPRESSIN 283381
281/KOLNP/2011 19‐05‐2017 3‐(3‐PYRIMIDIN‐2‐YL‐BENZYL)‐1,2,4‐TRIAZOLO (4,3‐B)PYRIDAZINE
DERIVATIVES AS MET KINASE INHIBITORS
283405
2939/DELNP/2006 19‐05‐2017 "LIQUID PHARMACEUTICAL COMPOSITION FOR THE PROLONGED
RELEASE OF INTERFERON (S)"
283425
6031/DELNP/2006 19‐05‐2017 "CARBOLINE COMPOUNDS AND COMPOSITION" 283435
335/DELNP/2007 19‐05‐2017 "USE OF COMPOUNDS CONTAINING THIOL GROUPS AS AN EFFLUX
PUMP INHIBITOR"
283436
4464/DELNP/2008 19‐05‐2017 "GANAXOLONE FORMULATIONS AND METHODS FOR MAKING AND
USE THEREOF"
283439
4785/DELNP/2008 22‐05‐2017 "ONCOGENIC RAS‐SPECIFIC CYTOTOXIC COMPOUND AND
METHODS OF USE THEREOF"
283463
2469/KOLNP/2010 22/05/2017 COMPRESSED CHEWING GUM TABLET 283446
6592/DELNP/2007 22‐05‐2017 "LAYERED NANOPARTICLES" 283462
3516/MUM/2010 23‐05‐2017 PHARMACEUTICAL COMPOSITIONS OF TENECTEPLASE 283474
1490/DELNP/2010 23‐05‐2017 "METHODS OF PREPARING 4‐PHENYL‐6‐(2,2,2‐TRIFLUORO‐1‐
PHENYLETHOXY)PYRIMIDINE‐BASED COMPOUNDS"
283482
2829/MUM/2009 25‐05‐2017 A PROCESS FOR THE PREPARATION OF RIFAMPICIN PELLETS OR
RIFAMPICIN GASTRORETENTIVE PELLETS
283558
6425/DELNP/2009 25‐05‐2017 "USE OF OLIGOMERS OF LACTIC ACID IN THE TREATMENT OF
GYNAECOLOGICAL DISORDERS"
283564
9025/DELNP/2008 26‐05‐2017 "ANDROGEN RECEPTOR MODULATOR FOR THE TREATMENT OF
PROSTATE CANCER AND ANDROGEN RECEPTOR‐ASSOCIATED
DISEASE"
283620
6657/DELNP/2010 26‐05‐2017 "ORALLY‐DISINTEGRATING SOLID PREPARATION" 283651
4760/DELNP/2012 29/05/2017 “PACLITAXEL/ STEROIDAL COMPLEX” 283662
2020/DELNP/2010 29/05/2017 "FOAMABLE FLUORIDE ORAL CARE COMPOSITION" 283660
2741/DELNP/2009 29‐05‐2017 “LIQUID CHALCOGENIDE COMPOSITIONS AND METHODS OF
MANUFACTURING AND USING THE SAME”
283663
1345/DEL/2008 29‐05‐2017 "COSMETIC COMPOSITION FOR APPLICATION TO THE SKIN" 283665
173/DELNP/2010 30‐05‐2017 "SUBSTITUTED 6‐ANILINOPURINE DERIVATIVES AS INHIBITORS OF
CYTOKININ OXIDASE/DEHYDROGENASE AND PREPARATIONS
CONTAINING THESE DERIVATIVES"
283713
2989/KOLNP/2010 30‐05‐2017 PARENTERAL FORMULATIONS FOR THE ADMINISTRATION OF
DOPAMINE
283740
672/DEL/2010 31‐05‐2017 A BIOMIMETIC PROCESS FOR THE SYNTHESIS OF AQUEOUS
FERROFLUIDS FOR BIOMEDICAL APPLICATIONS
283789
Page 20 of 85
4406/CHENP/2010 01‐06‐2017 A PROCESS FOR PRODUCING GAMMA MANGOSTIN 283874
3953/KOLNP/2009 02‐06‐2017 MODULATORS OF CFTR 283881
506/DEL/2010 02‐06‐2017 “A NOVEL SALMONELLA TYPHI PROTEIN AS SUBUNIT VACCINE” 283894
7205/DELNP/2007 03‐06‐2017 METHOD FOR OPTIMIZING FLUORIDE UPTAKE OF TEETH BY
APPLYING A LIQUID DENTIFRICE COMPOSITION
281045
1396/MUMNP/2009 05‐06‐2017 SKIN LIGHTENING COMPOSITION FOR HYPERPIGMENTED SKIN 283918
5622/DELNP/2012 06‐06‐2017 STABILIZATION OF ZINC OXIDE FILM IN ORAL COMPOSITIONS 283952
3137/DELNP/2010 06‐06‐2017 "ORAL CARE PRODUCT AND METHODS OF USE AND MANUFACTURE
THEREOF"
283970
2497/MUM/2010 06‐06‐2017 PEARLESCENT LIQUID COSMETIC COMPOSITION 283982
3642/CHENP/2009 06‐06‐2017 STABILIZATION OF UV‐SENSITIVE ACTIVE INGREDIENTS 283993
5909/CHENP/2009 07‐06‐2017 DEPILATORY COMPOSITION 283998
9607/DELNP/2011 07‐06‐2017 "SODIUM IBUPROFEN TABLETS AND METHODS OF
MANUFACTURING PHARMACEUTICAL COMPOSITIONS INCLUDING
SODIUM IBUPROFEN"
284003
455/KOL/2010 07‐06‐2017 PROCESS FOR PREPARING A COMPOSITION EFFECTIVE AGAINST
GASTRO‐INTESTINAL DISORDERS
284007
2676/CHENP/2009 07‐06‐2017 “DUAL ACTION, INHALED FORMULATIONS PROVIDING BOTH AN
IMMEDIATE AND SUSTAINED RELEASE PROFILE”
284045
2448/DEL/2008 08‐06‐2017 A HOMEOPATHIC PREPARATION FOR CONDITIONING OF BARREN
LAND/SALINE LAND
284077
2889/DELNP/2008 08‐06‐2017 “IMPROVED TESTOSTERONE GEL AND METHOD OF USE” 284078
254/DEL/2007 08‐06‐2017 "NOVEL IMMUNOTHERAPEUTIC METHOD FOR TREATMENT OF
CANCER"
284087
1925/KOLNP/2010 09‐06‐2017 PHARMACEUTICAL COMPOSITIONS WITH A MECHANISM OF MULTI‐
TARGET RECEPTOR RETROACTION FOR TREATING DEPRESSION
284094
3132/CHENP/2009 09‐06‐2017 LIQUID ANTI‐RABIES ANTIBODY FORMULATIONS 284108
1726/CHENP/2009 09‐06‐2017 THERAPEUTIC COMPOSITIONS COMPRISING A SPECIFIC
ENDOTHELIN RECEPTOR ANTAGONIST AND A PDE5 INHIBITOR
284113
9480/DELNP/2008 09‐06‐2017 "DIMPLED ADHERING TROCHE FOR USE ON TEETH OR
ORTHODONTIC BRACES"
284115
828/MUMNP/2011 09‐06‐2017 ANTIPERSPIRANT COMPOSITIONS 284126
829/MUMNP/2011 09‐06‐2017 ANTIPERSPIRANT COMPOSITIONS 284127
433/DEL/2009 11‐06‐2017 "A METHOD FOR PRODUCING CALCUIM CARBONATE
NANOPARTICIES USING RECOMBINANT CARBONIC ANHYDRASE
FROM AZOSPIRILLUM BRASILENSE".
289249
603/DEL/2008 12‐06‐2017 NOVEL BENZIMIDAZOLE LINKED PYRROLO[2, 1‐C] BENZODIAZEPINE
HYBRIDS AS POTENTIAL ANTITUMOUR AGENTS AND PROCESS FOR
THE PREPARATION THEREOF
284153
539/MUMNP/2011 12‐06‐2017 UNIVERSAL SENSORY STRUCTURANT 284155
5168/DELNP/2009 12‐06‐2017 "SOLID BETALAIN COMPOSITIONS AND METHODS" 284159
5540/DELNP/2008 12‐06‐2017 PERSONAL CARE COMPOSITIONS CONTAINING CATIONICALLY
MODIFIED STARCH AND AN ANIONIC SURFACTANT SYSTEM
284163
785/DEL/2008 13‐06‐2017 ISOXAZOLINE LINKED PYRROLO[2,1‐C][1,4]BENZODIAZEPINE
HYBRIDS AS POTENTIAL ANTICANCER AGENTS AND THE PROCESS
FOR PREPARATION THEREOF
284169
2136/MUM/2010 13‐06‐2017 "PROCESS FOR PREPARATION OF N‐BENZYL‐2‐
ACETAMIDOPROPIONAMIDE DERIVATIVE"
284175
6945/DELNP/2006 13‐06‐2017 "A COATED TABLET COMPOSTION" 284186
6008/DELNP/2006 13‐06‐2017 "A HOMOGENEOUS PHARMACEUTICAL COMPOSITION SUITABLE
FOR THE TREATMENT OF RHINITIS"
284190
4357/DELNP/2005 14‐06‐2017 "P38 INHIBITORS AND METHODS OF USE THEREOF" 284209
889/MUMNP/2010 14‐06‐2017 HERBAL COMPOSITIONS AND METHODS FOR TREATING HEPATIC
DISORDERS
284222
2180/CHENP/2007 14‐06‐2017 VACCINES AGAINST JAPANESE ENCEPHALITIS VIRUS AND WEST NILE
VIRUS
284237
2750/DELNP/2007 15/06/2017 "QUINUCLIDINE DERIVATIVES AND THEIR USE AS MUSCARINIC M3
RECEPTOR ANTAGONISTS"
284278
Page 21 of 85
2918/DELNP/2007 15‐06‐2017 "OPTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES" 284277
737/KOLNP/2008 16‐06‐2017 BETA‐LACTAMYL PHENYLALANINE, CYSTEINE, AND SERINE
VASOPRESSIN ANTAGONISTS
284299
2146/MUMNP/2009 19‐06‐2017 DPP‐IV INHIBITOR INCLUDING BETA‐AMINO GROUP, PREPARATION
METHOD THEREOF AND PHARMACEUTICAL COMPOSITION
CONTAINING THE SAME FOR PREVENTING AND TREATING A
DIABETES OR AN OBESITY
284333
858/DELNP/2009 19‐06‐2017 "A COMPOUND OF FORMULA (I)" 284343
4850/CHENP/2009 19‐06‐2017 PELLETS COMPRISING AN ACTIVE SUBSTANCE MATRIX RESISTANT
TO GASTRIC JUICE
284351
171/MUM/2012 19‐06‐2017 ANTI‐RHD MONOCLONAL ANTIBODIES 284359
2258/MUMNP/2011 20/06/2017 “METHOD FOR PREPARING ENCAPSULATED LIVER CELL
COMPOSITION”
284386
2137/DELNP/2009 20‐06‐2017 "CONTROLLED RELEASE COMPLEX COMPOSITION COMPRISING
ANGIOTENSIN‐II‐RECEPTOR BLOCKERS AND HMG‐COA REDUCTASE
INHIBITORS"
284361
546/DELNP/2007 20‐06‐2017 A POLYSACCHARIDE COMPOSITION OF GANODERMA 284383
4062/DELNP/2010 20‐06‐2017 "ORAL CARE PRODUCT AND METHODS OF USE AND MANUFACTURE
THEREOF"
284384
1573/DEL/2004 20‐06‐2017 "A NOVEL FUNGAL STRAIN OF CANDIDA TROPICALIS" 284387
2170/DELNP/2010 20‐06‐2017 "TOPICAL COMPOSITION" 284399
2575/DEL/2007 21‐06‐2017 "PROCESS FOR THE PURIFICATION OF SINGLE POLYPEPTIDE CHAIN
PROTEINS"
284404
1760/MUM/2010 21‐06‐2017 "A METHOD FOR PREPARATION OF HIGHLY PURE ASIATICOSIDE
COMPOSITION FROM CENTELLA ASIATICA
284406
306/KOLNP/2011 21‐06‐2017 DIRECTLY COMPRESSIBLE AND RAPIDLY DISINTEGRATING TABLET
MATRIX
284411
1084/MUM/2006 21‐06‐2017 A COMPOSITION FOR THE TREATMENT OF ASTHMA 284421
143/DEL/2010 21‐06‐2017 PROCESS FOR THE PREPARATION OF A GRANULAR ORAL
COMPOSITION
284433
6003/DELNP/2012 22‐06‐2017 PHARMACEUTICAL COMPOSITION COMPRISING METFORMIN AND
ROSUVASTATIN
284447
6561/CHENP/2008 22‐06‐2017 PHARMACEUTICAL FORMULATIONS FOR THE PROLONGED RELEASE
OF ACTIVE PRINCIPLE(S), AND PROCESS FOR PRODUCING THE SAME
284492
4966/CHENP/2008 23‐06‐2017 PHARMACEUTICAL COMPOSITION COMPRISING OSELTAMIVIR
PHOSPHATE
284534
3494/DELNP/2009 23‐06‐2017 "A CHEMICALLY MODIFIED PROTEINACEOUS CONSTRUCT" 284500
133/MUM/2008 23‐06‐2017 A METHOD FOR PREPARATION OF LIPOSOMES 284531
716/CHENP/2007 23‐06‐2017 MULTIPARTICULATES 284537
2445/DEL/2008 27/06/2017 A HOMEOPATHIC PREPARATION FOR TREATMENT OF ANIMALS
SUFFERING FROM PRIMARY STAGES OF MAMMARY GLAND
DISORDERS"
284568
2456/DEL/2008 27‐06‐2017 A HOMEOPATHIC PREPARATION FOR EASY MILKING OF ANIMALS 284570
5099/DELNP/2009 27‐06‐2017 “A NOVEL PHARMACEUTICAL COMPOSITION” 284577
8114/DELNP/2007 27‐06‐2017 COMPOSITIONS AND METHODS FOR TREATMENT OF EYE
DISORDERS
284595
4452/CHENP/2009 27‐06‐2017 "POLY(ADP‐RIBOSE)POLYMERASE INHIBITORY COMPOUND" 284604
2721/CHENP/2010 28‐06‐2017 A NEW NUTRACEUTICAL COMPOSITION FROM GARCINIA
MANGOSTANA
284654
154/MUMNP/2010 28‐06‐2017 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC
INHIBITORS
284671
2451/DEL/2008 28‐06‐2017 A HOMEOPATHIC PREPARATION FOR TREATMENT OF ANIMALS
SUFFERING FROM INTESTINAL PARASITES WORMS INFECTION AND
ASSOCIATED CONSTIPATION, STOMACH BLOATING ETC
284673
1596/CHENP/2010 28‐06‐2017 PH‐DEPENDENT CONTROLLED RELEASE PHARMACEUTICAL
COMPOSITION FOR NON‐OPIOIDS WITH RESISTANCE AGAINST THE
INFLUENCE OF ETHANOL
284682
Page 22 of 85
2454/DEL/2008 29‐06‐2017 A HOMEOPATHIC PREPARATION FOR TREATMENT OF ANIMALS
SUFFERING FROM MAMMARY GLAND DISORDERS
284699
5203/CHENP/2010 29‐06‐2017 PROTOPANAXADIOL‐TYPE GINSENOSIDE COMPOSITIONS 284703
194/CHENP/2008 29‐06‐2017 BREATH FRESHENING AND ORAL CLEANSING PRODUCT
COMPRISING A MAGNOLIA BARK EXTRACT AND SURFACTANT
284713
3871/CHENP/2008 29‐06‐2017 COMPOSITIONS FOR VAGINAL USE 284744
2791/DEL/2008 29‐06‐2017 SYNERGISTIC ANTIFUNGAL COMPOSITION OF DEHYDRATED
DIALDOL PRODUCT AND NATURAL PRODUCT
284748
3615/KOLNP/2010 29‐06‐2017 HCV PROTEASE INHIBITORS 284752
2876/CHENP/2008 29‐06‐2017 TARGETING VECTOR‐PHOSPHOLIPID CONJUGATES 284761
4507/KOLNP/2008 30‐06‐2017 SITE‐SPECIFIC INTESTINAL DELIVERY OF ADSORBENTS, ALONE OR IN
COMBINATION WITH DEGRADING MOLECULES
284798
10627/DELNP/2008 30‐06‐2017 COMPOSITONS AND METHODS FOR TREATING PARASITIC
INFECTIONS
284805
957/MUM/2004 30‐06‐2017 Novel tri –polymer combination based controlled release
composition
284820
3867/CHENP/2008 30‐06‐2017 PHARMACEUTICAL COMPOSITION FOR APPLICATION TO NAIL 284828
4254/KOLNP/2010 30‐06‐2017 QUINAZOLINE DERIVATIVES 284850
258/MUM/2007 03‐07‐2017 HERBAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF
MAREK'S DISEASE AND IMMUNITY ENHANCEMENT IN POULTRY
284870
1314/DELNP/2007 03‐07‐2017 "A DELAYED RELEASE PHARMACEUTICAL FORMULATION
COMPRISING KATP CHANNEL OPENERS"
284890
697/DELNP/2007 05‐07‐2017 "STABILISED PROSTAGLANDIN COMPOSITION" 284922
2359/DEL/2010 05‐07‐2017 ANTI‐INFLAMMATORY AND ANTI‐ANGIOGENIC PEPTIDES AND
THEIR USES
284923
5585/CHENP/2007 06‐07‐2017 IL‐31 MONOCLONAL ANTIBODIES AND METHODS OF USE 284946
6762/CHENP/2009 06‐07‐2017 PHARMACEUTICAL FORMULATIONS CONTAINING LIPOTIC ACID
DERIVATIVES
284941
4860/DELNP/2007 06‐07‐2017 "ORAL COMPOSITIONS CONTAINING OXIDIZED CAMELLIA" 284943
2080/CHE/2011 07‐07‐2017 PROCESS FOR PREPARATION OF A PLANT BASED ANTIVIRAL
COMPOSITION FOR THE TREATMENT OF HIV AND HIV RELATED
ACQUIRED IMMUNO DEFICIENCY SYNDROME
284965
316/CHE/2010 07‐07‐2017 PROCESS FOR THE PURIFICATION OF DEFERASIROX 284974
8293/DELNP/2008 07‐07‐2017 LOW MOLECULAR WEIGHT AMPHOLYTIC POLYMERS FOR
PERSONAL CARE APPLICATIONS
284975
5578/DELNP/2008 07‐07‐2017 USE OF TYPE II PNEUMOCYTES IN THE TREATMENT OF PULMONARY
DISEASES ASSOCIATED WITH PULMONARY FIBROSIS
284983
235/MUM/2011 09‐07‐2017 A method for making an extract of an overground part of
Hedychium
coronarium Koenig
287179
4188/DELNP/2007 10‐07‐2017 "A METHOD FOR PREPARING AN EXTRACT OF PIPER LAETISIPICUM
C.DC."
285022
305/DELNP/2007 11‐07‐2017 "CYCLIC PROGESTIN REGIMENS AND KITS" 289320
2540/DEL/2008 11‐07‐2017 CINNAMIDO‐PYRROLO[2,1‐C][1,4]BENZODIAZEPINES AS POTENTIAL
ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION
THEREOF
285045
3870/CHENP/2008 11‐07‐2017 HEMOSTATIC MATERIAL 285055
3512/CHENP/2009 11‐07‐2017 PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATION 285072
1785/CHE/2009 11‐07‐2017 "STABLE PHARMACEUTICAL COMPOSITIONS" 285082
2626/DELNP/2010 12‐07‐2017 "PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT
AND/OR THE PREVENTION OF OSTEOARTICULAR DISEASES"
285102
7338/DELNP/2006 12‐07‐2017 "OXIDATIVE DEGRADATION PRODUCTS OF ATORVASTATIN
CALCIUM".
285134
8103/CHENP/2011 13‐07‐2017 ANTIMYCOTIC PHARMACEUTICAL COMPOSITION 285139
2168/MUMNP/2011 14‐07‐2017 SWOLLEN SILICONE COMPOSITION AND PROCESS OF PRODUCING
SAME
285191
Page 23 of 85
4633/CHENP/2009 14‐07‐2017 COMPOSITION COMPRISING WATER SOLUBLE CHITOSAN AMINO‐
POLYSACCHARIDE
285207
6490/DELNP/2010 14‐07‐2017 'PHARMACEUTICAL COMPOSITION COMPRISING RACETAM AND
CARNITINE AND PROCESS FOR ITS PREPARATION'
285234
3869/DELNP/2010 17‐07‐2017 MACROCYCLIC CARBOXYLIC ACIDS AND ACYLSULFONAMIDES AS
INHIBITORS OF HCV REPLICATION
285245
2196/DELNP/2008 17‐07‐2017 "SACHET FORMULATION FOR AMINE POLYMERS" 285250
7342/DELNP/2008 17‐07‐2017 "NANOPARTICLES FOR IMMUNOTHERAPY" 285284
2121/DEL/2009 18/07/2017 "IMIDAZOTHIAZOLE‐CHALCONE HYBRIDS AS POTENTIAL
ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION
THEREOF"
285355
1711/DEL/2007 18‐07‐2017 AN IMPROVED PROCESS FOR THE ISOLATION OF 2,5‐DIHYDROXY‐1,
4‐BENZOQUINONE DERIVATIVES LIKE EMBELIN FROM NATURAL
RESOURCES
285296
1074/MUM/2012 18‐07‐2017 "PHARMACEUTICAL COMPOSITION CONTAINING ACRYLATE TYPE
AQUEOUS BASED PRESSURE SENSITIVE ADHESIVE FOR
TRANSDERMAL DRUG DELIVERY"
285298
9017/DELNP/2008 18‐07‐2017 "METHODS TO ADMINISTER SOLID DOSAGE FORMS OF ETHINYL
ESTRADIOL AND PRODRUGS THEREOF WITH IMPROVED
BIOAVAILABILITY"
285319
6795/DELNP/2009 18‐07‐2017 COSMETIC COMPOSITIONS COMPRISING ESTERS BASED ON
PROPYLHEPTANOL
285322
2456/DEL/2007 18‐07‐2017 5‐[TRIMETHOXY PHENYL]‐1‐THIOMTHYL‐N‐ARYLAMINO‐PENTA‐1,4‐
DIEN‐3‐ONES
285336
755/DEL/2007 18‐07‐2017 "COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A
POLYCONDENSATE, COSMETIC TREATMENT PROCESS USING THE
SAID COMPOSITION, THE SAID POLYCONDENSATE, AND
PREPARATION PROCESS THEREFOR"
285339
1182/DEL/2006 18‐07‐2017 "A PROCESS FOR THE PREPARATION OF ATAXANE DERIVATIVE" 285341
3136/KOLNP/2009 18‐07‐2017 A TRANSDERMAL DELIVERY DEVICE AND METHOD OF
PREPARATION THEREOF
285344
1814/CHENP/2010 19‐07‐2017 PHARMACEUTICAL COMPOSITION 285374
1203/MUMNP/2012 19‐07‐2017 HYDROPHILIC FILTRATION DURING MANUFACTURE OF VACCINE
ADJUVANTS
285375
3740/CHENP/2010 19‐07‐2017 PREPARATION OF CATIONIC TERPOLYMERS AND PERSONAL CARE
COMPOSITIONS
285399
645/DEL/2008 19‐07‐2017 "A PROCESS FOR SYNTHESIS OF POLYMERIC MICRO/
NANOPARTICLES FOR DRUG (BIOACTIVE AGENT) DELIVERY
APPLICATIONS"
285405
635/DELNP/2011 19‐07‐2017 CONTROLLED RELEASE ANTIMICROBIAL COMPOSITIONS AND
METHODS FOR THE TREATMENT OF OTIC DISORDERS
285410
956/CHENP/2010 20‐07‐2017 ANTIFUNGAL COMPOSITION 285431
876/DEL/2008 21‐07‐2017 "HERBAL COMPOSITION FOR CHIN AND NECK FIRMING" 285462
679/DEL/2008 21‐07‐2017 "HERBAL COMPOSITION FOR HIPS,THIGHS AND ARMS FIRMING" 285463
1357/CHENP/2010 21‐07‐2017 BUFFER SOLUTIONS HAVING SELECTIVE BACTERICIDAL ACTIVITY
AGAINST GRAM NEGATIVE BACTERIA AND METHODS OF USING
SAME
285468
3157/DELNP/2007 21‐07‐2017 "SOPHORAE SUBPROSTRATAE RADIX EXTRACT FOR PREVENTION
AND TREATMENT OF RESPIRATORY DISEASES"
285504
8256/DELNP/2009 22‐07‐2017 HYDROCARBON MIXTURES AND USE THEREOF 285507
2695/MUMNP/2010 24/07/2017 SUNSCREEN COMPOSITE PARTICLES DISPERSED IN WATER‐IN‐OIL
COSMETIC COMPOSITIONS
285510
2697/MUMNP/2010 24/07/2017 SUNSCREEN FORMULA VANISHING CREAM 285511
1920/DELNP/2010 24‐07‐2017 "PROCESS FOR THE MANUFACTURE OF A PHARMACEUTICAL
PRODUCT"
285514
2311/DEL/2006 24‐07‐2017 UREA BASED INCLUSION COMPLEXES OF ISOTRETINOIN ,ENALAPRIL
MALEATE AND AMILORIDE HYDROCHLORIDE AND PROCESSES
THEREOF
285521
2340/MUMNP/2011 24‐07‐2017 COMPOSITION 285536
Page 24 of 85
131/DELNP/2008 24‐07‐2017 POLYUNSATURATED FATTY ACIDS FOR TREATMENT OF DEMENTIA
AND PRE‐DEMENTIA‐RELATED CONDITIONS
285544
6304/DELNP/2006 24‐07‐2017 "COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS" 285553
7561/DELNP/2009 24‐07‐2017 "A PHARMACEUTICAL FORMULATION" 285557
9244/DELNP/2007 25‐07‐2017 "A SOLID PHARMACEUTICAL COMPOSITION WITH A FIRST
FRACTION OF A DISPERSION MEDIUM AND A SECOND FRACTION OF
A MATRIX, THE LATTER BEING AT LEAST PARTIALLY FIRST EXPOSED
TO GASTROINTESTINAL FLUIDS"
285617
4032/DELNP/2011 26/07/2017 "METHOD FOR PREPARING PERSONAL CARE COMPOSITION
COMPRISING SURFACTANT AND HIGH MELTING POINT FATTY
COMPOUND"
285641
3348/MUM/2012 26‐07‐2017 "A PROCESS FOR PREPARATION OF INTRAVENOUS COMPOSITION" 285627
5229/DELNP/2008 26‐07‐2017 ORAL THERAPEUTIC COMPOUND DELIVERY SYSTEM 285633
891/DEL/2006 26‐07‐2017 SYNTHESIS OF NOVEL PYRROLO [1'',2'':1,6]‐, AND MORPHOLINO
[1'',2'':1,6]TETRAHYDROPYRIDO[2,3‐B]‐QUINOLINE
285645
1114/DEL/2009 26‐07‐2017 A NOVEL ANTI‐DIABETIC FUROSTANOLIC‐SAPONIN‐RICH (FSR)
FRACTION FROM FENUGREEK SEEDS
285647
4181/DELNP/2012 27‐07‐2017 "ANTI‐EROSION TOOTHPASTE COMPOSITION" 285713
223/KOLNP/2010 27‐07‐2017 (2S,3R)‐N‐(2‐((3‐PYRIDINYL)METHYL)‐1‐AZABICYCLO[2,2,2]OCT‐3‐
YL)BENZOFURAN‐2‐CARBOXAMIDE, NOVEL SALT FORMS
285735
2466/CHENP/2011 28/07/2017 4,5,6,7‐TETRAHYDROIMIDAZO[4,5‐C]PYRIDINE COMPOUNDS 285810
2452/DEL/2008 28/07/2017 A HOMEOPATHIC PREPARATION FOR TREATMENT OF MOUTH
ULCERS AND FOOT ULCERS IN ANIMALS
285773
8668/DELNP/2010 28‐07‐2017 "CAPSULE PHARMACEUTICAL DOSAGE FORM COMPRISING A
SUSPENSION FORMULATION OF AN INDOLINONE DERIVATIVE"
285760
1391/MUM/2007 28‐07‐2017 A SYNERGISTIC ANTIBIOTIC FORMULATION 285771
3236/KOLNP/2009 28‐07‐2017 4‐NAPHTHYLOXY SUBSTITUTED QUINOLINE OR QUINAZOLINE
DERIVATIVES
285781
1136/MUMNP/2011 28‐07‐2017 HAIR CARE COMPOSITION COMPRISING A DENDRITIC
MACROMOLECULE
285785
1184/MUM/2009 28‐07‐2017 VACCINE COMPOSITION CONTAINING NOVEL ADJUVANTS 285791
5364/CHENP/2010 28‐07‐2017 METHOD FOR PRODUCTION OF ORALLY RAPIDLY DISINTEGRATING
TABLET COMPRISING IMIDAFENACIN AS ACTIVE INGREDIENT
285816
1726/DEL/2012 28‐07‐2017 "NEW CO‐CRYSTALS OF AGOMELATINE, A PROCESS FOR THEIR
PREPARATION AND PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM"
285822
213/MUMNP/2011 31/07/2017 LIQUID PERSONAL CLEANSING COMPOSITION 285880
4166/CHENP/2010 31‐07‐2017 COATED PHARMACEUTICAL OR NUTRACEUTICAL PREPARATION
WITH ENHANCED PULSED ACTIVE SUBSTANCE RELEASE
285888
732/KOLNP/2012 31‐07‐2017 FILM COATING AGENT FOR SOLID PREPARATION, AND SOLID
PREPARATION USING SAME
285860
3600/CHENP/2010 31‐07‐2017 A SOLID COMPRESSED CONTROLLED RELEASE FORMULATION 285887
611/DEL/2009 31‐07‐2017 PLANT EXTRACT FOR TREATING ANXIETY DISORDERS 285895
2100/KOLNP/2010 31‐07‐2017 ANALOGUES AND DERIVATIVES OF MYCOPHENOLIC ACID 285931
625/KOLNP/2010 31‐07‐2017 METHOD FOR PREPARING AN INHALABLE DRY‐POWDER
MEDICAMENT
285933
5052/DELNP/2009 02‐08‐2017 "SP35 ANTIBODIES AND USES THEREOF" 286022
925/CHENP/2009 03‐08‐2017 TRANSMUCOSAL DELIVERY DEVICES WITH ENHANCED UPTAKE 286045
1099/KOLNP/2010 03‐08‐2017 GAS57 MUTANT ANTIGENS AND GAS57 ANTIBODIES 286052
3288/CHENP/2009 03‐08‐2017 A SYSTEM FOR DETERMINING A DISTRIBUTION OF RADIOACTIVE
AGENTS IN A SUBJECT
286057
1193/KOLNP/2011 03‐08‐2017 A STABLE TOPICAL CREAM COMPOSITION 286059
514/KOLNP/2009 07‐08‐2017 PEPTIDES HAVING PHARMACOLOGICAL ACTIVITY FOR TREATING
DISORDERS ASSOCIATED WITH ALTERED CELL MIGRATION, SUCH AS
CANCER
286107
Page 25 of 85
7974/DELNP/2010 07‐08‐2017 "TRANSNASAL ANTICONVULSIVE PHARMACEUTICAL COMPOSITION
COMPRISING POORLY SOLUBLE ANTICONVULSANT"
286116
949/KOLNP/2010 08‐08‐2017 PSMA BINDING LIGAND‐LINKER CONJUGATES AND METHODS FOR
USING
286122
3068/MUM/2010 08‐08‐2017 PHARMACEUTICAL COMPOSITION OF TAXOIDS 286125
1204/MUM/2009 09‐08‐2017 A MEDICINAL COMPOSITION FOR CURING DIABETES TYPE II 286209
3404/CHENP/2010 10‐08‐2017 AGENT FOR TREATING ULCER 286222
6300/CHENP/2010 10‐08‐2017 NOVEL 1‐BENZYL‐3‐HYDROXYMETHYLINDAZOLE DERIVATIVES 286226
6866/CHENP/2009 10‐08‐2017 NEW METHOD FOR PREPARING ISOFAGOMINE AND ITS
DERIVATIVES
286227
6826/DELNP/2008 10‐08‐2017 "COMPOSITIONS AND METHODS FOR INDUCING BONE GROWTH
AND INHIBITING BONE LOSS"
286234
8431/DELNP/2008 10‐08‐2017 "MULTI‐LAYER MEDICAL PATCH WITH IMPERMEABLE CENTER" 286247
878/CHENP/2009 11‐08‐2017 A PHARMACEUTICAL LIPOSOMAL FORMULATION FOR
PHOTODYNAMIC THERAPHY
286260
3200/DELNP/2009 11‐08‐2017 "HPV ANTIGEN FUSION PROTEIN VACCINE COMPOSITIONS AND
USES THEREOF"
286292
8081/DELNP/2007 11‐08‐2017 "MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE‐PROTEIN
CONJUGATE COMPOSITION"
286321
795/CHE/2009 14‐08‐2017 AN IMPROVED PROCESS FOR THE PREPARATION OF ROTIGOTIN
AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
286338
7685/DELNP/2008 14‐08‐2017 "A PHARMACEUTICAL COMBINATION FOR CHEMOSENSIBILIZATION
"
286342
3015/DELNP/2007 16/08/2017 "ALIPHATIC AMINE POLYMER SALTS FOR TABLETING" 286357
2510/CHE/2010 16/08/2017 THE COMPRESSION COATED TABLET COMPOSITION FOR
CHRONOTHERAPY OF HYPERTENSION
286353
191/MUM/2008 16‐08‐2017 AN IMPROVED PROCESS FOR THE PREPARATION OF 2‐BUTYL‐4‐
CHLORO‐1‐[[(2'(1H‐TETRAZOLE‐5‐YL)[1,1 BIPHENYL]‐4‐YL]METHYL]‐
1H‐IMIDAZOLE‐5‐METHANOL
286363
4453/DELNP/2010 17‐08‐2017 "METHOD FOR PREPARING NANOPARTICLES BASED ON
FUNCTIONAL AMPHIPHILIC MOLECULES OR MACROMOLECULES,
AND THE USE THEREOF"
286387
662/DEL/2008 18‐08‐2017 HERBAL COMPOSITON OF WAIST & TUMMY TRIMMING / FIRMING 286399
4860/DELNP/2008 18‐08‐2017 “A DEPIGMENTING COMPOSITION ” 286408
5609/DELNP/2010 18‐08‐2017 "COMPOSITIONS AND METHODS FOR INFLUENCING RECOVERY
FROM STRENUOUS PHYSICAL ACTIVITY"
286425
631/CHE/2006 18‐08‐2017 PROCESS FOR ISOLATION OF BERGENIN FROM CAESALPINIA
DIGYNA ROTTLER
286441
151/MUM/2007 21‐08‐2017 NOVEL COMPOSITION OF PAPAIN AS DESLOUGHING SKIN CARE
AGENTS AND METHOD THEREOF
286455
4987/CHENP/2010 21‐08‐2017 SKIN WHITENING AGENT AND EXTERNAL PREPARATION FOR THE
SKIN
286495
3606/DELNP/2007 21‐08‐2017 "NONAQUEOUS PREPARATION FOR PERCUTANEOUS ABSORPTION
CONTAINING NONSTEROIDAL ANTI INFLAMMATORY ANALGESIC"
286497
1279/MUMNP/2011 22‐08‐2017 "EMULSIFIED COSMETIC COMPOSITION" 286512
4510/KOLNP/2010 22‐08‐2017 BENZOIMIDAZOLES AS PROLYL HYDROXYLASE INHIBITORS 286515
4912/DELNP/2010 22‐08‐2017 "USE OF POLYELECTROLYTE COMPLEXES IN ANTIPERSPIRANT
TECHNOLOGY"
286531
831/DELNP/2009 23‐08‐2017 "VITAMIN D COMPOSITIONS AND METHOD OF ADMINSTRATION TO
A HUMAN BEING"
286544
1962/KOLNP/2009 24‐08‐2017 IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASE
INHIBITORS
286624
126/DEL/2010 24‐08‐2017 A PROCESS FOR THE PREPARATION OF COLLAGENOUS FILM FOR
OPTHALMIC APPLICATIONS
286626
3774/DELNP/2010 25‐08‐2017 "A COMPOSITION SUITABLE FOR ENHANCING CONGNITIVE
FUNCTIONS IN AN ANIMAL"
286637
Page 26 of 85
6461/DELNP/2010 25‐08‐2017 "KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR
PREVENTING OCULAR PAIN"
286644
3183/DELNP/2010 25‐08‐2017 “PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ASTHMA,
COPD, ALLERGIC RHINITIS, ALLERGIC CONJUNCTIVITIS, ATOPIC
DERMATITIS, CANCER, HEPATITIS B, HEPATITIS C, HIV, HPV,
BACTERIAL INFECTIONS AND DERMATOSIS”
286652
6294/DELNP/2007 28‐08‐2017 "PHARMACEUTICAL LIPID COMPOSITIONS" 286691
6547/CHENP/2009 28‐08‐2017 "CRYSTAL MODIFICATIONS OF TRANSMISSION DYES" 286698
235/DEL/2011 28‐08‐2017 PROCESS FOR PREPARATION OF MONOISOAMYL
DIMERCAPTOSUCCINIC ACID AND APPLICATIONS THEREOF.
286702
252/DEL/2007 28‐08‐2017 "IMMUNOTHERAPEUTIC COMPOSITION" 286707
453/CHENP/2010 28‐08‐2017 MICROPARTICLES COMPRISING PCL AND USES 286712
3410/CHENP/2008 28‐08‐2017 BOTULINUM NANOEMULSIONS 286725
7476/DELNP/2010 28‐08‐2017 IMPROVEMENTS TO SOLUTION AND METHOD FOR CLEANING
TOOTH ENAMEL
286737
2419/KOLNP/2009 29/08/2017 SMALL VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS
CONTAINING SUFENTANIL FOR TREATMENT OF PAIN
286766
4918/DELNP/2008 29/08/2017 COSMETIC OR DERMATOLOGICAL COMPOSITIONS COMPRISING
MODIFIED TITANIUM DIOXIDE PARTICLES
286753
749/DELNP/2011 29‐08‐2017 "THERAPEUTIC AND PROPHYLACTIC FORMULATION FOR ORAL
CARE"
286787
2912/CHENP/2010 29‐08‐2017 “A COMPOSITION COMPRISING INSULINOTROPIC PEPTIDE
CONJUGATE”
286798
941/KOLNP/2009 29‐08‐2017 SELECTIVELY TARGETED ANTIMICROBIAL PEPTIDES AND THE USE
THEREOF
286802
1259/DEL/2007 29‐08‐2017 "A NOVEL DENGUE ENVELOPE DOMAIN III‐BASED TETRAVALENT
PROTEIN VACCINE"
286804
3786/KOLNP/2010 29‐08‐2017 SOLID ORAL FORM WITH DUAL RELEASE PROFILE, CONTAINING
MULTIPARTICULATES
286808
4185/DELNP/2012 30‐08‐2017 "DISSOLVABLE FILMS CONTAINING HIGH CONCENTRATIONS OF
NONIONIC SURFACTANTS SUCH AS POLYSORBATES TO ENHANCE
HIGH SOLID LOADINGS"
286811
86/DEL/2007 30‐08‐2017 "ROSAGLITAZONE LOADED BRAIN PERMEABLE NANOPARTICLES
AND METHOD OF PREPARATION"
286815
87/DEL/2007 30‐08‐2017 "STATIN LOADED BRAIN PERMEABLE NANOPARTICLES AND
METHOD OF PREPARATION"
286818
5810/DELNP/2005 30‐08‐2017 "PROCESS FOR OBTANING TRITERPENES FROM PLANT AND/OR
THEIR COMPONENTS."
286840
6520/DELNP/2006 30‐08‐2017 "LIPIDS, LIPID COMPLEXES AND USE THEREOF" 286846
1865/CHE/2009 30‐08‐2017 "AN IMPROVED PROCESS FOR PREPARATION OF ROSUVASTATIN
CALCIUM"
286863
4723/DELNP/2008 30‐08‐2017 "COMBINATION VACCINE COMPRISING AN ATTENUATED BOVINE
VIRAL DIARRHEA VIRUS"
286866
1300/KOL/2009 31‐08‐2017 STABLE EGUALENE SODIUM SOLID PREPARATION 286893
106/KOL/2012 31‐08‐2017 AN IMPROVED SKIN BRIGHTENING COMPLEX 286902
2778/CHENP/2010 31‐08‐2017 “A COMPLEX OF NUCLEIC ACID AND CATIONIC NANOPARTICLES
AND METHOD OF PREPARATION THEREOF”
286924
3462/DELNP/2008 31‐08‐2017 "SULFOALKYL ETHER CYCLODEXTRIN COMPOSITIONS AND
METHODS OF PREPARATION THEREOF"
286927
1874/MUMNP/2009 31‐08‐2017 BENZIMIDAZOLE CANNABINOID AGONISTS 286930
1811/CHENP/2010 31‐08‐2017 ANTIFUNGAL PHARMACEUTICAL COMPOSITION 286955
5708/DELNP/2009 31‐08‐2017 "BACTERIAL EXTRACT FOR DIGESTIVE OR URINARY TRACT
DISORDERS AND PROCESS FOR ITS PREPARATION"
286966
8845/DELNP/2008 31‐08‐2017 "PROCESS FOR PREPARING SPRAY DRIED FORMULATIONS OF TMC
125"
286996
2961/DELNP/2010 01‐09‐2017 " A Formulation in the form of a lozenge comprising an
endothermic cooling agent and one or more active ingredients"
287015
3862/DELNP/2010 01‐09‐2017 "THERAPEUTIC AGENT FOR PRURITUS" 287016
1340/DELNP/2010 01‐09‐2017 "A METHOD OF PREPARING THE VACCINE COMPOSITION" 287022
Page 27 of 85
5804/DELNP/2006 04‐09‐2017 "A‐3‐OR 4‐MONOSUBSTITUTED PHENOL OR THIOPHENOL
DERIVATIVES COMPOUND OF THE FORMULA (1) "
287044
618/DEL/2008 04‐09‐2017 STYRENE MALEIC ANHYDRIDE BASED FORMULATION FOR MALE
CONTRACEPTION AND PROSTATE CANCER
287045
1369/MUM/2008 04‐09‐2017 STABILIZED PREPARATION OF ERYTHROPOIETIN AND PROCESS OF
FORMULATION
287065
3674/KOLNP/2010 05‐09‐2017 STABILIZED OLEOSOME PREPARATIONS AND METHODS OF MAKING
THEM
287089
2971/KOLNP/2008 05‐09‐2017 VACCINES AND IMMUNOTHERAPEUTICS USING CODON OPTIMIZED
IL‐15 AND METHODS FOR USING THE SAME
287092
1008/KOLNP/2009 05‐09‐2017 LONG LASTING DRUG FORMULATIONS 287099
2763/KOLNP/2010 05‐09‐2017 MICROPARTICLE AND PHARMACEUTICAL COMPOSITION THEREOF 287102
7838/DELNP/2007 05‐09‐2017 A CONTROLLED RELEASE COMPOSITION FOR TREATING PROSTATE
RELATED
DISEASES
287112
2481/CHE/2007 06‐09‐2017 A PROCESS FOR PREPARATION OF TETRAHYDROCARBAZOLONE
DERIVATIVES
287156
1148/CHE/2008 07‐09‐2017 A PROCESS FOR THE PREPARATION OF VALPROIC ACID 287182
7808/DELNP/2010 07‐09‐2017 "SOLID PHARMACEUTICAL FORMULATION WITH DELAYED RELEASE" 287216
2929/CHE/2007 08‐09‐2017 PROCESS FOR PRODUCING 5‐FLUORO‐1‐(2R, 5S)‐[2‐
(HYDROXYMETHYL)‐1,3‐OXATHIOLAN‐5‐Y1]CYTOSINE
287250
6539/DELNP/2009 11‐09‐2017 "PYRAZOLO [3,4‐B] PYRIDINE DERIVATIVES AS
PHOSPHODIESTERASE INHIBITORS"
287282
14/KOLNP/2007 12‐09‐2017 "DIMENSIONAL ANALYSIS OF SACCHARIDE CONJUGATES WITH
GPC & SECMALS"
287314
747/DELNP/2011 13‐09‐2017 "COMPOSITIONS FOR TREATING ROSACEA COMPRISING CHITOSAN
AND A DICARBOXYLIC ACID"
287342
4018/DELNP/2005 13‐09‐2017 "COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING
CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA
CELLS, OR ANGIOGENESIS"
287343
2722/CHE/2009 14‐09‐2017 Process for preparation and purification of pegylated interferon 287389
105/MUM/2011 14‐09‐2017 SELF ASSEMBLED NANOSTRUCTURED SALIVA SUBSTITUTES. 287402
575/CHENP/2009 14‐09‐2017 "NANOLIPOSOME COMPRISING LIPOSOME MEMBRANE
CONTAINING ESTERIFIED LECITHIN"
287406
1921/KOLNP/2005 15‐09‐2017 A PROTECTED ANTINEOPLASTIC AGENT 287427
4043/DELNP/2009 18/09/2017 "GALENICAL FORM FOR THE ADMINISTRATION OF PARACETAMOL
BY TRANSMUCOUS MEANS"
287452
364/DELNP/2011 18/09/2017 A SINGLE PHASE PHARMACEUTICAL COMPOSITION OF A 5‐HT1
INHIBITOR AND AN NSAID
287444
1807/MUM/2008 18‐09‐2017 PROLONGED RELEASE FORMULATION OF AMISULPRIDE 287456
961/MUMNP/2011 18‐09‐2017 “PHARMACEUTICAL COMPOSITIONS WITH ATTENUATED RELEASE
OF PHENOLIC OPIOIDS”
287462
6451/DELNP/2009 18‐09‐2017 "A PHARMACEUTICAL COMPOSITION" 287478
288/CHENP/2009 19/09/2017 PHARMACEUTICAL COMPOSITIONS 287504
2710/CHENP/2011 19‐09‐2017 MIXTURES OF ALKYLSULFOCUCCINATES AND THEIR USE 287497
3003/CHE/2007 19‐09‐2017 A PROCESS FOR PREPARATION OF E‐ISOMER OF 1‐4‐
(METHYLPHENYL)‐1‐(2‐PYRIDYL)‐3‐PYRROLIDINO PROP‐1‐ENE AND
ACID ADDITION SALTS THEREOF
287509
3155/DELNP/2011 19‐09‐2017 "PERSONAL CARE COMPOSITIONS PROVIDING ENHANCED COOLING
SENSATION"
287520
6453/CHENP/2008 19‐09‐2017 PATCH AND USES THEREOF 287529
3540/DELNP/2011 20‐09‐2017 "NICOTINE IMMUNONANOTHERAPEUTICS" 287537
3541/DELNP/2011 20‐09‐2017 "TARGETING OF ANTIGEN PRESENTING CELLS WITH
IMMUNONANOTHERAPEUTICS"
287539
627/MUMNP/2011 21‐09‐2017 NEW CONTROLLED RELEASE ACTIVE AGENT CARRIER 287590
176/MUMNP/2011 21‐09‐2017 A process for preparing a compound of formula I 287592
Page 28 of 85
5401/DELNP/2011 21‐09‐2017 "OINTMENT FOR THE TOPICAL TREATMENT OF HAEMORRHOIDS" 287598
8104/CHENP/2011 22‐09‐2017 ANTIMYCOTIC PHARMACEUTICAL COMPOSITION 287640
1321/DELNP/2008 22‐09‐2017 “CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION” 287659
4349/DELNP/2012 22‐09‐2017 "A composition comprising as active ingredients one or more
antimicrobial agents and one or more chalcone compounds"
287669
5400/CHENP/2012 22‐09‐2017 PROCESS FOR THE PREPARATION OF GADOBENATE DIMEGLUMINE
COMPLEX IN A SOLID FORM
287677
1426/DELNP/2006 22‐09‐2017 BICYCLIC [3.1.0] DERIVATIVES AS GLYCINE TRANSPORTER
INHIBITORS
287678
2432/KOLNP/2009 25/09/2017 NEUROMUSCULAR BLOCKING AGENTS 287758
1943/CHENP/2011 25‐09‐2017 PH‐DEPENDENT CONTROLLED RELEASE PHARMACEUTICAL
COMPOSITION FOR NON‐OPIOIDS WITH RESISTANCE AGAINST THE
INFLUENCE OF ETHANOL
287692
4893/CHENP/2010 25‐09‐2017 DEPILATORY COMPOSITION COMPRISING HYDROPHOBIC
PARTICLES, PROCESS FOR PREPARATION AND METHOD OF USE
287702
4731/DELNP/2011 25‐09‐2017 "ADHESIVE MATERIAL CONTAINING 5‐METHYL‐1‐PHENYL‐2‐(1H)‐
PYRIDONE"
287717
6202/DELNP/2010 25‐09‐2017 "COMBINED USE OF CHOLESTANOL DERIVATIVE" 287752
3910/DELNP/2008 26/09/2017 "USE OF PYRROLOQUINOLINE COMPOUNDS TO KILL CLINICALLY
LATENT MICROORGANISMS"
287814
938/KOL/2007 26‐09‐2017 PROCESS FOR PREPARING HYDROXYCARBOXAMIDES 287797
7595/CHENP/2010 27‐09‐2017 PHARMACEUTICAL FORMULATION CONTAINING PALMITOYL
ETHANOLAMIDE AND STEAROYL ETHANOLAMIDE
287852
3748/KOLNP/2009 27‐09‐2017 A COMPOSITION COMPRISING BACTERIALLY‐DERIVED MINICELLS 287864
6394/CHENP/2009 28‐09‐2017 “ATTENUATED VIRUSES USEFUL FOR VACCINES” 287882
7526/DELNP/2010 28‐09‐2017 "A METHOD FOR INDUCING CD14 POSITIVE MONOCYTES TO
DIFFERENTIATE INTO DENDRITIC CELL‐LIKE CELLS."
287896
2749/DEL/2006 29‐09‐2017 "PROCESS FOR THE PREPARATION OF THIAZOLIDINE DERIVATIVES" 287961
161/DELNP/2011 29‐09‐2017 A process for the conjugation of a peptide or protein containing a
thiol or amino
group to a polymer"
287966
6638/DELNP/2009 29‐09‐2017 "A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF
MACULAR DEGENERATION"
287986
2326/MUMNP/2011 02‐10‐2017 A STABILIZER FOR PREPARING FREEZE‐DRIED VACCINE WITHOUT
GELATIN AND THE PREPARATION METHOD OF FREEZE‐DRIED
VACCINE
280148
5744/DELNP/2010 04‐10‐2017 "PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OR
PREVENTION OF OSTEOARTICULAR DISEASES"
288038
5710/DELNP/2011 05‐10‐2017 "HIGH DOSAGE DORAMECTIN FORMULATION" 288086
541/KOLNP/2009 08‐10‐2017 1H‐IMIDAZO[4.5‐B] PYRAZIN‐2‐OLS, AND COMPOSITIONS THEREOF 286254
2816/KOLNP/2009 09‐10‐2017 A Medicament System Comprising a Solvating System and A
Polymeric Film‐ Forming Medical Sealant
288165
7087/DELNP/2008 09‐10‐2017 "PHARMACEUTICAL AGENT COMPRISING A BENZAMIDE
DERIVATIVES AS ACTIVE INGREDIENT"
288172
1852/KOLNP/2005 10‐10‐2017 FORMULATIONS AND METHODS FOR TREATING RHINOSINUSITIS 288227
6398/CHENP/2010 10‐10‐2017 “PHENOXYPYRIDINYLAMIDE DERIVATIVES AND THEIR USE IN THE
TREATMENT OF PDE4 MEDIATED DISEASE STATES”
288235
1715/MUMNP/2011 10‐10‐2017 ANTIPERSPIRANT COMPOSITIONS 288246
576/MUMNP/2011 11‐10‐2017 “DISPERSION OF SOFT POLYMER PARTICLES, COSMETIC
COMPOSITION COMPRISING IT AND COSMETIC TREATMENT
METHOD”
288262
1178/MUM/2008 11‐10‐2017 A PROCESS FOR MANUFACTURING TOPICAL COMPOSITION 288263
1742/DEL/2009 12‐10‐2017 "A CONTROLLED RELEASE PHARMACEUTICAL FORMULATION" 288303
175/DEL/2010 12‐10‐2017 SYNTHETIC PHOSPHODIESTERASE 4 (PDE‐4) INHIBITOR WITH
ANTIASTHMATIC ACTIVITY
288310
Page 29 of 85
753/DELNP/2009 12‐10‐2017 "A COMPOUND OF FORMULA (I)" 288320
4684/DELNP/2010 12‐10‐2017 CYTOSTATIC COMPOSITION 288329
9394/DELNP/2008 13‐10‐2017 “A FORMULATION WHICH STABILIZES A POLYSACCHARIDE‐PROTEIN
CONJUGATE”
288364
2557/MUMNP/2010 13‐10‐2017 NOVEL CONJUGATES OF POLYMERS HAVING A THERAPEUTICALLY
ACTIVE AGENT AND AN ANGIOGENESIS TARGETING MOIETY
ATTACHED THERETO AND USES THEREOF IN THE TREATMENT OF
ANGIOGENESIS RELATED DISEASES
288386
1572/DELNP/2012 13‐10‐2017 IMPROVED PHARMACOKINETICS OF S‐ADENOSYLMETHIONINE
FORMULATIONS
288387
6382/CHENP/2011 16‐10‐2017 “ANTI‐RHESUS D MONOCLONAL ANTIBODY” 288399
360/CHE/2010 16‐10‐2017 PROCESS FOR THE PREPARATION OF METOPIMAZINE 288433
1714/DEL/2007 17‐10‐2017 "NOVEL EXTENDED RELEASE COMPOSITIONS COMPRISING
MYCOPHENOLATE SODIUM AND PROCESSES THEREOF"
288448
3448/KOLNP/2007 17‐10‐2017 A MULTIVALENT INFLUENZA IMMUNOGENIC COMPOSITION 288463
1882/DEL/2008 17‐10‐2017 "A METHOD OF PREPARING NEW ANTI CANCER HERBAL MEDICINE
AND PRODUCT THERE OF"
288464
746/CHE/2008 18‐10‐2017 HETEROCYCLIC COMPOUNDS AS ADENOSINE RECEPTOR
ANTAGONISTS
288516
6187/CHENP/2010 23‐10‐2017 SELF‐DESTRUCTING TRANSDERMAL THERAPEUTIC SYSTEM HAVING
IMPROVED FUNCTIONALITY AND EFFICACY
288566
3576/DELNP/2008 23‐10‐2017 "PHARMACEUTICAL COMPOSITION" 288580
4309/DELNP/2009 23‐10‐2017 "OPHTHALMIC AND OTIC COMPOSITIONS OF FACIALLY
AMPHIPHILIC POLYMERS AND OLIGOMERS AND USES THEROF"
288585
4478/KOLNP/2010 24/10/2017 PYRROLOPYRIDINES AS KINASE INHIBITORS 288627
8597/DELNP/2011 24‐10‐2017 POWDERED SOLID COSMETIC AND MANUFACTURING METHOD
THEREFOR
288609
3256/DELNP/2009 24‐10‐2017 "METHOD FOR PREPARING A POLYMER CONJUGATE" 288618
9708/DELNP/2008 24‐10‐2017 "VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL
ADMINISTRATON"
288621
9686/DELNP/2008 24‐10‐2017 "MATERNAL SUPPLEMENT" 288645
2473/CHENP/2011 25/10/2017 WATER INSOLUBLE POLYMER: STARCH‐BASED FILM COATINGS FOR
COLON TARGETING
288711
5339/CHENP/2009 25‐10‐2017 METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE
RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT
PROFILE
288663
2185/DELNP/2005 25‐10‐2017 "PHARMACEUTICAL COMPOSITIONS COMPRISING A BASIC
RESPECTIVELY ACIDIC DRUG COMPOUND, A SURFACTANT AND A
PHYSIOLOGICALLY TOLERABLE WATER‐SOLUBLE ACID RESPECTIVELY
BASE"
288678
7828/DELNP/2008 25‐10‐2017 "B CELL‐BASED VACCINE LOADED WITH THE LIGAND OF NATURAL
KILLER T CELL AND ANTIGEN"
288718
7719/CHENP/2010 25‐10‐2017 PRODRUGS AND DRUG‐MACROMOLECULE CONJUGATES HAVING
CONTROLLED DRUG RELEASE RATES
288725
7134/DELNP/2009 26‐10‐2017 COSMETIC COMPOSITIONS COMPRISING ESTERS BASED ON 2‐
PROPYLHEPTANOIC ACID
288747
840/DELNP/2010 26‐10‐2017 "METHOD OF MAKING AN ISETHIONATE SALT" 288752
569/CHENP/2009 26‐10‐2017 A SYNTHETIC BIFUNCTIONAL NON‐ANTIBODY COMPOUND. 288770
9900/DELNP/2008 26‐10‐2017 "FUNGICIDAL AZOCYCLIC AMIDES" 288780
567/DELNP/2010 27‐10‐2017 THE USE OF MONOMYCOLYL GLYCEROL (MMG) AS AN ADJUVANT 288789
131/KOLNP/2009 27‐10‐2017 VACCINES FOR MALARIA 288805
8101/DELNP/2010 27‐10‐2017 "AGENT FOR THE TREATMENT AND/OR PROPHYLAXIS OF AN
AUTOIMMUNE DISEASE AND FOR THE FORMATION OF
REGULATORY T CELLS"
288814
1152/CHENP/2011 27‐10‐2017 MODIFIED BOVINE G‐CSF POLYPEPTIDES AND THEIR USES 288818
3682/KOLNP/2010 27‐10‐2017 PYRIDOPYRAZINONES DERIVATIVES INSULIN SECRETION
STIMULATORS, METHODS FOR OBTAINING THEM AND USE
THEREOF FOR THE TREATMENT OF DIABETES
288842
Page 30 of 85
7080/DELNP/2011 27‐10‐2017 "ANALOGUES OF NEUROPEPTIDE Y HAVING A 4‐HYDROXYPROLINE
SUBSTITUTION AT POSITION 34"
288844
3148/KOLNP/2009 30/10/2017 "FORMULATIONS CONTAINING CYNARA SCOLYMUS AND
PHASEOLUS VULGARIS EXTRACTS FOR REDUCING OBESITY"
288913
2836/KOLNP/2011 30/10/2017 COMPOSITION COMPRISING EGG WHITE‐CHALCANTHITE FOR
PREVENTING OR TREATING CANCER
288953
1272/DELNP/2007 30‐10‐2017 "NUCLEOSIDE PHOSPHONATE CONJUGATES AS ANTI HIV AGENTS" 288882
1470/CHE/2007 30‐10‐2017 IMPROVED PROCESS FOR THE PREPARATION OF ZOLIPIDEM AND
PREPARATION OF ITS NOVEL INTERMEDIATE
288884
3735/DELNP/2011 30‐10‐2017 “PROCESS FOR PREPARING CHLORINS" 288917
7646/DELNP/2010 30‐10‐2017 "CONJUGATES OF A CHOLINESTERASE MOIETY AND A POLYMER" 288940
1294/KOLNP/2011 30‐10‐2017 NOVEL PROSTAGLANDIN I2 DERIVATIVE 288950
525/DEL/2006 31‐10‐2017 SYNTHESIS AND ANTIBACTERIAL ACTIVITIY OF NOVEL
ERYTHROMYCIN DERIVATIVES
288968
9228/DELNP/2008 31‐10‐2017 "USE OF MULTIVALENT SYNTHETIC LIGANDS OF SURFACE
NUCLEOLIN FOR TREATING CANCER OR INFLAMMATION"
288994
967/CHENP/2011 31‐10‐2017 HAIR CONDITIONING COMPOSITION 289007
2345/DELNP/2013 01‐11‐2017 HOMO AND HETERO POLYAMINO ACID DERIVATIVES OF
FULLERENE ,METHOD FOR PRODUCING AND PHARMACEUTICAL
COMPOSITIONS THEREOF
289108
3940/KOLNP/2010 02‐11‐2017 OXYMETHYLENE ARYL COMPOUNDS AND USES THEREOF 289112
4070/DELNP/2010 02‐11‐2017 METHOD FOR ENHANCING STABILITY OF PURIFIED LYSOSOMAL
ENZYME AND PHARMACEUTICAL COMPOSITION COMPRISING
PURIFIED LYSOSOMAL ENZYME AND ACTIVE SITE‐SPECIFIC
CHAPERONE
289121
3783/DELNP/2010 02‐11‐2017 Process for reducing tendency of a Glycopyrronium salt to
aggregate and/or agglomerate during storage
289126
1655/MUMNP/2010 03‐11‐2017 An orally ingestible composition as BLOOD LIPID LOWERING
AGENTS
289197
1216/MUM/2007 03‐11‐2017 NOVEL TETRAHYDROPYRIMIDINE COMPOUNDS AS ANTICANCER
AGENTS AND MICROWAVE ASSISTED PROCESS FOR THEIR
PREPARATION
289198
2324/MUM/2011 03‐11‐2017 "A METHOD AND APPARATUS FOR SYNTHESIZING VESICLES BY
INTERDIFFUSION OF STATIONARY PHASES"
289207
241/MUM/2008 05‐11‐2017 NOVEL PHENOTHIAZINE DERIVATIVES AS NOOTROPIC AGENTS 283259
8288/CHENP/2010 06‐11‐2017 NOVEL PHENYLIMIDAZOLE DERIVATIVES AS PDE10A ENZYME
INHIBITORS
289257
2059/MUMNP/2007 07‐11‐2017 A PHARMACEUTICAL PREPARATION COMPRISING IN SEPARATE
VIALS,A LYOPHILIZED EPOTHILONE ANALOG
289282
4946/KOLNP/2010 08‐11‐2017 NUTRITIVE COMPOSITION COMPRISING DEXTROSE AND AMINO
ACIDS
289344
6350/DELNP/2011 08‐11‐2017 "SOLID PHARMACEUTICAL COMPOSITION COMPRISING
AMLODIPINE AND LOSARTAN WITH IMPROVED STABILITY"
289348
5937/DELNP/2009 08‐11‐2017 "TREATMENT OF INFLAMMATION AND/OR ENDOTOXIC SHOCK" 289373
1164/DEL/2002 08‐11‐2017 "A TASTE MASKING PHARMACEUTICAL COMPOSITION" 289381
1313/CHENP/2010 09‐11‐2017 Pharmaceutical composition comprising N‐(5‐TERT‐BUTYL‐
ISOXAZOL‐3‐ YL)‐N''‐{4‐[7‐(2‐MORPHOLIN‐4‐YL‐
ETHOXY)IMIDAZO[2,1‐ B][1,3]BENZOTHIAZOL‐2‐YL]PHENYL}UREA
289420
6562/DELNP/2006 09‐11‐2017 "1‐AZA‐BICYCLO[3,3.1]NONANES" 289430
1211/DELNP/2007 09‐11‐2017 "NUCLEOSIDE PHOSPHONATE CONJUGATES AS ANTI HIV AGENTS" 289434
536/CHENP/2011 10‐11‐2017 ACTIVE TARGETING POLYMER MICELLE ENCAPSULATING DRUG AND
PHARMACEUTICAL COMPOSITION
289446
7802/DELNP/2008 10‐11‐2017 "DIETARY SUPPLEMENTS CONTAINING PROBIOTICS" 289460
8638/DELNP/2010 10‐11‐2017 "PHARMACEUTICAL COMBINATION" 289463
574/MUMNP/2012 10‐11‐2017 "A METHOD OF MANUFACTURING A PURIFIED NEWCASTLE DISEASE
VIRUS CLONE"
289477
8132/DELNP/2010 10‐11‐2017 "SULFOALKYL ETHER CYCLODEXTRIN COMPOSITIONS" 289487
Page 31 of 85
2980/CHENP/2012 10‐11‐2017 ANTIMICROBIAL AND VULNERARY ACTION PHARMACEUTICAL
COMPOSITION FOR EXTERNAL APPLICATION AND ITS PRODUCTION
PROCESS
289494
1358/MUMNP/2011 13‐11‐2017 ODOR CONTROLLED PERSONAL CARE COMPOSITIONS CONTAINING
HYDROXYPROPYL TRIALKYLAMMONIUM SALTS
289505
1551/DELNP/2009 13‐11‐2017 "COMPOUNDS AND METHODS FOR 18F LABELED AGENTS" 289509
10058/DELNP/2008 13‐11‐2017 "PHARMACEUTICAL COMPOSITION COMPRISING NICOTINE" 289515
7849/DELNP/2009 13‐11‐2017 "A METHOD FOR MODIFYING POLYPHENOL CONTAINING PLANT
MATERIALS AND MEDICAL USES OF MODIFIED POLYPHENOL PLANT
CONTAINING MATERIALS"
289522
6302/CHENP/2010 13‐11‐2017 NOVEL 1‐BENZYL‐3‐HYDROXYMETHYLINDAZOLE DERIVATIVES AND
USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE
EXPRESSION OF MCP‐1, CX3CR1 AND P40
289525
2350/DELNP/2011 13‐11‐2017 ALCOHOL‐RESISTANT SUSTAINED‐RELEASE ORAL PHARMACEUTICAL
FORM BASED ON MICROGRANULES
289526
1118/KOL/2011 14‐11‐2017 A PHARMACEUTICAL COMPOSITIONS FOR DEHYDRATING
ATROPHYING AND ELIMINATING PATHOLOGICAL TISSUES
289545
7513/DELNP/2009 14‐11‐2017 "QUINOLINE DERIVATIVES AS P13 KINASE INHIBITORS" 289553
866/MUMNP/2010 14‐11‐2017 ANTIPERSPIRANT COMPOSITION AND PRODUCT 289557
384/DEL/2009 14‐11‐2017 "POLYMERIC NANOMATRIX ASSOCIATED DELIVERY OF
KAEMPFEROL IN RATS TO IMPROVE ITS OSTEOGENIC ACTION"
289560
3478/DEL/2012 14‐11‐2017 “NEW PROCESS FOR THE SYNTHESIS OF IVABRADINE AND
ADDITION SALTS THEREOF WITH A PHARMACEUTICALLY
ACCEPTABLE ACID”
289578
4645/CHENP/2011 15‐11‐2017 METHOD FOR PRODUCING A MOLECULAR PROBE FOR IMAGING OF
PANCREATIC ISLET
289586
1166/MUMNP/2011 15‐11‐2017 ORAL COMPOSITION 289610
5619/DELNP/2012 16‐11‐2017 3‐(3‐AMINOPIPERIDIN‐1‐YL)‐5‐OXO‐1, 2,4‐TRIAZINE DERIVATES AS
DIPEPTIDYL PEPTIDASE IV(DPP‐IV) INHIBITORS
289659
1929/CHENP/2006 16‐11‐2017 ANTI‐GLYPICAN 3 ANTIBODY 289667
3103/KOLNP/2008 16‐11‐2017 HUMAN ANTI‐IL‐23 ANTIBODIES, COMPOSITIONS, METHODS AND
USES
289670
1989/DELNP/2010 17‐11‐2017 THERMO‐KINETIC MIXING FOR PHARMACEUTICAL APPLICATIONS 289679
7957/DELNP/2006 17‐11‐2017 "NANOPARTICLES OF A DERIVATIVE OF 2;,2'‐DIFLUORO‐2'‐
DEOXYCYTIDINE AND PROCESS FOR PREPARING THE SAME"
289693
3051/DELNP/2007 17‐11‐2017 "COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE
INHIBITORS"
289697
4761/DELNP/2012 17‐11‐2017 “SUBMICRO EMULSION OF PACLITAXEL USING STEROID COMPLEX
AS INTERMEDIATE CARRIER”
289710
2646/MUMNP/2010 20/11/2017 COMPOSITIONS FOR LIGHTENING SKIN COLOR. 289738
2464/DELNP/2009 20‐11‐2017 "CONTROLLED RELEASE COMPOSITIONS" 289714
2124/KOLNP/2011 20‐11‐2017 MICROCAPSULES AND USES THEREOF 289725
2735/CHE/2010 21/11/2017 PROCESS FOR PREPARATION OF A HEXANE EXTRACT OF AEGLE
MARMELOS FRUIT
289767
684/MUMNP/2010 21‐11‐2017 INHIBITORS OF THE INTERACTION BETWEEN MDM2 AND P53 289768
6367/DELNP/2006 21‐11‐2017 "HIV INTEGRASE INHIBITORS" 289772
458/DEL/2009 21‐11‐2017 "NOVEL SUBSTITUTED SPIRO [INDOLINE‐HETEROCYCLE]‐
CARBOXYLIC ACID DERIVATIVES AS ANTIDIABETIC AND METABOLIC
DISORDER TRATING AGENTS"
289774
2074/DEL/2004 21‐11‐2017 "ANTIMALARIAL COMPOUND FROM GOMPHOSTEMA NIVEUM" 289775
151/DELNP/2011 21‐11‐2017 "DRUG LOADED POLYMERIC NANOPARTICLES AND METHODS OF
MAKING AND USING SAME"
289790
1416/DEL/2003 21‐11‐2017 "A METHOD FOR THE PREPARATION OF A GEL OF PLASMA RICH IN
GROWTH FACTORS(P.R.G.F.)"
289802
134/DELNP/2009 21‐11‐2017 BICYCLIC HETEROARYL INHIBITORS OF PDE4 289804
9104/DELNP/2008 22‐11‐2017 "PYRAZOLO [3, 4‐D] PYRIMIDINE DERIVATIVES USEFUL TO TREAT
RESPIRATORY DISORDERS"
289809
Page 32 of 85
8571/CHENP/2010 22‐11‐2017 METHOD FOR USING INACTIVATED JAPANESE ENCEPHALITIS VIRUS
PARTICLES AS ADJUVANT
289819
1181/MUM/2009 22‐11‐2017 COMBINED MEASLES‐MALARIA VACCINE 289823
1949/MUM/2012 22‐11‐2017 ANTI‐RHD MONOCLONAL ANTIBODIES 289825
3390/CHENP/2013 22‐11‐2017 PIPERIDINONE CARBOXAMIDE AZAINDANE CGRP RECEPTOR
ANTAGONISTS
289826
5861/DELNP/2009 22‐11‐2017 "STIMULATION OF AN IMMUNE RESPONSE BY CATIONIC LIPIDS" 289829
544/MUMNP/2011 22‐11‐2017 "HYDROXYBUTYRATE ESTER AND MEDICAL USE THEREOF" 289830
2319/DELNP/2009 22‐11‐2017 "A body fluid purifying arrangement" 289835
3600/CHENP/2011 23‐11‐2017 METHOD OF MAKING SUSTAINED RELEASE MICROPARTICLES 289846
543/MUMNP/2012 23‐11‐2017 "ANTIBACTERIAL COMPOSITION COMPRISING BACTERIOPHAGE FOR
PREVENTION OR TREATMENT OF INFECTIOUS DISEASES BY ONE OR
MORE SALMONELLA STRAINS"
289856
4547/DELNP/2010 23‐11‐2017 "PHARMACEUTICAL COMPOSITION FOR PREVENTING AND
TREATING DIABETIC NEPHROPATHY AND THE PREPARATION
METHOD THEREOF"
289861
2599/DELNP/2009 23‐11‐2017 "An immunogenic composition comprising an inactivated form of
HPGGT"
289868
3788/CHE/2010 24‐11‐2017 PHARMACEUTICAL COMPOSITIONS COMPRISING STARCH
PHOSPHATE
289893
3564/KOLNP/2008 24‐11‐2017 STABILIZED PENTOSAN POLYSULFATE (PPS) FORMULATIONS AND
METHODS OF ANALYZING THEM
289902
1950/KOLNP/2012 24‐11‐2017 METHODS OF SYNTHESIZING AND ISOLATING N‐(BROMOACETYL)‐
3,3‐DINITROAZETIDINE AND A COMPOSITION INCLUDING THE
SAME
289908
2362/KOLNP/2010 27‐11‐2017 PERSONAL CARE AND COSMETIC COMPOSITION CONTAINING
TETRAPEPTIDES WITH THE MOTIFS GX1 X2G, PX1X2P, OR PX1X2K
289957
5237/DELNP/2010 27‐11‐2017 "METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF
INSULIN"
289970
1913/CHE/2011 28‐11‐2017 A PROCESS FOR PREPARATION OF NEVIRAPINE 290005
1770/MUM/2015 28‐11‐2017 A FREEZE DRIED PHARMACEUTICAL FORMULATION OF RIFABUTIN
AND PROCESS FOR PREPARATION THEREOF
290030
3858/MUM/2015 28‐11‐2017 PROCESS FOR PREPARATION OF PARENTERAL FORMULATION OF
MICAFUNGIN SODIUM
290034
1244/DEL/2010 28‐11‐2017 ANTI TUBERCULAR AGENTS 290036
1603/CHENP/2010 28‐11‐2017 A PHARMACEUTICAL COMPOSITION COMPRISING IRL‐1620 290038
3037/CHENP/2011 29/11/2017 “Antisense Oligonucleotides for Skipping of Exon 45” 290067
2239/DELNP/2004 29‐11‐2017 "A COSMETIC COMPOSITION FOR REDUCING SUBCUTANEOUS
EXCESS FAT"
290064
2438/CHENP/2008 29‐11‐2017 A COMPOUND COMPRISING AN AUTOANTIGENIC PEPTIDE AND A
CARRIER WITH A MHC BINDING MOTIF
290071
3090/KOLNP/2010 29‐11‐2017 AQUEOUS PHARMACEUTICAL COMPOSITIONS CONTAINING
BORATE‐ POLYOL COMPLEXES
290094
3865/CHENP/2011 29‐11‐2017 A METHOD FOR OBTAINING NALMEFENE HYDROCHLORIDE
DIHYDRATE
290098
528/DEL/2006 30/11/2017 "ISOLATION AND SYNTHESIS OF NOVEL FURANO‐AND
PYRANOFLAVONOIDS AS ANTIDIABETIC AGENTS"
290171
2929/DELNP/2010 30‐11‐2017 "METHOD OF DELIVERING AN ANTI‐CANCER AGENT TO A CELL" 290111
4633/KOLNP/2010 30‐11‐2017 Method for preparing a hypoallergen for immunotherapy 290115
522/DEL/2006 30‐11‐2017 A PHARMACEUTICAL COMPOSITION FOR THE
PREVENTION/TREATMENT OF BONE DISORDERS AND A PROCESS
FOR THE PREPARATION THEREOF
290121
7553/CHENP/2010 30‐11‐2017 MODULATORS OF DOPAMINE NEUROTRANSMISSION 290133
37/CHE/2010 30‐11‐2017 PROCESS FOR THE PURIFICATION OF LUMEFANTRINE 290142
3228/KOLNP/2009 30‐11‐2017 RECOMBINANT CHIMERIC PROTEIN OF NEUTROPHIL INHIBITORY
FACTOR AND HIRUGEN AND PHARMACEUTICAL COMPOSITION
THEREOF
290162
10564/DELNP/2008 04‐12‐2017 "Oral Adhering Disc For Dry Mouth" 290237
Page 33 of 85
1252/MUMNP/2011 05‐12‐2017 ANTIPERSPIRANT COMPOSITIONS AND PRODUCTS 290295
5793/CHENP/2010 05‐12‐2017 PHARMACEUTICAL COMPOSITION FOR PREVENTING DYSBIOSIS
ASSOCIATED WITH ENTERNAL ADMINISTRATION OF ANTIBIOTICS
290302
5799/CHENP/2011 05‐12‐2017 TOPICAL COMPOSITION 290313
3558/KOLNP/2009 06‐12‐2017 BINDING LIGAND LINKED DRUG DELIVERY CONJUGATES OF
TUBULYSINS
284161
3486/DELNP/2009 06‐12‐2017 PERSONAL CARE COMPOSITION COMPRISING AMINOSILICONE AND
NATURALLY DERIVED CATIONIC POLYMERS
284151
2887/KOLNP/2008 06‐12‐2017 COMPOSITION FOR INHIBITING ADVERSE IMMUNE RESPONSE IN
HISTOCOMPATIBILITY‐MISMATACHED
290333
127/DEL/2010 06‐12‐2017 A NEW SERIES OF ARTEMISININ DERIVATIVES WITH
POTENTANTICANCER ACTIVITIES
290351
2487/MUMNP/2011 07‐12‐2017 "A METHOD FOR PRODUCING A COMPOSITION COMPRISING
METAXALONE"
290367
392/DEL/2011 07‐12‐2017 2‐PHENYL BENZOTHLAZOLE LINKED IMIDAZOLE COMPOUNDS AS
POTENTIAL ANTICANCER AGENTS
290369
2488/MUMNP/2011 07‐12‐2017 "A METHOD FOR PRODUCING A COMPOSITION COMPRISING
MELOXICAM"
290371
2490/MUMNP/2011 07‐12‐2017 "A COMPOSITION COMPRISING PARTICLES OF DICLOFENAC ACID" 290373
3852/CHENP/2012 07‐12‐2017 BODY CARE PRODUCT COMPRISING BENZOTROPOLONE
COMPOUNDS
290374
349/CHE/2009 07‐12‐2017 A PROCESS FOR COVALENTLY BONDING A DRUG TO THE SURFACE
OF CHEMICALLY EXFOLIATED GRAPHITE OXIDE (CEGO) WITHOUT
SPACER FOR THE TREATMENT OF CANCER
290382
2450/MUM/2011 07‐12‐2017 "COMPOSITIONS FOR EXTENDED PERIODS OF SKIN
MOISTURIZATION"
290384
3932/CHENP/2011 07‐12‐2017 BENZYLIDENE COMPOUNDS COMPRISING PHOSPHONO‐GROUPS 290390
385/KOLNP/2009 07‐12‐2017 INHIBITORS OF PLASMA KALLIKREIN 290393
208/DEL/2009 08‐12‐2017 "COLLOIDAL COMPOSITION OF GRISEOFULVIN" 290424
4000/CHENP/2010 08‐12‐2017 LIQUID ANTISEPTIC COMPOSITIONS CONTAINING IODINE AND A
SUGAR AND/OR SUGAR ALCOHOL
290430
6823/CHENP/2011 08‐12‐2017 COMPOSITIONS,SYNTHESIS AND METHODS OF UTILIZING
ARYLPIPERAZINE DERIVATIVES
290431
932/KOLNP/2008 08‐12‐2017 MULTIPLE VACCINATION INCLUDING SEROGROUP C
MENINGOCOCCUS
290435
2077/DELNP/2011 10‐12‐2017 "BIOPOLYMER CONJUGATES COMPRISING AN INTERLEUKIN‐11
ANALOG"
288349
6377/DELNP/2008 11‐12‐2017 "STABLIZED PHARMACEUTICAL COMPOSITION" 290455
3516/KOLNP/2010 11‐12‐2017 BUTENAFINE HYDROCHLORIDE‐CONTAINING AQUEOUS PATCH 290456
7944/CHENP/2010 11‐12‐2017 3‐AMINOCARBAZOLE COMPOUND, PHARMACEUTICAL
COMPOSITION CONTAINING IT AND PREPARATION METHOD
THEREFOR
290468
34/DELNP/2008 12‐12‐2017 ORALLY DISINTEGRATING POWDER COMPRISING CILOSTAZOL AND
MANNITOL
290528
1177/MUMNP/2010 12‐12‐2017 TOPICAL COMPOSITION COMPRISING COLORING ANTIOXIDANTS 290491
1036/CHENP/2010 12‐12‐2017 IMMUNOGENIC COMPOSITION COMPOSED OF AN ISOLATED
CARBOHYDRATE POLYMER AGAINST CAMPYLOBACTER JEJUNI
290519
2615/DELNP/2008 12‐12‐2017 "AUTOMATED RADIOLABELLING METHOD" 290523
2651/DELNP/2004 13/12/2017 "AMINO‐SUBSTITUTED (E)‐2, 6‐DIALKOXYSTYRYL4‐SUBSTITUTED
BENZYLSULFONES FOR TREATING PROLIFERATIVE DISORDERS"
290561
7876/DELNP/2006 13‐12‐2017 "ALPHA, BETA‐UNSATURATED SULFONES, SULFOXIDES,
SULFONIMIDES, SULFINIMIDES, ACYLSULFONAMIDES AND
ACYLSULFINAMIDES AND THERAPEUTIC USES THEREOF"
290535
1105/KOL/2010 13‐12‐2017 COMPOSITIONS COMPRISING AN NFKB‐INHIBITOR AND A
TROPOELASTIN PROMOTER
290558
Page 34 of 85
83/DEL/2010 13‐12‐2017 "A PROCESS FOR THE PREPARATION OF NANOSILVER
NANOHYDROGEL BASED ANTIMICROBIAL AGENT"
290584
3050/DEL/2010 14‐12‐2017 “PHARMACEUTICAL COMPOSITION IN FORM OF AQUEOUS SYRUP
COMPRISING LEVOCETIRIZINE DIHYDROCHLORIDE AND
MONTELUKAST SODIUM ”
290589
5735/CHENP/2012 14‐12‐2017 MACROMOLECULE FOR DELIVERING PROTEIN, POLYPEPTIDE OR
PEPTIDE DRUGS AND A PRODUCTION METHOD FOR THE SAME,
AND A SLOW RELEASE COMPOSITION FOR PROTEIN, POLYPEPTIDE
OR PEPTIDE DRUGS AND A PRODUCTION METHOD FOR THE SAME
290608
1121/CHE/2009 14‐12‐2017 PROCESS FOR THE PREPARATION OF LANTHANUM CARBONATE
DIHYDRATE
290621
2384/CHENP/2011 14‐12‐2017 GRANULATES, PROCESS FOR PREPARING THEM AND
PHARMACEUTICAL PRODUCTS CONTAINING THEM
290635
5013/CHENP/2010 14‐12‐2017 DOXORUBICIN ADJUVANTS TO REDUCE CARDIOTOXICITY 290641
2182/DELNP/2009 15/12/2017 "SUSTAINED RELEASE DEVICE AND METHOD FOR OCULAR DELIVERY
OF ADRENERGIC AGENTS"
290692
9859/CHENP/2011 15‐12‐2017 BENZYLIDENE MALONATES 290678
3515/CHENP/2011 18‐12‐2017 3‐PHENYL‐3‐METHOXY‐PYRROLIDINE DERIVATIVES USEFUL AS
MODULATORS OF CORTICAL CATECHOLAMINERGIC
NEUROTRANSMISSION
290754
208/KOLNP/2008 18‐12‐2017 MELANOCORTIN RECEPTOR LIGANDS 290770
4039/KOLNP/2009 19/12/2017 A MELANOCORTIN‐4 SELECTIVE RECEPTOR AGONIST COMPOUND 290823
7211/DELNP/2009 19/12/2017 "NUCLEIC ACID MICROPARTICLES FOR PULMONARY DELIVERY" 290813
9774/CHENP/2011 19‐12‐2017 “DRUG DELIVERY SYSTEM COMPRISING POLYOXAZOLINE AND A
BIOACTIVE AGENT”
290788
2527/MUM/2007 20/12/2017 NANODISPERSION 290850
2204/CHENP/2011 20‐12‐2017 CHELATING AMPHIPHILIC POLYMERS 290834
85/DELNP/2011 20‐12‐2017 "HIGH CONTENT SODIUM IBUPROFEN GRANULES, THEIR
PREPARATION AND THEIR USE IN PREPARING NON‐EFFERVESCENT
SOLID DOSAGE FORMS"
290843
642/KOLNP/2011 20‐12‐2017 SILICON DIOXIDE NANOPARTICLES AND THE USE TEREOF FOR
VACCINATION
290859
5522/CHENP/2011 20‐12‐2017 COSMETIC COMPOSITION AND HAIR WASH 290862
3098/CHENP/2012 21‐12‐2017 DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS 290946
5123/DELNP/2011 21‐12‐2017 NOVEL COMPOSITION COMPRISING ANAGRELIDE PARTICLES FOR
THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA
290954
2838/CHE/2009 22‐12‐2017 "BICYCLIC COMPOUNDS AS ALPHA4 BETA2 NICOTINIC
ACETYLCHOLINE RECEPTOR LIGANDS"
290964
872/CHENP/2010 22‐12‐2017 PHARMACEUTICAL COMPOSITION COMPRISING 11‐DEOXY‐
PROSTAGLANDIN COMPOUND AND METHOD FOR STABILIZING THE
COMPOUND
290970
1830/KOLNP/2010 22‐12‐2017 A METHOD FOR PRODUCING ADAPALENE GELS 291017
6577/DELNP/2013 26‐12‐2017 EFFERVESCENT GAMMA HYDROXYBUTYRIC ACID GRANULES 291051
3223/CHENP/2011 27‐12‐2017 “BENZIMIDAZOLE DERIVATIVES FOR MODULATING THE GABAA
RECEPTOR COMPLEX“
291082
7448/CHENP/2010 27‐12‐2017 BENZIMIDAZOLE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS 291092
8145/DELNP/2011 27‐12‐2017 "A STABLE IRON OLIGOSACCHARIDE COMPOUND" 291100
3579/CHENP/2010 27‐12‐2017 FLUORESCENT MARKER FOR CELL DEATH IN THE EYE 291113
4243/KOLNP/2011 28‐12‐2017 SYNTHESIS OF 1‐AMINO‐1,;5‐CYCLOHEXANE MESYLATE 291134
9506/DELNP/2008 28‐12‐2017 "DPP IV INHIBITOR FORMULATIONS" 291136
8454/CHENP/2011 28‐12‐2017 A MICROSPHERE CONTAINING A POORLY SOLUBLE DRUG AND
METHOD OF PREPARING THE SAME
291164
1874/DELNP/2010 29‐12‐2017 RNA VACCINES 291203
2559/MUM/2009 29‐12‐2017 AN IMPROVED PROCESS FOR PREPARATION OF TAXANE
DERIVATIVES
291223
Page 35 of 85
5835/CHENP/2011 29‐12‐2017 “ANIONIC OIL‐IN‐WATER EMULSIONS CONTAINING
PROSTAGLANDINS AND USES THEREOF”
291232
802/DEL/2008 29‐12‐2017 "TUNGSTEN NANOPARTICLE AND ITS TARGETING TO THE LIVER" 291242
1971/DELNP/2010 29‐12‐2017 "LH LIQUID FORMULATIONS" 291255
758/DEL/2013 01‐01‐2018 NEW PROCESS FOR THE SYNTHESIS OF IVABRADINE AND ADDITION
SALTS THEREOF WITH A PHARMACEUTICALLY ACCEPTABLE ACID
291264
5252/CHENP/2011 01‐01‐2018 AN S NS INHIBITOR COMPRISING NOVEL BICYCLIC HETEROCYCLIC
COMPOUND
291268
4857/KOLNP/2010 02‐01‐2018 CONJUGATED VI SACCHARIDES 291300
2150/DEL/2004 02‐01‐2018 "PROCESS OF MAKING STABLE NEEM MELIACIN(S) CONCENTRATES
AND PRODUCTS WITH CONTROLLED ACTIVE INGREDIENT RELEASE"
291334
1336/KOL/2011 03‐01‐2018 SKIN CARE COMPOSITION CONTAINING ACTIVES IN HIGH
INTERFACIAL PHASE EMULSIFICATION SYSTEM
291360
6038/DELNP/2009 04‐01‐2018 "AN IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION
CONTAINING DAPAGLIFLOZIN PROPYLENE GLYCOL HYDRATE "
291392
2491/MUMNP/2011 04‐01‐2018 "A COMPOSITION COMPRISING PARTICLES OF INDOMETHACIN" 291396
2476/MUM/2008 04‐01‐2018 STABLE PHARMACEUTICAL COMPOSITION OF OLOPATADINE 291399
6571/DELNP/2007 04‐01‐2018 "PROCESS FOR THE PRODUCTION OF CALCIUM COMPOSITIONS IN A
CONTINUOUS FLUID BED"
291411
7343/DELNP/2009 05‐01‐2018 "CONJUGATED BIOLOGICAL MOLECULES AND THEIR PREPARATION" 291424
9912/DELNP/2008 05‐01‐2018 "PHARMACEUTICAL COMPOSITION COMPRISING AMLODIPINE AND
LOSARTAN"
291426
1311/MUM/2009 05‐01‐2018 SUSTAINED RELEASE DOSAGE FORM OF GLICLAZIDE 291443
953/DEL/2007 05‐01‐2018 NOVEL 4β‐AMINO PODOPHYLLOTOXIN CONGENERS AS POTENTIAL
ANTICANCER AGENTS AND A PROCESS FOR THE PREPARATION
THEREOF
291453
1928/MUM/2011 05‐01‐2018 "PROCESS FOR PREPARATION OF SEVELAMER HYDROCHLORIDE
AND FORMULATION THEREOF"
291454
1114/MUMNP/2010 08‐01‐2018 “CYCLIC, CYSTEIN‐FREE PROTEIN” 291474
2657/CHE/2011 08‐01‐2018 NEW BARBITURATES OF NITRO AROMATIC COMPOUNDS AS ANTI
CONVULSANTS, HYPNOTIC AGENTS, DYES AND FLUORESCENT
MOLECULES
291497
1978/MUMNP/2009 09‐01‐2018 “IMIDAZOQUINOLINES WITH IMMUNO‐MODULATING PROPERTIES” 291520
8254/DELNP/2009 09‐01‐2018 HYDROCARBON MIXTURE COMPRISING LINEAR C11 AND LINEAR
C13 HYDROCARBONS
291535
8544/DELNP/2009 09‐01‐2018 A process for producing an extract from Neobeguea spp. root tissue 291545
1677/MUMNP/2011 09‐01‐2018 ANTISEPTIC COMPOSITIONS COMPRISING SILVER IONS AND
MENTHOL AND USES THEREOF
291549
5909/DELNP/2009 09‐01‐2018 “NOVEL VIII FACTORS FOR THE TREATMENT OF HEMOPHILIA A ” 291559
1315/CHENP/2011 10‐01‐2018 “PHARMACEUTICAL COMPOSITIONS AND METHODS FOR
PRODUCING LOW IMPURITY CONCENTRATIONS OF THE SAME”
291582
5996/CHENP/2008 10‐01‐2018 A BIODEGRADABLE IMPLANT CONSISTING OF A CORE AND
HYDROPHOBIC POLYMER COATING
291595
2195/DELNP/2010 10‐01‐2018 "AN ORALLY BIOAVAILABLE COMPOSITION & METHOD OF
PREPARATION THEREOF"
291611
5253/CHENP/2010 11‐01‐2018 FENTANYL‐CONTAINING PATCH FOR EXTERNAL USE 291620
8425/DELNP/2008 11‐01‐2018 "OPHTHALMIC COMPOSITIONS COMPRISING POVIDONE‐IODINE" 291629
11284/DELNP/2012 11‐01‐2018 2 PYRIDYL SUBSTITUTED IMIDAZOLES AS THERAPEUTIC ALK5
AND/OR ALK4 INHIBITORS
291635
7173/DELNP/2010 11‐01‐2018 "OLIGOMER‐ARYLOXY‐SUBSTITUTED PROPANAMINE CONJUGATES" 291651
426/MUM/2009 12‐01‐2018 COMPOSITION FOR THE TREATMENT OF HAIR LOSS AND BALDNESS 291673
Page 36 of 85
8454/DELNP/2010 12‐01‐2018 "COMPOSITION COMPRISING A COMPLEXED (M) RNA AND A
NAKED MRNA FOR PROVIDING OR ENHANCING AN
IMMUNOSTIMULATORY RESPONSE IN A MAMMAL AND USES
THEREOF"
291696
2846/DELNP/2010 15‐01‐2018 "CONSTRUCTS CONTAINING MULTIPLE EXPRESSION CASSETTES FOR
CANCER THERAPY"
291707
584/MUM/2007 15‐01‐2018 NOVEL PHARMACEUTICALLY ACTIVE COMPOUNDS USEFUL AS
ANTIVIRAL AGENTS AND PROCESS OF PREPARATION THEREOF
291708
2984/CHE/2012 15‐01‐2018 POLYMORPHIC FORM OF BORTEZOMIB AND PROCESS FOR
PREPARATION THEIR OF
291709
1396/CHENP/2008 15‐01‐2018 “BALSALAZIDE FORMULATIONS AND MANUFACTURE AND USE
THEREOF”
291731
1595/CHENP/2010 16‐01‐2018 PH‐DEPENDENT CONTROLLED RELEASE PHARMACEUTICAL OPIOID
COMPOSITION WITH RESISTANCE AGAINST THE INFLUENCE OF
ETHANOL
291755
2657/DELNP/2012 16‐01‐2018 "DENTIFRICE COMPRSING STANNOUS FLUORIDE PLUS ZINC CITRATE
AND LOW LEVELS OF WATER"
291756
7189/CHENP/2010 17‐01‐2018 ACTIVATOR FOR PEROXISOME PROLIFERATOR‐ACTIVATED
RECEPTOR
291801
6343/CHENP/2009 17‐01‐2018 "INHIBITORS OF BRUTON'S TYROSINE KINASE" 291810
1834/MUM/2009 17‐01‐2018 NOVEL SILICONE PRESSURE SENSITIVE ADHESIVE COMPOSITION
FOR TRANSDERMAL DRUG DELIVERY
291817
2008/DELNP/2009 17‐01‐2018 EFFICIENT SYNTHESIS OF CHELATORS FOR NUCLEAR IMAGING AND
RADIOTHERAPY: COMPOSITIONS AND APPLICATIONS
291824
6400/DELNP/2009 18‐01‐2018 "A PHARMACEUTICAL COMPOSITION COMPRISING AN
OLIGOGULURONATE OR OLIGOGALACTURONATE AND A
MACROMOLECULAR DRUG”
291836
4526/DELNP/2010 18‐01‐2018 COMPOSITIONS COMPRISING NICOTINIC AGONISTS AND METHODS
OF USING SAME
291847
501/DELNP/2010 19/01/2018 "PHARMACEUTICAL PREPARATIONS CONTAINING HIGHLY VOLATILE
SILICONES"
291883
7962/DELNP/2010 19‐01‐2018 "PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHEIS OF 2'‐
CYANO‐2'‐DEOXY‐N4‐PALMI‐TOYL‐1‐BETA‐D‐
ARABINOFURANOSYLCYTOSINE"
291891
858/KOL/2007 19‐01‐2018 BIOACTIVE COMPOUND(S) FROM MARINE GASTROPOD MOLLUSC
(TELESCOPIUM TELESCOPIUM) AS POTENTIAL ANTICANCER/
ANTIPROLIFERATIVE AGENTS
291906
2995/MUM/2009 22‐01‐2018 PROCESS FOR THE PREPARATION OF NIMORAZOLE 291929
3686/DELNP/2011 22‐01‐2018 "IMPROVED DISSOLUTION STABILITY OF CALCIUM CARBONATE
TABLETS"
291937
3027/DELNP/2010 22‐01‐2018 A PHARMACEUTICAL COMPOUND FOR TREATING POLYCYSTIC
KIDNEY DISEASES WITH CARAMIDE DERIVATIVES AND METHOD
THEREOF
291938
196/KOLNP/2011 22‐01‐2018 PRODRUGS OF CABOTEGRAVIR 291942
1363/DELNP/2010 22‐01‐2018 IMMUNOGENIC COMPOSITIONS AND METHODS 291956
2632/MUM/2009 22‐01‐2018 COMPOSITION FOR RELEIVING STRESS 291959
408/KOLNP/2010 23/01/2018 DOUBLE FUSION YERSINIA PESTIS ANTIGENS, VACCINE
COMPOSITIONS, AND RELATED METHODS
292028
209/KOL/2012 23‐01‐2018 LIQUID FILM FORMING POLYMERIC COMPOSITE MATERIALS THAT
CAN SERVE AS DELIVERY VEHICLES FOR ACTIVE INGREDIENTS USED
IN DERMATOLOGICAL,COSMETICS AND FOOD
FORMULATIONS/PRODUCTS
291983
6845/CHENP/2010 23‐01‐2018 PARTIAL PEPTIDE OF SURVIVIN PRESENTED ON MHC CLASS II
MOLECULE
292013
234/MUM/2009 23‐01‐2018 PROCESS FOR THE SYNTHESIS OF CLEISTANTHIN 292014
8912/DELNP/2010 23‐01‐2018 "LIQUID COMPOSITION OF CISPLATIN COORDINATION
COMPOUND"
292019
9187/DELNP/2011 23‐01‐2018 "DENTIFRICE COMPOSITION" 292020
Page 37 of 85
1280/KOLNP/2011 23‐01‐2018 A COMPOSITION COMPRISING RIBOFLAVIN PHOSPHATE AND
ENHANCERS SELECTED FROM BIOENHANCERS AND
PHOTOENHANCERS
292030
122/KOLNP/2012 23‐01‐2018 A DOUBLE‐ STRANDED RNA COMPOUND. 292031
8975/DELNP/2007 23‐01‐2018 "BACTERIAL CELLULOSE‐CONTAINING FORMULATIONS AND
METHOD OF PRODUCING EFFECTIVE BACTERIAL CELLULOSE‐
CONTAINING FORMULATIONS"
292039
2343/MUMNP/2011 24‐01‐2018 COMPOSITION 292100
5174/DELNP/2010 25/01/2018 "MICROVESICLES" 292114
2898/DELNP/2011 25/01/2018 A PROCESS FOR MANUFACTURING RESERVOIR MICROCAPSULES 292133
3429/DELNP/2011 25/01/2018 PLANT EXTRACTION METHOD AND COMPOSITIONS 292151
1030/DELNP/2008 25‐01‐2018 "DEFECTIVE RIBOSOMAL PRODUCTS IN BLEBS (DRIBBLES) AND
METHODS OF USE TO STIMULATE AN IMMUNE RESPONSE"
292118
4915/CHENP/2011 25‐01‐2018 STABLE CONSTITUTIVELY HIGH EXPRESSION VECTOR FOR
PREPARING HPV VACCINE AND RECOMBINANT LACTIC ACID
BACTERIA TRANSFORMED THEREBY
292126
7531/DELNP/2010 25‐01‐2018 HER2/NEU‐SPECIFIC ANTIBODIES AND METHODS OF USING SAME 292128
3672/DELNP/2011 25‐01‐2018 PROLONGED RELEASE COMPOSITIONS COMPRISING
BRIVARACETAM AND SELETRACETUM
292131
991/CHENP/2011 25‐01‐2018 ENCAPSULATION OF LIPOPHILIC OR AMPHIPHILIC THERAPEUTIC
AGENTS IN NANO‐EMULSIONS
292135
7435/CHENP/2009 25‐01‐2018 ANTIBODIES TO HPD‐1 292137
8136/DELNP/2010 25‐01‐2018 CANNABINOIDS IN COMBINATION WITH NON‐CANNABINOID
CHEMOTHERAPEUTIC AGENTS (E.G.SERM OF ALKYLATING AGENTS)
292146
4225/DELNP/2009 25‐01‐2018 "OXYGEN SUPPLY FOR CELL TRANSPLANT AND VASCULARIZATION" 292157
470/CHENP/2011 29/01/2018 PHARMACEUTICAL COMPOSITIONS COMPRISING TRICYCLIC
CARBOXAMIDES
292218
3559/DELNP/2011 29‐01‐2018 “INCLUSION COMPLEXES OF PINOCEMBRIN WITH CYCLODEXTRIN
OR ITS DERIVATIVES”
292191
520/DELNP/2011 30/01/2018 "PHARMACEUTICAL COMPOSITIONS" 292310
960/KOL/2009 30‐01‐2018 FORMULATION FOR PREVENTION AND TREATMENT OF BACTERIAL
INFECTIONS AND PROCESS FOR PREPARATION THEREOF
292257
2959/DELNP/2012 30‐01‐2018 IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS,
COMPOSITIONS, AND THEIR USE
292259
1897/CHE/2010 30‐01‐2018 IMPROVED PROCESS FOR THE PREPARATION OF SEVELAMER AND
ITS PHARMACEUTICALLY ACCEPTABLE SALTS
292268
1652/CHE/2007 30‐01‐2018 A PROCESS FOR PREPARATION OF A NOVEL COMPOUND
GYMNEMIC DIACETATE FROM GYMNEMA SYLVESTRE R.BR. LEAVES
WITH ANTIDIABETIC ACTIVITY
292282
8215/CHENP/2010 30‐01‐2018 PEPTIDE MANUFACTURING PROCESS 292289
807/DEL/2010 30‐01‐2018 PROCESS FOR PRODUCING 4‐AMINOPYRIDINES 292313
9682/DELNP/2013 30‐01‐2018 CLEAR HAIR CARE COMPOSITION COMPRISING BASE OIL AND
HYDROPHILIC COMPONENT
292320
2834/CHENP/2012 30‐01‐2018 "TOPICAL FORMULATIONS COMPRISING A STEROID" 292323
7336/DELNP/2010 30‐01‐2018 “CHEWING GUM COMPOSITIONS COMPRISING CANNABINOIDS” 292329
4151/DELNP/2011 30‐01‐2018 IMMUNOSTIMULATORY OLIGONUCLEOTIDES 292330
2611/KOLNP/2012 30‐01‐2018 "A COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT AND
METHOD OF PREPARING THE SAME"
292337
1223/KOLNP/2010 30‐01‐2018 FLUID COSMETIC COMPOSITION COMPRISING A MONOALCOHOL 292339
6524/CHENP/2010 31‐01‐2018 AMYLOID BETA PEPTIDES RESISTANT TOWARDSFIBRILLOGENESIS
AND OLIGOMERS THEREOF
292362
569/DEL/2007 31‐01‐2018 UTERINE STIMULATION STICKS. 292377
Page 38 of 85
1827/MUM/2006 31‐01‐2018 A PROCESS FOR THE PREPARATION OF A HERBAL FORMULATION
FOR THE CONTROL O F APHID, WHITE FLY AND HELIOTHIS
292390
7014/DELNP/2010 31‐01‐2018 A pharmaceutical composition for producing a desired change in a
target structure
292401
1345/KOLNP/2010 31‐01‐2018 AN IMMUNOGENIC FORMULATION THAT CONFERS PROTECTION
AGAINST THE INFECTION BY A RESPIRATORY SYNCTIAL VIRUS (RSV).
292436
6335/DELNP/2012 31‐01‐2018 “THIENO [2, 3‐B] PYRIDINEDIONE ACTIVATORS OF AMPK AND
THERAPEUTIC USES THEREOF”
292442
2073/MUM/2008 01‐02‐2018 PHARMACEUTICAL COMPOSITION COMPRISING COENZYME Q10 291287
3279/DELNP/2006 01‐02‐2018 "A COMPOSITION FOR TRANSDERMAL DELIVERY" 292450
4533/DELNP/2010 01‐02‐2018 "COUNTER‐PRESSURE FILTRATION OF PROTEINS" 292468
3566/DEL/2011 02‐02‐2018 "STABILIZED MICROBICIDAL COMPOSITION" 292490
1030/KOLNP/2011 02‐02‐2018 INHALABLE PARTICLES COMPRISING TIOTROPIUM 292499
2422/CHENP/2011 02‐02‐2018 2‐ARYL‐PROPIONIC ACIDS AND DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
292514
34/KOL/2010 04‐02‐2018 NOVEL BASE FOR EFFECTIVE TRANSDERMAL DELIVERIES OF ACTIVES 295383
59/CHENP/2011 05‐02‐2018 STABILIZER AND VACCINE COMPOSITION COMPRISING ONE OR
MORE LIVE ATTENUATED FLAVIVIRUSES
296466
7323/DELNP/2012 05‐02‐2018 ORAL CARE COMPOSITION 292541
7800/DELNP/2009 05‐02‐2018 "SUSTAINED DELIVERY FORMULATIONS OF RISPERIDONE
COMPOUNDS"
292550
2959/MUM/2010 05‐02‐2018 "A NOVEL HOLLOW MULTIPARTICULATE EXCIPIENT FOR DRUG
DELIVERY"
292575
3885/DELNP/2012 06‐02‐2018 RHODACYANINE DERIVATIVE AND PHARMACEUTICAL
COMPOSITION FOR TREATING LEISHMANIASIS
292588
11315/DELNP/2012 06‐02‐2018 METHODS OF DELIVERING A HEALTH CARE ACTIVE BY
ADMINISTERING PERSONAL HEALTH CARE ARTICLES COMPRISING A
FILAMENT
292589
2878/MUM/2011 06‐02‐2018 "A TOPICAL COMPOSITION FOR TREATMENT OF WOUNDS" 292591
2492/KOLNP/2012 06‐02‐2018 NOVEL COMPOSITION 292606
3870/CHENP/2011 07‐02‐2018 SUBSTITUTED TETRAHYDROPYRAN SPIRO PYRROLIDINONE AND
PIPERIDINONE
298401
2695/MUM/2011 07‐02‐2018 "NANOPARTICLE BASED COSMETIC COMPOSITION" 292636
3959/DELNP/2011 07‐02‐2018 THIENOTRIAZOLODIAZEPINE DERIVATIVES ACTIVE ON APO A 292639
280/CHENP/2011 07‐02‐2018 PROCESS FOR THE PREPARATION OF SPIROKETAL DERIVATIVES 292641
1908/MUM/2012 07‐02‐2018 "A NOVEL PROCESS FOR THE FOUR STEP PROTECTING GROUP FREE
SYNTHESIS OF (+)‐HAGEN'S GLAND LACTONES"
292674
1622/KOLNP/2011 07‐02‐2018 LIPIDATED IMIDAZOQUINOLINE DERIVATIVES 292680
10666/DELNP/2012 08‐02‐2018 CLEAR LEAVE ON HAIR CARE COMPOSITION COMPRISING
AMINOSILICONE AND ITS SOLVENT
292697
1345/DELNP/2010 08‐02‐2018 SCREENING METHODS USING G‐PROTEIN COUPLED RECEPTORS
AND RELATED COMPOSITIONS
292709
1950/DEL/2010 09‐02‐2018 CARBONATE FREE LAYERED DOUBLE HYDROXIDES AND A PROCESS
FOR THE PREPARATION THEREOF
292752
7502/CHENP/2009 09‐02‐2018 HOMOGENEOUS VACCINE COMPOSITION FOR THE TUMOR
TREATMENT AND ITS OBTAINING METHOD
292772
3019/DELNP/2011 11‐02‐2018 ANTIGENS THAT ELICIT IMMUNE RESPONSE AGAINST FLAVIVIRUS
AND METHODS OF USING SAME
302865
2663/MUM/2010 11‐02‐2018 "A METHOD FOR PREPARING AN ANTI VIRAL AGENT" 302868
2699/MUMNP/2010 12‐02‐2018 NIACINAMIDE CONTAINING COSMETIC COMPOSITIONS WITH
IMPROVED SKINFEEL PROPERTIES
292818
7420/DELNP/2010 12‐02‐2018 "NICOTINE LOZENGE COMPOSITIONS" 292827
7205/DELNP/2011 13‐02‐2018 TREATMENT OF CANCER WITH IMMUNOSTIMULATORY HIV TAT
DERIVATIVE POLYPEPTIDES
292852
Page 39 of 85
841/CHE/2009 13‐02‐2018 “HERBAL EXFOLIATING COMPOSITION COMPRISING PHASEOLUS
MUNGO AND CYPHOMANDRA BETACEAE"
292860
2656/CHENP/2010 15‐02‐2018 ULTRAVIOLET ABSORBER WATER‐DISPERSED COMPOSITION 292961
7410/DELNP/2009 16‐02‐2018 "USE OF 4‐PYRROLIDIN‐1‐YL)QUINOLINE COMPOUNDS TO KILL
CLINICALLY LATENT MICROORGANISMS"
292987
1143/CHENP/2010 19‐02‐2018 HUMANIZED CXCR5 ANTIBODIES, DERIVATIVES THEREOF 293032
3774/KOLNP/2009 20‐02‐2018 “A TRUNCATED L1 PROTEIN OF HUMAN PAPILLOMAVIRUS TYPE 16” 293074
3392/DELNP/2011 20‐02‐2018 IMPROVED ANTI‐CD19 ANTIBODIES 293079
2383/MUMNP/2009 21‐02‐2018 “NOVEL COMPOUNDS 951: A BIPHENYLOXYPROPANOIC ACID AS
CRTH2 MODULATOR AND INTERMEDIATES”
293122
1498/MUM/2010 21‐02‐2018 "PROCESS TO MANUFACTURE MEDICINAL PREPARATION
INTERALIA CONTAINING AND LUMEFANTRINE IN SOFT GELATIN
CAPSULE"
293129
472/DELNP/2010 21‐02‐2018 "LEISHMANIA STEROL 24‐C‐METHYLTRANSFERASE COMPOSITIONS
FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF
LEISHMANIASIS"
293168
5408/DELNP/2012 22/02/2018 ORAL CARE FORMULATIONS FOR MALODOR CONTROL 293200
1645/MUM/2008 22‐02‐2018 A PROCESS OF LYOPHILIZING HIGH FILL VOLUME FORMULATIONS
CONTAINING MANNITOL
293201
1278/MUM/2008 22‐02‐2018 CONTROLLED RELEASE ORAL PHARMACEUTICAL
PREPARATION OF CEFIXIME TRIHYDRATE WITH
PROBENECID
293219
3303/DELNP/2013 22‐02‐2018 ORAL COMPOSITIONS CONTAINING MICROAGGREGATES 293244
1430/DEL/2011 22‐02‐2018 "A SOFT‐GEL CAPSULE FORMULATION FOR NUTRACEUTICAL VALUE
FROM SEABUCKTHORN"
293255
67/CHENP/2012 23/02/2018 METALLIC NANOPARTICLES, PREPARATION AND USES THEREOF 293287
8468/CHENP/2011 23‐02‐2018 “Pharmaceutical Compositions comprising Controlled release
floatingmicroparticles”
293282
8981/DELNP/2010 23‐02‐2018 "USE OF CELL‐PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL
TRANSDUCTION PATHWAY FOR THE TREATMENT OF CHRONIC OR
NON‐CHRONIC INFLAMMATORY DIGESTIVE DISEASES"
293291
7265/DELNP/2010 23‐02‐2018 "DRY TRANSGLUTAMINASE COMPOSITION" 293310
7340/DELNP/2010 23‐02‐2018 VITAMIN E DERIVATIVES AND THEIR USES 293317
3498/CHENP/2010 23‐02‐2018 QUARTERNIZATION OF THE ADDITIVE AMINO ALKYLMETHACRYLATE
COPOLYMER E FOR IMPROVING PERMEABILITY AND SOLUBILITY OF
PHARMACEUTICALS
293335
4843/CHENP/2011 26/02/2018 PROCESS FOR THE PREPARATION OF ASYMMETRICAL BIS
(THIOSEMICARBAZONES)
293406
2937/CHENP/2011 26‐02‐2018 CARBAZOLE COMPOUNDS AND THERAPEUTIC USES OF THE
COMPOUND
293340
4256/KOLNP/2009 26‐02‐2018 A PROCESS FOR THE PREPARATION OF NOVEL PIPERAZINE SALTS AS
D3/D2 ANTAGONISTS
293352
9974/DELNP/2008 26‐02‐2018 "A PHARMACEUTICAL COMPOSITION FOR INTRAMUSCULAR
ADMINISTRATION COMPRISING E‐TMC278 BASE"
293368
2703/DEL/2011 26‐02‐2018 "PHARMACEUTICAL COMPOSITIONS OF ARTEMISININ DERIVATIVE
AND PROCESS OF PREPARATION THEREOF"
293399
183/DEL/2010 26‐02‐2018 AN ANTITUBERCULAR FORMULATION OF 4‐ALKOXY PHENYL
CYCLOPROPYL ALKANOLS
293425
425/DELNP/2013 26‐02‐2018 NEW FORMULATIONS OF 14 ‐ EPI ‐ANALOGUES OF VITAMIN D 293434
617/KOLNP/2010 26‐02‐2018 ISOTHIAZOLOPYRIDINONES USEFUL FOR THE TREATMENT OF
(INTER ALIA) CYSTIC FIBROSIS
293436
9045/DELNP/2011 27‐02‐2018 CHEMOSENSORY RECEPTOR LIGAND‐BASED THERAPIES 293443
5402/DELNP/2010 27‐02‐2018 "CONJUGATED FACTOR VIII MOLECULES" 293445
2741/DELNP/2011 27‐02‐2018 "COMPOUNDS THAT EXPAND HEMATOPOIETIC STEM CELLS" 293447
4334/DELNP/2012 27‐02‐2018 “ENDODONTIC SEALING COMPOSITION” 293466
5574/DELNP/2011 27‐02‐2018 “PHARMACEUTICAL FORMULATION OF NANONISED FENOFIBRATE” 293509
Page 40 of 85
6093/DELNP/2010 27‐02‐2018 "MODIFIED RELEASE COMPOSITION COMPRISING DOXOFYLLINE" 293512
1903/DEL/2013 27‐02‐2018 PROCESS FOR THE ENZYMATIC SYNTHESIS OF (7S)‐1‐(3,4‐
DIMENTHOXYBICYCLO[4.2.0]ICTA‐,3,5‐TRIEN‐7‐YL) N‐METHYL
METHANAMINE, AND APPLICATION IN THE SYNTHESIS OF
IVABRADINE AND SALTS THEREOF
293519
6626/DELNP/2010 27‐02‐2018 MIMOTOPES OF ALPHA‐SYNUCLEIN FOR THE TREATMENT OF
NEURODEGENERATIVE DISORDERS
293522
2401/CHENP/2012 27‐02‐2018 PERSONAL CARE COMPOSITIONS WITH ETHYLENE ACRYLIC ACID
COPOLYMER AQUEOUS DISPERSIONS
293541
232/CHENP/2010 28/02/2018 MOLECULES FOR TARGETING COMPOUNDS TO VARIOUS SELECTED
ORGANS OR TISSUES
293576
4211/CHENP/2008 28/02/2018 MICROPARTICULATE PHARMACEUTICAL FORMS RESISTANT TO
IMMEDIATERELEASE OF THE ACTIVE PRINCIPLE IN THE PRESENCE
OF ALCOHOL
293628
5294/DELNP/2013 28‐02‐2018 CONTINUOUS ARYCYCLIC COMPOUND 293557
4387/CHENP/2012 28‐02‐2018 AQUEOUS PATCHES CONTAINING DICLOFENAC SODIUM 293558
2307/CHE/2009 28‐02‐2018 "IMPROVED PROCESS FOR THE PREPARATION OF ZILEUTON" 293566
2697/DEL/2010 28‐02‐2018 SUBSTITUTED 4‐ACRYLAMIDOPODOPHYLLOTOXIN CONGENERS AS
ANTITUMOUR ANTIBIOTICS AND PROCESS FOR THE PREPARATION
THEREOF
293591
32/MUM/2013 28‐02‐2018 "INTRANASAL MICRO‐EMULSION OF AN ANTI‐MALARIAL DRUG,
ARTEMETHER"
293596
2718/MUMNP/2012 28‐02‐2018 HYDROXY ACID COMPOUND OF SUBSTITUTED PHENOL
PREPARATION METHOD AND MEDICAL USE THEREOF
293601
1294/DELNP/2013 28‐02‐2018 PROCESS FOR THE PRODUCTION OF L CARNITINE TARTRATE 293603
2131/MUM/2011 28‐02‐2018 A PHARMACEUTICAL COMPOSITION OF CINNARIZINE 293609
5157/CHENP/2009 28‐02‐2018 "TREATING STROKE AND OTHER DISEASES WITHOUT INHIBITING N‐
TYPE CALCIUM CHANNELS"
293614
1149/MUM/2010 01‐03‐2018 "CALCIUM CONTAINING ORAL COMPOSITIONS" 293675
2471/DELNP/2011 02‐03‐2018 "3,3'4,4'‐TETRAHYDROXY‐2,2'‐BIPYRIDINE‐N, N'‐DIOXIDES FOR THE
TREATMENT OF RENAL CELL CARCINOMA"
293753
3537/CHENP/2010 02‐03‐2018 SUNSCREEN COMPOSITIONS COMPRISING COLOUR PIGMENTS 293757
514/MUMNP/2011 04‐03‐2018 “PHARMACEUTICAL FORMULATION 514” 295417
1258/KOL/2009 05‐03‐2018 A NOVEL FORMULATION FOR TREATING FUNGAL INFECTION 293776
7838/DELNP/2013 06‐03‐2018 COMPOSITION COMPRISING PERLITE AND A POLYMER BEARING A
CARBOSILOXANE DENDRIMER BASED UNIT
293830
6557/CHENP/2012 06‐03‐2018 4' ‐ AZIDO‐NUCLEOSIDES AS ANTI‐HCV COMPOUNDS 293832
6566/DELNP/2010 06‐03‐2018 “A Cytokine‐antibody DNL (Dock and Lock) Complex” 293871
4710/CHENP/2009 06‐03‐2018 "MICROCAPSULES COMPRISING ENCAPSULATED FRAGRANCES" 293873
6318/DELNP/2010 06‐03‐2018 "AN AQUEOUS SUSPENSION CONTAINING SURFACE‐ MODIFIED
PARTICLE OF A THERAPEUTIC AGENT COATED WITH OPSONIN "
293894
8442/CHENP/2011 06‐03‐2018 TRANSDERMAL PREPARATION 293895
4364/KOLNP/2009 07‐03‐2018 VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR
POLYSACCHARIDE CONJUGATES
293947
4655/DELNP/2007 07‐03‐2018 "A PHARMACEUTICAL COMPOSITION FOR INHIBITING GROWTH OF
CANCER CELLS"
293956
4363/KOLNP/2009 07‐03‐2018 VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR
POLYSACCHARIDE CONJUGATES
293958
5194/DELNP/2010 07‐03‐2018 “PHARMACEUTICAL COMPOSITION INCLUDING BETA‐
ADRENORECEPTOR
ANTAGONISTS
293974
2576/DELNP/2012 08‐03‐2018 "OXALIPLATIN NANOPARTICLES AND METHOD FOR PREPARING
SAME"
293981
3937/KOLNP/2011 08‐03‐2018 INTRAVENOUS FORMULATION WITH WATER‐SOLUBLE COCRYSTALS
OF ACETYLSALICYLIC ACID AND THEANINE
293988
3538/MUM/2010 09‐03‐2018 CURCUMIN MONOSULPHATE, ITS SALTS, PROCESS FOR SYNTHESIS
THEREOF AND TREATMENT OF CANCER
294015
Page 41 of 85
2511/DEL/2008 09‐03‐2018 SUBSTITUTED BENZFUROCHROMENES AND RELATED COMPOUNDS
FOR THE PREVENTION AND TREATMENT OF BONE RELATED
DISORDERS
294021
9644/DELNP/2011 09‐03‐2018 DIKETOPIPERAZINE MICROPARTICLES WITH DEFINED ISOMER
CONTENTS
294023
1473/DELNP/2011 09‐03‐2018 "MULTI‐ARM POLYMERIC ALKANOATE CONJUGATES" 294034
6843/DELNP/2012 09‐03‐2018 ANDROGEN RECEPTOR MODULATORS AND USES THEREOF 294038
2152/DELNP/2011 09‐03‐2018 ISOLATION AND IDENTIFICATION OF GLYCOSAMINOGLYCANS 294040
2138/CHE/2007 09‐03‐2018 SKIN CARE AGENT AND COMPOSITIONS THEREOF 294050
6664/CHENP/2011 09‐03‐2018 CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION WITH
RESISTANCE AGAINST THE INFLUENCE OF ETHANOL EMPLOYING A
COATING COMPRISING NEUTRAL VINYL POLYMERS AND EXCIPIENTS
294064
4018/DELNP/2011 09‐03‐2018 “CONCENTRATED LIQUID DIET” 294076
2937/MUM/2009 09‐03‐2018 AN IMPROVED PROCESS FOR THE PREPARATION OF PERINDOPRIL
AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
294106
4574/DELNP/2011 12‐03‐2018 "DYE SOLUTION" 294109
4428/DELNP/2008 12‐03‐2018 "OLANEXIDINE GLUCONATE" 294133
6877/DELNP/2010 12‐03‐2018 "METHOD FOR ACHIEVING DESIRED GLIAL GROWTH FACTOR 2
PLASMA LEVELS"
294146
6090/DELNP/2010 12‐03‐2018 "STABILIZED ANGIOPOIETIN‐2 ANTIBODIES AND USES THEREOF" 294150
8427/CHENP/2011 13‐03‐2018 “METHOD FOR STORING AN IMMUNOGENIC COMPOSITION
AVAILABLE UNTIL NEEDED FOR ADMINISTRATION TO AN ANIMAL”
294183
6968/DELNP/2011 13‐03‐2018 RILUZOLE AQUEOUS SUSPENSIONS 294188
8949/DELNP/2010 13‐03‐2018 "USE OF CELL‐PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL
TRANSDUCTION PATHWAY FOR THE TREATMENT OF VARIOUS
DISEASES"
294191
1341/CHENP/2011 13‐03‐2018 LYOPHILIZED FORMULATIONS OF ENGINEERED ANTI‐IL‐23P19
ANTIBODIES
294196
562/KOL/2009 13‐03‐2018 NOVEL INTERMEDIATES IN THE PREPARATION OF 1,4‐DIPHENYL
AZETIDINONE
294217
528/MUM/2009 13‐03‐2018 LIPID BASED PHARMACEUTICAL PREPARATIONS FOR ORAL AND
TOPICAL APPLICATION; THEIR COMPOSITIONS, METHODS AND
USES THEREOF
294226
1423/KOLNP/2010 13‐03‐2018 ANTIBODIES SPECIFIC FOR THE PROTOFIBRIL FORM OF BETA‐
AMYLOID PROTEIN
294232
124/DEL/2010 14‐03‐2018 NOVEL PORPHYRIN DERIVATIVES FOR PHOTODYNAMIC THERAPY
(PDT): A PROCESS FOR THE PREPARATION THEREOF AND THEIR USE
AS PDT AGENTS AND FLUORESCENCE PROBES FOR BIOLOGICAL
APPLICATIONS
294263
9005/DELNP/2012 14‐03‐2018 HIGH SHEAR APPLICATION IN DRUG DELIVERY 294264
2340/DELNP/2009 14‐03‐2018 "A STABLE COMPOSITION COMPRISING A BONE ANABOLIC
PROTEIN, NAMELY A PTHRP ANALOGUE, AND USES THEREOF"
294317
6300/CHENP/2011 15‐03‐2018 PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL
COMPOSITION COMPRISING EZETIMIBE
294328
4017/DELNP/2013 15‐03‐2018 ORAL AND PERSONAL CARE COMPOSITIONS COMPRISING ZINC
CONTAINING FILMS
294333
182/DEL/2010 15‐03‐2018 NOVEL DISPIRO CYCLOALKANONES USEFUL AS INHIBITORS OF NAD+‐
DEPENDENT DNA LIGASE AND ANTITUBERCULAR AGENTS
294354
10929/DELNP/2012 16‐03‐2018 POLYMERIC SYSTEM FOR DELIVERING A PRESERVATIVE‐FREE
PROSTAGLANDIN‐BASED NONVISCOUS SOLUTION
294408
420/DEL/2012 16‐03‐2018 PROCESS FOR PREPARATION OF FORMULATION OF NANOCOPPER
TO COMBAT BACTERIAL BLIGHT POMEGRANATE, RICE AND BEAN
294416
8185/CHENP/2010 16‐03‐2018 ORODISPERSIBLE MANNITOL 294448
2064/CHE/2010 16‐03‐2018 A PROCESS TO PREPARE ANTIOXIDANT AND ANTIINFLAMMATORY
CONCENTRATES FROM BROWN AND RED SEAWEEDS AND A
PRODUCT THEREOF
294451
Page 42 of 85
6488/DELNP/2012 16‐03‐2018 AN ANTIMICROBIAL SOLUTION 294460
2435/CHENP/2012 20‐03‐2018 (Z)‐2‐CYANO‐3‐HYDROXY‐BUT‐2‐ENOIC ACID‐(4'‐
TRIFLUORMETHYLPHENYL)‐AMIDE TABLET FORMULATIONS WITH
IMPROVED STABILITY
294535
452/DELNP/2010 20‐03‐2018 "METHODS AND COMPOSITIONS FOR TREATING DISORDERS" 294564
3146/DEL/2012 20‐03‐2018 AN ORAL LIQUID FORMULATION AS CYANIDE ANTIDOTE 294602
5002/DELNP/2013 21‐03‐2018 FILMS AND COMPOSITIONS COMPRISING THE SAME 294639
9438/DELNP/2011 21‐03‐2018 "COMPOSITIONS AND METHODS FOR DRUG DELIVERY" 294657
2990/MUM/2011 21‐03‐2018 A QUINALDINE DERIVATIVE AND ITS PREPARATION 294671
7207/DELNP/2011 21‐03‐2018 "CARRIER COMPRISING A VITAMIN E DERIVATIVE" 294679
1580/DEL/2011 21‐03‐2018 "SUBSTITUTED 4‐ ARYLTHIAZOL‐2‐HYDRAZONES FOR THE
TREATMENT OF TUBERCULOSIS"
294724
3428/DELNP/2010 22/03/2018 METHODS FOR DESIGNING AND PREPARING VACCINES
COMPRISING DIRECTED SEQUENCE POLYMER COMPOSITIONS VIA
THE DIRECTED EXPANSION OF EPITOPES
294760
1859/DELNP/2012 22‐03‐2018 "NOVEL PHARMACEUTICAL FORMULATION AGAINST DRUG
MISUSE"
294725
2601/MUM/2009 22‐03‐2018 A NOVEL MULTIPARTICULATE CONTROLLED POROSITY OSMOTIC
PUMP OF OXYBUTYNIN HYDROCHLORIDE
294752
2091/MUMNP/2010 22‐03‐2018 "AN ANTIVIRAL COMPOSITION" 294778
8361/DELNP/2009 22‐03‐2018 "SUBSTITUTED IMIDAZOHETEROCYCLES" 294786
307/CHENP/2011 23/03/2018 CDCA1 EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME 294790
2792/DEL/2008 23‐03‐2018 OSMOTIC CONTROLLED RELEASE ORAL FORMULATION OF
LYCOPENE WITH ENHANCED SOLUBILITY
294829
2154/DELNP/2014 23‐03‐2018 PERSONAL CARE COMPOSITIONS AND METHODS OF MAKING SAME 294845
3489/DELNP/2012 23‐03‐2018 MICROCRYSTALLINE CELLULOSE AND CALCIUM PHOSPHATE
COMPOSITIONS USEFUL AS PHARMACEUTICAL EXCIPIENTS
294846
3643/DELNP/2012 26‐03‐2018 ENDOGLIN ANTIBODIES 294860
1404/KOLNP/2010 26‐03‐2018 "A CHIMERIC CONSTRUCT" 294874
1700/CHE/2012 26‐03‐2018 A PROCESS FOR PREPARATION OF IRON SUCROSE COMPLEX 294877
6552/CHENP/2009 26‐03‐2018 "SOLID DOSAGE FORMS COMPRISING AN ENTERIC COATING WITH
ACCELERATED DRUG RELEASE"
294881
6328/CHENP/2009 26‐03‐2018 "COMBINATION OF BLYS INHIBITION AND/OR APRIL INHIBITION
AND IMMUNOSUPPRESSANTS FOR TREATMENT OF AUTOIMMUNE
DISEASE"
294883
676/CHENP/2012 26‐03‐2018 COMPOSITION FOR TREATMENT OF TUBERCULOSIS 294897
1622/MUMNP/2010 26‐03‐2018 “COMPOUNDS” 294899
6207/DELNP/2013 26‐03‐2018 LONG LASTING CONTROLLED RELEASE LIPOSOME COMPOSITION
AND METHOD FOR PRODUCING SAME
294934
2148/KOLNP/2011 26‐03‐2018 STABLE TABLET CONTAINING 4,5‐EPOXYMORPHINAN DERIVATIVE 294936
2304/DELNP/2013 27/03/2018 HYDRATED N FULLERENE AMINO ACIDS METHOD FOR PRODUCING
THE LATTER AND PHARMACEUTICAL COMPOSITIONS ON THE BASIS
THEREOF
294981
9957/CHENP/2011 27‐03‐2018 “COSMETIC COMPOSITION COMPRISING ENCAPSULATED SILICONE
COMPOUNDS”
295008
3769/DELNP/2007 27/03/2018 "A pharmaceutical composition" 295009
7208/CHENP/2010 27‐03‐2018 METHOD OF FORMING NON‐IMMUNOGENIC HYDROPHOBIC
PROTEIN NANOPARTICLES AND USES THEREFOR
294979
4920/DELNP/2005 27‐03‐2018 "FREEZE‐DRIED PREPARATION CONTAINING METHYLCOBALAMIN
AND PROCESS FOR PRODUCING SAME"
295018
1424/DELNP/2010 27‐03‐2018 "METHOD FOR PRODUCING VIRAL VACCINES" 295041
4935/DELNP/2012 28/03/2018 "INVERSE EMULSIONS COMPRISING AN ALKOXYLATED ESTER OIL" 295106
3746/DEL/2012 28/03/2018 DEVELOPMENT OF POLYMERIC FORMULATIONS OF BIOACTIVE
MOLECULES AND METHOD OF PREPARATION THEREOF
295150
Page 43 of 85
4189/KOLNP/2010 28/03/2018 THIENOPYRIDONE DERIVATIVES AS AMP‐ACTIVATED PROTEIN
KINASE (AMPK) ACTIVATORS
295269
1219/DELNP/2011 28‐03‐2018 DOCK‐AND‐LOCK (DNL) VACCINES FOR MULTIPLE MYELOMA
THERAPY
295098
4941/DELNP/2012 28‐03‐2018 CARNITINE GRANULATE AND METHODS FOR ITS PRODUCTION 295113
3061/DELNP/2011 28‐03‐2018 "PYRAZOLYLAMINOPYRIDINES AS INHIBITORS OF FAK" 295116
10165/DELNP/2007 28‐03‐2018 " COMPOSITION FOR INCREASING THE CYTOTOXIC ACTIVITY OF
EXHAUSTED T CELLS"
295146
734/KOL/2012 28‐03‐2018 HERBAL COMPOSITION AND MEDICAMENT THEREOF FOR
TREATING EPILEPSY
295175
2640/DELNP/2011 28‐03‐2018 "CHEWABLE GELLED EMULSIONS" 295188
733/CHENP/2007 28‐03‐2018 TRANSDERMAL DRUG DELIVERY DEVICE WITH TRANSLUCENT
PROTECTIVE FILM
295241
1374/MUM/2012 28‐03‐2018 "A PHARMACEUTICAL COMPOSITION FOR CONTROLLING NAUSEA
AND VOMITING"
295259
2299/KOLNP/2010 28‐03‐2018 METHODS AND DEVICES FOR MINIMALLY‐INVASIVE EXTRAOCULAR
DELIVERY OF RADIATION TO THE POSTERIOR PORTION OF THE EYE
295266
2378/MUM/2009 30/03/2018 AN EFFICIENT PROCESS FOR SYNTHESIS OF DEXMETHYLPHENIDATE 295308
3307/DELNP/2011 30‐03‐2018 "LEPTIN COMPOSITIONS AND METHODS FOR TREATING
PROGRESSIVE COGNITIVE FUNCTION DISORDERS RESULTING FROM
ACCUMULATION OF NEUROFIBRILLARY TANGLES AND AMLYOID
BETA"
295300
4601/KOLNP/2010 30‐03‐2018 NIP THIAZOLE DERIVATIVES AS INHIBITORS OF 11‐BETA‐
HYDROXYSTEROID DEHYDROGENASE‐1
295304
1742/MUMNP/2011 30‐03‐2018 PROCESS FOR THE PREPARATION OF PYRAZOLE DERIVATIVES. 295315
8913/DELNP/2010 31‐03‐2018 NON‐HORMONAL STEROID MODULATORS OF NF‐KB FOR
TREATMENT OF DISEASE
295321
107/KOL/2012 31‐03‐2018 SKIN CARE FORMULATIONS COMPRISING HERBAL COMPONENTS 295331
2524/DELNP/2011 31‐03‐2018 FAT EMULSION FOR ARTIFICIALLY FEEDING SERIOUSLY ILL
INTENSIVE CARE PATIENTS
295337
4103/KOLNP/2011 31‐03‐2018 ORALLY DISINTEGRATING COATED TABLET 295349
953/MUMNP/2013 31‐03‐2018 IMPROVED PHARMACEUTICAL STARTER PELLETS 295350
244/KOL/2012 02‐04‐2018 NANOMATERIAL BASED COSMETIC PRODUCTS 295357
22/CHENP/2011 02‐04‐2018 ALPHA HELIX MIMETICS AND METHODS RELATING THERETO 295395
2979/DELNP/2009 04‐04‐2018 "A PERSONAL CARE COMPOSITION COMPRISING GLYOXAL
CROSSLINKED CATIONIC GUAR"
295462
5098/DELNP/2011 04‐04‐2018 A PHARMACEUTICAL COMPOSITION AND A PROCESS FOR
PREPARING THE SAME
295477
9474/DELNP/2012 04‐04‐2018 LIQUID FORMULATIONS OF RUPATADINE FUMARATE 295488
2856/KOLNP/2006 05‐04‐2018 A COMPOSITION COMPRISING BOTULINUM TOXINS AND KIT FOR
ADMINISTERING THE SAME THEREOF
295534
1145/CHENP/2010 06‐04‐2018 AMINO‐ACID‐CONTAINING MEDICINAL GRANULAR PREPARATION
HIGHLY EASY TO TAKE
295572
1103/MUMNP/2011 06‐04‐2018 PA method for producing an active ingredient‐containing
polyurethane
patch
295576
2874/MUM/2012 07‐04‐2018 CAPSULE FOR ENCAPSULATING A TABLET 298520
5708/CHENP/2011 09‐04‐2018 “COMPLEX AND PRODUCTION PROCESS” 300720
4783/DELNP/2011 09‐04‐2018 RECOMBINANT AVIAN INFLUENZA VACCINE AND USES THEREOF 300704
1728/MUM/2010 09‐04‐2018 STABLE LIQUID PHARMACEUTICAL COMPOSITIONS OF RANITIDINE 295604
8388/CHENP/2011 10‐04‐2018 FENTANYL‐CONTAINING ADHESIVE PREPARATION FOR EXTERNAL
USE
295642
6197/DELNP/2013 10‐04‐2018 ORAL COMPLEX COMPOSITION COMPRISING OMEGA 3 FATTY ACID
ESTER AND HMG COA REDUCTASE INHIBITOR
295652
1843/DEL/2010 11‐04‐2018 NOVEL COUMARIN‐CHALCONE HYBRIDS AS ANTICANCER AGENTS 295689
Page 44 of 85
4109/CHE/2011 12‐04‐2018 PROCESS OF PREPARATION OF TETRACYCLINE LOADED O ‐
CARBOXYMETHYL CHITOSAN NANOPARTICLES
303963
3328/DELNP/2011 12‐04‐2018 "HIV‐1 INTEGRASE DERIVED STIMULATORY PEPTIDES INTERFERING
WITH INTEGRASE‐REV PROTEIN BINDING"
295729
4168/KOLNP/2009 13/04/2018 “OPTIMIZED TACI‐FC FUSION PROTEIN” 295755
6935/DELNP/2010 13‐04‐2018 "ANTIGEN‐AND‐DRUG VEHICLE COMPRISING SYNTHETIC PEPTIDE,
AND MUCOSAL VACCINE USING THE SAME"
295762
1511/KOLNP/2011 16‐04‐2018 POLYSACCHARIDES COMPRISING CARBOXYL FUNCTIONAL GROUPS
SUBSTITUTED BY A HYDROPHOBIC ALCOHOL DERIVATIVE
295816
3867/CHE/2010 17‐04‐2018 SALTS OF 3‐CYCLOPROPYLMETHOXY ‐4‐
DIFLUOROMETHOXYBENZOIC ACID AND ITS USE
295824
4748/DELNP/2013 17‐04‐2018 ORAL CARE COMPOSITIONS 295833
9927/DELNP/2012 17‐04‐2018 VACCINES COMPRISING CHOLESTEROL AND CPG AS SOLE
ADJUVANT ‐ CARRIER MOLECULES
295853
7389/DELNP/2013 17‐04‐2018 PROCESS FOR THE PRODUCTION OF A PEMETREXED SALT 295856
381/MUMNP/2012 17‐04‐2018 "EXTERNAL PREPARATION" 295859
4987/CHE/2012 18/04/2018 PROCESS FOR THE PREPARATION OF ALCAFTADINE 295901
1531/DELNP/2011 19‐04‐2018 “PDE10 INHIBITORS AND RELATED COMPOSITIONS AND METHODS” 295904
1965/KOLNP/2011 19‐04‐2018 THIOCHROMENE DERIVATIVES AS HIP HYDROXYLASE INHIBITORS 295924
5604/DELNP/2012 20‐04‐2018 INTERMEDIATES AND SURFACTANTS USEFUL IN HOUSEHOLD
CLEANING AND PERSONAL CARE COMPOSITIONS AND METHODS
OF MAKING THE SAME
295939
795/KOLNP/2011 23‐04‐2018 "A METHOD FOR PREPARING MULTILAYERED BLOOD PRODUCT" 295992
2859/CHE/2009 23‐04‐2018 “FORMULATIONS OF ANTIBODY” 295994
1703/KOLNP/2010 23‐04‐2018 "MULTITYPE HPV PEPTIDE COMPOSITIONS FOR TREATMENT OR
PREVENTION OF HUMAN PAPILLOMAVIRUS INFECTION"
295995
545/KOLNP/2011 23‐04‐2018 PHOSPHATE BINDING MATERIALS AND THEIR USES 295998
9825/CHENP/2011 23‐04‐2018 ESTER MIXTURES AND COMPOSITIONS COMPRISING SUCH ESTER
MIXTURES
296003
3080/KOLNP/2013 24/04/2018 NOVEL PIPERIDINYL MONOCARBOXYLIC ACIDS AS S1P1 RECEPTOR
AGONISTS
296041
3544/DELNP/2011 24/04/2018 "ADJUVANT INCORPORATION IN IMMUNONANOTHERAPEUTICS" 296027
900/DEL/2006 24‐04‐2018 "A PROCESS FOR THE PREPARATION OF POTENTIAL ANTIULCER
COMPOUNDS FROM GINGER (ZINGIBER OFFCINALE) RHIZOME "
296011
7507/CHENP/2012 24‐04‐2018 ANTI LEISHMANIAL COMPOUND AND ANTI LEISHMANIAL DRUG 296047
9746/CHENP/2012 24‐04‐2018 “GLUCAGON‐LIKE PEPTIDE‐1 ANALOGUE AND USE THEREOF” 296089
4791/DELNP/2013 25‐04‐2018 METAL SALT COMPOSITIONS 296112
5099/DELNP/2011 25‐04‐2018 "A DISINTEGRATING TABLET" 296125
5447/CHENP/2010 25‐04‐2018 PROCESS FOR STABILIZING AN ADJUVANT CONTAINING VACCINE
COMPOSITION
296126
10775/DELNP/2012 25‐04‐2018 PHARMACEUTICAL FORMULATION IN THE FORM OF BILAYERED
TABLETS COMPRISING HMG COA REDUCTASE INHIBITOR AND
IRBESARTAN
296129
170/KOL/2014 25‐04‐2018 AN AQUEOUS ALCOHOL FREE WATERLESS CLEANSING SYSTEM FOR
COSMETICS AND DERMATOLOGICAL APPLICATION
296133
2375/KOLNP/2011 25‐04‐2018 SILICA‐BASED ANTIBACTERIAL AND ANTIFUNGAL
NANOFORMULATION
296136
5461/CHENP/2009 26/04/2018 "ANTIBODIES AGAINST ERBB3" 296147
358/MUMNP/2012 26/04/2018 DELIVERY SYSTEM 296231
1801/MUMNP/2013 26‐04‐2018 PHARMACEUTICAL COMPOSITION FOR TREATING HEPATIC DISEASE 296164
2116/MUMNP/2014 26‐04‐2018 SOLID COMPOSITION COMPRISING SALT OF AMINOCARBOXYLIC
ACID
296173
Page 45 of 85
4895/KOLNP/2011 26‐04‐2018 IMPROVED RECONSTITUTED SURFACTANT COMPOSITION
CONTAINING ANALOGS OF SURFACTANT PROTEIN B (SP‐B) AND
SURFACTANT PROTEIN C (SP‐C)
296183
829/MUM/2011 26‐04‐2018 A PHARMACEUTICAL COMPOSITION COMPRISING FIBRATE AND
FOLIC ACID
296191
10869/DELNP/2012 27‐04‐2018 “ANTIPSYCHOTIC INJECTABLE DEPOT COMPOSITION” 296238
5363/DELNP/2010 27‐04‐2018 "PHARMACEUTICAL COMPOSITION OR COMBINATION DRUG" 296259
4712/DELNP/2006 27‐04‐2018 A COMPOUND OF FORMULA (II) 296299
3000/MUM/2009 28‐04‐2018 A PROCESS FOR THE PREPARATION OF SUBSTANTIALLY PURE
PERINDOPRIL
296354
779/KOL/2009 01‐05‐2018 A METHOD FOR PREPARING A WATER DISPERSIBLE GLYCERYL
MONOOLEATE (GMO) MAGNETIC NANOPARTICLE (MNP)
FORMULATION AND USE OF THE SAME
296360
10893/DELNP/2012 01‐05‐2018 “SYNERGISTIC HERBICIDAL COMPOSITIONS CONTAINING
PROPYZAMIDE AND AMINOPYRALID”
296377
2653/MUMNP/2012 01‐05‐2018 ARYL AND HETEROARYL‐QUINOLIN COMPOUND 296393
1960/DEL/2011 02‐05‐2018 PHARMACEUTICAL COMPOSITIONS FOR ENHANCING ANTICANCER
EFFICACY OF TAMOXIFEN”
296411
3455/CHE/2011 02‐05‐2018 "A METAL DOPED PROTEIN–SORAFENIB NANOMEDICINE
FORMULATIONFOR CANCER TREATMENT"
296417
1038/KOL/2009 02‐05‐2018 "HERBAL COMPOSITION FOR USE IN A HYDRO GENERATOR FAN" 296425
4993/KOLNP/2007 02‐05‐2018 A METHOD OF MAKING AN IMMUNOGENIC COMPOSITION 296428
252/KOL/2011 02‐05‐2018 ORAL CARE COMPOSITIONS 296431
1838/DELNP/2012 02‐05‐2018 "SPLA2 HYDROLYSABLE LIPOSOMES WITH IMPROVED STORAGE
STABILITY"
296446
2793/CHENP/2009 02‐05‐2018 “CHIMERICAL PEPTIDIC MOLECULES WITH ANTIVIRAL PROPERTIES
AGAINST THE VIRUSES OF THE FLAVIVIRIDAE FAMILY”
296464
2071/CHE/2007 03‐05‐2018 PROCESS FOR THE PREPARATION OF LAMIVUDINE FORM I 293798
2039/MUM/2010 03‐05‐2018 A HERBAL COMPOSITION (FC) FOR THE TREATMENT OF CERVICAL
CANCER
293782
1846/DELNP/2014 03‐05‐2018 METHOD FOR PURIFICATION OF CLEAVED PRO INSULIN 296509
3889/CHE/2011 03‐05‐2018 CATIONIC ANTIBACTERIAL COMPOSITION 296510
236/CHENP/2010 04‐05‐2018 INTRADERMAL INFLUENZA VACCINE 296525
731/DELNP/2013 04‐05‐2018 An oral prolonged release pharmaceutical composition comprising
oxycodone and naloxone
296540
2412/MUM/2011 07‐05‐2018 1,6‐DIAZABICYCLO[3,2,1]OCTAN‐7‐ONE DERIVATIVES 298526
2780/DELNP/2013 07‐05‐2018 TRANSDERMAL ABSORPTION PREPARATION 298570
768/DELNP/2006 07‐05‐2018 "SYNTHETIC PEPTIDE VACCINES FOR FOOT‐AND‐MOUTH DISEASE" 296573
4056/DELNP/2008 07‐05‐2018 FORMULATION FOR ORAL ADMINISTRATION FOR THE TREATMENT
OF TYPE 2 DIABETES
296580
949/KOLNP/2011 08‐05‐2018 PROCESSES FOR THE PREPARATION OF SGLT2 INHIBITORS 296612
9363/CHENP/2011 09‐05‐2018 FACTOR VII COMPOSITION 296635
1075/MUMNP/2012 09‐05‐2018 SUNSCREEN COMPOSITION 296641
1943/DEL/2010 09‐05‐2018 "SCAR PRIMERS AND A KIT FOR THE AUTHENTICATION OF UNANI
DRUG MULETHI (GLYCERRHIZA GLABRA) AND ITS ADULTERANT
ABRUS PRECATORIOUS".
296647
435/KOL/2012 10‐05‐2018 SKIN CARE COMPOSITION COMPRISING EXTRACTS OF
APHANAMIXIS ROHITUKA
301895
354/KOLNP/2008 14‐05‐2018 "COMPOSITIONS FOR EXTERNAL APPLICATION, CONTAINING
ADENOSYL COBALAMIN FOR IMPROVEMENT OF SKIN DISEASES"
296736
3933/DELNP/2013 14‐05‐2018 NOVEL PYRIDYL BENZOXAZINE DERIVATIVES PHARMACEUTICAL
COMPOSITION COMPRISING THE SAME AND USE THEREOF
296762
1334/MUM/2012 14‐05‐2018 READY TO BE INFUSED GEMCITABINE SOLUTION 296771
3840/DEL/2012 15‐05‐2018 “NEW PROCESS FOR THE SYNTHESIS OF IV ABRADINE AND
ADDITION SALTS THEREOF WITH A PHARMACEUTICALLY
ACCEPTABLE ACID”
296775
Page 46 of 85
1358/CHENP/2012 15‐05‐2018 A COMPOSITION COMPRISING AN AFUCOSYLATED ANTI‐CD20
ANTIBODY AND BENDAMUSTINE
296780
4924/DELNP/2011 15‐05‐2018 "COMPOSITIONS COMPRISING PROBIOTIC AND PREBIOTIC
COMPONENTS AND MINERAL SALTS, WITH LACTOFERRIN"
296785
3118/KOLNP/2009 15‐05‐2018 ACTIVIN ‐ACTRIIA ANTAGONISTS AND USES FOR PROMOTING BONE
GROWTH IN CANCER PATIENTS
296794
4929/CHENP/2010 15‐05‐2018 NON‐POLYMERIC COMPOSITIONS FOR CONTROLLED DRUG
DELIVERY
296799
2793/CHENP/2013 15‐05‐2018 A PHARMACEUTICAL COMPOSITION 296804
6775/CHENP/2011 15‐05‐2018 PAEDIATRIC SOLUTIONS COMPRISING A BETA‐BLOCKER 296807
7277/CHENP/2010 15‐05‐2018 3‐PHENYLPYRAZOLO[5,1‐b]THIAZOLE COMPOUND 296814
3600/CHENP/2012 15‐05‐2018 FORMULATIONS COMPRISING TRIPTAN COMPOUNDS 296816
1328/DEL/2010 16‐05‐2018 "A RECOMBINANT HAEMAGGLUTININ DOMAIN‐CONTAINING
PROTEIN FOR THE DETECTION AND DIAGNOSIS OF GLANDERS AND
METHOD OF PREPARATION THEREOF"
296824
4826/KOLNP/2007 16‐05‐2018 MULTIVALENT IMMUNOGENIC COMPOSITION CONTAINING
BACTERIAL CAPSULAR CONJUGATE VACCINES CONJUGATED USING
DIFFERENT PROCESSES
296830
319/MUMNP/2013 16‐05‐2018 CLEAR LIQUID COMPOSITION COMPRISING ALKANOYL GLYCINATE,
AMPHOTERIC SURFACTANT, ALKYL SULFATE AND SPECIFIC
ASSOCIATIVE ACRYLATE POLYMERS
296850
1268/MUMNP/2012 17‐05‐2018 “OXYNTOMODULIN PEPTIDE ANALOGUE” 296856
8910/DELNP/2012 17‐05‐2018 PRODUCTION OF ATORVASTATIN LOW IN ETHER IMPURITIES 296865
230/KOL/2011 18‐05‐2018 A PROCESS FOR EXTRACTION OF PURE SILICA FROM LOW GRADE
COAL AND OTHER LOW GRADE SILICIOUS MINERAL
296906
524/DELNP/2011 21/05/2018 "COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING
COMPLEMENT PROTEIN C5"
296918
2211/DELNP/2009 21‐05‐2018 "LIPID CONTAINING FORMULATIONS" 296912
6966/DELNP/2012 21‐05‐2018 ANTAGONIST ANTI IL 7 RECEPTOR ANTIBODIES AND METHODS 296934
2612/MUM/2009 22/05/2018 "STABILIZERS FOR VACCINE COMPOSITIONS" 296960
2580/DELNP/2013 22/05/2018 PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN
PROCESSES FOR THEIR OBTAINMENT AND METHOD OF TREATING
INTESTINAL DISEASE
296974
684/MUM/2010 22‐05‐2018 "STABILIZED PROLONGED RELEASE PHARMACEUTICAL
COMPOSITION COMPRISING ATYPICAL ANTIPSYCHOTIC"
296983
4608/CHENP/2011 22‐05‐2018 “PHARMACEUTICAL DOSAGES DELIVERY SYSTEM” 296988
4598/DELNP/2012 23/05/2018 PHARMACEUTICAL COMPOSITION 297012
3670/DEL/2012 23‐05‐2018 CHITOSAN MICROPARTICLES FOR MUCOSAL DRUG DELIVERY 297023
216/KOL/2013 24‐05‐2018 ANTI‐HAIR LOSS FORMULATION 297049
01124/DELNP/2003 25‐05‐2018 "SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE COMPOUND" 297089
537/MUMNP/2011 25‐05‐2018 SENSORY MODIFIER 297098
3870/KOLNP/2009 25‐05‐2018 COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND
TREATMENT OF ADDICTIONS
297102
2179/DEL/2010 25‐05‐2018 BENZOTHIAZOLE COMPOUNDS AND PROCESS FOR THE
PREPARATION THEREOF
297106
2272/DEL/2009 25‐05‐2018 “A PROCESS FOR PREPARATION OF HERBAL APHRODISIAC HARD
BOILED CANDY FORMULATION”
297117
2340/CHE/2007 25‐05‐2018 AN ORALLY ADMINISTRABLE SOLID PHARMACEUTICAL
COMPOSITION AND A PROCESS THEREOF
297120
3203/CHE/2011 28‐05‐2018 HETEROARYL COMPOUNDS AS 5‐HT4 RECEPTOR LIGANDS 297139
1216/DELNP/2012 28‐05‐2018 "CRYSTALLIZATION METHOD AND BIOAVAILABILITY" 297148
905/MUMNP/2012 28‐05‐2018 TRANSDERMALLY ABSORBABLE DONEPEZIL‐CONTAINING
PREPARATION
297158
655/MUM/2010 28‐05‐2018 "AN EFFICIENT PROCESS FOR SYNTHESIS OF FLUORO‐SUBSTITUTED
ARYL CARBONYL PIPERIDINYL COMPOUNDS"
297176
3704/CHENP/2011 29/05/2018 CYTOTOXIC T CELL EPITOPE PEPTIDE FOR SARS CORONAVIRUS, AND
USE THEREOF
297193
Page 47 of 85
4286/CHENP/2012 29‐05‐2018 A PROCESS FOR CONVERTING A SOLID (METH) ACRYLATE
COPOLYMER INTO A DISPERSED FORM BY MEANS OF A DISPERSING
AGENT
297199
370/KOLNP/2012 29‐05‐2018 ε‐POLYLYSINE CONJUGATES AND THE USE THEREOF 297215
8373/DELNP/2011 30‐05‐2018 COMPRESSIBLE AND FREE‐FLOW CO‐AGGLOMERATES OF
MANNITOL AND GRANULAR STARCH
297219
1437/CHENP/2011 30‐05‐2018 COPOLYMERS USEFUL AS RHEOLOGY MODIFIERS AND HOME AND
PERSONAL CARE COMPOSITIONS
297223
2043/MUMNP/2013 30‐05‐2018 NOVEL DIPHENYLMETHANE DERIVATIVES AS SGLT2 INHIBITORS 297239
8870/DELNP/2012 30‐05‐2018 COMPOSITION FOR AMELIORATING HYPOALBUMINEMIA
CONTAINING A BRANCHED‐CHAIN AMINO ACID
297249
2765/MUM/2009 30‐05‐2018 "Oripavine to 4,5a‐epoxy‐3,14‐dihydroxynormorphinan‐7‐ene‐6‐
one"
297260
6664/CHENP/2012 31‐05‐2018 PHARMACEUTICAL COMPOSITION AND PREPARATION FOR ORAL
ADMINISTRATION
297289
8568/CHENP/2010 31‐05‐2018 PHARMACEUTICAL DOSAGE FORM COMPRISING POLYMERIC
CARRIER COMPOSITION
297310
1963/KOLNP/2011 31‐05‐2018 PYRAZINOPYRAZINES AND DERIVATIVES AS KINASE INHIBITORS 297333
797/DEL/2012 01‐06‐2018 "A PROCESS FOR SYNTHESIS OF CHIRAL 3‐SUBSTITUTED
TETRAHYDROQUINOLINE DERIVATIVES
"
297355
2089/KOLNP/2011 03‐06‐2018 TGR5 MODULATORS AND METHODS OF USE THEREOF 293851
2153/CHENP/2011 04‐06‐2018 SILVER ION DELIVERY PLATFORM 297382
433/KOL/2011 04‐06‐2018 A METHOD OF PREPARATION OF COMPOSITION 297386
10072/CHENP/2012 04‐06‐2018 IMPROVEMENTS IN OR RELATING TO DEPILATORY COMPOSITIONS 297388
10903/DELNP/2012 05‐06‐2018 NOVEL SPIROHETEROCYCLIC COMPOUNDS AS MGLU5
ANTAGONISTS
297395
2125/MUM/2011 05‐06‐2018 PHARMACEUTICAL COMPOSITIONS COMPRISING SULBACTAM AND
BETA‐LACTAMASE INHIBITOR
297397
6793/CHENP/2010 06‐06‐2018 IMPROVED FORMULATIONS FOR POORLY PERMEABLE ACTIVE
PHARMACEUTICAL INGREDIENTS
297423
6869/CHE/2015 06‐06‐2018 TOPICAL COMPOSITIONS FOR THE TREATMENT OF ACNE 297442
2440/CHENP/2012 06‐06‐2018 PROCESS FOR THE SYNTHESIS OF 4,5,6,7‐TETRACHLORO‐3',6'‐
DIHYDROXY‐2',4',5',7'‐TETRAIODO‐3H‐SPIRO[ISOBENZOFURAN‐1,9'‐
XANTHEN]‐3‐ONE (ROSE BENGAL) AND RELATED XANTHENES
297453
4394/DELNP/2012 06‐06‐2018 "A METHOD OF LYOPHILIZING A COMPOSITION COMPRISING
ANTITHROMBIN III (AT III)"
297470
3819/DELNP/2006 08‐06‐2018 ANTIVIRAL AGENTS 299722
4924/KOLNP/2011 08‐06‐2018 “TRIPTOLIDE PRODRUGS” 297525
217/MUMNP/2013 09‐06‐2018 SKIN CARE COMPOSITIONS COMPRISING SUBSTITUTED DIAMINES 300773
9461/CHENP/2013 11‐06‐2018 2 ‐ (2, 4, 5 ‐ SUBSTITUTED ‐ANILINO) PYRIMIDINE DERIVATIVES AS
EGFRMODULATORS USEFUL FOR TREATING CANCER
297581
8079/CHENP/2012 11‐06‐2018 PROCESSES FOR THE SYNTHESIS OF DIARYLTHIOHYDANTOIN AND
DIARYLHYDANTOIN COMPOUNDS
297583
5102/CHENP/2013 12‐06‐2018 "MICROPARTICLES CONTAINING PHYSIOLOGICALLY ACTIVE
PEPTIDE, METHOD FOR PREPARING THE SAME, AND
PHARMACEUTICAL COMPOSITION COMPRISING THE SAME"
304098
4697/DELNP/2011 12‐06‐2018 PHARMACEUTICAL FORMULATIONS COMPRISING VORICONAZOLE
AND PROCESSES FOR PREPARATION THEREOF
297589
161/MUM/2010 12‐06‐2018 "SUSTAINED RELEASE DOSAGE FORM OF QUETIAPINE" 297608
2674/CHENP/2014 13/06/2018 FOAM‐FORMING AEROSOL PRODUCT 297633
158/MUMNP/2012 13‐06‐2018 4‐(benzimidazol‐2‐ylamino)benzamide derivatives and salts or
solvates thereof and a method of synthesizing a pharmaceutical
compound
297616
7544/DELNP/2010 13‐06‐2018 "STIMULATION OF AN IMMUNE RESPONSE BY ENANTIOMERS OF
CATIONIC LIPIDS"
297624
Page 48 of 85
2623/MUMNP/2012 14/06/2018 LEVOCARRIMYCIN PHARMACEUTICAL COMPOSITIONS
PREPARATION METHODS AND USES THEREOF
297672
464/MUM/2010 14‐06‐2018 A PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL
COMPOSITION OF KILLED CELLS WITH SUBSTANTIALLY RETAINED
IMMUNOGENICITY
297641
6040/DELNP/2011 14‐06‐2018 TRANSDERMAL DELIVERY OF DICLOFENAC, CARBAMAZEPINE AND
BENZYDAMINE
297658
10805/CHENP/2012 14‐06‐2018 COSMETICS COMPRISING COSMETIC COMPOSITION‐IMPREGNATED
URETHANE FOAM
297667
3694/DELNP/2009 15‐06‐2018 “IMIDAZO[1,2‐B]PYRIDAZINE AND PYRAZOLO[1,5‐A]PYRIMIDINE
DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS”
297681
1718/MUMNP/2012 15‐06‐2018 SUSTAINED RELEASE NUCLEIC ACID MATRIX COMPOSITIONS 297683
2061/CHE/2008 18‐06‐2018 OSMOTIC CONTROLLED RELEASE DOSAGE FORM OF METFORMIN 297753
2350/KOLNP/2011 19/06/2018 AQUEOUS COMPOSITION CONTAINING FOLLICLE‐STIMULATING
HORMONE
297793
5713/DELNP/2009 19‐06‐2018 "BACTERIAL EXTRACT FOR RESPIRATORY DISORDERS AND PROCESS
FOR ITS PREPARATION"
297775
11220/DELNP/2012 19‐06‐2018 “A Solid Composition Comprising dimethyl (2S,2’S)‐1,1’‐((2S,2’S)‐
2,2’‐(4,4’‐((2S,5S)‐1‐(4‐tertbutylphenyl)pyrrolidine‐2,5‐diyl)bis(4,1‐
phenylene))bis(azanediyl)bis(oxomethylene)bis(pyrrolidine‐2,1‐
diyl))bis(3‐methyl‐1‐oxobutane‐2,1‐diyl)dicarbamate
297792
6995/DELNP/2008 19‐06‐2018 "A PHARMACEUTICAL COMPOSITION" 297811
394/DELNP/2011 19‐06‐2018 STRUCTURAL VARIANTS OF ANTIBODIES FOR IMPROVED
THERAPEUTIC CHARACTERISTICS
297817
20/DEL/2009 19‐06‐2018 A TOPICAL FORMULATION 297820
8331/DELNP/2009 19‐06‐2018 "INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE DELIVERY OF
MACROMOLECULES AND WATER‐SOLUBLE DRUGS"
297833
1149/MUMNP/2012 20‐06‐2018 SKIN CARE COMPOSITIONS COMPRISING PHENOXYALKYL AMINES 297847
800/MUM/2014 20‐06‐2018 "MICROEMULSIONS OF LIPIDATED GLYCINES AND PHENOXY
ETHANOL FOR PRESERVATION OF PERSONAL CARE PRODUCTS
297869
2189/CHE/2013 20‐06‐2018 PROCESS FOR THE PREPARATION OF LINAGLIPTIN VIA NOVEL
INTERMEDIATES
297872
757/CHE/2011 20‐06‐2018 PROCESS FOR PREPARING POLYMORPH OF CURCUMIN 297877
551/MUMNP/2012 21‐06‐2018 SEAMLESS ALGINATE CAPSULES AND METHOD OF PRODUCTION
THEREOF
297918
4072/DELNP/2013 22/06/2018 A PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT
OF NON INFECTIOUS DISEASES
297979
6027/CHENP/2012 22‐06‐2018 FUSED HETEROAROMATIC PYRROLIDINONES AS SYK INHIBITORS 297952
7663/DELNP/2012 22‐06‐2018 ORAL CARE COMPOSITION 297976
3968/CHENP/2011 25‐06‐2018 "ANTI‐PD‐L1 ANTIBODIES AND THEIR USE TO ENHANCE T‐CELL
FUNCTION"
297982
1299/CHENP/2012 25‐06‐2018 “SKIN EXTERNAL‐PREPARATION COMPOSITION” 297987
1465/DELNP/2011 25‐06‐2018 CARDIOPLEGIC PREPARATION 298000
1649/CHE/2009 25‐06‐2018 A COMPOSITION USEFUL AS ROTAVIRUS VACCINE AND A METHOD
THEREFOR
298017
2947/DELNP/2011 25‐06‐2018 "NUTRITIONAL COMPOSITION TO PROMOTE HEALTHY
DEVELOPMENT AND GROWTH"
298024
759/CHENP/2012 25‐06‐2018 A COMPOSITION COMPRISING A THERAPEUTICALLY EFFECTIVE
AMOUNT OF O‐CARBAMOYL‐(D)‐PHENYLALANINOL COMPOUND
298037
1076/MUMNP/2012 26‐06‐2018 SUNSCREEN COMPOSITION WITH FATTY ACID ALKANOLAMIDES 298064
5300/CHE/2013 26‐06‐2018 FORMULATIONS FOR DISSOLUTION OF PETROLEUM SLUDGE OR
WAXES AND METHOD FOR EVALUATION THEREOF
298066
Page 49 of 85
6673/CHENP/2013 26‐06‐2018 NOVEL POLYSACCHARIDE DERIVATIVES, DOSAGE FORMS AND A
PROCESS FORPREPARING A DOSAGE FORM
298075
6800/CHENP/2009 26‐06‐2018 A PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES AND
ITS PROCESS FOR PREPARATION
298083
1180/DELNP/2013 26‐06‐2018 METHOD FOR PRODUCING PHENYL SUBSTITUTED HETEROCYCLIC
DERIVATIVE BY MEANS OF COUPLING METHOD USING A
PALLADIUM COMPOUND
298092
9853/CHENP/2011 27‐06‐2018 ESTER MIXTURES AND COMPOSITIONS COMPRISING SUCH ESTER
MIXTURES
298113
1180/DEL/2007 27‐06‐2018 ANTI‐LEISHMANIAL ACTIVITY OF PARAMOMYCIN IN CATIONIC
LIPOSOMAL FORMULATION
298145
213/DEL/2011 27‐06‐2018 PROCESS FOR THE PREPARATION OF TALC BASED FORMULATION
FOR LDPE‐DEGRADING BACTERIAL CONSORTIA
298158
2309/MUM/2010 28/06/2018 A PHARMACEUTICAL COMPOSITION COMPRISING OFLOXACIN AND
CEFUROXIME
298212
2951/MUM/2010 28‐06‐2018 A PHOTOSTABLE SUNSCREEN COMPOSITION 298208
4940/DELNP/2012 28‐06‐2018 PROLYL HYDROXYLASE INHIBITORS 298216
6017/CHENP/2011 28‐06‐2018 A SOLID DISPERSION 298234
1066/MUMNP/2013 28‐06‐2018 COMPOSITIONS COMPRISING FATTY ACYL ISETHIONATE
SURFACTANT PRODUCT ALKANOYL COMPOUNDS AND
TRIGLYCERIDES WITH LOW LEVEL OF HYDROGENATION
298249
2689/MUM/2009 29/06/2018 EXTENDED RELEASE VENLAFAXINE HCI PELLETS 298260
1559/DELNP/2012 29‐06‐2018 NOVEL PHARMACEUTICAL COMPOSITION COMPRISING A
MACROLIDE IMMUNOSUPPRESSANT DRUG
298252
148/MUM/2011 29‐06‐2018 "AN IMPROVED PROCESS FOR THE PREPARATION OF NEPAFENAC" 298253
217/CHE/2005 29‐06‐2018 A process for production of a by‐product dimethyl sulphoxide 298268
7275/CHENP/2009 29‐06‐2018 HUMANIZED ANTIBODIES TO AMYLOID BETA 298269
123/DELNP/2013 29‐06‐2018 COMPOSITION FOR NUCLEIC ACID DELIVERY, CARRIER
COMPOSITION, PHARMACEUTICAL COMPOSITION USING THE
COMPOSITION FOR NUCLEIC ACID DELIVERY OR THE CARRIER
COMPOSITION AND METHOD FOR DELIVERING NUCLEIC ACID
298271
8513/CHENP/2010 29‐06‐2018 ORAL COMPOSITIONS CONTAINING ENHANCED ANTIBACTERIAL
COMBINATIONS OF ANTIOXIDANTS AND EXTRACTS OF MAGNOLIA
298278
1065/DELNP/2012 29‐06‐2018 "PARTICULATE COMPOSITION AND PHARMACEUTICAL
COMPOSITION CONTAINING THE SAME"
298297
8185/CHENP/2012 29‐06‐2018 IMPROVED STABLE AQUEOUS FORMULATION OF (E)‐4‐
CARBOXYSTYRYL‐4‐CHLOROBENZYL SULFONE
298302
3071/KOLNP/2011 29‐06‐2018 C5AR ANTAGONISTS 298319
7776/DELNP/2013 29‐06‐2018 TABLET TYPE COMPOSITION FOR ORAL ADMINISTRATION AND
METHOD FOR PRODUCING SAME
298323
1715/MUM/2010 29‐06‐2018 MICROSPHERES AND PHOTOPROTECTIVE PERSONAL CARE
COMPOSITION COMPRISING SAME
298352
2580/KOLNP/2008 02‐07‐2018 ORGAN PRESERVATION AND/OR PERFUSION 292660
6567/DELNP/2015 02‐07‐2018 METHOD FOR PREPARING HAIR CARE COMPOSITIONS COMPRISING
A STEP OF ADDING PERFUMES AND/OR SILICONES BEFORE
ANTIDANDRUFF AGENTS
298390
31/MUM/2013 02‐07‐2018 "SYNTHESIS AND CHARACTERIZATION OF NOVEL DI‐AZO CROSS‐
LINKED POLYMER FOR COLON SPECIFIC DELIVERY"
298408
5066/DELNP/2012 02‐07‐2018 "BETA‐CARBOLINES FOR USE IN THE TREATMENT OF HEARING LOSS
AND VERTIGO"
298416
2028/CHENP/2013 03‐07‐2018 COMPOSITION CONTAINING TETRACYCLIC COMPOUND 298424
2049/DEL/2008 03‐07‐2018 "A PROCESS OF PREPARATION OF OINTMENT BASE" 298425
1827/DEL/2008 03‐07‐2018 CURCUMIN NANOPARTICLES AND METHODS OF PRODUCING THE
SAME
298432
221/KOL/2012 03‐07‐2018 MICROEMULSION COMPOSITION FOR COSMETICS AND
DERMATOLOGICAL APPLICATION
298450
1441/CHE/2011 03‐07‐2018 NOVEL PROCESS FOR THE PREPARATION OF ETRAVIRINE 298456
Page 50 of 85
39/KOLNP/2011 03‐07‐2018 A PROCESS FOR PREPARING A CRYSTALLINE MODIFICATION OF (R)‐
DOPC
298457
1849/KOLNP/2007 03‐07‐2018 CELL‐PENETRATING CHIMERIC POLYPEPTIDE AND
PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
298459
1500/DELNP/2013 04‐07‐2018 5a‐ANDROSTANE‐3ß,5,6ß‐TRIOL INJECTION AND PREPARATION
METHOD THEREFOR
298479
1228/CHENP/2011 04‐07‐2018 “PHARMACEUTICAL COMPOSITION FOR TREATING HYPERTENSION
AND METABOLIC SYNDROME AND USE THEREOF”
298487
2220/MUM/2009 04‐07‐2018 AN ANTIMICROBIAL COMPOSITION 298498
837/DEL/2009 05‐07‐2018 "SEA BUCKTHORN (HIPPOPHAE RHAMNOLDES L.)EXTRACT
ENCAPSULATED IN PVA CRYOGELS FOR TREATMENT OF BURN
WOUNDS"
298527
8315/DELNP/2011 05‐07‐2018 "PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL
DERIVATIVES AND METHODS OF MAKING THE SAME"
298546
4999/CHENP/2010 06‐07‐2018 A PROCESS FOR PRODUCTION OF NANOPARTICLE CARRIERS FOR
DRUG DELIVERY
297476
2743/MUMNP/2011 06‐07‐2018 ORAL CARE COMPOSITIONS COMPRISING A POLYMERIC DYE 298582
938/KOLNP/2011 06‐07‐2018 PHARMACEUTICAL COMPOSITION FOR TREATMENT AND
PREVENTION OF CANCERS
298597
9828/DELNP/2011 06‐07‐2018 Cosmetic depigmenting composition 298611
4355/KOLNP/2009 08‐07‐2018 “LINEAR EXPRESSION CONSTRUCTS FOR PRODUCTION OF
INFLUENZA VIRUS PARTICLES”
299784
365/DELNP/2013 09‐07‐2018 QUINAZOLINE COMPOUNDS 298627
7728/DELNP/2012 09‐07‐2018 DENTURE ADHESIVE COMPOSITIONS 298671
1882/MUMNP/2014 10‐07‐2018 "HETEROBICYCLIC COMPOUNDS AS BETA‐LACTAMASE INHIBITORS" 298697
8065/DELNP/2011 11‐07‐2018 CARBINOL COMPOUND HAVING HETEROCYCLIC LINKER 298742
1068/KOLNP/2011 11‐07‐2018 1‐PHENYLPYRROLE COMPOUNDS 298734
2397/CHENP/2011 11‐07‐2018 BISPECIFIC ANTI‐VEGF/ANTI‐ANG‐2 ANTIBODIES 298751
1719/KOLNP/2012 11‐07‐2018 PROCESS FOR THE PREPARATION OF O‐DESMETHYL‐VENLAFAXINE
AND SALTS THEREOF
298754
1521/KOLNP/2012 11‐07‐2018 PREPARATION OF A POWDERY PHARMACEUTICAL COMPOSITION
BY MEANS OF AN EXTRUDER
298756
562/CHENP/2014 12‐07‐2018 INHIBITORS OF INFLUENZA VIRUSES REPLICATION 304215
8194/DELNP/2012 12‐07‐2018 METHOD FOR PRESERVING ALUM ADJUVANTS AND ALUM
ADJUVANTED VACCINES
298773
2195/KOLNP/2009 12‐07‐2018 NOVEL PROSTATE KALLIKREIN ALLERGEN 298789
2516/MUMNP/2011 12‐07‐2018 SUNSCREEN COSMETIC COMPOSITION CONTAINING ULTRAVIOLET
ABSORBER
298804
433/DELNP/2010 13‐07‐2018 "AMIDE COMPOUNDS" 298834
3759/CHENP/2010 16/07/2018 AN ANTI‐CD20 HUMAN MONOCLONAL ANTIBODY FORMULATION 298856
8158/DELNP/2010 16‐07‐2018 "ANTIOXIDANT INFLAMMATION MODULATORS: OLEANOLIC ACID
DERIVATIVES WITH AMINO AND OTHER MODIFICATIONS AT C‐17"
298853
436/KOL/2011 16‐07‐2018 “A METHOD FOR THE PREPARATION OF HERBAL MEDICAMENT FOR
TREATMENT OF NERVE DISORDERS AND VARIOUS FORMS OF
NEURONAL INJURIES”
298858
201641027672 16‐07‐2018 QUORUM SENSING BASED POLYMER FOR STIMULATION OF
BIOFILMS AND RELATED PHENOTYPES, AND PROCESS THEREOF
298859
2149/MUMNP/2011 16‐07‐2018 “A PROCESS FOR THE PREPARATION OF A TREHALULOSE‐
CONTAINING COMPOSITION”
298865
2193/MUMNP/2013 16‐07‐2018 BICYCLO (3.1.0) HEXANE 2,6 DICARBOXYLIC ACID DERIVATIVES AS
MGLU2 RECEPTOR AGONIST
298866
2053/DEL/2013 16‐07‐2018 AN ARTHROPOD REPELLENT NANOGEL FORMULATION. 298872
2188/CHE/2013 17‐07‐2018 A MICROBICIDAL COMPOSITE MATERIAL 298904
Page 51 of 85
3293/KOLNP/2011 18/07/2018 PYRIDAZINONE COMPOUNDS AND THEIR PHARMACEUTICALLY
USABLE SALTS
298943
3085/DELNP/2012 18‐07‐2018 “SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE
USES THEREOF”.
298938
4577/CHENP/2010 18‐07‐2018 A SLOW‐RELEASE FORMULATION BASED ON AN ASSOCIATION OF
GLYCOGEN AND ALGINATE
298924
265/DELNP/2012 18‐07‐2018 "SOLUTIONS COMPRISING POLYETHYLENE GLYCOL AND
ELECTROLYTES"
298926
5677/DELNP/2011 18‐07‐2018 "PHOSPHOINOSITIDE 3‐KINASE INHIBITORS WITH A ZINC BINDING
MOIETY"
298946
2585/DELNP/2011 19‐07‐2018 "IRON SOURCE PRODUCT IN THE FORM OF CAPSULES AND PROCESS
FOR THEIR PREPARATION"
298965
1620/MUM/2006 19‐07‐2018 A PROCESS FOR THE PREPARATION OF AN HERBAL SKIN OINTMENT 298977
2798/MUM/2011 19‐07‐2018 BIOACTIVE COMPOSITION FOR THE PROPHYLAXIS AND TREATMENT
OF MALARIA, METHOD OF MANUFACTURING AND USING THE
SAME.
298988
914/DEL/2008 19‐07‐2018 “A SUPRAMOLECULAR INSULIN ASSEMBLY USEFUL AS PROTEIN
THERAPEUTICS FOR THE TREATMENT OF METABOLIC DISORDERS
AND A PROCESS FOR THE PREPARATION”
298991
926/DEL/2011 20‐07‐2018 "IMPROVED PROCESS FOR THE PREPARATION OF IMATINIB AND ITS
MESYLATE SALT"
299009
8341/CHENP/2010 20‐07‐2018 MONOCLONAL ANTIBODIES HAVING HOMOSUBTYPE CROSS‐
NEUTRALIZATION PROPERTIES AGAINST INFLUENZA A VIRUSES
SUBTYPE H1
299017
8821/DELNP/2010 20‐07‐2018 “EXTRACT OF COPTIDIS RHIZOMA AND USE THEREOF IN TREATING
RESPIRATORY DISEASE”
299057
10866/CHENP/2012 20‐07‐2018 A PROCESS FOR ETRA VIRINE INTERMEDIATE AND POLYMORPHS OF
ETRAVIRINE
299062
2096/DELNP/2014 23‐07‐2018 SELF ASSEMBLED NANO STRUCTURE PARTICLE AND METHOD FOR
PREPARING
299068
1536/DEL/2008 23‐07‐2018 FORMULATIONS AND METHODS THEREOF FOR MAKING
RADIOLABELED DRY POWDER INHALATION PREPARATION
CONTAINING MICRONIZED SALBUTAMOL OR SALBUTAMOL
SULPHATE
299076
1411/MUMNP/2014 23‐07‐2018 IMPROVED INJECTIONS 299079
5514/DELNP/2005 23‐07‐2018 "STABILIZED PHARMACEUTICAL PEPTIDE COMPOSITIONS." 299085
1391/CHENP/2012 23‐07‐2018 PLASMODIUM FALCIPARUM HLA CLASS I RESTRICTED T‐CELL
EPITOPES
299101
2466/MUMNP/2010 24/07/2018 NALMEFENE PRODRUGS 299165
267/MUMNP/2011 24/07/2018 “Novel Pleuromutilin compounds” 299126
2012/MUM/2013 24‐07‐2018 "PALLADIUM CATALYZED SYNTHESIS OF BENZOFURANS AND
COUMARINS USING PHENOL OR SUBSTITUTED PHENOLS"
299110
1153/DEL/2009 24‐07‐2018 NOVEL TOPICAL MICROEMULSION FORMULATIONS FOR THE
TREATMENT OF RHEUMETIC DISORDERS AND RELATED
INFECTIONS"
299151
1960/KOLNP/2010 24‐07‐2018 COMPOSITIONS AND METHODS OF ENHANCING IMMUNE
RESPONSES TO EIMERIA
299158
2359/MUM/2008 24‐07‐2018 A POLYMORPHIC FORM OF NICORANDIL AND PROCESS FOR THE
PREPARATION THEREOF
299167
1391/DEL/2013 25‐07‐2018 NEW PROCESS FOR THE PREPARATION OF AN ANTICONVULSANT
AGENT PREGABALIN
299217
9012/DELNP/2012 25‐07‐2018 EMULSION COMPOSITION 299223
8361/DELNP/2010 26‐07‐2018 "METHODS AND COMPOSITIONS FOR MAKING ANTIBODIES AND
ANTIBODY DERIVATIVES WITH REDUCED CORE FUCOSYLATION"
299247
580/CHENP/2011 26‐07‐2018 MICRONEEDLE DEVICE AND METHOD FOR ENHANCING THE
EFFICACY OF JAPANESE ENCEPHALITIS VIRUS ANTIGEN WITH THE
MICRONEEDLE DEVICE
299249
1618/CHENP/2010 26‐07‐2018 DENTAL CEMENT SYSTEM 299251
Page 52 of 85
323/MUMNP/2010 26‐07‐2018 “ALKYLSULFONYL‐SUBSTITUTED THIAZOLIDE COMPOUNDS” 299275
219/MUMNP/2013 26‐07‐2018 ORAL CARE COMPOSITIONS 299277
6297/CHENP/2013 26‐07‐2018 COMPOUNDS AND METHODS FOR KINASE MODULATION AND
INDICATIONS THEREFOR
299291
1611/MUMNP/2012 26‐07‐2018 "OIL‐IN‐WATER TYPE EMULSION SUNSCREEN COSMETIC
COMPOSITION"
299301
2480/CHENP/2010 27/07/2018 HIGH CONCENTRATION CHITOSAN‐NUCLEIC ACID POLYPLEX
COMPOSITIONS
299354
2876/DELNP/2014 27/07/2018 COSMETIC CLEANSING COMPOSITION 299345
1905/CHENP/2009 27‐07‐2018 FULLY HUMAN HIGH YIELD PRODUCTION SYSTEM FOR IMPROVED
ANTIBODIES AND PROTEINS
299326
692/DELNP/2009 27‐07‐2018 "TAMPER RESISTANT ORAL PHARMACEUTICAL DOSAGE FORMS
COMPRISING AN OPIOID ANALGESIS"
299334
166/MUMNP/2013 27‐07‐2018 SUBSTITUTED PYRIDINE COMPOUND 299335
9828/DELNP/2013 27‐07‐2018 LOW WATER METAL ION DENTIFRICE 299339
1510/DELNP/2013 27‐07‐2018 METHOD FOR PREPARING MICROSPHERES AND MICROSPHERES
PRODUCED THEREBY
299351
5733/CHENP/2013 30/07/2018 OPTICALLY ACTIVE DIAZABICYCLOOCTANE DERIVATIVE AND
METHOD FOR MANUFACTURING SAME
299416
6346/CHENP/2011 30‐07‐2018 AMPHOLYTIC TER‐POLYMERS FOR USE IN PERSONAL CARE
COMPOSITIONS
299398
1682/MUMNP/2012 30‐07‐2018 DEGRADABLE REMOVABLE IMPLANT FOR THE SUSTAINED RELEASE
OF AN ACTIVE COMPOUND
299418
1029/MUM/2009 30‐07‐2018 A MEDICINAL ANTIBACTERIAL AND STEROIDS CREAM
INCORPORATING A BIO POLYMERAND A PROCESS TO MAKE IT
299419
861/DEL/2009 30‐07‐2018 PROCESS FOR PRODUCING GALANTAMINE AND SALTS THEREOF 299431
453/KOL/2012 30‐07‐2018 "A DEVICE FOR TREATMENT OF GLAUCOMA". 299450
2351/KOLNP/2009 30‐07‐2018 HUMAN ANTIBODIES THAT BIND CD22 AND USES THEREOF 299460
10237/CHENP/2012 30‐07‐2018 NITROGEN‐CONTAINING HETEROCYCLIC COMPOUND HAVING
INHIBITORY EFFECT ON PRODUCTION OF KYNURENINE
299461
257/MUM/2011 31/07/2018 A COMPOUND FOR THE TREATMENT OF LIPODYSTROPHY 299505
99/CHENP/2011 31‐07‐2018 SULFUR‐CONTAINING HETEROCYCLIC DERIVATIVE HAVING BETA
SECRETASE INHIBITORY ACTIVITY
299474
1140/DELNP/2008 31‐07‐2018 ANTI‐ALPHA V BETA 6 ANTIBODIES AND USES THEREOF 299479
80/CHENP/2013 31‐07‐2018 TETRAHYDROCARBOLINE DERIVATIVE 299491
1438/MUM/2012 31‐07‐2018 HIGH DOSE, LOW VOLUME INJECTABLE PREPARATION OF
DICLOFENAC
299503
1512/KOLNP/2013 31‐07‐2018 IMIDAZOLE DERIVATIVES AS PDE10A ENZYME INHIBITORS 299518
781/KOLNP/2010 31‐07‐2018 PROTEIN‐POLYMER CONJUGATES 299529
5968/CHENP/2012 31‐07‐2018 BUFALIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS
THEREOF
299539
6426/DELNP/2012 31‐07‐2018 ANTICOAGULANT ANTIDOTES 299553
1074/KOLNP/2013 31‐07‐2018 PHARMACEUTICAL TOPICAL COMPOSITION OF MUPIROCIN 299558
1025/DEL/2010 31‐07‐2018 “FRACTIONATION OF ADHATODA VASICA LEAVES” 299559
1813/KOLNP/2010 31‐07‐2018 CANCER VACCINE COMPOSITION 299564
989/CHENP/2011 31‐07‐2018 NANOCRYSTAL NANO‐EMULSION 299583
2375/MUM/2009 01‐08‐2018 "PHARMACEUTICAL COMPOSITIONS" 291470
1759/CHENP/2011 01‐08‐2018 "A SUBSTITUTED PYRROLINDINE‐2‐CARBOXAMIDE COMPOUND OF
THE FORMULA I”
299612
2799/CHENP/2010 01‐08‐2018 Multi‐layer co‐extrusion film generating and releasing Sulfur dioxide 299614
7996/DELNP/2014 01‐08‐2018 PYRAZOLE COMPOUNDS AS SGLT1 INHIBITORS 299618
3555/DELNP/2013 01‐08‐2018 A dual phase mouth wash 299619
3333/DEL/2015 02‐08‐2018 AN INTEGRATED PACKING, RECONSTITUTION AND DELIVERY DEVICE
FOR ORAL VACCINES AND DRUGS CONTAINING MULTIPLE
COMPONENTS
299645
1645/KOLNP/2013 03‐08‐2018 PYRAZOLE COMPOUNDS 299680
Page 53 of 85
1449/DEL/2008 03‐08‐2018 "A METHOD OF PREPARATION OF A PHARMACEUTICAL
COMPOSITION OF VACCINE AGAINST RABIES, WHICH COMPRISES
OF DNA VACCINE BASED ON GLYCOPROTEIN GENE OF RABIES VIRUS
CONJUGATED TO LAMP‐1SIGNAL SEQUENCE AT THE C‐TERMINUS
AND AN ADJUVANT "
299697
2256/MUMNP/2012 05‐08‐2018 PERSONAL WASH CLEANSER WITH MILD SURFACTANT SYSTEMS
COMPRISING DEFINED ALKANOYL COMPOUNDS AND DEFINED
FATTY ACYL ISETHIONATE SURFACTANT PRODUCT AND OPTIONAL
SKIN OR HAIR BENEFIT AGENT
296615
4529/DELNP/2010 06‐08‐2018 "NOVEL VACCINES AGAINST MULTIPLE SUBTYPES OF DENGUE
VIRUS"
297542
670/MUMNP/2013 06‐08‐2018 COMPOUNDS FOR INHIBITING CHK1 299723
2808/CHE/2010 06‐08‐2018 FUSED TRICYCLIC COMPOUNDS AS ADENOSINE RECEPTOR
ANTAGONIST
299726
1783/DELNP/2003 06‐08‐2018 "A pharmaceutical composition of polymethoxyflavone compound " 299738
993/CHE/2005 07‐08‐2018 "A PROCESS FOR THE PREPARATION OF ALMOTRIPTAN" 299757
246/KOL/2008 07‐08‐2018 A NOVEL PROCESS FOR THE PREPARATION OF ZOPICLONE 299774
44/MUMNP/2011 07‐08‐2018 “TRIAZOLE DERIVATIVE OR SALT THEREOF” 299780
782/DELNP/2009 07‐08‐2018 "A solid pharmaceutical comprising human growth hormone (hGH)
and N‐(5‐chlorosalicyloyl)‐8‐aminocaprylic acid (5‐CNAC)"
299781
6730/CHENP/2009 08‐08‐2018 "PHARMACEUTICAL COMPOSITION COMPRISING PHENYLALANINE
AMMONIA‐LYASE VARIANT"
299803
6065/DELNP/2013 08‐08‐2018 COMMERCIAL SCALE PROCESS FOR PRODUCTION OF PRRSV 299810
147/KOLNP/2011 09‐08‐2018 AN APPARATUS FOR TREATING CHRONIC WOUNDS WITH AN
EXTRACELLULAR POLYMERIC SUBSTANCE SOLVATING SYSTEM
299831
2339/CHE/2013 10‐08‐2018 AN IMPROVED PROCESS FOR PREPARATION OF DABIGATRAN
ETEXILATE AND PHARMCEUTICALLY ACCEPTABLE ACID ADDITION
SALTS THEREOF
301964
3290/KOLNP/2011 10‐08‐2018 PYRIDAZINONE DERIVATIVES 299859
3899/DELNP/2013 10‐08‐2018 METHOD FOR CHEMICALLY MODIFYING THE INTERNAL REGION OF
A HAIR SHAFT
299864
36/KOL/2013 10‐08‐2018 AN ANTI‐HAIR LOSS/HAIR GROWTH FORMULATION 299871
1350/MUM/2010 13‐08‐2018 An oral dosage for the treatment of viral diseases 299902
1082/MUMNP/2010 13‐08‐2018 TAPENTADOL COMPOSITIONS 299912
8140/DELNP/2010 13‐08‐2018 "PERFLUORCARBON NANOEMULSIONS WITH ENDOCYTOSIS
ENHANCING SURFACE FOR GENE‐TRANSFER"
299928
7209/DELNP/2012 14‐08‐2018 TOOTH WHITENING COMPOSITION 299977
10399/CHENP/2012 14‐08‐2018 A PROCESS OF CONVERSION OF ANY FORM OF IMATINIB MESYLATE
TO IMATINIB MESYLATE FORM α
299984
2488/DEL/2007 16/08/2018 "CONTROLLED PH‐DEPENDENT RELEASE PHARMACEUTICAL
COMPOSITION FOR TREATING METALLIC POISONING"
299996
2602/DEL/2008 16/08/2018 ISOXAZOLE/ISOXAZOLINE/COMBRETASTATIN LINKED
DIHYDROQUINAZOLINONE HYBRIDS AS POTENTIAL ANTICANCER
AGENTS AND PROCESS FOR THE PREPARATION THEREOF
300026
6630/DELNP/2008 16‐08‐2018 "A COMPOSITION FOR THE DYEING WITH LIGHTENING EFFECT OF
KERATIN SUBSTANCES"
300001
5446/DELNP/2010 17‐08‐2018 "ADHESIVE PATCH" 300033
5647/CHENP/2011 17‐08‐2018 NOVEL AMINOPYRAZINE DERIVATIVE AND
COMPOSITIONSCOMPRISING AMINOPYRAZINE DERIVATIVE AS
ACTIVEINGREDIENT
300040
6564/DELNP/2008 17‐08‐2018 IMMUNOGENIC SUBSTANCES COMPRISING A POLYINOSINIC ACID‐
POLYCYTIDILIC ACID BASED ADJUVANT
300041
685/KOLNP/2010 17‐08‐2018 METHOD FOR PREPARING A HYPERICUM EXTRACT IN NEEM OIL
AND A SUBSTANCE SO OBTAINED
300048
9828/DELNP/2012 17‐08‐2018 “NEW CYCLOHEXYLAMINE DERIVATIVES HAVING ?2 ADRENERGIC
AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES.”
300052
Page 54 of 85
1733/DEL/2013 17‐08‐2018 CURCUMIN CONJUGATED GD NANOPARTICLES FOR IMAGING AND
THERAPY.
300053
524/KOL/2003 17‐08‐2018 STABILISATION OF PROTEIN IN AQUEOUS SUSPENSION 300055
1606/CHENP/2011 20‐08‐2018 "A CHIMERIC ANTIBODY CAPABLE OF BINDING VHZ" 300086
843/MUMNP/2014 20‐08‐2018 NEW COATED CONTROLLED RELEASE ACTIVE AGENT CARRIERS 300094
636/MUMNP/2012 20‐08‐2018 "WATER‐IN‐OIL‐TYPE SKIN CARE COMPOSITION" 300096
4525/DELNP/2008 21‐08‐2018 "NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE" 300117
8674/DELNP/2007 23‐08‐2018 "PTERIDINES USEFUL AS HCV INHIBITORS AND METHODS FOR THE
PREPARATION THEREOF"
300181
6850/DELNP/2011 23‐08‐2018 "LIPOSOME COMPOSITION" 300213
4892/CHENP/2014 24‐08‐2018 WHITENING COSMETIC 300257
10292/CHENP/2013 24‐08‐2018 METHOD FOR MANUFACTURING PYRAZOLE DERIVATIVE 300270
905/DELNP/2009 24‐08‐2018 "CASEIN COMPLEXES" 300280
2778/MUMNP/2012 27‐08‐2018 NON AQUEOUS ORAL CARE COMPOSITIONS 300285
9376/CHENP/2011 27‐08‐2018 PHARMACEUTICALLY ACCEPTABLE LIQUID COMPOSITIONS OF
CARBIDOPA
300294
2079/MUM/2007 27‐08‐2018 HERBAL COMPOSITION FOR REDUCING ADD/ADHD AND METHOD
THEREOF
300305
2582/DEL/2012 27‐08‐2018 "NOVEL ANTI‐PROLIFERATIVE COMPLEX AND A METHOD FOR
PREPARATION THEREOF"
300324
3029/CHENP/2014 28/08/2018 GRANULES COMPRISING AN ACTIVE SUBSTANCE 300380
990/CHE/2005 28‐08‐2018 A NOVEL PHARMACEUTICAL COMPOSITION 300350
9502/DELNP/2012 28‐08‐2018 “The Direct compression process 300378
4087/CHENP/2011 28‐08‐2018 ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2 300388
4754/CHENP/2013 28‐08‐2018 COMPOSITION OF MESALAMINE IN TREATING AND PREVENTING
INFLAMMATION RELATED DISORDER
300390
1427/KOLNP/2011 28‐08‐2018 COMBINATION GAS VACCINES AND THERAPEUTICS 300392
201741000424 28‐08‐2018 ORAL DISPERSIBLE FILM COMPOSITION 300396
1908/CHENP/2013 28‐08‐2018 PYRAZOLOQUINOLINE COMPOUND 300398
10925/CHENP/2012 28‐08‐2018 OPTICALLY ACTIVE DIBENZYLAMINE DERIVATIVE AND METHOD
FOR PREPARING THEREOF
300407
2622/MUMNP/2014 29‐08‐2018 NOVEL COMPOUND HAVING ABILITY TO INHIBIT 11?‐HSD1 ENZYME
OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND METHOD
FOR PRODUCING SAME
300444
616/CHENP/2011 29‐08‐2018 “ANTI ‐ P2X7 PEPTIDES AND EPITOPES” 300457
709/KOLNP/2010 30/08/2018 PHARMACEUTICAL COMPOSITIONS FOR ADMINISTERING
THERAPEUTIC CELLSTO THE ANIMAL CENTRAL NERVOUS SYSTEM
300506
9922/CHENP/2012 30‐08‐2018 FLAVONOID DIMERS AND THEIR USE 300485
3736/DEL/2013 30‐08‐2018 ORAL CARE COMPOSITIONS WITH REDUCED SURFACE STAINING 300512
1034/KOLNP/2011 30‐08‐2018 RABIES VIRUS‐BASED RECOMBINANT IMMUNOCONTRACEPTIVE
COMPOSITIONS AND METHODS OF USE
300529
8121/DELNP/2010 30‐08‐2018 CYTOTOXIC IMMUNOGLOBULIN 300536
3597/DELNP/2006 31‐08‐2018 "SURFACE PROTECTION OF EXPOSED BIOLOGICAL TISSUES" 300567
201727019575 31‐08‐2018 AN INJECTABLE PREPARATION OF DICLOFENAC SALTS WITH
HYDROXYPROPYL‐BETA CYCLODEXTRIN AND POLYSORBATE 80
300571
4060/KOLNP/2012 31‐08‐2018 COATING AGENT FOR PHARMACEUTICAL SOLID PREPARATION,
PHARMACEUTICAL FILM FORMULATION, AND COATED
PHARMACEUTICAL SOLID PREPARATION
300625
1128/CHENP/2014 31‐08‐2018 AQUEOUS COMPOSITIONS COMPRISING ARBEKACIN 300629
924/DEL/2006 31‐08‐2018 NOVEL INTEGRIN BINDING RGD‐HIPOPEPTIDES WITH GENE
TRANSFER ACTIVITIES
300638
5631/DELNP/2009 01‐09‐2018 "OLIGOMER‐PROTEASE INHIBITOR CONJUGATES" 291566
2444/DEL/2008 03‐09‐2018 A HOMEOPATHIC PREPARATION FOR INCREASING IMMUNITY OF
ANIMALS DURING PREGNANCY AND DURING POST PREGNANCY
PERIOD
294035
2646/MUMNP/2011 04‐09‐2018 "IMPROVED LIPID FORMULATION" 300692
Page 55 of 85
1305/MUM/2011 04‐09‐2018 HERBAL BISCUITS AND METHODS OF PREPARATION THEREOF. 300698
1213/MUMNP/2010 05‐09‐2018 A pharmaceutical composition 300732
4617/DELNP/2009 05‐09‐2018 "A GUANIDINE COMPOUND FOR IMAGING CARDIAC INNERVATION" 300756
1080/MUMNP/2013 05‐09‐2018 ORAL CARE COMPOSITIONS COMPRISING PEARLESCENT PIGMENTS 300764
109/MUMNP/2012 06‐09‐2018 ANTIVIRAL COMPOUNDS, AN AGGREGATE COMPRISING PLURALITY
OF THE
COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING
THE SAME
300794
3026/MUM/2013 06‐09‐2018 A WOUND DRESSING CAPABLE OF IN‐SITU NOX RELEASE AND A
PROCESS FOR MANUFACTURING THE SAME
300809
220/KOL/2012 07‐09‐2018 SKIN CARE COMPOSITION FOR ANTI‐AGING AND SKIN LIGHTENING 300830
3417/MUM/2010 07‐09‐2018 A PHARMACEUTICAL COMPOSITION OF NIOSOMAL GEL FOR THE
TOPICAL DELIVERY OF LORNOXICAM
300843
1577/MUMNP/2014 07‐09‐2018 CYCLOALKANE DERIVATIVE 300845
358/MUM/2009 10‐09‐2018 A PROCESS TO MANUFACTURE A NOVEL CREAM 300880
147/DEL/2009 10‐09‐2018 A PROCESS OF PREPARATION OF A TOPICAL DERMAL PATCH 300882
9322/DELNP/2012 10‐09‐2018 A Method For Manufacturing An Oral Prolonged Release
Pharmaceutical Composition
300888
4741/KOLNP/2010 11‐09‐2018 ANTI‐AGING OR ANTIOXIDANT COMPOSITION 300921
1262/KOLNP/2009 11‐09‐2018 "A COMPOSITION FOR IMPROVING IMMUNE FUNCTION" 300928
808/MUMNP/2014 12‐09‐2018 A PERSONAL CLEANING COMPOSITION 300954
2767/KOLNP/2011 12‐09‐2018 NOVEL AMINO C‐XYLOSIDE COMPOUNDS, AND COSMETIC USE 300959
1319/MUM/2011 12‐09‐2018 "AN AMORPHOUS ILOPERIDONE AND PROCESSES FOR PREPARING
SAME"
300969
413/MUMNP/2012 12‐09‐2018 Composition for decreasing pigmentation 300981
1312/DEL/2008 12‐09‐2018 "COMPOSITIONS COMPRISING EUPHORBIA PROSTRATA AND
PROCESS OF PREPARATION THEREOF"
300984
10157/DELNP/2008 13‐09‐2018 "A PROCESS FOR OBTAINING AN ISOLATED STABLE JUGLONE
EXTRACT OF WALNUTS"
300995
5391/DELNP/2006 13‐09‐2018 "A MONOCLONAL HUMANIZED ANTI‐CS1 Luc63 ANTIBODY OR AN
ANTI‐CS1 Luc63 ANTIGEN BINDING FRAGMENT"
301005
6565/DELNP/2015 14‐09‐2018 METHOD FOR PREPARING HAIR CARE COMPOSITIONS COMPRISING
A STEP OF CONTROLLING TEMPERATURE TO ADD ANTIDANDRUFF
AGENTS
301025
4185/KOLNP/2008 14‐09‐2018 METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP‐2
DEPENDENT COMPLEMENT ACTIVATION
301040
2073/DEL/2004 14‐09‐2018 "BIOACTIVE WATER FRACTION FROM GOMPHOSTEMA NIVEUM" 301042
107/MUMNP/2013 14‐09‐2018 FOAM ENHANCEMENT OF FATTY ACYL GLYCINATE SURFACTANTS 301058
23/MUM/2013 14‐09‐2018 "AN IMPROVED PROCESS FOR THE PREPARATION OF
BESIFLOXACIN"
301060
3148/DELNP/2011 17/09/2018 "FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING
MOLECULES"
301111
4763/CHENP/2011 17/09/2018 COMPOSITIONS FOR DRUG ADMINISTRATION 301093
913/CHENP/2012 17‐09‐2018 A PHARMACEUTICAL COMPOSITION FOR AN IONTOPHORESIS 301083
840/MUMNP/2011 17‐09‐2018 A COMPOSITION FOR BUCCAL ABSORPTION OF NICOTINE FOR THE
PURPOSE OF SMOKING CESSATION
301086
1738/DELNP/2008 19‐09‐2018 "NOVEL 1 ARYL‐3‐AZABICYCLO[3.1.0]HEXANES:PREPARATION AND
USE TO TREAT NEUROPSYCHIATRIC DISORDERS"
301169
2816/DELNP/2009 19‐09‐2018 "NOVEL ALBUMIN‐FREE FACTOR VIII FORMULATIONS" 301183
3482/DEL/2005 19‐09‐2018 MOUTH DISSOLVING PHARMACEUTICAL COMPOSITION AND
PROCESS FOR PREPARING THE SAME
301189
5747/DELNP/2006 19‐09‐2018 "NUCLEOSIDE DERIVATIVES OF FORMULA I & II AND COMPOSITION
THEREOF"
301190
3369/MUM/2011 19‐09‐2018 "A MEDICINAL FORMULATION FOR USE IN PROTECTION FROM
GAMMA IRRADIATION"
301192
Page 56 of 85
1524/MUM/2011 19‐09‐2018 AN IMPROVED PROCESS FOR PREPARING LOSARTAN POTASSIUM 301193
1945/CHENP/2009 19‐09‐2018 KINASE INHIBITORS USEFUL FOR THE TREATMENT OF
MYLEOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE
DISEASES
301194
3797/CHE/2012 20‐09‐2018 "DENDRIMERS, CONJUGATES AND METHODS THEREOF" 301223
1453/MUM/2008 21‐09‐2018 PHARMACEUTICAL COMPOSITION OF INSULIN ANALOGS 301247
635/MUM/2008 21‐09‐2018 ANTIMICROBIALLY ACTIVE BIARYL OXAZOLIDINONE COMPOUNDS 301248
3942/MUM/2014 24‐09‐2018 PHARMACEUTICAL COMPOSITION COMPRISING METFORMIN 301257
5375/CHENP/2011 24‐09‐2018 OLIGOMER PHENOTHIAZINE CONJUGATES 301274
1196/DELNP/2010 24‐09‐2018 "LENTIVIRAL GENE TRANSFER VECTORS AND THEIR MEDICINAL
APPLICATIONS"
301284
9053/DELNP/2014 25‐09‐2018 METHOD FOR PRODUCING SEPIAPTERIN AND
TETRAHYDROLACTOYLPTERIN
301318
10332/DELNP/2013 25‐09‐2018 ORAL CARE COMPOSITIONS 301323
1018/CHE/2013 25‐09‐2018 AN IMPROVED PROCESS FOR THE SYNTHESIS OF MELPHALAN AND
THE HYDROCHLORIDE SALT
301329
2774/MUM/2010 25‐09‐2018 PROCALCITONIN FOR THE DIAGNOSIS OF BACTERIAL INFECTIONS
AND GUIDANCE OF ANTIBIOTIC TREATMENT IN PATIENTS WITH
ACUTE STROKE OR TRANSIENT ISCHEMIC ATTACK
301334
7265/DELNP/2012 25‐09‐2018 “PDE10 INHIBITOR COMPOUNDS” 301341
816/CHENP/2013 25‐09‐2018 COSMETIC PREPARATIONS 301344
9403/DELNP/2013 25‐09‐2018 NOVEL AMINO PYRROLINE DERIVATIVES AND USE THEREOF IN THE
PREVENTION AND/OR TREATMENT OF METABOLIC SYNDROME
301358
9831/CHENP/2012 25‐09‐2018 TOPICAL PHARMACEUTICAL COMPOSITIONS 301360
290/DELNP/2012 25‐09‐2018 "IMMUNOGENIC COMPOSITIONS OF STAPHYLOCOCCUS AUREUS
ANTIGENS"
301361
3421/MUM/2010 25‐09‐2018 A PROCESS OF PREPARATION OF EZETIMIBE NANOSUSPENSION 301372
4342/CHENP/2013 26/09/2018 "8‐[5‐(1‐hydroxy‐1‐methylethyl)pyridin‐3‐yl]‐l‐[(2S)‐2‐
methoxypropyl]‐3‐methyl‐1,3‐dihydro‐2H‐imidazo[4,5‐c]quinolin‐2‐
one or a pharmaceutically acceptable salt thereof”
301425
1861/MUMNP/2013 26‐09‐2018 NOVEL PHENYLPYRIDINE DERIVATIVE AND DRUG CONTAINING
SAME
301396
4043/DEL/2012 26‐09‐2018 FIBER WADDING FOR FILLING BONE DEFECTS 301410
201641011015 26‐09‐2018 APREMILAST PHARMACEUTICAL COMPOSITIONS 301416
9296/CHENP/2011 26‐09‐2018 “DOSAGE FORM” 301419
568/KOLNP/2011 26‐09‐2018 IMIDAZOLIDINE DERIVATIVES AS INHIBITORS OF GLUTAMINYL
CYCLASE
301430
1399/CHE/2011 26‐09‐2018 AN IMPROVED PROCESS FOR THE PREPARATION OF
CURCUMINOIDS
301470
2541/MUMNP/2012 26‐09‐2018 “NOVEL CONJUGATES OF CC‐1065 ANALOGS AND BIFUNCTIONAL
LINKERS”
301476
1695/KOLNP/2013 26‐09‐2018 TOPICAL COMPOSITIONS FOR PRESERVING OR RESTORING THE
INTEGRITY OF MUCOSAE
301478
1483/KOLNP/2009 27‐09‐2018 LIVE BACTERIAL VACCINES FOR VIRAL INFECTION PROPHYLAXIS OR
TREATMENT
301571
7116/DELNP/2011 27‐09‐2018 "THERAPEUTIC USES OF MASTIC GUM FRACTIONS" 301575
2814/CHENP/2011 28/09/2018 “A PHARMACEUTICAL COMPOSITION USING GONADOTROPIN ‐
RELEASING HORMONE (GNRH) COMBINED VARIANTS AS
IMMUNOGEN”
301683
4908/CHENP/2010 28/09/2018 ANTIBODIES DIRECTED TO ANGIOPOIETIN‐1 AND ANGIOPOIETIN‐2
AND USE THEREOF
301634
641/MUM/2012 28‐09‐2018 "AN IMPROVED PROCESS FOR THE PREPARATION OF
DIHYDROPYRIMIDIN‐2‐ONES"
301613
Page 57 of 85
3528/DELNP/2013 28‐09‐2018 COSMETIC COMPOSITION HAIR COSMETIC AND HAIR TREATMENT
COSMETIC
301672
1697/MUM/2014 28‐09‐2018 "LOW VISCOUS, SULFATE‐FREE COLD‐DISPERSIBLE PEARLESCENT
CONCENTRATE"
301693
3154/CHENP/2013 29‐09‐2018 POLYMERIZABLE DENTAL MATERIAL COMPRISING REACTIVE PASTE
FORMERS HARDENED DENTAL MATERIAL AND USE THEREOF
301700
424/DELNP/2013 01‐10‐2018 FORMULATIONS OF 14 ‐ EPI ‐ANALOGUES OF VITAMIN D 291572
2664/MUMNP/2012 01‐10‐2018 “PURINONE DERIVATIVE” 301734
929/KOLNP/2013 03‐10‐2018 COMPOSITION FOR ACTIVE PRINCIPLES DELIVERY BY IMPLANT
DEVICES
301814
4528/CHENP/2011 04‐10‐2018 AVIAN INFLUENZA VACINE 295639
9901/CHENP/2012 04‐10‐2018 NOVEL AMIDE DERIVATIVE AND USE THEREOF AS MEDICINE 301821
2818/CHENP/2012 04‐10‐2018 OLIGOMER‐CALCIMIMETIC CONJUGATES AND RELATED
COMPOUNDS
301830
7255/CHENP/2015 04‐10‐2018 COMPOSITIONS AND METHODS FOR THE TREATMENT OF DIABETES
AND PRE‐DIABETES
301837
1192/MUMNP/2013 04‐10‐2018 NOVEL PURINYLPYRIDINYLAMINO‐2,4‐DIFLUOROPHENYL
SULFONAMIDE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE
SALT THEREOF, PREPARATION METHOD THEREOF, AND
PHARMACEUTICAL COMPOSITION WITH INHIBITORY ACTIVITY
AGAINST RAF KINASE, CONTAINING SAME AS ACTIVE INGREDIENT
301856
2879/MUMNP/2012 04‐10‐2018 HAIR CARE COMPOSITION 301864
3619/KOLNP/2012 04‐10‐2018 FORMULATION COMPRISING NICOTINE AND A CATION EXCHANGE
RESIN
301869
201721031262 05‐10‐2018 SCAFFOLD GRAFT AND METHOD OF MANUFACTURING THEREOF 301880
1372/MUMNP/2009 05‐10‐2018 5,6‐SUBSTITUTED PYRIMIDINES 301894
5541/DELNP/2011 05‐10‐2018 "BETA‐AMINO ESTER COMPOUNDS AND USES THEREOF" 301904
285/KOLNP/2013 05‐10‐2018 DRY POWDER FORMULATION COMPRISING A PHOSPHODIESTERASE
INHIBITOR
301910
7467/CHENP/2009 05‐10‐2018 PRESERVATIVE FREE COMPOSITION COMPRISING 4‐
HYDROXYBENZALDEHYDE AND ANISIC ACID
301919
1593/KOL/2007 05‐10‐2018 CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF
PREGABALIN
301923
3313/CHENP/2013 07‐10‐2018 3‐SUBSTITUTED‐6‐(PYRIDINYLMETHOXY)‐PYRROLOPYRIDINE
COMPOUNDS
298700
4150/KOLNP/2009 08‐10‐2018 “GLP‐1 Fc FUSION PROTEIN FORMULATION” 301942
6974/CHENP/2013 08‐10‐2018 FORMULATION COMPRISING PHENYLAMINOPYRIMIDINE
DERIVATIVE AS ACTIVE AGENT
301950
538/CHENP/2013 08‐10‐2018 A METHOD OF CONTROLLING THE RELEASE OF AN ACTIVE
INGREDIENT FROM A DOSAGE FORM
301953
1694/CHENP/2013 08‐10‐2018 P2X4 RECEPTOR ANTAGONIST 301958
5745/CHENP/2014 08‐10‐2018 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF 301965
7801/CHENP/2010 08‐10‐2018 ANTI‐INFLAMMATORY AGENTS 301968
30/MUM/2013 09‐10‐2018 A topical formulation in the form of cream for use in burn wound 301987
338/MUMNP/2012 09‐10‐2018 A PEPTIDE FOR TREATING AND PREVENTING DEGENERATIVE DISC
AND AFFECTING INHIBITION OF TGF‐B1
302003
988/KOL/2013 09‐10‐2018 TRANSPARENT PERSONAL CARE AND COSMETIC PRODUCTS WITH
INORGANIC ACTIVE INGREDIENTS IN MICRONIZED/COLLOIDAL
FORM
302035
6338/DELNP/2013 09‐10‐2018 FILMCOATED SOLID DOSAGE FORMS COMPRISING HONEY IN THE
COATING
302036
1396/KOLNP/2013 10‐10‐2018 FELBINAC‐CONTAINING EXTERNAL PATCH 302061
899/CHE/2011 10‐10‐2018 PROCESS FOR PREPARATION OF LENALIDOMIDE POLYMORPH 302068
2642/CHE/2013 10‐10‐2018 SUBSTITUTED 4‐HYDRAZINOTHIAZOLES AND PROCESSES FOR THEIR
PREPARATION
302079
Page 58 of 85
5261/DELNP/2012 10‐10‐2018 "ORAL CARE COMPOSITIONS" 302100
1937/DEL/2006 10‐10‐2018 A PROCESS FOR PREPARATION OF ANTIDIARRHOEAL FRACTION
FROM
XYLOCARPUS AND A PHARMACEUTICAL COMPOSITION
THEREFROM
302104
2648/DEL/2006 10‐10‐2018 "HERBAL FORMULATION FOR WOUND HEALING" 302105
816/KOL/2011 11‐10‐2018 a,a‐DIALKYL‐BENZYL ALCOHOL AND RELATED DERIVATIVES FOR
SKIN‐LIGHTENING, ANTI‐AGEING AND ANTI‐BACTERIAL
COMPOSITIONS
302120
2408/MUM/2008 11‐10‐2018 SOFT GELATIN PASTILLES 302122
694/DELNP/2013 11‐10‐2018 4‐ALKYLRESORCINOL DERIVATIVE AND EXTERNAL PREPARATION
FOR SKIN CONTAINING SAME
302136
2884/CHENP/2011 12‐10‐2018 HIGH AFFINITY HUMAN ANTIBODIES TO HUMAN IL‐4 RECEPTOR 302148
779/KOLNP/2012 12‐10‐2018 PRESSURIZED METERED DOSE INHALER COMPRISING FORMOTEROL
AND BECLOMETASONE DIPROPIONATE
302151
5013/CHENP/2011 12‐10‐2018 NOVEL EICOSANOID DERIVATIVES 302152
10411/CHENP/2012 12‐10‐2018 NOVEL PHARMACEUTICAL COMPOUNDS 302155
2352/CHENP/2014 12‐10‐2018 NOVEL COMPOUNDS AS HIF‐ 1a INHIBITORS AND
MANUFACTURING PROCESS THEREOF
302181
5040/CHENP/2012 15‐10‐2018 ANTIBODY BINDING TO HUMAN CSF‐IR 302196
2266/MUM/2010 15‐10‐2018 A NOVEL PROCESS FOR PREPARATION OF BOSENTAN 302213
3708/DELNP/2006 15‐10‐2018 "A FORMULATION COMPRISING A CORTICOSTEROID, A SULFOALKYL
ETHER‐BETA‐CYCLODEXTRIN (SAE‐B‐CD), AND AN AQUEOUS
LIQUID"
302216
537/DEL/2008 15‐10‐2018 CHALCONE LINKED PYRROLO [2,1‐C][1,4] BENZODIAZEPINE HYBRIDS
AS POTENTIAL ANTICANCER AGENTS AND PROCESS FOR THE
PREPARATION THEREOF
302219
181/CHENP/2011 16‐10‐2018 PATCHES AND METHODS FOR THE TRANSDERMAL DELIVERY OF A
THERAPEUTICALLY EFFECTIVE AMOUNT OF IRON
302235
3817/DELNP/2013 16‐10‐2018 DENTIFRICE COMPOSITIONS CONTAINING CALCIUM SILICATE AND A
BASIC AMINO ACID
302241
1554/DELNP/2009 16‐10‐2018 “PROTEIN MATRIX VACCINES AND METHODS OF MAKING THEM” 302247
3759/DEL/2012 22/10/2018 ORAL GEL FOR SENSITIVITY AND TOOTH PAIN 302297
2867/DEL/2011 22‐10‐2018 "AN IMPROVED PROCESS OF CONVERSION OF LANTADENE A AND B
TO REDUCED LANTADENE A AND B"
302295
2483/MUMNP/2011 22‐10‐2018 "PRODUCTION OF ENCAPSULATED NANOPARTICLES AT HIGH
VOLUME FRACTIONS"
302300
6152/CHENP/2014 22‐10‐2018 Gambogenic acid derivative and method of preparing the same 302327
2994/MUM/2010 23‐10‐2018 USE OF MUCILAGE ISOLATED FROM SEEDS OF OCIMUM BASILICUM
AS PHARMACEUTICAL EXCIPIENT
302343
734/KOL/2011 23‐10‐2018 METHODS OF PREPARING NON‐ALCOHOL BIOACTIVE ESSENTIAL OIL
MOUTH RINSE
302345
7797/DELNP/2014 24‐10‐2018 METHOD FOR PRODUCING DISINTEGRATING PARTICULATE
COMPOSITION COMPRISING ACID TYPE
CARBOXYMETHYLCELLULOSE DISINTEGRATING PARTICULATE
COMPOSITION COMPRISING ACID TYPE
CARBOXYMETHYLCELLULOSE AND ORALLY DISINTEGRATING
TABLET INCLUDING DISINTEGRATING PARTICULATE COMPOSITION
COMPRISING ACID TYPE CARBOXYMETHYLCELLULOSE
302372
960/MUM/2009 24‐10‐2018 A NOVEL CREAM AND A PROCESS TO MANUFACTURE THE SAME 302376
7/MUMNP/2015 24‐10‐2018 TOOTH WHITENING ORAL CARE COMPOSITION 302377
1044/DELNP/2011 24‐10‐2018 ALPHA‐GALACTOSYL CERAMIDE ANALOGS AND THEIR USE AS
IMMUNOTHERAPIES, ADJUVANTS, AND INTIVIRAL, ANTIBACTERIAL,
AND ANTICANCER AGENTS
302381
1539/CHENP/2013 25‐10‐2018 P2X4 RECEPTOR ANTAGONIST 302407
4040/CHENP/2012 25‐10‐2018 “COPPER SALTS OF ION EXCHANGE MATERIALS FOR USE IN THE
TREATMENT AND PREVENTION OF INFECTIONS”
302410
Page 59 of 85
5127/CHE/2012 26/10/2018 AMINO ACID COMPOSITIONS FOR THE TREATMENT OF DIABETIC
RETINOPATHY
302481
4691/CHENP/2011 26/10/2018 IN VITRO METHOD FOR INDUCING AN ANTIGENPRESENTINGCELL
(APC) WITH CTL INDUCIBILIT
302477
4793/CHENP/2012 26‐10‐2018 “METHOD FOR REMOVING CYTOKINES FROM BLOOD WITH
SURFACE IMMOBILIZED POLYSACCHARIDES”
302453
2551/DELNP/2012 26‐10‐2018 NOVEL PHENOL DERIVATIVE 302459
8116/CHENP/2012 26‐10‐2018 PHARMACEUTICAL OR NEUTRACEUTICAL FORMULATION 302483
3636/CHENP/2013 26‐10‐2018 "POLYPEPTIDES DERIVED FROMIL‐2 HAVING AGONIST ACTIVITY,FOR
THE THERAPY OF CANCER AND CHRONIC INFECTIONS"
302486
4160/DELNP/2009 26‐10‐2018 "P38 INHIBITORS AND METHODS OF USE THEREOF" 302490
1969/DEL/2009 29‐10‐2018 "COSMETIC COMPOSITION CONTAINING A DIBENZOYLMETHANE
DERIVATIVE AND A DITHIOLANE COMPOUND; PROCESS FOR
PHOTOSTABILIZING THE DIBENZOYLMETHANE DERIVATIVE"
302530
2017/KOLNP/2011 29‐10‐2018 ANTITUMOR COMBINATIONS CONTAINING ANTIBODIES
RECOGNIZING SPECIFICALLY CD38 AND CYTARABINE
302541
4145/CHENP/2012 30‐10‐2018 PHARMACEUTICAL COMPOSITION COMPRISING A GLP‐1 AGONIST
AND METHIONINE
302570
9618/DELNP/2012 30‐10‐2018 “INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC
APPLICATIONS”
302601
236/MUM/2010 30‐10‐2018 "AN IMPROVED PROCESS FOR THE PREPARATION OF REBOXETINE
AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF"
302604
10257/CHENP/2013 30‐10‐2018 PYRANO [3,2‐D] [1,3] THIAZOLE AS GLYCOSIDASE INHIBITORS 302619
2473/CHENP/2013 31/10/2018 PROCESS FOR PRODUCING DRUG BLOCK COPOLYMER COMPOSITE
AND PHARMACEUTICAl PREPARATION CONTAINING SAME
302757
1043/DELNP/2012 31‐10‐2018 ANTI‐RSV IMMUNOGENS AND METHODS OF IMMUNIZATION 302655
4962/CHE/2012 31‐10‐2018 A PROCESS FOR THE ISOLATION AND PURIFICATION OF LYCOPENE
FROM RHODOSPIRILLUM SULFUREXIGENS JA143T AND
RHODOSPIRILLUM ORYZAE JA318T AND UTILIZATION THEREOF
302668
1035/MUMNP/2015 31‐10‐2018 HAIR CARE COMPOSITION 302685
8285/CHENP/2014 31‐10‐2018 NITROGEN‐CONTAINING HETEROCYCLIC COMPOUND OR
SALTTHEREOF
302696
348/CHENP/2011 31‐10‐2018 IMMUNOGENIC COMPOSITION FOR TREATING INFLUENZA 302699
1019/MUM/2009 31‐10‐2018 A Medicinal Antifungal And Steroid Cream incorporating a
biopolymer And A Process To Make The Same
302761
436/DELNP/2011 01‐11‐2018 "TRANSDERMAL PATCH CONTAINING FENTANYL OR SALT THEREOF" 291645
2723/MUM/2015 01‐11‐2018 PROCESS FOR PREPARATION OF CLEAR INJECTABLE SOLUTION OF
MIDAZOLAM AND PENTAZOCINE AND INJECTABLE SOLUTION
THEREOF
302794
2065/CHE/2010 01‐11‐2018 A PROCESS TO CONCENTRATE ANTI‐INFLAMMATORY PRINCIPLES
FROM GREEN MUSSEL PERNA VIRIDIS L. AND A PRODUCT
INCORPORATING THESE INGREDIENTS
302803
69/MUMNP/2014 01‐11‐2018 NON AQUEOUS ORAL CARE COMPOSITIONS 302814
3384/KOLNP/2011 01‐11‐2018 IMMUNOGENIC COMPOSITION 302822
1523/KOLNP/2013 01‐11‐2018 NOVEL ANTI‐CANCER AGENTS 302828
2079/CHE/2014 02‐11‐2018 NOVEL ANTI‐FUNGAL COMPOSITION 302838
4661/DELNP/2013 02‐11‐2018 NON AQUEOUS ORAL CARE COMPOSITION CONTAINING DENTAL
OCCLUSION ACTIVES
302839
1696/MUM/2011 02‐11‐2018 AN IMPROVED PROCESS FOR PREPARATION OF MORNIFLUMATE 302854
2158/KOLNP/2014 02‐11‐2018 NOVEL THIENOPYRIMIDINE DERIVATIVES, PROCESSES FOR THE
PREPARATION THEREOF AND THERAPEUTIC USES THEREOF
302857
758/MUMNP/2013 02‐11‐2018 BIOERODIBLE SILICON BASED DEVICES FOR DELIVERY OF
THERAPEUTIC AGENTS
302862
Page 60 of 85
6565/DELNP/2010 02‐11‐2018 "NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF
CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS"
302866
3554/DELNP/2011 02‐11‐2018 A Polypeptide for the Suppression of Cancer 302870
13/DEL/2011 02‐11‐2018 "A PHARMACEUTICAL FORMULATION COMPRISING z‐
BUTYLIDENEPHTHALIDE"
302874
2749/DEL/2013 02‐11‐2018 A NOVEL NANOCURCUMIN FORMULATION FOR AMELIORATING
HYPOBARIC HYPOXIA INDUCED MALADIES.
302877
5410/DELNP/2013 02‐11‐2018 A Formulation Comprising A Melt‐Processed Solid Dispersion
Product’
302878
5283/DELNP/2012 05‐11‐2018 "METHODS OF REDUCING HAIR LOSS AND / OR FACILITATING HAIR
GROWTH AND / OR REGROWTH"
302908
1681/MUMNP/2010 05‐11‐2018 COMPOSITION OF SERINE PROTEASE INHIBITORS IN THE
TREATMENT OF SKIN DISEASES
302911
1831/CHE/2013 09‐11‐2018 NOVEL PROCESS FOR THE PREPARATION OF PURE AND
CRYSTALLINE FORM OF REGADENOSON MONOHYDRATE
302980
3119/CHE/2011 09‐11‐2018 PROCESSES FOR PREPARING EPTIFIBATIDE 302987
3906/KOLNP/2008 13/11/2018 AN ISOLATED NUCLEIC ACID MOLECULE 303055
2764/KOLNP/2010 14/11/2018 A VACCINE COMPRISING A RECOMBINANT STAPHYLOCOCCAL
CLUMPING FACTOR A "
303110
3712/DELNP/2009 14‐11‐2018 "VON WILLEBRAND FACTOR‐AND FACTOR VIII‐POLYMER
CONJUGATES HAVING A RELEASABLE LINKAGE"
303118
6772/CHENP/2014 15‐11‐2018 MIXED ESTERS AS VASELINE SUBSTITUTE 303141
2829/MUM/2015 16‐11‐2018 STABILIZED INJECTABLE EMULSION OF PROPOFOL AND KETAMINE 303184
3692/DELNP/2014 16‐11‐2018 METHOD FOR PRODUCING SUBSTITUTED 5‐FLUORO‐1H‐
PYRAZOLOPYRIDINES
303187
4471/DELNP/2013 16‐11‐2018 A synergistic anticancer combination 303200
1394/DEL/2011 19‐11‐2018 "A NOVEL SUBMICRONIC TOPICAL FORMULATION FOR THE
EFFECTIVE TREATMENT OF PSORIASIS"
303213
8190/CHENP/2013 19‐11‐2018 PYRIMIDINE CYCLOHEXYL GLUCOCORTICOID RECEPTOR
MODULATORS
303234
4370/DELNP/2010 20/11/2018 TARGETING LIPIDS 303274
4871/DELNP/2015 20‐11‐2018 1 ‐[1‐ (BENZOYL)‐ PYRROLIDINE‐ 2‐ CARBONYL] ‐PYRROLIDINE ‐2 ‐
CARBONITRILE DERIVATIVES
303264
8144/CHENP/2012 20‐11‐2018 FUNGAL NAIL TREATMENT COMPOSITION 303299
1974/CHE/2009 20‐11‐2018 "NOVEL SALTS OF ETHYL (3R,4S,5R)‐4,5‐IMINO‐3‐(1‐
ETHYLPROPOXY) ‐ 1‐ CYCLOHEXENE‐1‐ CARBOXYLATE"
303314
3384/CHENP/2011 22‐11‐2018 COMPOUNDS 303329
637/KOLNP/2013 24‐11‐2018 PHARMACEUTICAL COMPOSITIONS 303371
5729/CHENP/2013 24‐11‐2018 NOVEL PREPARATION OF AN ENTERIC RELEASE SYSTEM 303373
263/KOLNP/2011 26/11/2018 PHARMACEUTICAL COMPOSITION FOR TREATMENT AND
PREVENTION OF CANCER
303441
10904/CHENP/2012 26‐11‐2018 FILLERS FOR DENTAL COMPOSITES 303397
3977/CHENP/2013 26‐11‐2018 COMPLEX FORMULATION COMPRISING LERCANIDIPINE
HYDROCHLORIDE AND VALSARTAN AND METHOD FOR THE
PREPARATION THEREOF
303402
6329/DELNP/2009 26‐11‐2018 ORAL CEPHALOTAXINE DOSAGE FORMS 303405
4549/CHENP/2011 26‐11‐2018 PHARMACEUTICAL COMPOSITION COMPRISING EZETIMIBE AND
SIMVASTATIN
303424
2439/CHENP/2011 27/11/2018 CARBOHYDRATE BINDING MOLECULES 303517
8785/DELNP/2013 27‐11‐2018 COSMETIC COMPOSITION IN A CONTAINER 303458
378/DELNP/2011 27‐11‐2018 DELIVERY PARTICLE 303502
932/MUMNP/2013 27‐11‐2018 METHOD OF PREPARATION FOR STABLE MEDICINAL PREPARATION
CONTAINING SELENIUM
303506
8070/DELNP/2012 27‐11‐2018 KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH
SAME
303508
7697/DELNP/2013 27‐11‐2018 AMORPHOUS (5 FLUORO 2 METHYL 3 QUINOLIN 2 YLMETHYL
INDOL 1 YL) ACETIC ACID
303532
Page 61 of 85
376/KOL/2014 28/11/2018 IN‐SITU GENERATED MICRONIZED PARTICLES IN PERSONAL CARE
RINSE‐OFF PRODUCTS FOR SUPERIOR SENSORIAL BENEFITS
303579
4509/CHENP/2013 28‐11‐2018 AMINE‐CONTAINING TRANSFECTION REAGENTS AND METHODS
FOR MAKING AND USING SAME
303558
361/MUMNP/2014 28‐11‐2018 PHARMACEUTICAL COMPOSITION CONTAINING DIAMINE
DERIVATIVE
303566
2367/KOLNP/2010 28‐11‐2018 DRUG DELIVERY SYSTEM FOR ADMNIISTRATION OF A WATER
SOLUBLE, CATIONIC AND AMPHIPHILIC PHARMACEUTICALLY
ACTIVE SUBSTANCE
303598
3095/MUM/2014 28‐11‐2018 AN ABUSE DETERRENT PHARMACEUTICAL COMPOSITION 303600
2855/CHENP/2011 28‐11‐2018 AN ANTISENSE OLIGONUCLEOTIDE FOR EFFICIENT SKIPPINGOF
EXON 52 OF HUMAN DUCHENNE MUSCULAR DYSTROPHYGENE
303615
5219/DELNP/2012 29/11/2018 “COMPOSITION FOR PREVENTING HAIR LOSS AND STIMULATING
HAIR GROWTH”
303681
1626/MUMNP/2011 29‐11‐2018 EDIBLE COMPOSITION FOR TREATING CUTANEOUS SIGNS OF
AGEING
303730
5676/DELNP/2009 29‐11‐2018 "COMPOSITIONS AND METHODS FOR DELIVERY OF ANTI‐CANCER
AGENTS"
303734
329/MUMNP/2013 29‐11‐2018 MICROPARTICLE FORMULATION FOR PULMONARY DRUG DELIVERY
OF ANTI‐INFECTIVE MOLECULE FOR TREATMENT OF INFECTIOUS
DISEASES
303747
4536/DELNP/2014 30/11/2018 MULTIPHASE ORAL CARE COMPOSITIONS 303862
2349/MUMNP/2012 30‐11‐2018 ORAL CARE COMPOSITIONS COMPRISING CURCUMIN COMPOUNDS
AND SOURCE OF ZINC IONS
303760
2066/CHE/2010 30‐11‐2018 A PRODUCT CONTAINING ANTI‐INFLAMMATORY PRINCIPLES FROM
GREEN MUSSEL PERNA VIRIDIS L. AND A PROCESS THEREOF
303813
5018/CHENP/2012 30‐11‐2018 METHOD FOR PREVENTING THE CRYSTALLISATION OF
PHARMACEUTICALS IN A POLYMER FILM
303838
9323/DELNP/2012 30‐11‐2018 Method of manufacturing an oral prolonged release pharmaceutical
composition
303849
3545/KOLNP/2010 03‐12‐2018 “COMPOSITION, VACCINE AND IMMUNOTHERAPEUTIC USING IL‐
28”
294136
2121/MUMNP/2011 03‐12‐2018 PETROLATUM BASED COMPOSITION COMPRISING GREATER THAN
10% SILICONE FOR IMPROVED FEEL WHILE REMAINING STABLE
294116
6464/DELNP/2014 03‐12‐2018 ADHESIVE PATCH WITH ANTIMICROBIAL COMPOSITION 303902
1184/KOLNP/2012 03‐12‐2018 A PHARMACEUTICAL COMPOSITION COMPRISING TRYPSINOGEN
AND CHYMOTRYPSINOGEN
303918
3064/MUM/2011 04‐12‐2018 "NANOSUSPENSION FOR OCULAR DRUG DELIVERY" 303931
749/MUM/2009 04‐12‐2018 AN IMPROVED METHOD FOR PREPARATION OF LAFUTIDINE
INTERMEDIATE
303932
2111/DELNP/2006 04‐12‐2018 ANTIBODY‐DRUG CONJUGATES AND INTERMEDIATES 303986
860/MUM/2011 04‐12‐2018 "CONTROLLED RELEASE GASTRORETENTIVE COMPOSITION" 303996
4471/KOLNP/2010 04‐12‐2018 LIPID COMPOSITION 303998
10203/CHENP/2012 05‐12‐2018 COATED PARTICLE AND METHOD FOR PRODUCING COATED
PARTICLE
304024
1814/KOLNP/2013 05‐12‐2018 USE OF TEA POLYPHENOLS AND/OR TEA PIGMENTS AS DYES AND
PRODUCTS THEREOF
304041
1055/MUMNP/2013 05‐12‐2018 NOVEL ANTIFUNGAL 5 6‐DIHYDRO‐4H‐PYRROLO[1 2 ‐A][1 4]‐
BENZODIAZEPINES AND 6H‐PYRROLO[1 2‐A][1 4]BENZODIAZEPINES
SUBSTITUTED WITH BICYCLIC BENZENE DERIVATIVES
304064
7685/DELNP/2013 06‐12‐2018 COMPOSTIONS AND METHODS FOR TREATING CHRONIC
INFLAMMATION AND INFLAMMATORY DISEASES
304085
8502/DELNP/2012 06‐12‐2018 VIRAL INHIBITOR COMPOSITIONS FOR IN VIVO THERAPEUTIC USE
COMPRISING A COMBINATION OF ( ) CARVONE GERANIOL AND A
FURTHER ESSENTIAL OIL COMPONENT
304100
Page 62 of 85
269/MUMNP/2014 06‐12‐2018 BENEFIT AGENT DELIVERY PARTICLES COMPRISING NON IONIC
POLYSACCHARIDES
304101
7243/CHENP/2013 06‐12‐2018 BIS(FLUOROALKYL)‐1,4‐BENZODIAZEPINONE COMPOUNDS 304107
434/KOL/2012 06‐12‐2018 SKIN CARE COMPOSITION COMPRISING EXTRACTS OF
ACHYRANTHES ASPERA
304117
245/MUMNP/2014 06‐12‐2018 BENEFIT AGENT DELIVERY PARTICLES COMPRISING DEXTRAN 304118
1990/KOLNP/2011 06‐12‐2018 ANTITUMOR COMBINATIONS CONTAINING ANTIBODIES
RECOGNIZING SPECIFICALLY CD38 AND VINCRISTINE
304120
8089/CHENP/2013 07‐12‐2018 PROCESS FOR THE PREPARATION OF A SULFATED DERIVATIVE OF 3
5 DIIODO O [3 IODOPHENYL] L TYROSINE
304156
3349/DELNP/2011 07‐12‐2018 "POLYPEPTIDE FOR TREATING OR PREVENTING ADHESIONS" 304174
217/MUM/2011 07‐12‐2018 NOVEL COMBINATION FOR USE IN TREATING HAIR LOSS 304181
3851/DELNP/2011 07‐12‐2018 VACCINE AGAINST AFRICAN HORSE SICKNESS VIRUS 304188
49/KOL/2013 07‐12‐2018 ISOLATION OF PHYTOCONSTITUENT FROM BOMBAX CEIBA 304196
3599/DELNP/2009 07‐12‐2018 "FACTOR IX MOIETY‐POLYMER CONJUGATES HAVING A RELEASABLE
LINKAGE"
304197
3448/KOLNP/2012 07‐12‐2018 SHIP INHIBITORS AND USES THEREOF 304203
2687/CHENP/2013 07‐12‐2018 HETERO RING FUSED IMIDAZOLE DERIVATIVE HAVING AMPK
ACTIVATING EFFECT
304220
436/KOL/2012 07‐12‐2018 SKIN CARE COMPOSITION COMPRISING EXTRACTS OF FUMARIA
OFFICINALIS
304222
9455/DELNP/2014 10‐12‐2018 RADIANCE COMPOSITIONS AND METHODS OF USE 304247
3594/CHE/2012 10‐12‐2018 7‐BENZYL‐4‐HYDRAZINYL‐5,6‐DIMETHYL‐2‐PROPYL‐7H‐ PYRROLO
[2,3‐D] PYRIMIDINE AS POTENT ANTIMYCOBACTERIALAGENT
304256
2639/MUM/2015 11‐12‐2018 HYPERBARIC INJECTION SOLUTION OF ROPIVACAINE
HYDROCHLORIDE AND PROCESS FOR PREPARATION THEREOF
304288
201821010337 11‐12‐2018 DRUG COATED BALLOON 304293
9166/CHENP/2013 11‐12‐2018 SHARK LIKE CHONDROITIN SULPHATE AND PROCESS FOR THE
PREPARATION THEREOF
304313
2453/MUMNP/2015 11‐12‐2018 "NOVEL PYRIMIDINE AND PYRIDINE COMPOUNDS AND THEIR
USAGE"
304315
2203/MUM/2012 12‐12‐2018 "AN AMORPHOUS VILAZODONE HYDROCHLORIDE AND PROCESSES
FOR PREPARING SAME"
304321
5045/DELNP/2011 12‐12‐2018 "PHARMACEUTICAL COMPOSITIONS COMPRISING 2‐OXO‐1‐
PYRROLIDINE DERIVATIVES"
304327
4558/DELNP/2011 12‐12‐2018 "ONCOLYTIC ADENOVIRAL VECTORS AND METHODS AND USES
RELATED THERETO"
304364
2911/CHENP/2011 13/12/2018 “FRUIT EXTRACTS” 304430
6896/DELNP/2012 13‐12‐2018 “LIQUID FORMULATIONS FOR LONG‐ACTING ERYTHROPOIETIN
CONJUGATE”
304383
2868/MUMNP/2012 13‐12‐2018 METHOD FOR PRODUCTION OF F‐18 LABELED AMYLOID BETA
LIGANDS
304388
2131/DEL/2010 13‐12‐2018 AQUEOUS EXTRACT OF ANIMAL SKIN FOR THERAPEUTIC BENEFITS
IN EPILEPSY
304390
2146/KOLNP/2012 13‐12‐2018 ORALLY ADMINISTRABLE PHARMACEUTICAL PELLET OF EPIDERMAL
GROWTH FACTOR
304412
3405/CHENP/2013 13‐12‐2018 SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF 304417
6867/CHENP/2012 13‐12‐2018 KIT COMPRISING REVERSE THERMOSETTINGFORMULATION FOR
APPLYING MOXIFLOXACIN TO THE EAR
304427
2830/MUM/2010 13‐12‐2018 A SUNSCREEN COMPOSITION 304431
2839/DELNP/2013 13‐12‐2018 4‐(METHYLAMINOPHENOXY) PYRDIN‐3‐YL‐ BENZAMIDE
DERIVATIVES FOR TREATING CANCER
304438
6252/CHENP/2012 14‐12‐2018 TRICYCLIC ANTIBIOTICS 304461
2116/CHE/2014 14‐12‐2018 AN IMPROVED PROCESS FOR THE PREPARATION OF LORNOXICAM 304478
9581/CHENP/2013 14‐12‐2018 HYDRAZINO 1H‐IMIDAZOQUINOLIN‐4‐AMINES AND CONJUGATES
MADE THEREFROM
304483
Page 63 of 85
9690/CHENP/2013 14‐12‐2018 HETEROBIFUNCTIONAL LINKERS WITH POLYETHYLENE GLYCOL
SEGMENTS AND IMMUNE RESPONSE MODIFIER CONJUGATES
MADE THEREFROM
304485
4535/DELNP/2014 14‐12‐2018 COLOR CHANGING COMPOSITIONS 304500
2145/KOL/2008 17/12/2018 SYNERGISTIC HAIR CARE COMPOSITION 304561
2063/DELNP/2014 17‐12‐2018 HETEROCYCLIC COMPOUNDS MEDICAMENTS CONTAINING SAID
COMPOUNDS USE THEREOF AND PROCESSES FOR THE
PREPARATION THEREOF
304527
1172/MUM/2011 17‐12‐2018 A PROCESS FOR PREPARING FESOTERODINE 304529
498/CHENP/2011 17‐12‐2018 A PREPARATION COMPRISING A NON‐MAMMALIAN DERIVED
MIXTURE OF SERINE GLYCEROPHOSPHOLIPID CONJUGATES
304543
7824/CHENP/2013 17‐12‐2018 GASTRIC RESISTANT PHARMACEUTICAL OR NUTRACEUTICAL
COMPOSITION WITH RESISTANCE AGAINST THE INFLUENCE OF
ETHANOL
304549
5888/DELNP/2013 17‐12‐2018 A SIGMA LIGAND FOR USE IN TREATMENT OF BONE CANCER PAIN 304562
10434/DELNP/2015 18‐12‐2018 “METHOD AND DEVICE FOR PRODUCING HYDROGEN CONTAINING
FLUID”
304570
255/MUM/2007 18‐12‐2018 “A COMPOSITION FOR SELECTIVE SEROTONIN REUPTAKE
INHIBITION AND PROCESS THEREOF”
304584
3276/CHE/2010 18‐12‐2018 NOVEL MICRO‐PARTICLES OF MIZOLASTINE FOR NASAL DELIVERY 304606
6156/CHENP/2012 18‐12‐2018 TOPICAL OPHTHALMIC PEPTIDE FORMULATION 304619
7171/CHENP/2010 18‐12‐2018 LONG‐CHAIN FATTY ACYL ELONGASE INHIBITOR COMPRISING
ARYLSULFONYL DERIVATIVE AS ACTIVE INGREDIENT
304623
2624/MUMNP/2012 18‐12‐2018 LEVOISOVALERYLSPIRAMYCIN I II OR III PREPARATIONS
PREPARATION METHODS AND USES THEREOF
304630
3196/KOLNP/2012 19‐12‐2018 PROCESS FOR PROVIDING PARTICLES WITH REDUCED
ELECTROSTATIC CHARGES
304644
830/MUMNP/2011 19‐12‐2018 ANTIPERSPIRANT OR DEODORANT COMPOSITIONS 304661
448/MUMNP/2014 20/12/2018 ORAL CARE COMPOSITIONS 304790
4012/KOLNP/2011 20‐12‐2018 DIMENSIONAL ANALYSIS OF SACCHARIDE CONJUGATES WITH GPC
& SECMANS
304750
1508/DELNP/2014 20‐12‐2018 3,5‐ DISUBSTITUTED ALKYNYLBENZENE COMPOUND AND SALT
THEREOF
304755
4213/CHENP/2011 20‐12‐2018 HIGH AFFINITY HUMAN ANTIBODIES TO PCSK9 304766
2280/MUMNP/2012 21‐12‐2018 EASILY DOSABLE SOLID PREPARATION 304808
3253/CHENP/2009 21‐12‐2018 MICROORGANISMS OR FRACTIONS THEREOF CAPABLE OF
ACTIVATING CELLULAR IMMUNITY AGAINST CARBOHYDRATES
304814
1556/DEL/2009 21‐12‐2018 “NOVEL ANTI‐HIV COMPOUNDS” 304819
1968/DEL/2009 21‐12‐2018 A COMPOSITION FOR EXTERNAL TROPICAL USE 304836
4537/CHENP/2011 24‐12‐2018 RECOMBINANT AVIAN INFECTIOUS CORYZA VACCINE AND PROCESS
FOR PREPARING SAME
304906
5059/KOLNP/2010 24‐12‐2018 MONOCLONAL ANTIBODY THAT BINDS FIBROBLAST GROWTH
FACTOR RECEPTOR 2
304913
3353/KOLNP/2011 26‐12‐2018 FORMULATIONS OF VIABLE CELLS FOR ORAL DELIVERY 304958
8295/DELNP/2011 26‐12‐2018 "LIQUID DEPOT FORMULATIONS" 304972
6677/CHENP/2013 27‐12‐2018 METHODS AND COMPOSITIONS FOR PREPARING NORIBOGAINE
FROM VOACANGINE
305003
1262/MUMNP/2012 27‐12‐2018 MODULATION OF HSP47 EXPRESSION 305006
5628/CHENP/2014 27‐12‐2018 Azaadmantane Compounds for treatment of disorders relating to
11 beta HSD‐1activity and method of production thereof
305017
7417/CHENP/2013 27‐12‐2018 ISOPENTYL ESTERS FOR THE USE IN COSMETIC DERMATOLOGICAL
OR PHARMACEUTICAL COMPOSITIONS
305020
7462/CHENP/2009 27‐12‐2018 METHODS AND COMPOSITIONS FOR STIMULATING NEUROGENESIS
AND INHIBITING NEURONAL DEGENERATION USING
ISOTHIAZOLOPYRIMIDINONES
305026
6782/CHENP/2013 27‐12‐2018 METHOD OF PREPARATION OF METAXALONE 305029
Page 64 of 85
261/CHENP/2015 28‐12‐2018 LIQUID COMPOSITION CONTAINING TAXANE BASED ACTIVE
INGREDIENT PROCESS FOR PRODUCING SAME AND LIQUID
MEDICINAL PREPARATION
305055
4123/DELNP/2011 28‐12‐2018 AN ANTIBODY FRAGMENT LINKED TO AN EPITOPE COMPLEXED
WITH AN ANTIBODY THAT BINDS TO AN EPITOPE
305059
7803/DELNP/2012 28‐12‐2018 ADDITIVE FOR ERYTHROCYTE‐RICH SOLUTION, AND CONTAINER
FOR MEDICAL PURPOSES
305065
1999/CHENP/2011 28‐12‐2018 PH‐DEPENDENT CONTROLLED RELEASE PHARMACEUTICAL OPIOID
COMPOSITION WITH RESISTANCE AGAINST THE INFLUENCE OF
ETHANOL
305073
533/KOLNP/2013 28‐12‐2018 COMPOUND COMPOSITION FOR INHALATION USED FOR TREATING
ASTHMA
305095
5565/CHENP/2011 28‐12‐2018 OPTIMIZED EARLY‐LATE PROMOTER COMBINED WITH REPEATED
VACCINATION FAVORS CYTOTOXIC T CELL RESPONSE AGAINST
ANTIGENS IN REPLICATION DEFICIENT RECOMBINANT VIRUS
VACCINES
305110
7290/DELNP/2009 31/12/2018 "DUCK EMBRYONIC DERIVED STEM CELL LINES FOR THE
PRODUCTION OF VIRAL VACCINES"
305130
4483/DELNP/2011 31‐12‐2018 DERMATOLOGICAL OR COSMETIC COMPOSITION COMPRISING AN
EXTRACT OF AERIAL PARTS OF OATS HARVESTED BEFORE EAR
EMERGENCE
305141
239/MUMNP/2015 31‐12‐2018 METHOD OF PREPARING BENZOFURAN DERIVATIVE 305149
246/DEL/2013 01‐01‐2019 PHARMACEUTICAL COMPOSITION FOR THE PROLONGED RELEASE
OF TRIMETAZIDINE
305171
7221/DELNP/2014 01‐01‐2019 COSMETIC COMPOSITION COMPRISING SILICA AEROGEL PARTICLES
AND A CLAY
305177
7515/CHENP/2012 01‐01‐2019 AN AQUEOUS COMPOSITION 305179
3552/DELNP/2013 01‐01‐2019 METHOD AND SYSTEM FOR FORMING A PHARMACEUTICAL
PRODUCT DIRECTLY ONTO A PACKAGING SURFACE
305182
117/MUMNP/2012 01‐01‐2019 "IMMUNOSTIMULATORY COMPOSITIONS COMPRISING LIPOSOME‐
ENCAPSULATED OLIGONUCLEOTIDES AND EPITPOES"
305216
3379/KOLNP/2015 02‐01‐2019 MICROEMULSION TOPICAL DELIVERY PLATFORM 305229
2753/MUM/2010 02‐01‐2019 A SKIN LIGHTENING COMPOSITION 305261
2239/KOLNP/2013 02‐01‐2019 PYRIMIDINE GYRASE AND TOPOISOMERASE IV INHIBITORS 305263
1169/MUMNP/2012 02‐01‐2019 LIPOSOME OF IRINOTECAN OR ITS HYDROCHLORIDE AND
PREPARATION METHOD THEREOF
305281
582/KOLNP/2013 03‐01‐2019 MONOCLONAL ANTIBODY SPECIFIC TO MAJOR NEUTRALIZING
EPITOPE OF INFLUENZA H5 HEMAGGLUTININ
308437
1434/DELNP/2012 03‐01‐2019 "COMPOSITIONS COMPRISING TRAMADOL AND CELECOXIB IN THE
TREATMENT OF PAIN"
305298
2002/DEL/2011 03‐01‐2019 AN ANTIDIABETES HEALTH FOOD PRODUCT FROM SOYBEAN
(GLYCINE MAX)SEEDS
305316
4531/CHENP/2014 03‐01‐2019 2',4'‐DIFLUORO‐2'‐METHYL SUBSTITUTED NUCLEOSIDE
DERIVATIVES ASINHIBITORS OF HCV RNA REPLICATION
305321
1157/MUMNP/2013 03‐01‐2019 INDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS 305335
2717/MUMNP/2012 03‐01‐2019 PHOSPHORIC ACID ESTER COMPOUND OF HYDROXY ACID
SUBSTITUTED PHENYL ESTER, SYNTHESIS METHOD AND MEDICAL
USE THEREOF
305349
551/KOLNP/2010 04‐01‐2019 ENGINEERED ANTI‐ALPHA V‐INTEGRIN HYBRID ANTIBODIES 305395
3183/KOLNP/2011 05‐01‐2019 PURIFIED PLASMODIUM AND VACCINE COMPOSITIONS 312113
5291/DELNP/2015 07‐01‐2019 HIGH CONTENT SODIUM IBUPROFEN GRANULES, THEIR
PREPARATION AND THEIR USE IN PREPARING NON EFFERVESCENT
SOLID DOSAGE FORMS
315295
2749/CHENP/2011 07‐01‐2019 PRE FILLED SYRINGE COMPRISING PERIPHERAL OPIOID RECEPTOR
ANTAGONISTS
305409
2360/DEL/2012 07‐01‐2019 A PHARMACEUTICAL FORMULATION FOR THE PREVENTION OF
SEXUAL TRANSMISSION OF HIV
305412
1505/MUMNP/2013 07‐01‐2019 HAIR TREATMENT COMPOSITIONS 305413
5193/DELNP/2010 08‐01‐2019 MODIFIED INFLUENZA VIRUS 305470
Page 65 of 85
715/CHENP/2013 09‐01‐2019 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF 305497
10507/CHENP/2012 09‐01‐2019 “AN AGENT THAT INCREASES THE NUCLEAR LOCALIZATION OF
COMMD1 PROTEIN”
305498
7909/DELNP/2013 09‐01‐2019 AZOLE DERIVATIVE 305508
1000/MUM/2011 09‐01‐2019 CONTROLLED RELEASE SOLID DOSAGE FORM OF BETAHISTINE 305513
1077/CHENP/2013 09‐01‐2019 P2X4 RECEPTOR ANTAGONIST 305515
3447/DELNP/2014 10‐01‐2019 METHOD FOR PREPARING 1 (4 (4 (3 4 DICHLORO 2
FLUOROPHENYLAMINO) 7 METHOXYQUINAZOLIN 6
YLOXY)PIPERIDIN 1 YL) PROP 2 EN 1 ONE HYDROCHLORIDE AND
INTERMEDIATES USED THEREIN
305534
1171/MUMNP/2013 10‐01‐2019 A SKIN LIGHTENING COMPOSITION 305558
2645/MUMNP/2012 10‐01‐2019 “MORPHOLINO PYRIMIDINES AND THEIR USE IN THERAPY” 305564
416/KOLNP/2012 11‐01‐2019 HETEROCYLCIC DERIVATIVES AS INHIBITORS OF GLUTAMINYL
CYCLASE
305585
7836/CHENP/2014 14‐01‐2019 C 17 BICYCLIC AMINES OF TRITERPENOIDS WITH HIV MATURATION
INHIBITORY ACTIVITY
305662
73/DELNP/2013 15‐01‐2019 PHARMACEUTICAL COMPOSITION COMPRISING AMIDE DERIVATIVE
OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
305671
6546/DELNP/2014 16‐01‐2019 CONDITIONING COMPOSITION ADDITIVE FOR PROVIDING
IMMEDIATE AND LONG LASTING BENEFITS TO KERATIN
SUBSTRATES
305716
8696/DELNP/2012 16‐01‐2019 NOVEL COMPOSITION FOR TREATMENT OF ESSENTIAL
THROMBOCYTHEMIA
305717
1372/MUMNP/2012 16‐01‐2019 FORMULATIONS, SALTS AND POLYMORPHS OF
TRANSNORSERTRALINE AND USES THEREOF
305720
2047/KOLNP/2013 16‐01‐2019 COMPOSITIONS AND METHODS FOR STABILIZING INGREDIENTS
USING 2,4‐PENTANEDIONE COMPOUNDS
305728
201627010917 16‐01‐2019 SUBSTITUTED PIPERIDYL‐ETHYL‐PYRIMIDINE AS GHRELIN O‐ACYL
TRANSFERASE INHIBITOR
305730
3610/CHENP/2014 16‐01‐2019 TRICYCLIC COMPOUNDS, COMPOSITIONS COMPRISING THEM AND
USES THEREOF
305743
3184/DELNP/2013 16‐01‐2019 LIPOSOME COMPOSITION AND PROCESS FOR PRODUCTION
THEREOF
305744
201617011378 16‐01‐2019 A METHOD OF PRODUCING A PERSONAL CARE COMPOSITION 305748
2610/DELNP/2012 16‐01‐2019 "A COMPOUND" 305754
55/DELNP/2013 17‐01‐2019 PERSONAL CARE COMPOSITION ADDITIVE FOR APPLICATION ON
KERATIN SUBSTRATES TO PROVIDE LONG LASTING BENEFITS
305781
1510/MUMNP/2014 17‐01‐2019 AURORA AND FLT3 KINASES MODULATORS 305804
1211/KOLNP/2014 17‐01‐2019 PROCESS FOR RECOVERY OF NALMEFENE HYDROCHLORIDE 305808
6214/DELNP/2011 17‐01‐2019 "ABUSE RESISTANT FORMULATION" 305817
10403/DELNP/2014 17‐01‐2019 KIT AND METHOD FOR PRODUCING A RADIOPHARMACEUTICAL 305828
9083/CHENP/2012 17‐01‐2019 “CGRP ANTIBODIES” 305835
108/KOLNP/2015 18‐01‐2019 COSMETIC COMPOSITION FOR MAKING UP THE SKIN COMPRISING
SEBUM PUMP FILLER AND HYDROPHOBIC FILM FORMING POLYMER
305857
3674/KOLNP/2012 18‐01‐2019 COSMETIC COMPOSITION BASED ON A SUPRAMOLECULAR
POLYMER AND AN ABSORBENT FILLER
305868
1685/MUMNP/2013 18‐01‐2019 ORAL CARE COMPOSITIONS 305871
8962/DELNP/2010 18‐01‐2019 EMOLLIENT COMPOSITION 305878
1237/DELNP/2012 18‐01‐2019 "PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF
CANCER AND OTHER DISEASES OR DISORDERS"
305913
5320/DELNP/2012 21‐01‐2019 AMINOPYRIMIDINES AS SYK INHIBITORS 305941
2880/CHE/2012 21‐01‐2019 A NOVEL COMPOUND AND A PROCESS FOR PREPARATION THEREOF 305967
6081/CHENP/2013 21‐01‐2019 A liquid composition in the form of a physically stable O/W‐
emulsion
305981
2098/MUM/2015 21‐01‐2019 MOLECULAR GELATORS FOR CONTAINING OIL SPILLAGE 306015
Page 66 of 85
9112/CHENP/2014 21‐01‐2019 COSMETIC COMPOSITION AND METHOD FOR USING THEREOF 306023
411/MUMNP/2014 22/01/2019 HAIR COMPOSITION 306034
9651/DELNP/2011 22‐01‐2019 "SEMI‐SOLID COMPOSITIONS AND PHARMACEUTICAL PRODUCTS" 306031
2211/DELNP/2011 22‐01‐2019 “METHOD OF TREATING DYSGLYCEMIA AND GLUCOSE
EXCURSIONS”
306043
1138/CHENP/2012 22‐01‐2019 UV FILTER COMBINATIONS COMPRISING BENZYLIDENE MALONATES 306084
8778/DELNP/2012 23‐01‐2019 SUPERCRITICAL FLUID TREATMENT OF HIGH MOLECULAR WEIGHT
BIOPOLYMERS
306103
3091/KOLNP/2011 23‐01‐2019 7‐PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES 306118
1323/MUMNP/2013 24‐01‐2019 SUBSTITUTED [(5H‐PYRROLO[2,1‐C] [1,4]BENZODIAZEPIN‐11‐
YL)PIPERAZIN‐1‐YL]‐2,2 DIMETHYLPROPANOIC ACID COMPOUNDS
AS DUAL ACTIVITY H1 INVERSE AGONISTS/5‐HT2A ANTAGONISTS
306188
1191/MUM/2009 24‐01‐2019 MELT IN MOUTH SUSTAINED RELEASE TABLETS 306223
1596/MUMNP/2013 24‐01‐2019 IL17 AND IFN GAMMA INHIBITION FOR THE TREATMENT OF
AUTOIMMUNE INFLAMMATION
306242
746/MUMNP/2013 24‐01‐2019 A PHARMACEUTICAL COMPOSITION CONTAINING ESTERS OF
ACYLOXYMETHYL)ACRYLAMIDE FOR INHIBITION OF THE
THIOREDOXIN ‐
THIOREDOXIN REDUCTASE SYSTEM
306259
2982/MUM/2012 24‐01‐2019 DRUG‐CONTAINING BIOABSORBABLE FIBERS AND IMPLANTS 306269
2199/MUM/2012 25‐01‐2019 A PROCESS FOR PREPARATION OF HERBAL GELATINE 306273
446/CHE/2012 25‐01‐2019 IMPROVED PROCESS FOR THE PREPARATION OF TRIAZOLE
ANTIFUNGAL DRUG
306285
7580/DELNP/2009 25‐01‐2019 "A PHARMACEUTICAL COMPOSITION COMPRISING TETRA‐
NITROSYL‐IRON
COMPLEX WITH THIOPHENOL"
306292
1164/MUMNP/2013 25‐01‐2019 ANALGESIC COMPOUNDS, METHODS AND FORMULATIONS 306298
144/MUMNP/2014 25‐01‐2019 (THIENO[2,3‐b][1,5]BENZOXAZEPIN‐4‐YL)PIPERAZIN‐1‐YL
COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5‐HT2A
ANTAGONISTS
306303
10233/CHENP/2012 25‐01‐2019 FURANYL COMPOUNDS AND THE USE THEREOF 306307
8684/DELNP/2011 25‐01‐2019 "ORAL CARE FORMULATIONS THAT ENHANCE AMOUNT OF
SOLUBLE ZINC"
306318
2573/DELNP/2010 25‐01‐2019 "HAIR CARE COMPOSITIONS AND METHODS OF TREATING HAIR" 306323
9224/DELNP/2013 28‐01‐2019 PROCESS FOR THE PREPARATION OF 1 ‐ ( 2‐ METHYL ‐ 4 ‐ ( 2, 3, 4, 5
‐ TETRAHYDRO ‐ 1 ‐ BENZAZEPIN ‐1 ‐ YLCARBONYL)
BENZYLCARBAMOYL) ‐ L ‐ PROLINE ‐ N, N‐ DIMETHYLAMIDE
306340
4119/DELNP/2011 28‐01‐2019 "FRUIT AND VEGETABLE‐DERIVED COMPOSITIONS" 306346
1467/CHENP/2013 28‐01‐2019 PHARMACEUTICAL COMPOSITION COMPRISING AN AZIDE‐
MODIFIED FATTY ACID, CARBOHYDRATE AND LIPID
306347
917/MUMNP/2012 28‐01‐2019 ORAL SOLID DOSAGE FORM CONTAINING NANOPARTICLES AND
PROCESS OF FORMULATING THE SAME USING FISH GELATIN
306366
185/DELNP/2014 28‐01‐2019 NOVEL COMPOUND WITH AMYLOID AFFINITY 306378
8115/CHENP/2012 28‐01‐2019 PERSONAL CARE COMPOSITIONS FOR COLORING HAIR 306394
790/MUMNP/2012 29‐01‐2019 MILD, FOAMING LIQUID CLEANSERS COMPRISING LOW LEVELS OF
FATTY ISETHIONATE PRODUCT AND LOW TOTAL FATTY ACID
AND/OR FATTY ACID SOAP CONTENT
306489
945/MUM/2009 29‐01‐2019 A NOVEL CREAM AND A PROCESS TO MAKE THE SAME 306407
1230/CHE/2011 29‐01‐2019 SOLID FORMS OF ANTIRETROVIRAL COMPOUNDS, PROCESS FOR
THE PREPARATION AND THEIR PHARMACEUTICAL COMPOSITION
THEREOF
306459
5367/CHENP/2012 29‐01‐2019 INDOLE COMPOUND AND PHARMACEUTICAL USE THEREOF 306479
4797/DELNP/2015 30‐01‐2019 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND
BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY
306529
7922/DELNP/2012 30‐01‐2019 PHARMACEUTICAL COMPRISING MYRAMISTIN 306539
Page 67 of 85
5046/DELNP/2013 30‐01‐2019 BROMODOMAIN INHIBITORS AND USES THEREOF 306551
9269/DELNP/2012 30‐01‐2019 HIGH PURITY SOLUBLE THROMBOMODULIN AND METHOD FOR
PRODUCING SAME
306554
4605/KOLNP/2011 30‐01‐2019 LXR MODULATORS 306583
11/CHENP/2011 31‐01‐2019 AMINO ACID SEQUENCES DIRECTED AGAINST ENVELOPE PROTEINS
OF A VIRUS AND POLYPEPTIDES COMPRISING THE SAME FOR THE
TREATMENT OF VIRAL DISEASES
306585
3219/CHENP/2011 31‐01‐2019 MODULATION OF FACTOR 11 EXPRESSION 306586
4441/DELNP/2011 31‐01‐2019 "ANTI‐IGF ANTIBODIES" 306589
877/KOL/2012 31‐01‐2019 COMPOSITION FOR LOWERING BLOOD LIPID AND ELEVATING HIGH‐
DENSITY LIPOPROTEIN AND METHOD FOR MANUFACTURING THE
SAME
306593
2860/DELNP/2012 31‐01‐2019 "VACCINE AGAINST CHOLERA AND ENTEROTOXIGENIC E. COLI
(ETEC) DIARRHEA"
306613
7487/DELNP/2012 31‐01‐2019 LIVE VACCINE FOR AVIARY DISEASES 306614
7522/CHENP/2015 31‐01‐2019 AGENT CONTAINING LARGE QUANTITIES OF UV STABILIZERS 306619
1059/MUMNP/2013 31‐01‐2019 ANTIFUNGAL 5,6‐DIHYDRO‐4H‐PYRROLO[1,2‐A][1,4]‐
BENZODIAZEPINES AND 6H‐PYRROLO[1,2‐A][1,4]BENZODIAZEPINES
SUBSTITUTED WITH PHENYL DERIVATIVES
306639
2466/CHE/2013 31‐01‐2019 COMPOUND OF FORMULA I, PROCESS OF PREPARATION AND
APPLICATION IN SYNTHESIS OF PQQ THEREOF
306662
10558/DELNP/2013 01‐02‐2019 DIALYSIS PRECURSOR COMPOSITION 306700
668/MUMNP/2015 01‐02‐2019 COSMETIC COMPOSITION 306718
3898/DELNP/2015 01‐02‐2019 COSMETIC COMPOSITIONS AND METHODS FOR INHIBITING
MELANIN SYNTHESIS
306754
201617010759 04‐02‐2019 TOPICAL ANTI INFLAMMATORY PHARMACEUTICAL COMPOSITION
WITH ZILEUTON CREAM FORMULATION
306785
891/DEL/2008 04‐02‐2019 A RADIOACTIVE TRIMER COMPLEX FOR THE DETECTION OF
TUMORS
306804
2290/MUM/2012 05‐02‐2019 A NOVEL PHARMACEUTICAL COMPOSITION OF LINEZOLID. 312223
9905/DELNP/2011 05‐02‐2019 "DISULFIDE‐LINKED POLYETHYLENEGYLCOL/PEPTIDE CONJUGATES
FOR THE TRANSFECTION OF NUCLEIC ACIDS"
306837
2559/DEL/2011 05‐02‐2019 “STEP‐WISE FREEZE DRYING PROCESS FOR IMPROVING STABILITY
OF NANO‐DRUG
DELIVERY SYSTEMS”
306846
1452/KOL/2013 05‐02‐2019 A METHOD TO MEASURE THE RINSABILITY OF CLEANSING
FORMULATIONS
306850
2003/MUMNP/2015 06‐02‐2019 ORAL CARE COMPOSITIONS 306894
201647010113 06‐02‐2019 CYCLIC PEPTIDOMIMETIC COMPOUNDS AS IMMUNOMODULATORS 306909
281/MUM/2010 06‐02‐2019 A PHOTOSTABLE SUNSCREEN COMPOSITION 306917
4677/KOLNP/2011 06‐02‐2019 CHEWING GUM AND PARTICULATE MATERIAL FOR CONTROLLED
RELEASE OF ACTIVE INGREDIENTS
306942
201747047012 07‐02‐2019 SUBSTITUTED HETEROCYCLYL DERIVATIVES AS CDK INHIBITORS 306947
1189/CHENP/2015 07‐02‐2019 COMPOUNDS OF SPERMIDINE AND COMPOSITIONCOMPRISING
THE SAME FOR TREATING ALOPECIA
306967
2652/DEL/2012 07‐02‐2019 "PROCESS FOR THE SYNTHESIS OF ANTIPILEPTIC DRUG
LEVETIRACETAM"
306977
3334/MUM/2012 07‐02‐2019 "NOVEL POLYMORPHIC FORMS OF ALCAFTADINE" 306979
254/MUMNP/2013 07‐02‐2019 WATER IN OIL TYPE EMULSION COSMETIC 306998
6382/DELNP/2008 07‐02‐2019 "An antioxidant comprising DocosaHexaenoic Acid(DHA)" 307001
553/DEL/2009 07‐02‐2019 "PROCESS FOR PRODUCING RIZATRIPTAN OR ITS
PHARMACEUTICALLY ACCEPTABLE SALT"
307012
3050/DELNP/2011 07‐02‐2019 "COMBINATION OF A PHOSPHATIDYLINOSITOL‐3‐KINASE (PI3K)
INHIBITOR AND A MTOR INHIBITOR"
307019
2323/DELNP/2013 08‐02‐2019 CONCENTRATE FOR MEDICAL SOLUTIONS PRODUCTION THEREOF
AND USE THEREOF IN DIALYSIS
307028
Page 68 of 85
267/MUMNP/2013 08‐02‐2019 Process for the prepara on
of erlotinib base or a salt thereof
307036
6907/CHENP/2012 08‐02‐2019 INHIBITORS OF CATECHOL O‐METHYL TRANSFERASE AND THEIR USE
IN THE TREATMENT OF PSYCHOTIC DISORDERS
307049
2915/MUMNP/2012 08‐02‐2019 CYTOCHROME P450 INHIBITORS AND USES THEREOF 307052
6066/DELNP/2011 08‐02‐2019 "A COMPOSITION COMPRISING SILVER NANOPARTICLES AND
EXTRACTS OF POLYGONUM MULTIFLORUM THUNB AND THE USE
THEREOF
307055
8458/DELNP/2012 08‐02‐2019 “AN INTRAOCULAR IMPLANT COMPRISING A POLYMERIC LAYER
COVERING A CORE CONTAINING A STEROID, THE POLYMERIC
LAYER”
307060
5667/DELNP/2012 08‐02‐2019 6 SUBSTITUTED ESTRADIOL DERIVATIVES AND COMPOSITION
THEROF“
307065
1098/DEL/2012 08‐02‐2019 CONTROLLED RELEASE GABAPENTIN COMPOSITION AND PROCESS
OF PREPARATION THEREOF
307093
1262/MUM/2012 11‐02‐2019 "AN IMPROVED PROCESS FOR THE MANUFACTURING OF
ROFLUMILAST"
307162
3135/KOLNP/2007 12‐02‐2019 ANTIBODIES TO TGFBETA 307227
3375/DELNP/2013 12‐02‐2019 COMPOSITION FOR ENTERIC HARD CAPSULES AND ENTERIC HARD
CAPSULE PREPAREDUSING THE COMPOSITION
307255
4196/DELNP/2011 13‐02‐2019 "VESICLE PREPARATION" 307304
9723/DELNP/2012 13‐02‐2019 “NOVEL FORMULATIONS OF ACTIVE INGREDIENT(S) OF PLANT
ORIGIN OR SYNTHETIC ANALOGUES THEREOF OR OF EXTRACT(S) OF
PLANT ORIGIN CONTAINING SAME AND OF LECITHIN”
307311
3795/CHENP/2013 13‐02‐2019 Pyrrolopyrimidine Fused Piperazinone Compounds as CDK
Inhibitors
307331
1856/MUMNP/2013 13‐02‐2019 PYRROLOPYRIDINEAMINO DERIVATIVES AS MPS1 INHIBITORS 307348
1897/MUM/2010 14‐02‐2019 A SUSTAINED RELEASE COMPOSITION HAVING THERAPEUTIC
ACTIVITY AGAINST INTERSTITIAL CYSTITIS
307378
583/MUMNP/2014 14‐02‐2019 COMPOSITIONS COMPRISING SALBUTAMOL SULPHATE 307393
6472/DELNP/2009 14‐02‐2019 PHARMACEUTICAL CYCLOSPORIN COMPOSITIONS 307422
2747/CHE/2012 14‐02‐2019 "NANOPARTICLE COMPOSITIONS OF ANTIBACTERIAL COMPOUNDS
AND OTHER USES THEREOF"
307423
5980/DELNP/2013 15‐02‐2019 SOLID MOLECULAR DISPERSION 307450
6771/CHENP/2014 15‐02‐2019 GUERBET ALCOHOLS AS VASELINE SUBSTITUTE 307455
2789/KOLNP/2014 16/02/2019 PYRROLOTRIAZINONE DERIVATIVES 307495
3370/DELNP/2014 18‐02‐2019 APPARATUS AND METHOD FOR PRODUCING CONTROLLED DOSAGE
OF BIOACTIVE AGENT
307520
6441/DELNP/2013 18‐02‐2019 COSMETIC COMPOSITION COMPRISING SILICA AEROGELS
PARTICLES AND HYDROCARBON BASED OILS
307539
1504/MUMNP/2015 18‐02‐2019 PHARMACEUTICAL FORMULATION OF N‐ [5 ‐ [2‐ (3, 5
DIMETHOXYPHENYL) ETHYL]‐ 2H‐ PYRAZOL‐ 3‐ YL]‐ 4‐ [(3R, 5S) 3, 5
DIMETHYLPIPERAZIN‐ 1‐ YL] BENZAMIDE
307540
1103/MUM/2012 18‐02‐2019 ORAL PATCHES FOR APHTHOUS ULCER 307541
1483/MUMNP/2015 18‐02‐2019 (THIENO[2, 3 b][1, 5]BENZOXAZEPIN ‐4‐ YL)PIPERAZIN‐ 1‐ YL
COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5 HT2A
ANTAGONISTS
307561
3246/DEL/2011 19/02/2019 “NOVEL LAYERSOME COMPOSITION FOR ORAL DELIVERY OF ANTI
CANCER AGENTS”
307621
4021/KOLNP/2012 19‐02‐2019 FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL
MODULATORS
307592
833/DELNP/2015 19‐02‐2019 PROCESS FOR THE PREPARATION OF PEMETREXED AND LYSIN SALT
THEREOF
307594
1209/MUMNP/2012 19‐02‐2019 CARBOXYVINYL POLYMER‐CONTAINING NANOPARTICLE
SUSPENSION
307619
9291/DELNP/2012 19‐02‐2019 ORALLY DISITEGRATING TABLET CONTAINING ACARBOSE 307654
1084/CHE/2010 20‐02‐2019 NOVEL PROCESS FOR THE PREPARATION OF SITAGLIPTIN AND ITS
PHARMACEUTICALLY ACCEPTABLE SALTS
307699
4027/KOLNP/2012 20‐02‐2019 C5AR ANTAGONISTS 307706
Page 69 of 85
6347/DELNP/2014 20‐02‐2019 COMPOSITION AND ASSOCIATION OF SUNSCREENS FOR
PHOTOSTABILIZING BUTYL METHOXYDIBENZOYLMETHANE
(BMDBM)
307723
3279/MUM/2011 21/02/2019 EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS 307799
4847/DELNP/2014 21‐02‐2019 CELLULOSE ETHERS WITH IMPROVED THERMAL GEL STRENGTH 307743
2099/MUM/2012 21‐02‐2019 "A process for preparing 2‐(SUBSTITUTED‐ARYL)‐3‐(2‐OXOINDOLIN‐
3‐YLIDENE)AMINO)‐THIAZOLIDIN ‐4‐ONE COMPOUNDS
307750
2953/MUM/2011 21‐02‐2019 AN IMPROVED PROCESS FOR THE PREPARATION OF
PROMETHAZINE HYDROCHLORIDE.
307758
2595/KOLNP/2013 21‐02‐2019 PYRIDINYL ‐ AND PYRAZINYL ‐ METHYLOXY ‐ ARYL DERIVATIVES
USEFUL AS INHIBITORS OF SPLEEN TYROSINE KINASE (SYK)
307781
3301/CHENP/2011 21‐02‐2019 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF
TRANSTHYRETIN
307782
7839/CHENP/2012 21‐02‐2019 CGRP RECEPTOR ANTAGONIST 307814
211/KOLNP/2013 22/02/2019 CIS‐TETRAHYDRO‐SPIRO(CYCLOHEXANE‐1,1' ‐PYRIDO[3,4‐B]INDOLE)‐
4‐AMINE DERIVATIVES
307840
2582/KOLNP/2011 22/02/2019 ANTI‐FXI ANTIBODIES AND METHODS OF USE 307903
10426/CHENP/2012 22‐02‐2019 “GLUCAGON LIKE PEPTIDE ANALOGS” 307830
10888/CHENP/2012 22‐02‐2019 STABLE ANTISEPTIC COMPOSITIONS AND METHODS 307849
876/KOL/2012 22‐02‐2019 SYNERGISTIC BLEND FOR ENHANCING ANTIFUNGAL ACTIVITY AND
SOLUBILIZING ZPTO IN PERSONAL CARE FORMULATIONS
307872
3589/DEL/2011 22‐02‐2019 "SYSTEM AND METHOD OF PROVIDING COMPLIANCE AND
ALERTING OF TOXIC GAS EXPOSURE FOR HEALTH MONITORING
AND PLANT MAINTENANCE"
307881
2463/CHENP/2014 25/02/2019 PYRAZOLOQUINOLINE DERIVATIVE 307941
2153/CHE/2012 25‐02‐2019 STABILIZED PHARMACEUTICAL COMPOSITIONS OF SAXAGLIPTIN 307927
1530/MUMNP/2010 25‐02‐2019 STABILIZED FACTOR IX FORMULATIONS CONTAINING TREHALOSE 307954
7857/CHENP/2013 25‐02‐2019 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS 307977
7331/CHENP/2012 25‐02‐2019 RECOMBINANT ATTENUATED PARVOVIRUS 307980
1424/CHENP/2011 25‐02‐2019 AGENT FOR TREATING MYELOFIBROSIS 307999
7868/CHENP/2013 25‐02‐2019 MACROCYCLIC COMPOUND AND METHODS FOR ITS PRODUCTION 308000
3358/CHENP/2011 25‐02‐2019 “RAB6KIFL/KIF20A EPITOPE PEPTIDE AND VACCINES CONTAINING
THE SAME"
308012
1065/MUMNP/2014 25‐02‐2019 SKIN ANTI AGEING COMPOSITION 308023
4169/CHENP/2012 26/02/2019 PHARMACEUTICAL COMPOSITION COMPRISING A GLP‐1 AGONIST,
AN INSULIN AND METHIONINE
308054
145/MUMNP/2014 26‐02‐2019 COMPLEX ZINC AND ALPHA CHLOROCARBOXYLIC ACID
COMPOUNDS FOR TREATING SKIN LESIONS
308037
8435/DELNP/2013 26‐02‐2019 PROCESS OF SEPARATING CHIRAL ISOMERS OF CHROMAN
COMPOUNDS AND THEIR DERIVATIVES AND PRECURSORS
308050
4920/CHE/2012 26‐02‐2019 GARLIC FORMULATION AND A PROCESS FOR PREPARING THE SAME
FOR TREATMENT OF DIABETES
308057
9063/CHENP/2013 26‐02‐2019 A TOPICAL FORMULATION FOR TREATMENT OF HYPERKERATOTIC
SKIN
308061
7955/CHENP/2013 26‐02‐2019 ALKYNE SUBSTITUTED QUINAZOLINE COMPOUND 308063
37/MUM/2010 26‐02‐2019 "A PROCESS FOR THE PREPARATION OF DIHYDROPYRIDINE
COMPOUNDS"
308103
6524/CHENP/2013 26‐02‐2019 Compositions of mTOR inhibitors and JAK inhibitors 308113
270/DEL/2011 26‐02‐2019 BENZOTHIAZOLE HYBRIDS USEFUL AS POTENTIAL ANTICANCER
AGENTS AND PROCESS FOR THE PREPARATION THEREOF
308121
8036/CHENP/2014 26‐02‐2019 FUNCTIONALIZED THIENO INDOLE DERIVATIVES FOR THE
TREATMENT OF CANCER
308148
3154/DELNP/2012 27/02/2019 "MONOCLONAL ANTIBODIES" 308160
2439/CHE/2009 27/02/2019 NOVEL MODULATORS OF CALCIUM RELEASE‐ACTIVATED CALCIUM
CHANNEL
308182
Page 70 of 85
8692/DELNP/2011 27‐02‐2019 "MODIFIED COMPSTATIN WITH PEPTIDE BACKBONE AND C‐
TERMINAL MODIFICATIONS"
308168
711/CHENP/2014 27‐02‐2019 OXAZETIDINE BASED COMPOUNDS OF FORMULA (I) AND
COMPOSITIONS THEREOF
308173
9759/CHENP/2012 27‐02‐2019 PROCESS FOR PREPARATION OF DARUNAVIR 308174
312/MUMNP/2012 28/02/2019 METHOD FOR MAKING 3a‐HYDROXY; 3ß‐ METHYL‐5a‐PREGNAN‐2O‐
ONE (GANAXOLONE)
308304
3182/DEL/2010 28/02/2019 A NOVEL METHOD FOR SIMULTANEOUS QUANTIFICATION OF
AMLODIPINE BESYLATE AND TELMISARTAN IN TABLET
308356
2777/KOLNP/2012 28‐02‐2019 PROCESS FOR PREPARING CARBAMOYLPYRIDONE DERIVATIVES
AND INTERMEDIATES
308276
5925/DELNP/2013 28‐02‐2019 AZOLE PHARMACEUTICAL FORMULATIONS FOR PARENTERAL
ADMINISTRATION AND METHODS FOR PREPARING AND USING THE
SAME AS TREATMENT OF DISEASES SENSITIVE TO AZOLE
COMPOUNDS
308297
3321/MUM/2010 28‐02‐2019 AN ANTIMICROBIAL MOUTHWASH COMPOSITION 308317
6186/CHE/2013 28‐02‐2019 N‐ METHYLPYRROLIDININE HYDROPEROXIDE AS AN EFFICIENT
EPOXIDATIN REAGENT
308318
4616/CHE/2011 28‐02‐2019 MULTIPARTICULATE PHARMACEUTICAL COMPOSITIONS
COMPRISING ORLISTAT
308333
201641042604 28‐02‐2019 IMPROVED PROCESS FOR THE PREPARATION OF ARIPIPRAZOLE
LAUROXIL
308361
1565/DELNP/2013 28‐02‐2019 ANTIBODIES TO MATRIX METALLOPROTEINASE 9 308368
548/DELNP/2015 01‐03‐2019 ATX MODULATING AGENTS 305315
8884/DELNP/2011 01‐03‐2019 "A COMPOSITION COMPRISING RADIOPHAMACEUTICAL
COMPOUNDS"
308393
10530/DELNP/2013 01‐03‐2019 DEUTERATED 1 PIPERAZINO 3 PHENYL INDANES FOR TREATMENT
OF SCHIZOPHRENIA
308420
5670/DELNP/2011 01‐03‐2019 "PRODUCT FOR PREVENTING OR TREATING HAIR GREYING" 308441
502/CHENP/2011 01‐03‐2019 SOLUBLE HYBRID FCY RECEPTORS AND RELATED METHODS 308450
264/CHENP/2014 04‐03‐2019 SELECTIVE GLYCOSIDASE INHIBITORS 310774
2861/KOLNP/2012 04‐03‐2019 SOLID COMPOSITIONS 308476
1789/KOLNP/2013 04‐03‐2019 COMPOUNDS USEFUL FOR TREATING AIDS 308479
3783/MUM/2014 05‐03‐2019 COMBINATORIAL THERAPEUTIC REGIMEN OF ANTIDIABETIC WITH
ANTIHYPERTENSIVE DRUGS
312245
10344/DELNP/2014 05‐03‐2019 FERMENTED INFANT FORMULA WITH NON DIGESTIBLE
OLIGOSACCHARIDES
308513
862/MUMNP/2014 05‐03‐2019 PURINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS 308523
2049/DEL/2013 05‐03‐2019 A TOPICAL EYE FORMULATION FOR DRY EYE DISEASE DISORDER. 308532
3655/DELNP/2014 05‐03‐2019 SKIN LIGHTENING FORMULATIONS 308545
2387/MUMNP/2013 05‐03‐2019 1,3‐DI‐OXO‐INDENE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE
SALT OR OPTICAL ISOMER THEREOF, PREPARATION METHOD
THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING
SAME AS AN ANTIVIRAL ACTIVE INGREDIENT
308571
1951/DELNP/2014 05‐03‐2019 NEW DIHYDROQUINOLINE 2 ONE DERIVATIVES 308577
2515/MUMNP/2012 05‐03‐2019 METHODS AND LIPID COMPOSITIONS FOR PROMOTING
DEVELOPMENT OF GUT FLORA
308585
672/KOLNP/2014 05‐03‐2019 DERIVATIVES OF 1‐PHENYL‐2‐PYRIDINYL ALKYL ALCOHOLS AS
PHOSPHODIESTERASE INHIBITORS
308589
5277/DELNP/2014 05‐03‐2019 “PEPTIDE APTAMERS THAT BIND TO THE REP PROTEINS OF SSDNA
VIRUSES”
308597
8466/CHENP/2010 06‐03‐2019 “INORGANIC NANOPARTICLES OF HIGH DENSITY TO DESTROY CELLS
IN‐VIVO”
308636
201647004315 06‐03‐2019 QUININE COMPOUNDS AND PREPARATION METHOD THEREOF 308649
8004/DELNP/2009 06‐03‐2019 A NOVEL COMPOUND OF FORMULA 1 308650
301/KOL/2015 06‐03‐2019 A COMPOSITION COMPRISING AVOBENZONE AND LEUCAS ASPERA
EXTRACT AND USES THEREOF
308656
Page 71 of 85
3451/CHE/2010 06‐03‐2019 “PREPARATION OF FIBRIN NANOCONSTRUCTS FOR TISSUE
ENGINEERING AND DRUG DELIVERY APPLICATIONS”
308660
775/DELNP/2015 06‐03‐2019 “COMPOUNDS FOR INHIBITING NHE‐MEDIATED ANTIPORT” 308667
3947/DELNP/2015 06‐03‐2019 METHOD FOR PREPARING AN AQUEOUS STABLE PHARMACEUTICAL
COMPOSITION
308670
7867/CHENP/2014 06‐03‐2019 CAPSULE DISINTEGRABLE IN LARGE INTESTINE SPECIFIC MANNER 308674
2525/KOLNP/2014 06‐03‐2019 COMPOSITIONS AND METHODS FOR INHIBITING VIRAL
POLYMERASE
308689
4635/KOLNP/2011 07‐03‐2019 A TOPICAL COMPOSITION 315503
48/DELNP/2014 07‐03‐2019 PHOTOPROTECTIVE COMPOSITION 308815
9234/DELNP/2014 07‐03‐2019 COMPLEX COMPOUNDS OF GERMANIUM, METHODS FOR
PRODUCING SAME , AND DRUGS
308722
182/KOLNP/2014 07‐03‐2019 TAMPER‐RESISTANT TABLET PROVIDING IMMEDIATE DRUG
RELEASE
308730
3227/KOLNP/2013 07‐03‐2019 NOVEL PYRAZOLE DERIVATIVE 308761
1828/MUMNP/2011 07‐03‐2019 STABLE PHARMACEUTICAL COMPOSITIONS OF DICLOFENAC 308764
4311/DELNP/2015 07‐03‐2019 NOVEL ROCK INHIBITORS 308778
5017/CHENP/2012 07‐03‐2019 METHOD OF PROCESSING ACTIVE INGREDIENT FOR INHALATION 308790
7963/CHENP/2011 07‐03‐2019 PROCESS TO FORM AN ORALLY DISINTEGRATING TABLET FOR
HUMAN USE
308819
6279/DELNP/2014 08‐03‐2019 ORALLY DISINTEGRATING TABLET CONTAINING BITTERNESS
MASKING GRANULES
308832
1963/CHENP/2013 08‐03‐2019 GASTRIC RESISTANT PHARMACEUTICAL OR NUTRACEUTICAL
FORMULATION COMPRISING ONE OR MORE SALTS OF ALGINIC
ACID
308833
2153/DELNP/2013 08‐03‐2019 N HETEROARYL COMPOUNDS 308875
2499/KOLNP/2011 08‐03‐2019 PYRAZINE DERIVATIVES USEFUL AS INHIBITORS OF ATR KINASE 308876
2052/MUMNP/2012 08‐03‐2019 STABLE ORAL CARE COMPOSITIONS 308897
3280/KOLNP/2009 09‐‐03‐2019 “ATROPISOMER OF PYRROLE DERIVATIVE” 308904
1308/KOLNP/2013 09‐03‐2019 BENZIMIDAZOLE DERIVATIVES AS PI3 KINASE INHIBITORS 308903
2222/MUMNP/2012 11‐03‐2019 TUBERCULOSIS DRUG COMPOSITION BASED ON 4 ‐THIOUREIDO ‐
IMINOMETHYLPYRIDINIUM PERCHLORATE
309007
3620/CHE/2012 11‐03‐2019 A PROCESS FOR EXTRACTION OF BIO‐ACTIVE COMPOUNDS
EXHIBITING ANTICANCER PROPERTY FROM LENTINUS
TUBERREGIUM
308951
9556/DELNP/2011 11‐03‐2019 Compositions comprising essential oil of Chinese cinnamon and
cinnamon bark
308921
540/MUMNP/2014 11‐03‐2019 PYRROLOBENZODIAZEPINES 308922
8940/CHENP/2013 11‐03‐2019 COATING COMPOSITION SUITABLE FOR PHARMACEUTICAL OR
NUTRACEUTICAL DOSAGE FORMS
308942
10130/DELNP/2015 11‐03‐2019 NOVEL FLUORINATED BENZILIC ACID ESTER COMPOUND, AND SALT
THEREOF
308949
1266/MUMNP/2013 11‐03‐2019 METHOD FOR PREPARING CRYSTALLINE FORM OF ERTAPENEM
SODIUM
308952
1574/MUMNP/2013 11‐03‐2019 SUBSTITUTED MORPHOLINES AS MODULATORS FOR THE CALCIUM
SENSING RECEPTOR
308969
417/CHE/2010 12‐03‐2019 CONTROLLED RELEASE DOSAGE FORM WITH IMPROVED
BIOAVAILABILITY
309060
2157/MUM/2011 12‐03‐2019 PHARMACEUTICAL COMPOSITIONS COMPRISING BETA‐LACTAM
ANTIBIOTIC, SULBACTAM AND BETA‐LACTAMASE INHIBITOR
309017
2740/MUM/2011 12‐03‐2019 A process for preparing S‐(‐)‐9‐fluoro‐6,7‐dihydro‐8‐(4‐
hydroxypiperidin1‐yl)‐5‐methyl‐1‐oxo‐1H,‐5H‐benzo[i,j]quinolizine‐
2‐carboxylic acid L‐arginine salt tetrahydrate
309023
2514/MUMNP/2012 12‐03‐2019 TEMPLATED ISLET CELLS AND SMALL ISLET CELL CLUSTERS FOR
DIABETES TREATMENT
309047
201721028736 12‐03‐2019 DIRECT COMPRESSIBLE DUAL DRUG RELEASING PHARMACEUTICAL
COMPOSITION
309051
Page 72 of 85
1575/MUM/2015 12‐03‐2019 A METHOD AND A SYSTEM FOR PRODUCING THERMOLABILE
NANOPARTICLES WITH CONTROLLED PROPERTIES AND
NANOPARTICLES MATRICES MADE THEREBY
309059
3942/DELNP/2015 13/03/2019 RINSE OFF SKIN CARE COMPOSITIONS CONTAINING CELLULOSIC
MATERIALS
309095
3296/MUM/2013 13‐03‐2019 A PROCESS FOR THE PREPARATION OF BENZAZEPINE DERIVATIVE 309124
6364/CHENP/2011 13‐03‐2019 A PROCESS FOR PRODUCING AN INJECTABLE COMPOSITION 309139
7094/CHENP/2013 13‐03‐2019 NITROGEN‐CONTAINING SATURATED HETEROCYCLIC COMPOUND 309148
2486/DELNP/2012 13‐03‐2019 COMPOSITION HAVING LIPOLYSIS‐PROMOTING EFFECT 309156
2393/MUMNP/2014 14‐03‐2019 NOVEL PYRIMIDINYL‐DIAZOSPIRO COMPOUNDS 309171
7153/CHENP/2011 14‐03‐2019 PHARMACEUTICAL COMPOSITION OF AN ANTIGENIC TAU PEPTIDE
RECONSTITUTED IN A LIPOSOME.
309199
3215/KOLNP/2012 14‐03‐2019 ARGININE / PHENYLALANINE PEPTIDES 309223
8862/DELNP/2014 14‐03‐2019 IMMORTALIZED STEM CELLS AND MEDICINAL COMPOSITION AND
MEDICINAL PREPARATION COMPRISING PRODUCT THEREOF AS
ACTIVE INGREDIENT
309229
7190/DELNP/2012 14‐03‐2019 ANAESTHETIC FORMULATION 309244
707/MUMNP/2015 15‐03‐2019 AGGRECANASE INHIBITORS 309279
3389/KOLNP/2012 16/03/2019 IRE‐1a‐INHIBITORS 309316
2492/MUMNP/2012 16‐03‐2019 “LOW‐OIL PHARMACEUTICAL EMULSION COMPOSITIONS
COMPRISING PROGESTOGEN”
309318
1230/CHE/2013 16‐03‐2019 SITAGLIPTIN PTEROSTILBENE PHOSPHATE SALT, PROCESS FOR THE
PREPARATION AND PHARMACEUTICAL COMPOSITION THEREOF
309319
1025/MUM/2009 18‐03‐2019 A NOVEL CREAM AND A PROCESS TO MAKE THE SAME 309330
201617021294 18‐03‐2019 NOVEL TETRAHYDROPYRIDOPYRIMIDINE COMPOUND OR SALT
THEREOF
309366
511/MUMNP/2011 18‐03‐2019 “FUSED, SPIROCYCLIC HETEROAROMATIC COMPOUNDS FOR THE
TREATMENT OF BACTERIAL INFECTIONS”
309375
409/MUMNP/2013 18‐03‐2019 PROCESS OF MANUFACTURING A STABLE SOFTGEL CAPSULE
CONTAINING MICROENCAPSULATED PROBIOTIC BACTERIA
309400
4972/CHENP/2015 19/03/2019 ANHYDROUS COSMETIC OR DERMATOLOGICAL COMPOSITION
COMPRISING A MEROCYANINE AND AN OILY PHASE
309481
2583/KOLNP/2011 19‐03‐2019 ANTIBODIES TO IL‐6 AND USE THEREOF 309445
4169/KOLNP/2009 19‐03‐2019 “BORDETELLA PARAPERTUSSIS‐CONTAINING WHOLE‐CELL VACCINE
COMPOSITION”
309464
1237/MUM/2012 19‐03‐2019 "AN IMPROVED PROCESS FOR BENDAMUSTINE HYDROCHLORIDE" 309487
3307/KOLNP/2011 19‐03‐2019 BENZOIC ACID (1‐PHENYL‐2‐PYRIDIN‐4‐YL) ETHYL ESTERS AS
PHOSPHODIESTERASE INHIBITORS
309498
6144/CHENP/2013 20/03/2019 PHARMACEUTICAL COMPOSITION COMPRISING PYRIDONE
DERIVATIVES
309529
3063/MUM/2011 20‐03‐2019 A process for preparing antifungal compound 309532
4/MUMNP/2012 20‐03‐2019 FORMULATIONS FOR THE TREATMENT OF DEEP TISSUE PAIN 309536
572/MUM/2009 20‐03‐2019 GRANULAR ASSEMBLIES OF HYDROXYL PROPYL METHYL CELLULOSE
AND PROCESS OF PREPARING THE SAME
309550
126/CHENP/2014 20‐03‐2019 METHODS FOR THE SYNTHESIS AND PURIFICATION OF
DEOXYCHOLIC ACID
309562
271/CHENP/2013 21‐03‐2019 ANTI ANGIOGENIC AGENT AND METHOD OF USING SUCH AGENT 309605
1232/DELNP/2014 21‐03‐2019 NEW BICYCLIC DIHYDROQUINOLINE 2 ONE DERIVATIVES 309623
1761/MUMNP/2015 22‐03‐2019 SKIN CARE FORMULATIONS 309629
2304/CHENP/2015 22‐03‐2019 BIODEGRADABLE DRUG DELIVERY SYSTEMS FOR THE SUSTAINED
RELEASE OF PROTEINS
309632
732/CHENP/2013 22‐03‐2019 A composition for use in the therapeutic treatment of the skin of a
mammal
309638
2911/MUM/2009 22‐03‐2019 VACCINE COMPOSITION 309639
445/MUM/2011 22‐03‐2019 "ORAL COMPOSITIONS" 309649
Page 73 of 85
5575/CHENP/2010 22‐03‐2019 METHOTREXATE ADJUVANTS TO REDUCE TOXICITY AND METHODS
FOR USING THE SAME
309673
2965/DEL/2012 22‐03‐2019 A NOVEL SYNERGISTIC HERBAL FORMULATION OF WITHANIA
SOMNIFERA FOR ANTIHYPERLIPIDEMIC AND ANTIOBESITY ACTIVITY
309685
2430/MUMNP/2012 25/03/2019 HAIR CARE COMPOSITION 309853
4721/CHENP/2013 25/03/2019 USE OF LIQUID MEDIUM EXCHANGE BY CROSS FLOW FILTRATION IN
THE PREPARATION OF DRUG SUSPENSIONS
309796
8739/DELNP/2011 25‐03‐2019 COMPOSITION FOR PREVENTING HAIR LOSS OR FOR STIMULATING
HAIR GROWTH
309756
2098/DELNP/2012 25‐03‐2019 ANIONIC‐CORE COMPOSITION FOR DELIVERY OF THERAPEUTIC
AGENTS; AND METHODS OF MAKING AND USING THE SAME
309765
3671/CHENP/2011 25‐03‐2019 MONO‐AND DI‐PEG IL‐10 PRODUCTION; AND USES 309772
9069/CHENP/2013 25‐03‐2019 SUBSTITUTED PYRIMIDINYL PYRROLES ACTIVE AS KINASE
INHIBITORS
309812
2361/CHENP/2014 25‐03‐2019 SOLID COSMETIC COMPOSITION IN COMPACT POWDER FORM 309830
1700/KOLNP/2012 25‐03‐2019 COMPOSITIONS COMPRISING ANDROGRAPHIS PANICULATA AND
GINKGO BILOBA EXTRACTS COMPLEXED WITH PHOSPHOLIPIDS
309835
2332/CHENP/2011 25‐03‐2019 TARGETING CONSTRUCT COMPRISING ANTI‐POLYMER ANTIBODY
AND LIPOSOMES OR MICROVESICLES BINDING TO THE SAME
309838
1841/MUM/2011 25‐03‐2019 FORMULATION DEVELOPMENT AND EVALUATION OF FLOATING
MICROBALLOONS FOR ORAL CONTROLLED DELIVERY OF
DOMPERIDONE
309848
1214/CHENP/2015 25‐03‐2019 CHLORHEXIDINE GLUCONATE SOLUBILIZED IN A HYDROPHOBIC
MONOACYLGLYCERIDE
309860
2342/CHE/2010 25‐03‐2019 TIME AND PH DEPENDENT COLON SPECIFIC SUSTAINED RELEASE
PHARMACEUTICAL COMPOSITION FOR ONCE‐A‐DAY THERAPY FOR
THE TREATMENT OF RHEUMATOID ARTHRITIS
309872
8827/CHENP/2014 25‐03‐2019 AN OIL‐IN‐WATER EMULSION‐TYPE COMPOSITION 309875
862/MUMNP/2013 25‐03‐2019 COMPOSITIONS OF ROTIGOTINE AND DERIVATIVES THEREOF 309882
1837/KOLNP/2012 25‐03‐2019 SUBSTITUTED N‐(1H‐INDAZOL‐4‐YL)IMIDAZO[1, 2‐A]PYRIDINE‐3‐
CARBOXAMIDE COMPOUNDS AS CFMS INHIBITORS
309894
2332/CHENP/2014 26/03/2019 PHENYL DERIVATIVE 309910
577/MUMNP/2012 26/03/2019 A MONOCLONAL ANTIBODY BINDS TO PROTEIN PBP2A FROM
METHICILLIN‐RESISTANT STAPHYLOCOCCUS AUREUS AND PBP5
FROM ENTEROCOCCI
310007
1625/DEL/2013 26‐03‐2019 METHOD FOR PREPARING COMPOSITE GRANULE COMPRISING LOW‐
SUBSTITUTED HYDROXYPROPYL CELLULOSE AND RAPID RELEASE
PREPARATION
309913
4885/DELNP/2011 26‐03‐2019 PHARMACEUTICAL COMPOUNDS 309953
226/MUMNP/2009 26‐03‐2019 “COMBINATIONS FOR ORAL COMPOSITIONS, THEIR PREPARATION
AND USE”
309963
3579/KOLNP/2013 26‐03‐2019 PROCESS FOR THE PREPARATION OF A CHIRAL COMPOUND 309968
1139/CHENP/2015 26‐03‐2019 AMINE SALT AND CRYSTALS THEREOF 309971
3773/MUM/2013 26‐03‐2019 "A COMPOSITION FOR PREPARATION OF VISCOELASTIC
CROSSLINKED HYALURONIC ACID, AND CROSSLINKED HYALURONIC
ACID OBTAINED BY USING THE SAME"
309981
2428/MUMNP/2013 26‐03‐2019 STABLE LIQUID FORMULATION OF ETANERCEPT 309986
3912/KOLNP/2012 26‐03‐2019 VACCINE AND METHODS TO REDUCE CAMPYLOBACTER INFECTION 309989
201617005421 26‐03‐2019 HETEROBICYCLOARYL RORC2 INHIBITORS AND METHODS OF USE
THEREOF
309994
10622/DELNP/2013 26‐03‐2019 FILM FORMING COMPOSITION AND USE THEREOF FOR TREATING
HERPES
310014
2607/CHENP/2011 27/03/2019 HUMAN ANTI‐PD‐1, PD‐L1, AND PD‐L2 ANTIBODIES AND USES
THEREFOR
310071
9836/CHENP/2012 27‐03‐2019 PROCESS FOR RALTEGRAVIR POTASSIUM FORM H1 310021
Page 74 of 85
159/MUM/2010 27‐03‐2019 METHOD FOR PREPARATION OF PITAVASTATIN AND ITS
PHARMACEUTICAL ACCEPTABLE SALTS THEREOF
310062
4199/KOLNP/2011 27‐03‐2019 ENZYME DELIVERY SYSTEMS AND METHODS OF PREPARATIONS
AND USE
310064
2392/DEL/2013 27‐03‐2019 NICOTINAMIDE‐HYDROCHLOROTHIAZIDE COCRYSTAL WITH
IMPROVED HYPERTENSIVE ACTIVITY
310067
6789/CHENP/2015 27‐03‐2019 2‐AMINOPYRIDO[4,3‐D]PYRIMIDIN‐5‐ONE DERIVATIVES AND THEIR
USE AS WEE‐1 INHIBITORS
310088
894/MUMNP/2013 27‐03‐2019 LEAVE ON NON SOLID SKIN CONDITIONING COMPOSITIONS
CONTAINING 12 [(12 HYDROXYOCTADECANOYL)OXY]
OCTADECANOIC ACID
310121
1773/MUM/2011 27‐03‐2019 NOVEL PLASMODIUM PROTEIN AS MALARIAL VACCINE AND DRUG
TARGET
310142
958/CHENP/2013 27‐03‐2019 BACKING HAVING THREE‐LAYER STRUCTURE AND AQUEOUS PATCH
USING THE BACKING
310146
5019/DELNP/2015 28/03/2019 NON‐ STAINING TOOTHPASTE 310198
424/KOL/2011 28/03/2019 NOVEL TARGETS FOR ANTI‐AGEING 310176
2086/CHE/2007 28‐03‐2019 A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF
PATHOLOGIES CAUSED BY THE GENERAL RESPONSE OF THE
IMMUNE SYSTEM
310174
7867/CHENP/2013 28‐03‐2019 ANTIMICROBIAL/ADJUVANT COMPOUNDS AND METHODS 310203
781/CHENP/2015 28‐03‐2019 ARYLETHYNYL PYRIMIDINES 310215
2626/KOLNP/2013 28‐03‐2019 COMPOSITIONS AND METHODS FOR SEPARATING,
CHARACTERIZING AND ADMINISTERING SOLUBLE
SELENOGLYCOPROTEINS
310228
1503/DELNP/2013 28‐03‐2019 NON LIPIDATED VARIANTS OF NEISSERIA MENINGITIDIS ORF2086
ANTIGENS
310236
5084/CHENP/2015 28‐03‐2019 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A
MEROCYANINE AN OILY PHASE AND A C1‐C4 MONOALKANOL
310251
7180/DELNP/2015 28‐03‐2019 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A
MEROCYANINE AND AN INSOLUBLE ORGANIC UV‐SCREENING
AGENT AND/OR AN INSOLUBLE INORGANIC UV‐SCREENING AGENT
310265
5217/DELNP/2013 28‐03‐2019 NOVEL BACTERIUM AND EXTRACTS OF SAID BACTERIUM AND THE
USE OF SAME IN DERMATOLOGY
310277
5798/CHENP/2013 28‐03‐2019 THIAZOLYLPHENYL BENZENESULFONAMIDO DERIVATIVES AS
KINASE INHIBITORS
310287
9711/DELNP/2013 28‐03‐2019 SODIUM HYPOCHLORITE BASED BODY WASH COMPOSITIONS 310305
201621042074 28‐03‐2019 APPARATUS FOR SYNTHESIS OF NANOPARTICLE SYSTEM FOR
DESALINATION AND METHOD THEREOF
310318
37/CHENP/2010 28‐03‐2019 IN SITU, LIQUID‐ACTIVATED FILM COATED TABLETS AND A PROCESS
FOR MAKING THE SAME
310329
1855/MUMNP/2010 28‐03‐2019 A COMPOSITION FOR DECREASING THE EXTRACELLULAR MATRIX‐
PRODUCING CELLS IN THE LUNGS
310345
7617/DELNP/2013 28‐03‐2019 CEFUROXIME SAFETY DELIVERY SYSTEM 310347
2661/MUMNP/2014 29/03/2019 THIENOPYRIDONE DERIVATIVES USEFUL AS ACTIVATORS OF AMPK 310499
5486/DELNP/2012 29/03/2019 TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING
RIVASTIGMINE OR DERIVATIVES THEREOF
310367
2760/DELNP/2015 29/03/2019 COMPOUNDS AND METHODS FOR PREVENTING , TREATING
AND/OR PROTECTING AGAINST SENSORY HAIR CELL DEATH
310488
201617011380 29‐03‐2019 PROCESS FOR MAKING PERSONAL CARE COMPOSITION USING
COMPACTED RHEOLOGY MODIFIERS
310356
7489/CHENP/2014 29‐03‐2019 GREEN CHEMISTRY SYNTHESIS OF THE MALARIA DRUG
AMODIAQUINE AND ANALOGS THEREOF
310371
2507/KOLNP/2012 29‐03‐2019 KETOPROFEN‐CONTAINING AQUEOUS ADHESIVE SKIN PATCH 310427
2560/DEL/2011 29‐03‐2019 “NANO‐DRUG DELIVERY FOR QUINAPYRAMINE SULPHATE” 310429
3677/DELNP/2013 29‐03‐2019 METHOD FOR PRODUCING AND USING A COPOLYMER OF SODIUM
CARBOXYMETHYL CELLULOSE AND GOSSYPOL
310432
Page 75 of 85
8927/DELNP/2011 29‐03‐2019 COMPOSITION CONTAINING SORBITAN MONOCAPRYLATE AND
ANTIMICROBIAL ACTIVE INGREDIENTS"
310446
2898/MUM/2009 29‐03‐2019 PEPTIDE 310477
7249/DELNP/2015 29‐03‐2019 LIPOSOME FORMULATION AND MANUFACTURE 310485
201617035178 29‐03‐2019 BISMUTH CONTAINING LIQUID PHARMACEUTICAL SUSPENSIONS 310498
6169/DELNP/2014 29‐03‐2019 FUSED TETRA OR PENTA CYCLIC
DIHYDRODIAZEPINOCARBAZOLONES AS PARP INHIBITORS
310500
5550/DELNP/2009 29‐03‐2019 "OLIGOMER‐OPIOID AGONIST CONJUGATES" 310508
1563/KOLNP/2014 29‐03‐2019 DRY POWDER FORMULATION COMPRISING A CORTICOSTERIOD
AND A BETA‐ADRENERGIC FOR ADMINISTRATION BY INHALATION
310528
698/KOLNP/2013 29‐03‐2019 SUBSTITUTED PYRAZOLO‐QUINAZOLINE DERIVATIVES KINASE
INHIBITORS
310569
4839/CHE/2012 30/03/2019 PHARMACEUTICAL COMPOSITION FOR THE PREPARATION OF
INFUSION SOLUTIONS OF ANTIMICROBIAL PREPARATIONS, ITS'
PRODUCTION PROCESS (VARIATIONS)
310575
4950/KOLNP/2011 30/03/2019 COMPOUNDS USEFUL FOR TREATING PREMATURE AGING AND IN
PARTICULAR PROGERIA
310608
2598/MUMNP/2014 30‐03‐2019 INHIBITORS OF HEPATITIS C VIRUS 310576
488/MUMNP/2014 30‐03‐2019 (THIENO[2 3 B][1 5]BENZOXAZEPIN 4 YL)PIPERAZIN 1 YL
COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5
HT<SB>2A</SB> ANTAGONISTS
310590
6658/DELNP/2011 30‐03‐2019 "ALKYLAMIDO COMPOUNDS AND USES THEREOF" 310600
1415/KOL/2009 30‐03‐2019 PROCESS FOR PREPARING PHARMACEUTICAL OPHTHALMIC
COMPOSITIONS
310609
2736/KOLNP/2013 30‐03‐2019 ISOXAZOLIDINE DERIVATIVES 310617
6670/DELNP/2013 31‐03‐2019 EMULSION POLYMERISATION METHOD 310626
382/MUMNP/2013 31‐03‐2019 COMPOSITE PARTICLE ACTIVE AND METHOD FOR MAKING THE
SAME
310628
9540/DELNP/2011 01‐04‐2019 "PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF
A BCL‐2 FAMILY INHIBITOR"
310647
10374/CHENP/2013 01‐04‐2019 ACID LABILE LIPOPHILIC PRODRUGS OF CANCER
CHEMOTHERAPEUTIC AGENTS
310673
6573/DELNP/2014 03‐04‐2019 PROCESS FOR OBTAINING A MODAFINIL BASED PHARMACEUTICAL
COMPOSITION RESULTING PHARMACEUTICAL COMPOSITION AND
USE THEREOF
310771
201647035515 03‐04‐2019 METHOD OF MANUFACTURING ENTERIC SOFT CAPSULE 310809
3640/DELNP/2015 04‐04‐2019 PYRIDINE DERIVATIVE 310832
10204/CHENP/2012 04‐04‐2019 PHARMACEUTICAL DOSAGE FORM COMPRISING ONE OR MORE
ANTIRETROVIRAL ACTIVE INGREDIENTS
310844
5302/DELNP/2014 04‐04‐2019 PURINONE DERIVATIVE HYDROCHLORIDE 310867
1368/DELNP/2013 04‐04‐2019 PROCESS FOR PRODUCING 1 TRIAZOLE 2 BUTANOL DERIVATIVES 310870
10408/DELNP/2013 05‐04‐2019 A SUSTAINED RELEASE COMPOSITION CONTAINING A
MELANOCORTIN RECEPTOR LIGAND AS THE ACTIVE INGREDIENT
310923
1158/MUMNP/2013 05‐04‐2019 BENZIMIDAZOLE RESPIRATORY SYNCYTIAL VIRUS INHIBITORS 310934
2366/CHENP/2013 08‐04‐2019 AMATOXIN CONJUGATES WITH IMPROVED LINKERS 310961
1988/MUM/2010 08‐04‐2019 PROCESS FOR PREPARATION OF CRYSTALLINE POLYMORPH OF
BROMFENAC SODIUM
310987
9403/DELNP/2012 09‐04‐2019 A solid support coupled to a multiplicity of substituents of the
formula 2
311001
958/MUM/2011 09‐04‐2019 A SUNCREEN COMPOSITION 311011
2008/CHENP/2012 09‐04‐2019 SUBLINGUAL AND BUCCAL FILM COMPOSITIONS 311041
10592/DELNP/2014 09‐04‐2019 NEW HYDROXYSAFFLOR YELLOW PHARMACEUTICAL SALTS 311046
204/DEL/2014 09‐04‐2019 A process for preparation medicated nano patch from nanofibre
and its composition
311049
929/MUMNP/2010 10‐04‐2019 A method of making a pharmaceutical composition 311058
Page 76 of 85
4646/CHE/2011 10‐04‐2019 " A COMPOSITION COMPRISING NANOSPHERE AND HISTONE
ACETYLTRANSFERASE (HAT) ACTIVATOR, PROCESSES AND
METHODS THEREOF "
311070
2229/DELNP/2013 10‐04‐2019 A COATED STENT CONTAINING DRUG AND POLYMER COATINGS 311099
775/MUMNP/2013 12‐04‐2019 PHARMACEUTICAL COMPOSITIONS COMPRISING NANO SIZE
DROPLETS OF SKIN WHITENING AGENTS
311181
8510/DELNP/2011 12‐04‐2019 DIALYSIS SOLUTION COMPRISING CREATINE COMPOUNDS 311186
10484/CHENP/2012 12‐04‐2019 LIQUID NASAL SPRAY CONTAINING LOW DOSE NALTREXONE 311195
8894/DELNP/2012 15‐04‐2019 MICRO PARTICLES FOR ORAL DELIVERY IN ANIMALS 311208
761/CHE/2013 15‐04‐2019 COMPOSITION OF A COPPER‐QUERCETIN NANO COMPLEX FOR
TREATING HUMAN PAPILLOMA VIRUS INFECTED CERVICAL CANCER
311217
5397/CHENP/2012 15‐04‐2019 METHOD OF TREATING ATRIAL FIBRILLATION 311225
6516/CHENP/2014 15‐04‐2019 CGRP RECEPTOR ANTAGONIST COMPOUNDS AND PROCESSES
FORMAKING THE SAME
311239
4024/CHENP/2012 16‐04‐2019 PHOTOPROTECTIVE COMPOSITIONS OF A 2‐ALKOXY‐4‐ALKYL
KETONE PHENOL BASED COMPOUND(S)
311255
2682/MUMNP/2012 16‐04‐2019 A Peptide and Composition Containing The Same Peptide and
TGFß1
311292
1461/MUMNP/2014 16‐04‐2019 HAIR COMPOSITION WITH IMPROVED RHEOLOGY 311308
2062/DELNP/2013 16‐04‐2019 QUINOLINE AND QUINOXALINE DERIVATIVES AS KINASE INHIBITORS 311315
2452/DEL/2010 22‐04‐2019 A PHYTO‐PHARMACEUTICAL PREPARATION FOR THE CONTROL OF
ACARICIDE RESISTANT TICK INFESTATIONS IN ANIMALS.
311377
3885/CHENP/2013 22‐04‐2019 USE OF SILANE AND SILOXANE BIS(BIPHENYL)TRIAZINE DERIVATIVES
AS UV ABSORBERS
311378
201621042076 22‐04‐2019 ANIONIC NANOPARTICLE SYSTEM FOR DESALINATION AND
METHOD THEREOF”
311379
864/DELNP/2011 22‐04‐2019 "FILM‐FORMING LIQUID FORMULATIONS FOR DRUG RELEASE TO
HAIR AND SCALP"
311380
4945/CHENP/2014 22‐04‐2019 SITAXSENTAN DERIVATIVE 311402
940/MUM/2008 22‐04‐2019 HOMEOPATHIC COMBINATION TREATMENT TO HEAL
NEUROLOGICAL DISORDERS
311417
585/KOLNP/2014 23‐04‐2019 AN ADHESIVE PATCH CONTAINING RIVASTIGMINE AND AN ALKYL
(METH) ACRYLATE ‐BASED COPOLYMER
311440
2753/MUMNP/2012 23‐04‐2019 “OPTIMIZED IN VIVO DELIVERY SYSTEM WITH ENDOSOMOLYTIC
AGENTS FOR NUCLEIC ACID CONJUGATES”
311443
3218/MUMNP/2015 23‐04‐2019 SUBSTITUTED INDOLE COMPOUNDS 311453
3530/CHENP/2011 23‐04‐2019 “COSMETIC METHOD FOR TREATING HUMAN PERSPIRATION USING
PARTICLES OF AN EXPANDED AMORPHOUS MINERAL MATERIAL;
COMPOSITIONS”
311458
4686/DELNP/2011 23‐04‐2019 A MICROENCAPSULATION PROCESS OF SERTOLI CELLS,
MICROCAPSULES OBTAINED AND THEIR USE FOR PREVENTION AND
CURE OF TYPE 1 DIABETES MELLITUS
311475
2219/CHENP/2014 24‐04‐2019 ORALLY DISINTEGRATING TABLET CONTAINING HYDROXYALKYL
CELLULOSE FINE PARTICLES
311512
1792/MUM/2011 24‐04‐2019 "NOVEL SUSTAINED‐RELEASE GASTRORETENTIVE DOSAGE FORM OF
ACICLOVIR"
311516
810/MUMNP/2014 24‐04‐2019 COSMETIC COMPOSITION 311527
22/MUM/2010 24‐04‐2019 A SYNERGISTIC COMPOSITION FOR IMPROVING MALE SUB‐
FERTILITY AND INFERTILITY.
311535
350/MUMNP/2014 24‐04‐2019 TOOTH REMINERALIZING DENTIFRICE 311536
1443/MUM/2014 24‐04‐2019 "METHOD FOR THE SIMPLIFIED PRODUCTION OF FASCIOLICIDE AND
DERIVATIVE THEREOF"
311538
1124/KOLNP/2015 24‐04‐2019 QUINAZOLINONE DERIVATIVES AS PARP INHIBITORS 311543
811/CHE/2012 24‐04‐2019 TENOFOVIR PHOSPHATE, PROCESSES FOR THE PREPARATION AND
PHARMACEUTICAL COMPOSITION THEREOF
311570
9662/CHENP/2013 24‐04‐2019 TOPICAL WASH COMPOSITION FOR USE IN ACNE PATIENTS 311577
3553/DELNP/2015 24‐04‐2019 NOVEL BENZAZEPINE DERIVATIVE AND PHARMACEUTICAL USE
THEREOF
311579
Page 77 of 85
495/DELNP/2014 24‐04‐2019 PHARMACEUTICAL COMPOSITION FOR TREATING PREMATURE
EJACULATION AND METHOD FOR TREATING PREMATURE
EJACULATION
311585
2298/MUM/2010 25‐04‐2019 CONTROLLED‐RELEASE FORMULATION COMPRISING HCG 311592
201617019192 25‐04‐2019 SERINE GLYCEROPHOSPHOLIPID PREPARATION AND METHOD FOR
TREATMENT OF SEIZURES
311605
1094/MUMNP/2013 25‐04‐2019 LEAVE ON NON‐SOLID SKIN CONDITIONING COMPOSITIONS
CONTAINING 12‐HYDROXYSTEARIC ACID AND ETHOXYLATED
HYDROGENATED CASTOR OIL
311623
9103/DELNP/2011 25‐04‐2019 "NITRILE DERIVATIVES AND THEIR PHARMACEUTICAL USE AND
COMPOSITIONS"
311629
962/KOLNP/2010 25‐04‐2019 ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING
THE SAME
311668
842/MUMNP/2014 26‐04‐2019 METHODS OF PREPARING ICOTINIB AND ICOTINIB HYDROCHLORIDE
AND INTERMEDIATES THEREOF
311673
41/CHENP/2013 26‐04‐2019 D2 ANTAGONISTS METHODS OF SYNTHESIS AND METHODS OF USE 311677
6436/CHENP/2013 26‐04‐2019 ORGANIC AMINE SALTS OF AZILSARTAN PREPARATION METHOD
AND USE THEREOF
311684
4379/CHENP/2012 26‐04‐2019 BIOSYNTHETIC SYSTEM THAT PRODUCES IMMUNOGENIC
POLYSACCHARIDES IN PROKARYOTIC CELLS
311691
8211/CHENP/2012 26‐04‐2019 NON‐NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS 311693
806/KOLNP/2014 26‐04‐2019 CRYSTALLINE MICROPARTICLES OF A BETA‐AGONIST COATED WITH
A FATTY ACID
311733
57/CHENP/2011 26‐04‐2019 CONDITIONED MEDIUM OF LIVER PROGENITOR CELLS 311737
1413/DELNP/2013 26‐04‐2019 HETEROCYCLIC COMPOUND AND USE THEREOF 311751
6266/DELNP/2014 29/04/2019 A DETECTING AGENT COMPOSITION AND METHOD FOR
PREPARATION THEREOF
311788
547/CHE/2012 29/04/2019 PROCESS TO PREPARE ERTAPENEM AND ITS SALTS 311872
4096/DELNP/2015 29‐04‐2019 FLOWABLE PEROXIDE CONTAINING ORAL CARE COMPOSITIONS 311768
921/DELNP/2014 29‐04‐2019 CONFORMABLE PERSONAL CARE ARTICLES 311786
7666/CHENP/2011 29‐04‐2019 COMBINATION THERAPY 311800
2738/CHENP/2013 29‐04‐2019 MELT EXTRUDED SOLID DISPERSIONS CONTAINING AN APOPTOSIS
INDUCING AGENT
311802
1860/MUM/2011 29‐04‐2019 "IMPROVED ONE POT PROCESS FOR SYNTHESIS OF BUSPIRONE
BASE"
311837
6751/CHENP/2009 29‐04‐2019 “UNACYLATED GHRELIN AS THERAPEUTIC AGENT IN THE
TREATMENT OF METABOLIC DISORDERS”
311846
1464/MUMNP/2014 29‐04‐2019 WATER IN OIL TYPE EMULSION SKIN COSMETIC 311847
10303/CHENP/2013 29‐04‐2019 PHARMACEUTICAL COMPOSITION FOR TREATING SCARS ON THE
SKIN AND METHOD FOR TREATING SCARS ON THE SKIN USING
SAME
311850
3236/DELNP/2011 29‐04‐2019 "METHOD FOR PRODUCTION OF PH STABLE ENVELOPED VIRUSES" 311853
9421/DELNP/2008 29‐04‐2019 "RADIOLABELED DIHYDROTETRABENAZINE DERIVATIVES AND THEIR
USE AS IMAGING AGENTS"
311892
4774/DELNP/2013 30/04/2019 2 PIPERAZIN 1 YL 4H 1 3 BENZOTHIAZIN 4 ONE DERIVATIVES AND
THEIR USE FOR THE TREATMENT OF MAMMALIAN INFECTIONS
311965
3698/MUM/2012 30‐04‐2019 DISSOLVE 100% PURE OXYGEN GAS IN TO WATER FOR INJENCTION
IP WHICH BASE OF INFUSION SALINE AND DONATED BLOOD.
311914
751/DELNP/2014 30‐04‐2019 NOVEL BENZOIC ACID AMIDE COMPOUND 311917
5632/CHENP/2015 30‐04‐2019 SPHINGOSINE‐1‐PHOSPHATE RECEPTOR AGONISTS, METHODS OF
PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME AS AN ACTIVE AGENT
311950
5751/DELNP/2015 30‐04‐2019 POLYMYXINS , COMPOSITIONS AND METHODS OF USE 311955
267/MUMNP/2012 30‐04‐2019 "BISPHOSPHONATE‐PRODRUGS" 311958
6705/CHENP/2014 30‐04‐2019 MULTICOMPONENT ORAL CARE COMPOSITION 311961
Page 78 of 85
1614/KOLNP/2013 30‐04‐2019 HETEROCYCLIC DERIVATES, PREPARATION PROCESSES AND
MEDICAL USES THEREOF
311963
4450/CHENP/2011 30‐04‐2019 VIRUS LIKE PARTICLE COMPOSITIONS AND METHODS OF USE 311964
3062/KOLNP/2013 30‐04‐2019 NOVEL GOLD‐PLATINUM BASED BI‐METALLIC NANOCRYSTAL
SUSPENSIONS, ELECTROCHEMICAL MANUFACTURING PROCESSES
THEREFOR AND USES FOR THE SAME
311966
6669/CHENP/2012 30‐04‐2019 8 METHYL 1 PHENYL IMIDAZOL[1 5 A]PYRAZINE COMPOUNDS 312006
5218/CHENP/2011 30‐04‐2019 MELANOCORTIN ANALOGS WITH ANTIMICROBIAL ACTIVITY 312007
201847011475 30‐04‐2019 NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS
AND USES THEREOF
312021
7495/CHENP/2013 30‐04‐2019 PRODRUGS OF LXR MODULATING IMIDAZOLE 312025
2025/CHENP/2012 30‐04‐2019 MOLECULAR PROBE FOR IMAGING OF PANCREATIC ISLETS AND USE
OF THE SAME
312031
1168/KOLNP/2011 30‐04‐2019 PYRAZOLO PYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS 312047
335/DELNP/2015 30‐04‐2019 SUBSTITUTED THIOPHENE‐ AND FURAN‐FUSED AZOLOPYRIMIDINE‐
5‐(6H)‐ONE COMPOUNDS
312050
8081/CHENP/2012 30‐04‐2019 PROCESS FOR PRODUCTION AND PURIFICATION OF RECOMBINANT
LYSOSOMAL ALPHA‐MANNOSIDASE
312055
201647042606 30‐04‐2019 SUBSTITUTED IMIDAZO[1,2‐A]PYRIDINE COMPOUNDS USEFUL FOR
THE TREATMENT OF PAIN
312057
9473/DELNP/2012 30‐04‐2019 ANTICANCER STEROIDAL LACTONES UNSATURATED IN POSITION 7
(8)
312063
10790/CHENP/2012 30‐04‐2019 CYSTEINE DERIVATIVE 312064
3436/CHENP/2013 30‐04‐2019 NOVEL ANTI DR5 ANTIBODY 312077
3060/DELNP/2013 30‐04‐2019 AGENT FOR TREATMENT OF DRY EYE CHARACTERIZED BY
COMBINING P2Y<SB>2</SB> RECEPTOR AGONIST WITH
HYALURONIC ACID OR SALT THEREOF METHOD FOR TREATING DRY
EYE AND USE OF THE P2Y<SB>2</SB> RECEPTOR AGONIST AND
HYALURONIC ACID OR SALT THEREOF
312088
3338/KOLNP/2011 01‐05‐2019 BROAD SPECTRUM VACCINE AGAINST NON‐TYPHOIDAL
SALMONELLA
312110
1093/MUMNP/2013 01‐05‐2019 BOVINE VIRAL DIARRHEA VIRUS TYPE 1B VACCINE COMPOSITIONS
AND METHODS
312123
1495/MUMNP/2014 02‐05‐2019 CALMANGAFODIPIR A NEW CHEMICAL ENTITY AND OTHER MIXED
METAL COMPLEXES METHODS OF PREPARATION COMPOSITIONS
AND METHODS OF TREATMENT
312153
1573/MUM/2009 02‐05‐2019 A NOVEL PROCESS FOR LARGE SCALE PRODUCTION OF VIRAL
ANTIGEN
312154
1931/MUMNP/2015 02‐05‐2019 NOVEL AMINOPYRAZINE COMPOUNDS 312181
5041/KOLNP/2011 02‐05‐2019 MATERIALS AND METHODS RELATING TO GLYCOSYLATION 312186
1891/CHENP/2013 02‐05‐2019 METHOD FOR PURIFYING PEGYLATED ERYTHROPOIETIN 312209
2009/MUMNP/2013 02‐05‐2019 a composition comprising 5‐HT2A antagonist, a norepinephrine ‐
dopamine reuptake inhibitor
312213
241/DEL/2010 03‐05‐2019 RICE POLYNUCLEOTIDE ASSOCIATED WITH BLAST RESISTANCE AND
USES THEREOF
308533
588/CHENP/2011 03‐05‐2019 “SYNERGISTIC ANTIMICROBIAL MIXTURES” 308579
949/CHENP/2013 03‐05‐2019 COMPOSITION OF HEPATITIS C VIRUS INHIBITORS 312230
72/DELNP/2006 03‐05‐2019 "PYRIMIDINE‐2, 4‐DIONE BASED COMPOUNDS AS GONADOTROPIN‐
RELEASING HORMONE RECEPTOR ANTAGONISTS"
312234
6157/DELNP/2011 03‐05‐2019 "A Pharmaceutical Composition Comprising 1‐chloro‐4‐(ß‐D‐
glucopyranos‐1‐yl)‐2‐[4‐((S)‐tetrahydrofuran‐3‐yloxy)‐benzyl]‐
benzene and process thereof"
312235
9763/DELNP/2013 03‐05‐2019 PERSONAL CARE COMPOSITIONS 312237
1375/KOLNP/2012 03‐05‐2019 DERIVATIVES OF NOVEL PEROXIDES, METHOD OF PREPARATION
THEREOF AND USE THEREOF IN HUMAN MEDICINE AS WELL AS IN
COSMETICS FOR THE TREATMENT OR PREVENTION OF ACNE
312244
301/CHENP/2012 03‐05‐2019 PREPARATION COMPRISING INSULIN, NICOTINAMIDE AND AN
AMINO ACID
312254
Page 79 of 85
4943/DELNP/2013 03‐05‐2019 INFUSION PREPARATION 312259
8488/CHENP/2013 03‐05‐2019 Solid oral pharmaceutical composition comprising CNS stimulant 312267
464/CHENP/2015 03‐05‐2019 Composition comprising sulfated poloxamersand methods of
making same
312272
9854/CHENP/2013 03‐05‐2019 CONSTRUCTION AND APPLICATION OF MUTANT TYPE B HUMAN
ADENOVIRUS AD11 HAVING ENHANCED ONCOLYTIC POWER
312278
2483/MUM/2011 04‐05‐2019 "COMPOSITION AND METHOD FOR AN INTRADERMAL HAIR
GROWTH
SOLUTION"
310925
10626/DELNP/2013 06‐05‐2019 BIOPASSIVATING MEMBRANE STABILIZATION BY MEANS OF
NITROCARBOXYLIC ACID CONTAINING PHOSPHOLIPIDS IN
PREPARATIONS AND COATINGS
312301
2443/DELNP/2013 06‐05‐2019 CYCLOSPORINE EMULSION 312315
5063/KOLNP/2011 06‐05‐2019 PYRAZINOOXAZEPINE DERIVATIVES 312319
6243/DELNP/2006 06‐05‐2019 ""AN INTRACELLULAR DELIVERY SYSTEM FOR THE DELIVERY OF AT
LEAST ONE BIOACTIVE AGENT WITHIN A CELL AND A METHOD
THEREOF
312340
10454/DELNP/2012 06‐05‐2019 COMPOSITIONS FOR TREATING SKIN 312341
2993/MUMNP/2015 07‐05‐2019 COMPOSITION COMPRISING SALBUTAMOL SULPHATE 312348
4929/DELNP/2015 07‐05‐2019 1‐(substituted‐benzoyl)‐5‐fluoro‐4‐imino‐3‐methyl‐3,4‐
dihydropyrimidin‐2(1H)‐one
312351
496/DEL/2009 07‐05‐2019 "A PROCESS AND METHOD FOR STANDARDIZED EXTRACT OF
WITHANIA SOMNIFERA AND PHARMACEUTICAL USES THEREOF."
312354
533/MUMNP/2014 07‐05‐2019 PYRROLOBENZODIAZEPINES 312392
1455/CHENP/2012 07‐05‐2019 SILVER OXIDE FORMULATIONS HAVING IMPROVED WHITENESS
CHARACTERISTICS
312397
846/KOLNP/2013 07‐05‐2019 SUBSTITUTED 2‐OXO‐ AND 2‐THIOXO‐DIHYDROQUINOLINE‐3‐
CARBOXAMIDES AS KCNQ2/3 MODULATORS
312413
4545/CHENP/2014 08‐05‐2019 COSMETIC COMPOSITION COMPRISING OLEOGEL 312428
10677/CHENP/2012 08‐05‐2019 ANTIBODIES TO HUMAN GDF8 312458
10385/DELNP/2014 08‐05‐2019 EFFERVESCENT DOSAGE FORM 312472
516/DELNP/2012 09‐05‐2019 Topical composition containing sildenafil 312495
2539/MUM/2012 09‐05‐2019 A STABLE AQUEOUS SUSPENSION OF LOTEPREDNOL ETABONATE. 312519
6685/CHENP/2013 09‐05‐2019 METHOD FOR PREPARING MULTIPLE ANTIGEN GLYCOPEPTIDE
CARBOHYDRATE CONJUGATES
312498
1736/MUMNP/2014 09‐05‐2019 PIPERIDINO PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF
VIRAL INFECTIONS
312522
120/KOLNP/2011 09‐05‐2019 AN IMMUNOGENIC COMPOSITION 312549
463/MUMNP/2015 10‐05‐2019 HYDROMORPHONE HYDROCHLORIDE CONTAINING ORAL
SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION
312621
1821/CHENP/2013 10‐05‐2019 TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOUND THAT
CONTAINS SAME AND EXHIBITS ANALGESIC ACTIVITY
312593
2501/CHE/2009 10‐05‐2019 "A NOVEL METHOD FOR THE PREPARATION OF CHITIN/PVA/PEG
CROSSLINKED HYDROGEL FOR BIOMEDICAL APPLICATION"
312609
4997/DELNP/2011 10‐05‐2019 COVALENT DIABODIES AND USES THEREOF 312611
2511/KOLNP/2014 10‐05‐2019 METHOD FOR PREPARING LOW DOSAGE ENTECAVIR FORMULATION
FOR ORAL ADMINISTRATION
312614
2566/MUMNP/2015 10‐05‐2019 PERSONAL CARE PHOTOPROTECTIVE COMPOSITIONS WITH
TRICYCLODECANE AMIDES
312634
964/KOL/2011 10‐05‐2019 METHOD AND SYSTEM OF ENHANCED DEGRADATION OF BILIRUBIN
INVOLVING ZINC OXIDE (ZnO) NANOPARTICLES
312640
4174/CHENP/2014 10‐05‐2019 DIHYDRO BENZO OXAZINE AND DIHYDRO PYRIDO OXAZINE
DERIVATIVES
312642
10596/CHENP/2012 13‐05‐2019 BENZODIOXOLE OR BENZODIOXEPINE HETEROCYCLIC COMPOUNDS
AS PHOSPHODIESTERASE INHIBITORS
312656
8888/CHENP/2011 14‐05‐2019 ANTI‐IL17F ANTIBODIES AND METHODS OF USE THEREOF 312712
936/MUM/2012 14‐05‐2019 A PROCESS for PREPARATION of gelled ENEMA COMPOSITION 312713
Page 80 of 85
467/MUMNP/2014 14‐05‐2019 ANHYDROUS ANTIPERSPIRANT COMPOSITIONS AND METHOD FOR
REDUCING PERSPIRATION
312722
2470/MUM/2013 14‐05‐2019 “FORMULATION COMPRISING A HYPOLIPIDEMIC AGENT” 312723
2038/MUMNP/2014 15/05/2019 TOPICAL SPRAY COMPOSITION AND SYSTEM FOR DELIVERING THE
SAME
312773
1165/KOLNP/2011 15‐05‐2019 PYRAZOLO PYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS 312746
2503/DEL/2012 15‐05‐2019 PROCESS FOR THE PREPARATION OF DABIGATRAN ETEXILATE AND
INTERMEDIATES THEREOF
312752
535/KOLNP/2012 16‐05‐2019 A THERAPEUTIC COMBINATION COMPRISING A PULMONARY
SURFACTANT AND ANTIOXIDANT ENZYMES
312793
2578/DEL/2012 16‐05‐2019 FUTURE MAGIC BULLET OF "POLYHERBOCEUTICAL FORMULATION"
FOR TREATMENT OF HYPERTENSION.
312803
3093/MUMNP/2015 16‐05‐2019 A MOUTH WASH ORAL CARE COMPOSITIONS 312810
3904/CHENP/2012 17/05/2019 STABILISING EXCIPIENT FOR INACTIVATED WHOLE‐VIRUS VACCINES 312843
639/DELNP/2012 17‐05‐2019 "COMBINATION THERAPY FOR THE TREATMENT OF DIABETES" 312847
8274/CHENP/2011 17‐05‐2019 MENINGOCOCCAL AND PNEUMOCOCCAL CONJUGATE VACCINE
AND METHOD OF USING SAME
312855
4989/CHENP/2015 20/05/2019 MONOCYCLIC PYRIDINE DERIVATIVE 312904
1386/KOLNP/2011 20‐05‐2019 METHOD FOR PRODUCING A GRANULATE 312875
3029/KOLNP/2015 20‐05‐2019 SITE SPECIFIC INSULIN CONJUGATE 312893
10287/CHENP/2012 20‐05‐2019 A PHARMACEUTICAL SPRAY COMPOSITION COMPRISING A
VITAMIN D ANALOGUE AND A CORTICOSTEROID
312913
9555/DELNP/2011 20‐05‐2019 PREVENTION AND TREATMENT OF NOSEMA DISEASE IN BEES 312922
2759/MUM/2009 21‐05‐2019 AN IMPROVED PROCESS OF PREPARING OLOPATADINE AND
PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
312948
13/DEL/2014 21‐05‐2019 SILICON BASED FUNGICIDES 312955
10655/CHENP/2012 21‐05‐2019 PROCESS FOR PRODUCING MICROCAPSULES 312967
10088/DELNP/2014 21‐05‐2019 CAMSYLATE SALT 312976
172/MUMNP/2013 22‐05‐2019 SKIN CARE COMPOSITIONS COMPRISING SUBSTITUTED
MONOAMINES
313013
2085/MUMNP/2010 22‐05‐2019 “TETRAHYDROCYCLOPENTA[B]INDOLE ANDROGEN RECEPTOR
MODULATORS”
313020
2421/KOLNP/2013 23/05/2019 COMPOSITION FOR DYEING KERATINOUS FIBRES COMPRISING A
DIRECT DYE HAVING A DISULPHIDE/THIOL FUNCTIONAL GROUP, A
THICKENING POLYMER, AN ETHOXYLATED FATTY ALCOHOL AND/OR
A NONIONIC SURFACTANT, AN ALKALINE AGENT AND A REDUCING
AGENT
313105
3934/DELNP/2011 23‐05‐2019 "ANTITUMOR AGENT, A METHOD FOR THE PRODUCTION OF SAID
AGENT AND A METHOD FOR THE STABILISATION THEREOF"
313066
2956/DELNP/2014 23‐05‐2019 A composition comprising Sofosbuvir and Ledipasvir 313093
2919/DELNP/2012 24‐05‐2019 "RICE WHITENING" 313134
1991/MUMNP/2014 24‐05‐2019 PRE BLENDED MIXTURES OF SPECIFIC HYDROCARBON LIQUIDS
STRUCTURED WITH HIGH MELTING POINT STRUCTURING MATERIAL
313142
1686/MUMNP/2013 24‐05‐2019 HAIR CARE COMPOSITION COMPRISING PYRITHIONE AND A PURPLE
PINK OR RED COLOURING COMPONENT
313145
5329/DELNP/2013 27/05/2019 6‐DEOXY‐6‐THIOETHER‐AMINO ACID CYCLODEXTRIN DERIVATIVES
AND PREPARATION METHOD THEREOF
313225
201617042199 27‐05‐2019 DISPERSION COMPRISING A PARTIALLY NEUTRALIZED ESTERIFIED
CELLULOSE ETHER
313198
3760/DEL/2012 27‐05‐2019 ORAL GEL FOR RELIEF OF TOOTH PAIN 313201
2463/DELNP/2013 27‐05‐2019 MEDICAL ADSORBENT AND METHOD FOR PRODUCING SAME 313219
1063/KOLNP/2011 27‐05‐2019 ATROPISOMERS OF (HYDROXYALKYL) PYRROLE DERIVATIVES 313243
5146/DELNP/2013 28/05/2019 NOVEL SUBSTITUTED ISOQUINOLINE DERIVATIVE 313264
9366/CHENP/2014 28‐05‐2019 BENZIMIDAZOLE PROLINE DERIVATIVES 313297
2428/CHENP/2013 28‐05‐2019 VESICULAR STOMATITIS VIRUSES 313304
Page 81 of 85
201617004991 29‐05‐2019 NOVEL TRIAZOLO[4,5‐D]PYRIMIDINE DERIVATIVES 313316
8840/DELNP/2011 29‐05‐2019 HPV PARTICLES AND USES THEREOF 313360
2341/MUMNP/2011 29‐05‐2019 PREBIOTIC COMPOSITION 313377
7863/DELNP/2012 29‐05‐2019 PROCESS FOR PRODUCING AN ALLERGEN EXTRACT 313394
8883/DELNP/2013 30‐05‐2019 COSMETIC COMPOSITION COMPRISING 4‐(3‐ETHOXY‐4‐
HYDROXYPHENYL)‐2‐BUTANONE AND A LIPO‐ PHILIC SOLVENT
313412
1580/DEL/2010 30‐05‐2019 "PROCESS FOR THE PREPARATION OF ELETRIPTAN
HYDROBROMIDE"
313423
3675/DELNP/2013 30‐05‐2019 PHARMACEUTICAL FORMULATION FOR HISTONE DEACETYLASE
INHIBITORS
313431
1439/CHENP/2012 30‐05‐2019 PLASMODIUM FALCIPARUM SPOROZOITE AND LIVER STAGE
ANTIGENS
313436
2497/CHENP/2011 30‐05‐2019 P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN 313452
6778/CHENP/2014 30‐05‐2019 SUBSTITUTED HETEROCYCLIC ACETAMIDES AS KAPPA OPIOID
RECEPTOR (KOR) AGONISTS
313455
5394/CHENP/2013 30‐05‐2019 NOVEL PHARMACEUTICAL FORMULATION COMPRISING NSAID AND
CYCLODEXTRIN
313476
7779/CHENP/2010 30‐05‐2019 FGF21 MUTANTS AND USES THEREOF 313496
591/KOL/2013 31/05/2019 PROCESS FOR THE PREPARATION OF PROBIOTIC FENNEL AND USES
THEREOF.
313536
1402/MUMNP/2013 31‐05‐2019 A METHOD FOR FORMATION OF HYDROXYPYRONE COMPOUNDS 313515
2912/DELNP/2015 31‐05‐2019 OXAZOLIDIN ‐2 ‐ONE ‐PYRIMIDINE DERIVATIVES 313522
5967/CHENP/2011 31‐05‐2019 POLICOSANOL NANOPARTICLES 313549
201621014443 31‐05‐2019 ROTARY ENDODONTIC FILE IN BASKET FORM. 313552
968/MUMNP/2012 31‐05‐2019 ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS 313560
2463/MUMNP/2013 31‐05‐2019 ANTIBODIES THAT BIND TO OX40 AND THEIR USES 313562
8444/CHENP/2013 31‐05‐2019 5 MEMBERED RING AROMATIC HETEROCYCLIC DERIVATIVE HAVING
NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY
313582
187/KOL/2014 31‐05‐2019 "NOVEL POLYSACCHARIDE‐BASED AMPHIPHILIC COPOLYMER AND
PREPARATION OF ANTI‐RHINITIS MICELLAR SOLUTION THEREOF"
313586
1993/DELNP/2014 31‐05‐2019 Method for synthesizing N‐[5‐(aminosulfonyl)‐4‐methyl‐1,3‐thiazol‐
2‐yl]‐Nmethyl‐2‐[4‐(2‐pyridinyl)phenyl]acetamide
313595
1825/CHE/2012 31‐05‐2019 HYALURONIC ACID ESTERS, THEIR PREPARATIONAND USE IN
DERMATOLOGY
313613
1147/CHENP/2015 04‐06‐2019 NOVEL DEPILATORY PRODUCT 313710
5404/CHE/2015 04‐06‐2019 AN IMPROVED PROCESS FOR PREPARATION OF ATORVASTATIN OR
PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
313751
2023/DELNP/2013 05‐06‐2019 NOVEL D3 DOPAMINE RECEPTOR AGONISTS TO TREAT DYSKINESIA
IN PARKINSON'S DISEASE
312333
379/DEL/2011 05‐06‐2019 "A NOVEL PHAR MACEUTICAL COMPOSITION COMPRISING
LEVOSULPIRIDE AND HYOSCINE BUTYL BROMIDE FOR THE
TREATMENT OF SPASM RELATED GERD"
312307
2041/MUMNP/2014 06‐06‐2019 PRE BLENDED MIXTURES OF SPECIFIC NATURALLY SOURCED LIQUID
MATERIALS STRUCTURED WITH NATURALLY SOURCED HIGH
MELTING POINT STRUCTURING MATERIAL
313782
1546/DELNP/2013 06‐06‐2019 QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE
SAME
313803
7885/DELNP/2014 06‐06‐2019 THIADIAZOLIDINEDIONES AS GSK 3 INHIBITORS 313804
3558/DEL/2013 06‐06‐2019 NOVEL LIQUID CRYSTALLINE NANOPARTICULATE COMPOSITION
AND PROCESS OF PREPARATION THEREOF
313805
8733/DELNP/2012 07‐06‐2019 HETEROGENEOUS IMPLANTABLE DEVICES FOR DRUG DELIVERY 313830
201617006641 07‐06‐2019 ARTICLE WITH REACTIVE METALS BOUND TO ITS SURFACE AND
METHOD OF APPLICATION
313843
2915/KOLNP/2014 07‐06‐2019 PRODRUG DERIVATIVES OF (E)‐N‐METHYL‐N‐((3‐
METHYLBENZOFURAN‐2‐YL)METHYL)‐3‐(7‐OXO‐5, 6, 7, 8‐
TETRAHYDRO‐1, 8‐ NAPHTHYRIDIN‐3‐YL)ACRYLAMIDE
313852
Page 82 of 85
9559/DELNP/2015 07‐06‐2019 COMPOSITIONS AND METHODS FOR TOPICAL DELIVERY OF
PROSTAGLANDINS TO SUBCUTANEOUS FAT
313874
29/KOL/2014 10‐06‐2019 A COSMETIC COMPOSITION FOR EXTENDED UV PROTECTION 313909
207/DEL/2011 11‐06‐2019 A SYNTHETIC PEPTIDE FORMULATION AGAINST MELANOMA AND
OTHER CANCER OVER‐EXPRESSING S100B
314002
9939/DELNP/2014 11‐06‐2019 A PROCESS FOR THE PREPARATION OF ESSENTIALLY PURE,
CRYSTALLINE, N‐[({2‐[4‐(2‐ETHYL‐4,6‐DIMETHYL‐1H‐IMIDAZO[4,5‐
C]PYRIDIN‐1‐YL)PHENYL]ETHYL}AMINO)CARBONYL]‐4‐
METHYLBENZENESULFONAMIDE POLYMORPH FORM A
314005
10686/DELNP/2012 12‐06‐2019 TETRAHYDRO PYRIDO PYRIMIDINE COMPOUNDS 314019
5790/CHENP/2014 12‐06‐2019 IMPROVED PROCESS FOR PREPARATION OF PURE LINAGLIPTIN 314036
37/DEL/2014 12‐06‐2019 COATING COMPOSITION, DRUG‐CONTAINING PARTICLE, SOLID
PREPARATION AND METHOD FOR PREPARING DRUG‐CONTAINING
PARTICLE
314058
10282/CHENP/2012 12‐06‐2019 VECTORS AND SEQUENCES FOR THE TREATMENT OF DISEASES 314064
10121/CHENP/2013 12‐06‐2019 CAMPTOTHECIN DERIVATIVE METHOD FOR PREPARING SAME
PHARMACEUTICAL COMPOSITION AND USE THEREOF
314072
4057/DELNP/2015 12‐06‐2019 NOVEL COMPOUNDS AS DIACYLGLYCEROL ACYLTRANSFERASE
INHIBITORS
314085
3738/KOLNP/2011 13/06/2019 BACTERIA STRAINS HAVING A HIGH ANTI‐INFLAMMATORY ACTIVITY 314125
5957/DELNP/2012 13‐06‐2019 "A PHARMACEUTICAL COMPOSITION FOR VAGINAL APPLICATION" 314098
9281/DELNP/2012 13‐06‐2019 NOVEL HYDROXAMIC ACID DERIVATIVE 314104
158/KOL/2011 13‐06‐2019 LONG LASTING HAIR CONDITIONING FORMULATION 314112
158/CHENP/2015 13‐06‐2019 AN ANTIBODY COMPOSITION FOR PREVENTION OR TREATMENT OF
MUTANT HEPATITIS B VIRUS INFECTION
314118
3939/CHE/2013 13‐06‐2019 NOVEL ACID ADDITION SALTS OF DABIGATRAN ETEXILATE, PROCESS
FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITION
THEREOF
314140
1948/KOLNP/2011 13‐06‐2019 NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF
THERAPEUTICS
314151
588/KOLNP/2013 14‐06‐2019 TAMPER RESISTANT DOSAGE FORM COMPRISING INORGANIC SALT 314203
9793/DELNP/2012 14‐06‐2019 AMINOGLYCOSIDE DERIVATIVES 314208
8189/CHENP/2013 14‐06‐2019 MESH ENCLOSED TISSUE CONSTRUCTS 314210
10747/CHENP/2012 14‐06‐2019 MACROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF HISTONE
DEACETYLASES
314222
7026/CHE/2015 17‐06‐2019 COMPOSITION FOR SUSTAINED RELEASE OF CARBONATE AND A
WATER PURIFICATION DEVICE BASED ON THE SAME WITH
ENHANCED BIOCIDAL ACTIVITY
314266
1348/MUMNP/2014 19‐06‐2019 PERSONAL CARE COMPOSITIONS CONTAINING IONIC SILICONE AND
FILM FORMING AGENT
314283
9701/CHENP/2013 19‐06‐2019 METHOD FOR PRODUCING POWDER FOR INHALATION 314284
397/CHENP/2014 19‐06‐2019 CYCLIC P1 LINKERS AS FACTOR XIA INHIBITORS 314285
299/MUM/2010 19‐06‐2019 A PROCESS OF PREPARING 42‐O‐HETEROALKYL AND 42‐O‐
ALKOXYALKYL DERIVATIVES OF RAPAMYCIN.
314301
3123/DELNP/2012 19‐06‐2019 "STABLE FAT‐SOLUBLE ACTIVE PRINCIPLES PARTICLES" 314326
4922/CHENP/2014 20/06/2019 PAROXETINE DERIVATIVE 314368
201821016579 21/06/2019 PROCESS FOR PLEATING AND FOLDING DRUG COATED BALLOON 314415
5220/DELNP/2012 21‐06‐2019 “METHOD FOR TREATING RETINAL CONDITIONS USING AN
INTRAOCULAR TAMPONADE”
314400
2361/MUM/2010 21‐06‐2019 A PERSONAL CARE COMPOSITION 314428
1036/MUMNP/2014 21‐06‐2019 MICROBICIDAL COMPOSITION 314446
3487/KOLNP/2011 21‐06‐2019 DIPEPTIDE AS FEEDSTUFF ADDITIVE 314451
5675/DELNP/2013 24/06/2019 CYCLOPROPYLAMINES AS LSD1 INHIBITORS 314483
10377/CHENP/2012 24‐06‐2019 LONG‐TERM STORAGE OF NON‐GLYCOSYLATED RECOMBINANT
HUMAN G‐CSF
314457
Page 83 of 85
7624/DELNP/2014 24‐06‐2019 “A SOLID FORMULATION COMPRISING PIMOBENDAN” 314486
1061/MUMNP/2014 24‐06‐2019 ANTIMICROBIAL COMPOSITION 314522
10384/CHENP/2012 24‐06‐2019 METHOD FOR PREPARING BROUSSONETIA KAZINOKI EXTRACT 314553
2972/CHENP/2014 24‐06‐2019 IMPROVED CROSS LINKING COMPOSITION DELIVERED BY
IONTOPHORESIS USEFUL FOR THE TREATMENT OF KERATOCONUS
314564
663/MUMNP/2014 25‐06‐2019 'Compositions comprising bacteriophage' 314580
6897/CHENP/2010 25‐06‐2019 A pharmaceutical composition for effecting weight loss and treating
obesity
314596
3180/DELNP/2014 25‐06‐2019 [1 2 3] TRIAZOLO [4 5 D] PYRIMIDINE DERIVATIVES AS AGONISTS
OF THE CANNABINOID RECEPTOR 2
314598
6270/CHENP/2013 25‐06‐2019 MUTANT INTERLEUKIN 2 POLYPEPTIDES 314600
6667/DELNP/2015 25‐06‐2019 DYNAMIC SUSPENSION DRYING (DSD) TO CONTROL OSTWALD
RIPENING
314650
3969/CHE/2011 25‐06‐2019 A PHARMACEUTICAL COMPOSITION OF FORSKOLIN WITH
ENHANCED SOLUBILITY
314665
9416/DELNP/2014 25‐06‐2019 CRYSTALLINE MICROSPHERES AND THE PROCESS FOR
MANUFACTURING THE SAME
314670
9489/DELNP/2011 25‐06‐2019 "ONE OR MORE OF VIGNA MARINA, COCOS NUCIFERA L. OR
TERMINALIA CATAPPA L. EXTRACTS FOR TREATING WOUNDS, SKIN
DISORDERS AND HAIR LOSS"
314676
7035/CHENP/2013 25‐06‐2019 GUANIDINE COMPOUND 314678
83/KOLNP/2013 26‐06‐2019 NANOPARTICLE FILM DELIVERY SYSTEMS 314727
1631/CHENP/2015 26‐06‐2019 BIVALENT INHIBITORS OF IAP PROTEINS AND THERAPEUTIC
METHODS USING THE SAME
314736
201841004178 26‐06‐2019 A PROCESS FOR PREPARATION OF LULICONAZOLE 314738
8445/CHENP/2012 26‐06‐2019 HJURP PEPTIDES AND VACCINES INCLUDING THE SAME 314747
577/MUM/2014 26‐06‐2019 FUROSEMIDE NANOSUSPENSION 314760
513/MUMNP/2013 26‐06‐2019 MONOCLONAL ANTIBODY HAVING IMMUNOSUPPRESSIVE ACTIVITY
OR FRAGMENT TO WHICH ANTIGEN THEREOF IS BONDED
314780
7013/DELNP/2013 26‐06‐2019 DERIVATIVES OF AZAINDAZOLE OR DIAZAINDAZOLE TYPE AS
MEDICAMENT
314787
1420/KOLNP/2013 26‐06‐2019 PYRROLIDINONES AS METAP‐2 INHIBITORS 314801
20/KOLNP/2013 26‐06‐2019 "PHARMACEUTICAL DOSAGE FORM COMPRISING 6'‐FLUORO‐(N‐
METHYL‐ OR N,N‐DIMETHYL‐)‐4‐PHENYL‐4',9'‐DIHYDRO‐3'H‐
SPIRO[CYCLOHEXANE‐1,1'‐PYRANO[3,4,B]INDOL]‐4‐AMINE"
314816
48/MUMNP/2012 27/06/2019 PHARMACEUTICAL COMPOSITIONS COMPRISING
COMBINATIONS OF MANGANESE COMPLEX AND
NON‐MANGANESE COMPLEX COMPOUND
314853
2357/KOLNP/2014 27/06/2019 BICYCLIC PYRAZINONE DERIVATIVES 314949
9264/CHENP/2012 27‐06‐2019 “PHARMACEUTICAL EMULSION COMPOSITIONS COMPRISING
PROGESTOGEN”
314861
7848/DELNP/2013 27‐06‐2019 A METHOD FOR PREPARING A SILDENAFIL‐FREE BASE‐CONTAINING
FILM
314868
201617041090 27‐06‐2019 COMPOSITION FOR DYEING KERATIN FIBERS 314873
4065/CHENP/2014 27‐06‐2019 PYRAZINE KINASE INHIBITORS 314887
2817/DELNP/2012 27‐06‐2019 "LOW ETHER COMPOSITION AND DELIVERY APPARATUS" 314895
3789/CHENP/2015 27‐06‐2019 HETEROBICYCLO SUBSTITUTED [1 2 4]TRIAZOLO[1 5 C]QUINAZOLIN
5 AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES
314911
824/MUMNP/2013 27‐06‐2019 HUMAN ANTIBODIES AND DIAGNOSTIC AND THERAPEUTIC USES
THEREOF FOR THE TREATMENT OF NEUROLOGICAL DISEASE
314934
8195/DELNP/2015 27‐06‐2019 SILK BASED CAPSULES 314975
4633/CHENP/2015 27‐06‐2019 ANTI‐APOPTOTIC BCL‐2 PROTEINS INHIBITORS 314979
5005/KOLNP/2010 27‐06‐2019 GLOBO H AND RELATED ANTI‐CANCER VACCINES WITH NOVEL
GLYCOLIPID ADJUVANTS
314985
1040/CHENP/2015 27‐06‐2019 SUBSTITUTED PYRAZOLONE COMPOUNDS AND METHODS OF USE 314996
Page 84 of 85
862/DELNP/2014 27‐06‐2019 NOVEL FXR (NR1H4) BINDING AND ACTIVITY MODULATING
COMPOUNDS
315007
2243/KOLNP/2011 28/06/2019 A METHOD OF LOWERING CIRCULATING OXIDIZED LOW DENSITY
LIPOPROTEIN‐BETA‐2‐GLYCOPROTEIN 1 COMPLEX FOR TREATMENT
OF ATHEROSCLEROSCLEROSIS
315204
5660/CHENP/2015 28/06/2019 HETEROAROMATIC COMPOUNDS AS PI3 KINASE MODULATORS 315196
2446/KOLNP/2015 28‐06‐2019 INTERMEDIATES FOR USE IN THE PREPARATION OF INDAZOLE
DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF
315030
2317/MUMNP/2012 28‐06‐2019 URETHANES UREAS AMIDINES AND RELATED INHIBITORS OF
FACTOR XA
315047
7910/CHENP/2012 28‐06‐2019 THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN
OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG
DELIVERY DEVICE
315088
7495/CHENP/2011 28‐06‐2019 “NUCLEIC ACID MOLECULE” 315101
1489/KOLNP/2013 28‐06‐2019 ARYLAMIDE DERIVATIVES AS TTX‐S BLOCKERS 315110
5089/KOLNP/2011 28‐06‐2019 USE OF DERIVATIVES OF INDOLES FOR THE TREATMENT OF CANCER 315116
2993/KOLNP/2014 28‐06‐2019 INDOLECARBONITRILES AS SELECTIVE ANDROGEN RECEPTOR
MODULATORS
315124
4461/DELNP/2012 28‐06‐2019 "DUAL‐ACTION COMPOUNDS TARGETING ADENOSINE A2A
RECEPTOR AND ADENOSINE TRANSPORTER FOR PREVENTION AND
TREATMENT OF NEURODEGENERATIVE DISEASES"
315143
114/MUMNP/2015 28‐06‐2019 CHROMANYL DERIVATIVES FOR TREATING MITOCHONDRIAL
DISEASE
315199
201617017693 28‐06‐2019 IMIDAZOTHIAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY 315200
3226/CHE/2013 28‐06‐2019 A CHEMICAL POTENTIATING COMPOSITION 315202
2821/KOLNP/2011 28‐06‐2019 SYNERGISTIC COMBINATIONS OF CAROTENOIDS AND
POLYPHENOLS
315212
1296/MUM/2014 28‐06‐2019 METHOD FOR EFFICIENT ENZYMATIC HYDROLYSIS OF
LIGNOCELLULOSIC MATERIALS.
315214
4251/DELNP/2015 28‐06‐2019 STABLE METAL ION CONTAINING COMPOSITIONS 315235
954/MUM/2009 28‐06‐2019 A NOVEL CREAM AND A PROCESS TO MAKE THE SAME 315246
3224/KOLNP/2013 01‐07‐2019 METHOD FOR PRODUCING FINE POWDER OF LOXOPROFEN
SODIUM DIHYDRATE FOR PHARMACEUTICAL PREPARATIONS
305410
4618/DELNP/2011 02‐07‐2019 SUFENTANIL SOLID DOSAGE FORMS COMPRISING OXYGEN
SCAVENGERS AND METHODS OF USING THE SAME
315383
6609/CHENP/2013 02‐07‐2019 EMULSION W/SI FOUNDATION 315385
2194/MUMNP/2013 03‐07‐2019 COEXTRUDABLE MULTIPHASE DENTIFRICE COMPOSITIONS 308725
2880/KOLNP/2012 03‐07‐2019 PROCESS FOR PREPARING CARRIER PARTICLES FOR DRY POWDERS
FOR INHALATION
308802
4087/DELNP/2014 03‐07‐2019 LYOPHILIZED LIPOSOMES 315447
3424/DELNP/2014 03‐07‐2019 AMIDE DERIVATIVES OF N UREA SUBSTITUTED AMINO ACIDS AS
FORMYL PEPTIDE RECEPTOR LIKE 1 (FPRL 1) RECEPTOR
MODULATORS
315478
201621006380 04‐07‐2019 DRUG DELIVERY SYSTEM 315542
1839/DEL/2010 04‐07‐2019 ANTI‐PRECANCER AND ANTIMICROBIAL HERBAL MOUTHWASH AND
A PROCESS THEREOF.
315566
4016/KOLNP/2012 05‐07‐2019 ANTI‐DIABETIC COMPOSITIONS AND METHODS 315589
5264/DELNP/2013 05‐07‐2019 ANTI MICROBIAL COMPOSITION 315597
637/DELNP/2015 05‐07‐2019 FORMULATIONS AND METHODS OF MANUFACTURING
FORMULATIONS FOR USE IN COLONIC EVACUATION
315607
8086/DELNP/2014 05‐07‐2019 PYRAZOLO‐TRIAZINE DERIVATIVES AS SELECTIVE CYCLIN
DEPENDENT KINASE INHIBITORS
315609
5464/CHE/2012 06‐07‐2019 PROCESS FOR PREPARING CABAZITAXEL AND ITS SOLVATE 313846
Page 85 of 85